,Tweet content,date,symbol,increase
0,"Stochastic Sell https://t.co/yoaj8hmc44 $CNC $TRXC $BXLT $STZ $BVN $PCG $SYK $AMGN $NEE $BOFI $FIS $ZTS $TSS $QTWO $NUV $STE $POR $ENZ$AMGN:US Amgen, Inc. (AMGN) Stake Lowered by Wedbush Securities Inc. #AMGEN INC  https://t.co/GMpneJz6Ya #NASDAQThese $ITUS Profits Are much Bigger Than $AMGNWith an ROE of 26% Amgen management is doing a great job $AMGN https://t.co/TnRxtK7Ybx https://t.co/2EOlURENeERT @jonathanrockoff: Great chart from Bernstein's Gal comparing trial performances of CGRP mAbs for migraine $ALDR, $AMGN, $LLY, $TEVA http‚Ä¶Amgen won its own patent ruling and Portola Pharmaceuticals plunged... https://t.co/FBemUvn5se $AGIO $AMGN $BXLT https://t.co/8BIH3yx6YyRT @jonathanrockoff: Great chart from Bernstein's Gal comparing trial performances of CGRP mAbs for migraine $ALDR, $AMGN, $LLY, $TEVA http‚Ä¶TD Asset Management Inc. Reduces Stake in Amgen, Inc. $AMGN https://t.co/MR0TT3kcs8Tdam USA Inc. Increases Position in Amgen, Inc. $AMGN https://t.co/mCbW85mKqZInsider Buying At Antares Pharma https://t.co/g1IwHUpLb5 $ATRS $TEVA $AZN $LLY $ABBV $AMGNTdam USA Inc. Increases Position in Amgen, Inc. $AMGN https://t.co/l1ESWT3QPJTD Asset Management Inc. Reduces Stake in Amgen, Inc. $AMGN https://t.co/0tuvqInge7Henderson Group PLC Purchases 75,783 Shares of Amgen, Inc. $AMGN https://t.co/PiOg7s2YskRT @DayTradeWarrior: WIN a FREE Warrior PRO Bundle! | To enter #RT &amp; Sign up here: https://t.co/wqoC4WK6I6 | $BUFF $AMGN $FCEL $REGN $LUV h‚Ä¶Henderson Group PLC Purchases 75,783 Shares of Amgen, Inc. $AMGN https://t.co/s1r1hIyti3MS $AMGN mgt. indicated valuations look attractive,size similar to Onyx (~$10B) possible, but current discussions are smaller opportunitiesBiotech Forum Daily Digest: Merck's Pyrrhic Victory Against Gilead, Amgen's Patent Win, Spo... https://t.co/twefnArbZ4 $AGIO $AMGN $BXLT$TEVA $AMGN $LLY $AGN $ALDR:

Here‚Äôs Why Alder Pharmaceutical‚Äôs Stock Is Booming:

https://t.co/dNtQaOlPcKThese $ITUS Profits Are much Bigger Than $AMGNRT @biotech_forum: Biotech Forum Daily Digest: Merck's Pyrrhic Victory Against Gilead, Amgen's Patent Win, Spo... https://t.co/FBemUv5uAG $‚Ä¶RT @jonathanrockoff: Great chart from Bernstein's Gal comparing trial performances of CGRP mAbs for migraine $ALDR, $AMGN, $LLY, $TEVA http‚Ä¶RT @jonathanrockoff: Great chart from Bernstein's Gal comparing trial performances of CGRP mAbs for migraine $ALDR, $AMGN, $LLY, $TEVA http‚Ä¶RT @IBD_Areeves: Are biotech stocks giving you a headache? Let Alder ease your pain: https://t.co/8uFtK7W3Cj $ALDR $TEVA $AMGN $LLY $AGNBiotech Forum Daily Digest: Merck's Pyrrhic Victory Against Gilead, Amgen's Patent Win, Spo... https://t.co/FBemUv5uAG $AGIO $AMGN $BXLTRT @jonathanrockoff: Great chart from Bernstein's Gal comparing trial performances of CGRP mAbs for migraine $ALDR, $AMGN, $LLY, $TEVA http‚Ä¶RT @jonathanrockoff: Great chart from Bernstein's Gal comparing trial performances of CGRP mAbs for migraine $ALDR, $AMGN, $LLY, $TEVA http‚Ä¶Which healthcare stocks do brokers love? $JNJ $GERN $AMGN $SYN $CORT $VRX https://t.co/waLKsJIBngRT @jonathanrockoff: Great chart from Bernstein's Gal comparing trial performances of CGRP mAbs for migraine $ALDR, $AMGN, $LLY, $TEVA http‚Ä¶Great chart from Bernstein's Gal comparing trial performances of CGRP mAbs for migraine $ALDR, $AMGN, $LLY, $TEVA https://t.co/4HqoU2Ki7ZRT SeekingAlpha: Insider Buying At Antares Pharma https://t.co/QEVQAUv9cO $ATRS $TEVA $AZN $LLY $ABBV $AMGN$AMGN received a new alert. Find out why at https://t.co/nZwqReM0tj #stocks #daytrading #trading #mkt  #NYSE #NASDAQ #markets 360Insider Buying At Antares Pharma https://t.co/KqNUeQaLX6 $ATRS $TEVA $AZN $LLY $ABBV $AMGNInsider Buying At Antares Pharma https://t.co/5sVXfHfeMj $ATRS $TEVA $AZN $LLY $ABBV $AMGNNoteworthy ETF Outflows: $SPY  $JNJ  $UNH  $AMGN #etfs https://t.co/iOEHqzPESzRT SeekingAlpha: Biogen's Newer Problems; Their Relevance To The Biotech Sector https://t.co/Z6FIufwP58 $ABBV $AMGN $GILD $IBB $IONS $MRK ‚Ä¶Noteworthy ETF Outflows: $SPY  $JNJ  $UNH  $AMGN #etfs: Symbols mentioned in this story:  SPY, JNJ, UNH, AMGN
... https://t.co/goYLumZ0zmAMGN Top news - Mar 28th, 2016 $AMGN https://t.co/9CoXTu04d6Biogen's Newer Problems; Their Relevance To The Biotech Sector https://t.co/8FX0qpX1zJ $ABBV $AMGN $GILD $IBB $IONS $MRK $REGN $RHHBY $SNYBiogen's Newer Problems; Their Relevance To The Biotech Sector https://t.co/wE7qXBQpSH $ABBV $AMGN $GILD $IBB $IONS $MRK $REGN $RHHBY $SNYBiogen's Newer Problems; Their Relevance To The Biotech Sector https://t.co/ZjHUYBTlxq $ABBV $AMGN $GILD $IBB $IONS $MRK $REGN $RHHBY $SNYRT @ChinaInvest: RT SeekingAlpha: Biotechnology Poised To Move Higher https://t.co/IwULX56BKJ $ALXN $AMGN $BIIB $BMRN $CELG $CLDX $DVAX $EG‚Ä¶RT SeekingAlpha: Biotechnology Poised To Move Higher https://t.co/IwULX56BKJ $ALXN $AMGN $BIIB $BMRN $CELG $CLDX $DVAX $EGRX $GILD $IBB $I‚Ä¶Biotechnology Poised To Move Higher https://t.co/oFuep5f2Zi $ALXN $AMGN $BIIB $BMRN $CELG $CLDX $DVAX $EGRX $GILD $IBB $ILMN $INCY $IONSInvestment Analysts' Weekly Ratings Updates for #Amgen (). Read more: https://t.co/wIvA2Nk9n6 $AMGNInvestment Analysts‚Äô Weekly Ratings Updates for Amgen $AMGN https://t.co/NGOnC9EA4JInvestment Analysts‚Äô Weekly Ratings Updates for Amgen $AMGN https://t.co/NqpCww33NNAMGN Dividend
See Here ---&gt; https://t.co/FZVxCVmmxT

$AMGN $KST $TLT #nasdaqInvestment Analysts‚Äô Weekly Ratings Updates for Amgen $AMGN https://t.co/41s4XraUN8$AMGN short 148.25$LLY $AMGN:

Alder Surges as Drug Meets Migraine Goals in Mid-Stage Trial:

https://t.co/goEINqaB05Interview with Connor Bruggeman SchoolTrader Extraordinaire!: https://t.co/DgrNThhkJM $NFLX $HIMX $INO $AMGN $GOOGLRT @IBD_Areeves: Are biotech stocks giving you a headache? Let Alder ease your pain: https://t.co/8uFtK7W3Cj $ALDR $TEVA $AMGN $LLY $AGNAre biotech stocks giving you a headache? Let Alder ease your pain: https://t.co/8uFtK7W3Cj $ALDR $TEVA $AMGN $LLY $AGN$AMGN Phase II trial (NCT02174861) designed to assess the long- term safety and efficacy of AMG 334 in Chronic Migraine completed enrollment$AMGN AMG 820 combo with Keytruda in Advanced Solid Tumors. collaboration  in Dec, 2015. AMG 820 is an anti- CSF1R anitbody. NEW TRIALMarch 28 Biotech Update $ACAD $AGN $aldr $AMGN $GILD https://t.co/eDBD0zsJDJ$AMGN NEW SHORT $147.6XThe Zacks Analyst Blog Highlights: Gilead, #Amgen, Regeneron, Ionis and Biogen. Read more: https://t.co/4mj1shF1kB $AMGN$AMGN Max Pain = 146.00. Maturity = 04/01/2016.  Previous close = 149.24. bearish  https://t.co/BKKrfNah99These $ITUS Profits Are much Bigger Than $AMGNStock Market Chart Technical Analysis 
  https://t.co/lQC4o8V4SM
  $AMZN $BABA $BIDU $BAC $BA $AMGN40% Of Amgen Sales Are Due To Fall Off The Patent Cliff https://t.co/0GGlgMYMlG $AAPL $CSCO $GILD $AMGNRT @BentheFidler: With New Data, Alder Keeps Pace in Migraine Drug Race https://t.co/Nm50LI41EK $ALDR $TEVA $LLY $AMGNRT @BentheFidler: With New Data, Alder Keeps Pace in Migraine Drug Race https://t.co/Nm50LI41EK $ALDR $TEVA $LLY $AMGN$AMGN $MRK $JNJ $HCA  Is this the week for the Healthcare Sector? https://t.co/C9Kns96zZZWith New Data, Alder Keeps Pace in Migraine Drug Race https://t.co/Nm50LI41EK $ALDR $TEVA $LLY $AMGN$AMGN $UNH:

Analyst‚Äôs Noticeable Buzzers: Amgen Inc. (NASDAQ:AMGN ‚Ä¶:

https://t.co/B15aDTKI3w$TKAI will be here as well alongside $AFMD and $NVS $IDRA $AMGN $VSTM $PFE $ADXS AND! Medigene! @dhovekamp42 ? https://t.co/5RYcNZi7WzAMGN 2,831,961 Stock Charts $AMGN Amgen Inc. (NASDAQ) Last Updated: 03/28/2016 05:58:20 AMGN Stock Chart - 1 M https://t.co/qLh6RYL51k$AMGN total puts = 1,573 total calls = 4,292 OI CallPutRatio=0.37 for option expiration 04/01/2016 bullish. https://t.co/cx0ElgkkXrWeekly S&amp;P100 #Stocks Performance $ACN $AMZN $CELG $AMGN $BIIB $UNH $MRK $HPQ $LLY $PFE $AGN $BAC $GILD  more@ https://t.co/cKkr8cKsju$AMGN:

Market Analyst rating on Stocks: Amgen Inc. (NASDAQ:AMGN ‚Ä¶:

https://t.co/7OujaCIvV7SDRL Volume
See Here ---&gt; https://t.co/HPBVrzGeBK

$SDRL $CUTR $AMGN #tradeideasThese $ITUS Profits Are much Bigger Than $AMGN$AMGN:

Shares of Amgen (NASDAQ:AMGN) Sees Large Inflow of Net Money ‚Ä¶:

https://t.co/YGfU6lFSsJTrading Strategies Partners: https://t.co/Upddhj47pY $AAPL $NFLX $QQQ $SPY $DJIA $VZ $GS $INTC $AA $INTC $NFLX $GS $JPM $T $MMM $AMGN$AMGN:

Top Stocks of the day: Amgen Inc. (NASDAQ:AMGN):

https://t.co/hX83ClJnqCRT @theflynews: Judge puts off decision on possible ban of Praluent. What that means for $AMGN $REGN and $SNY: https://t.co/NLQSvVXnrJ@AndyBiotech Still not sure i sorted out their positioning in the competitve landscape if one even exists $ALDR $TEVA $AMGN",2016-03-28,AMGN,1
1,"RT @InsiderWire: Robert Bradway A Chairman, CEO and Pres Sells $8,874,407 Worth of $AMGN Amgen Inc. - #Form4 #InsiderTrading - https://t.co‚Ä¶RT @InsiderWire: Madhavan Balachandran EVP, Operations Sells $3,549,673 Worth of $AMGN Amgen Inc. - #Form4 #InsiderTrading - https://t.co/9‚Ä¶RT @InsiderWire: Sean Harper E EVP, Research &amp; Development Sells $3,549,673 Worth of $AMGN Amgen Inc. - #Form4 #InsiderTrading - https://t.‚Ä¶RT @InsiderWire: BRIAN MCNAMEE M EVP Sells $2,091,748 Worth of $AMGN Amgen Inc. - #Form4 #InsiderTrading - https://t.co/wBRULo0RwCRT @InsiderWire: ANTHONY HOOPER C EVP, Global Commercial Ops. Sells $3,549,673 Worth of $AMGN Amgen Inc. - #Form4 #InsiderTrading - https:/‚Ä¶RT @InsiderWire: Cynthia Patton M SVP &amp; CCO Sells $948,271 Worth of $AMGN Amgen Inc. - #Form4 #InsiderTrading - https://t.co/OFySXu1hpiShort Setups - If There Was Ever Going To Be A Sell-Off $AER $AGN $AL $AOS $BKS $F $HRS $NFX $URI $WES $TREE $AMGN https://t.co/Pz18An6zGYRT @Taarriqq: Bullish  options /patterns, levels to watch $NFLX $FB $BIDU $SPY $IWM $BWLD $AMGN $XBI $SPLS  $FEYE $AMGN $TWTR  https://t.co‚Ä¶@CNBCFastMoney none. $AMGNPIR Chart
See Here ---&gt; https://t.co/0i1lB6JKM3

$PIR $WATT $AMGN #stockmarket$AMGN - Statement of Changes in Beneficial Ownership (4) https://t.co/UUCmAvRZenBullish  options /patterns, levels to watch $NFLX $FB $BIDU $SPY $IWM $BWLD $AMGN $XBI $SPLS  $FEYE $AMGN $TWTR  https://t.co/9qsctro1h9$AMGN - Statement of Changes in Beneficial Ownership (4) https://t.co/Xeh67U174L$AMGN - Statement of Changes in Beneficial Ownership (4) https://t.co/TysW1RIPIN$AMGN - Statement of Changes in Beneficial Ownership (4) https://t.co/k25GzCYmgsCynthia Patton M SVP &amp; CCO Sells $948,271 Worth of $AMGN Amgen Inc. - #Form4 #InsiderTrading - https://t.co/OFySXu1hpi$AMGN - Statement of Changes in Beneficial Ownership (4) https://t.co/vtuzPjHNrbANTHONY HOOPER C EVP, Global Commercial Ops. Sells $3,549,673 Worth of $AMGN Amgen Inc. - #Form4 #InsiderTrading - https://t.co/9wJWkLcmgN$AMGN:

New Insider Transaction on AMGN by EVP, Operations:

https://t.co/7ofnd9fVunBRIAN MCNAMEE M EVP Sells $2,091,748 Worth of $AMGN Amgen Inc. - #Form4 #InsiderTrading - https://t.co/wBRULo0RwCSean Harper E EVP, Research &amp; Development Sells $3,549,673 Worth of $AMGN Amgen Inc. - #Form4 #InsiderTrading - https://t.co/Dimeccsv0Z$AMGN - Statement of Changes in Beneficial Ownership (4) https://t.co/ohrUyuqlnt$AMGN - Statement of Changes in Beneficial Ownership (4) https://t.co/ZEDHARCi5Y$AMGN ALERT: New Amgen SEC Filing
From our Stock News Alerts AppMadhavan Balachandran EVP, Operations Sells $3,549,673 Worth of $AMGN Amgen Inc. - #Form4 #InsiderTrading - https://t.co/9acQxNAzpLRobert Bradway A Chairman, CEO and Pres Sells $8,874,407 Worth of $AMGN Amgen Inc. - #Form4 #InsiderTrading - https://t.co/pI4DPQaQcm$AMGN - Statement of Changes in Beneficial Ownership (4) https://t.co/ujcXpjYrkVEVP of Amgen Inc. just disposed of 23,785 shares  https://t.co/54T52TnGTx $AMGNAmgen's overweight rating reiterated at Morgan Stanley. $193.00 PT. https://t.co/6CKB1KLWrb $AMGN #AMGN#Amgen, Inc. Rating Reiterated by Morgan Stanley. Read more: https://t.co/ooKJMebXi0 $AMGNAmgen, Inc. $AMGN Rating Reiterated by Morgan Stanley https://t.co/Oaf11Bll3D#Amgen, Inc. Receives ""Overweight"" Rating from Morgan Stanley. Read more: https://t.co/eLzXgZt5un $AMGNAmgen, Inc. $AMGN Rating Reiterated by Morgan Stanley https://t.co/n2s7ENhA3Q$AMGN - Amgen, Inc. #AMGN Rating Reiterated by Morgan Stanley https://t.co/nuDf7PtXjlAmgen Inc Reiterated Rating by Morgan Stanley (Ranked 37th) to Overweight with 193 PT $AMGN #AMGN https://t.co/bqjkWr2ARAAmgen's overweight rating reiterated at Morgan Stanley. $193.00 PT. https://t.co/h5C1UlMIrA $AMGN #AMGNRT @BioPharmaDive: $ALDR migraine data gives it boost in competition with $AMGN, $LLY, $TEVA https://t.co/uGBIKlZUxkRT @BioPharmaDive: $ALDR migraine data gives it boost in competition with $AMGN, $LLY, $TEVA https://t.co/uGBIKlZUxk$ALDR migraine data gives it boost in competition with $AMGN, $LLY, $TEVA https://t.co/uGBIKlZUxkDaiwa Securities Group Inc. Has $4,286,000 Position in Amgen, Inc. $AMGN https://t.co/ad6ax6FjTXAmgen, Inc. $AMGN Stake Lowered by Conning Inc. https://t.co/ZkMrrgRZNbWesbanco Bank Inc. Raises Position in Amgen, Inc. $AMGN https://t.co/wDNjWPUBMNToron Capital Markets Inc. Boosts Stake in Amgen, Inc. $AMGN https://t.co/4Aa2yit9p9New Buy Recommendation for This Healthcare Giant $AMGN https://t.co/Q3NA6zXrhPAMGN Top news - Mar 29th, 2016 $AMGN https://t.co/iBZBn23Uz5RT @LoncarFunds: $CNCR's top five immunotherapy holdings today include $CLLS $MRK $FPRX $INO and $AMGN. https://t.co/Cd8afEvQSk https://t.c‚Ä¶$AMGN total puts = 2,676 total calls = 3,813 OI CallPutRatio=0.70 for option expiration 04/01/2016 bullish. https://t.co/cx0ElgkkXr$AMGN Max Pain = 147.00. Maturity = 04/01/2016.  Previous close = 148.37. bearish  https://t.co/BKKrfNah99My 74 Stock Portfolio Quarterly Update Review For Income, Sectors And Value https://t.co/6ZBgsoDs1Z $AAPL #APPLE $ABBV $ADP $AMGN $BA $BCEMy 74 Stock Portfolio Quarterly Update Review For Income, Sectors And Value https://t.co/th2PUyE7VB $AAPL #APPLE $ABBV $ADP $AMGN $BA $BCEShort Setups - If There Was Ever Going To Be A Sell-Off $AER $AGN $AL $AOS $BKS $F $HRS $NFX $URI $WES $TREE $AMGN https://t.co/SaUQg40XE0RT @biotech_forum: Why The Rally Is Topping Out - Bret Jensen https://t.co/EY8QUVZSnb via @salphatrending $ABBV $AMGN $CLDT $M #markets htt‚Ä¶Why The Rally Is Topping Out - Bret Jensen https://t.co/EY8QUVZSnb via @salphatrending $ABBV $AMGN $CLDT $M #markets https://t.co/rMInR8LuvFRT @BioWriterChik: $ALDR has plans to set itself apart from the competition ( $TEVA $LLY $AMGN) in #migraine treatment - here's how: https:‚Ä¶Commented on: ""Why The Rally Is Topping Out"" https://t.co/r0TG9y9j8c $ABBV $AMGN $CLDT $MRT @chillipickle7: MS: Comparison of CGRP Based Migraine Therapies $ALDR $TEVA $AMGN $LLY https://t.co/w2MmgO73zWRT @chillipickle7: MS: Comparison of CGRP Based Migraine Therapies $ALDR $TEVA $AMGN $LLY https://t.co/w2MmgO73zWMS: Comparison of CGRP Based Migraine Therapies $ALDR $TEVA $AMGN $LLY https://t.co/w2MmgO73zWOur Picks Are Seeing Incredible Gains! Get Exclusive Early Access To Our New Alerts: https://t.co/dWbN7JMySK $CMCSA $INTC $AMGN$CNCR's top five immunotherapy holdings today include $CLLS $MRK $FPRX $INO and $AMGN. https://t.co/Cd8afEvQSk https://t.co/OGpVwR8TEuThree Penny Stock Picks More Than QUADRUPLED In Value! More Big Things On The Way: https://t.co/fctN9sytfZ $CMCSA $INTC $AMGNOver 1,466% Gains On Our Top Stock Picks Lately! See Our Big New Pick Early: https://t.co/4FeNl8zbvO $CMCSA $INTC $AMGN$LLY $AMGN:

Alder Biopharmaceuticals Inc (NASDAQ:ALDR)‚ÄôS Mid-Stage Clinical ‚Ä¶:

https://t.co/Fdud31IfmfRT @BioWriterChik: $ALDR has plans to set itself apart from the competition ( $TEVA $LLY $AMGN) in #migraine treatment - here's how: https:‚Ä¶$ALDR has plans to set itself apart from the competition ( $TEVA $LLY $AMGN) in #migraine treatment - here's how: https://t.co/MaRyYpRZfQDividends' True Contribution To Total Return May Surprise You https://t.co/42t1T09ygl $AMGN $BCR $ED $HCP $MNST $PG $SBUX $THCSFTW Investor long-term stock recommendation: $AMGN Amgen Inc. (SS: 82) https://t.co/ajLDr7suctAMGN Bid Size
See Here ---&gt; https://t.co/ogoF1aTKba

$AMGN $TSRA $MO #investing$AMGN:

Piper Jaffray rated Amgen Inc (NASDAQ:AMGN) to Target Down ‚Ä¶:

https://t.co/J8sfi1Ct1CWeekly Nasdaq100 #Stocks Performance $SPLS $AMZN $NVDA $FB $ORLY $CTSH $ALXN $SRCL $EA $BMRN $HSIC $AMGN  more@ https://t.co/YdSIjFJqHfWeekly S&amp;P100 #Stocks Performance $ACN $AMZN $UNH $FB $GE $AMGN $JNJ $MMM $EXC $TGT $XOM $AGN $TWX $LLY  more@ https://t.co/cKkr8cKsjuAmgen, Inc. $AMGN Assigned ‚ÄúA‚Äù Credit Rating https://t.co/FtemNMdkuoRT @tgtxdough: RBC $AMGN doesn't seem to get much credit for CGRP Phase III blockbuster migraine drug. $ALDR https://t.co/xmJKycffPIRT @jonathanrockoff: Great chart from Bernstein's Gal comparing trial performances of CGRP mAbs for migraine $ALDR, $AMGN, $LLY, $TEVA http‚Ä¶@Sharma1981N 1st time looking at $TEVA $LLY $AMGN ph3, all &gt;250 patients per dose arm. $LLY same for FEM and CM, $TEVA bigger in CM than FEMMS:""Catalysts Calendar: $GBT 2H focused with EHA. $AMGN PCSK9. MPS7, new KRN23 &amp; UX007 = $RARE, HBV and NASH data= $GILD ...""RT @tgtxdough: RBC $AMGN doesn't seem to get much credit for CGRP Phase III blockbuster migraine drug. $ALDR https://t.co/xmJKycffPIRBC $AMGN doesn't seem to get much credit for CGRP Phase III blockbuster migraine drug. $ALDR https://t.co/xmJKycffPITrading Strategies Partners: https://t.co/UpddhiMw1o $AAPL $NFLX $QQQ $SPY $DJIA $VZ $GS $INTC $AA $INTC $NFLX $GS $JPM $T $MMM $AMGN",2016-03-29,AMGN,0
2,"Over 1,466% Gains On Our Top Stock Picks Lately! See Our Big New Pick Early: https://t.co/4FeNl8zbvO $CMCSA $INTC $AMGNZero changes.Long $AMGN $BIIB $BCS $SUNE $RIO 2x Long $VSLR $TOL $TWTR $LNG $BZH sharing all timestamped entries/exits on stocktwits/twitterNR7-2 https://t.co/X0ACTyh5Pn $SGYP $VER $NKE $CLX $CVA $ORCL $HZNP $AMGN $ANF $EPD $TPX $FTSM $GRSH $CNL $FVE $RMP $RSYS $CBD{NEW POST} 3/30/16 MARKET ANALYSIS: $AAPL $AA $AKAM $AMBA $AMGN $ABBV - CLICK THE LINK &gt; https://t.co/LiijRA7xw3 https://t.co/qufq6hAYyBDo you think $GILD would buy $MDVN? $IBB $XBI $AMGN $JNJ $BIIB $INCYPremium Alerts Ranked #1 For Gains 2834% Last Week At https://t.co/ewcYkLb72h .. $AMGN $GLNG $PZZAThese $ITUS Profits Are much Bigger Than $AMGN#Amgen, Inc. Downgraded by Zacks Investment Research to ""Hold"". Read more: https://t.co/IBXV8ttzpG $AMGN@petenajarian @CardyTruster @kevinolearytv @HalftimeReport $GILD $AMGN low PE n dividend $BIIB $CELG growth #biotech #investing #TomsTruths$xom $JNJ $AAPL $FB $GOOGL $AMZN $DIS $HD $BAC $GS $AMGN $SPY $QQQ $IWM $SPX $NKE $KO $MCD $AXP $VZ #Market #RALLY ! https://t.co/Ex7Q2PfhKwBusey Trust CO Buys 1,016 Shares of Amgen, Inc. $AMGN https://t.co/aQ27Fdm0lgBusey Trust CO Buys 1,016 Shares of Amgen, Inc. $AMGN https://t.co/omj5Xto9J5Busey Trust CO Buys 1,016 Shares of Amgen, Inc. $AMGN https://t.co/dPwwTI05LS#Amgen, Inc. Shares Bought by California Public Employees Retirement System. Read more: https://t.co/qdJ9XNjz6t $AMGNAmgen, Inc. $AMGN Shares Bought by California Public Employees Retirement System https://t.co/MAoZszhVRrAmgen, Inc. $AMGN Shares Bought by California Public Employees Retirement System https://t.co/F7GF284nPcAmgen, Inc. $AMGN Shares Bought by California Public Employees Retirement System https://t.co/RJ0JkhWERKAmgen, Inc. $AMGN Stake Raised by Coldstream Capital Management Inc. https://t.co/PSLSL6vVRgMain Street Research LLC Buys 282 Shares of Amgen, Inc. $AMGN https://t.co/5Lubw0u99oAmgen, Inc. $AMGN Stake Raised by Coldstream Capital Management Inc. https://t.co/aRAa3UNiirAmgen, Inc. $AMGN Stake Raised by Coldstream Capital Management Inc. https://t.co/4hPry49nCH$AMGN has had a great earnings performance in the last few years https://t.co/UEnWb3pElR https://t.co/LdDJgcYkMUXOM Ask
See Here ---&gt; https://t.co/ord3r9Vtrs

$XOM $AMGN $HIW #nasdaqCommented on Gilead Sciences Vs. Its Peers https://t.co/j80HUQtQpC $ABBV $AMGN $CELG $IBB $XBI $GILDRT SeekingAlpha: CNCR: Investing In The Cancer Immunotherapy Industry https://t.co/8HpFIG6yWN $ADAP $ADRO $AGEN $AMGN $ATRA $AZN $BLCM $BL‚Ä¶CNCR: Investing In The Cancer Immunotherapy Industry https://t.co/afL4qQvEG2 $ADAP $ADRO $AGEN $AMGN $ATRA $AZN $BLCM $BLUE $BMY $CELGCNCR: Investing In The Cancer Immunotherapy Industry https://t.co/zFBgUGSqe7 $ADAP $ADRO $AGEN $AMGN $ATRA $AZN $BLCM $BLUE $BMY $CELGCNCR: Investing In The Cancer Immunotherapy Industry https://t.co/fTID7p1FtA $ADAP $ADRO $AGEN $AMGN $ATRA $AZN $BLCM $BLUE $BMY $CELGCNCR: Investing In The Cancer Immunotherapy Industry https://t.co/QKT7Sxbfs0 $ADAP $ADRO $AGEN $AMGN $ATRA $AZN $BLCM $BLUE $BMY $CELGMittelfristiges Signal! $AMGN: Ein Trendkanal wurde bei 148.565 USD nach unten durchbrochen:  https://t.co/4atPcJ8ZjfIn the high volatility world of Biotechs, $AMGN $GILD $CELG stand out as value companies with $$Billions in revenue! https://t.co/7fnYFzOR05#Amgen, Inc. Stock Rating Lowered by Zacks Investment Research. Read more: https://t.co/q9ulyGv0Iw $AMGN#Amgen, Inc. Stock Rating Lowered by Zacks Investment Research. Read more: https://t.co/qoYDL0ANvV $AMGNAmgen, Inc. $AMGN Stock Rating Lowered by Zacks Investment Research https://t.co/rPfPJu9YgRAmgen, Inc. $AMGN Stock Rating Lowered by Zacks Investment Research https://t.co/lA5o4tDagiGilead Sciences Vs. Its Peers https://t.co/tvujpr39Cq $GILD, $ABBV, $AMGN, $CELG, $IBB, $XBI

#BIOTECH@NorthmanTrader I want to grab some $REGN on the dip. How low can it go? Bad move? I am already in $AMGN. Thanks@petenajarian @kevinolearytv Pete is right $AMGN forward P/E 12.6 + 2.70% yield ( happy long-term AMGN holder) @HalftimeReport #biotech$AMGN total puts = 2,789 total calls = 3,754 OI CallPutRatio=0.74 for option expiration 04/01/2016 bullish. https://t.co/cx0ElgkkXr$AMGN high open interest range is 148.00 to 150.00 for option expiration 04/01/2016.  https://t.co/cx0ElgkkXr https://t.co/78o82IhUHf$AMGN Max Pain = 147.00. Maturity = 04/01/2016.  Previous close = 149.49. bearish  https://t.co/BKKrfNah99RT @EJLandis: ""Dumpster Diving The 2016 Dividend Challengers"" - https://t.co/nDg52b3wi0 [] $AMGN $CSCO $JCI $OGE $SEP $UNP $VTR https://t.c‚Ä¶RT @WrigleyTom: Qtr Cleaning, nLod
$IBB $GILD $OPHT $CBPO $BMRN
$NLNK $INCY $SAGE $DVAX $VRX
$ZIOP $ALXN $AMGN $CELG $CLVS
$XON $REGN $ALDR‚Ä¶RT @WrigleyTom: Qtr Cleaning, nLod
$IBB $GILD $OPHT $CBPO $BMRN
$NLNK $INCY $SAGE $DVAX $VRX
$ZIOP $ALXN $AMGN $CELG $CLVS
$XON $REGN $ALDR‚Ä¶RT @WrigleyTom: Qtr Cleaning, nLod
$IBB $GILD $OPHT $CBPO $BMRN
$NLNK $INCY $SAGE $DVAX $VRX
$ZIOP $ALXN $AMGN $CELG $CLVS
$XON $REGN $ALDR‚Ä¶RT @WrigleyTom: Qtr Cleaning, nLod
$IBB $GILD $OPHT $CBPO $BMRN
$NLNK $INCY $SAGE $DVAX $VRX
$ZIOP $ALXN $AMGN $CELG $CLVS
$XON $REGN $ALDR‚Ä¶Qtr Cleaning, nLod
$IBB $GILD $OPHT $CBPO $BMRN
$NLNK $INCY $SAGE $DVAX $VRX
$ZIOP $ALXN $AMGN $CELG $CLVS
$XON $REGN $ALDR $ALNY $BIIB@IncomeTrader I've been trying to buy $AMGN for awhileBiotech Investors: Here's How To Respond To The Bursting Bubble https://t.co/wZUaqFl2HG $AMGN $BIIB $CELG $GILD $SHPG $IBBRT @techwhitepapers: @techwhitepapers and LASTLY $AFMD convenience. 4 trivials. BTW Blincyto is the 10th biggest driver f growth for $AMGN‚Ä¶RT @techwhitepapers: so ya $AFMD vs CAR-T vs $AMGN Blincyto .. it boils down to few ""small"" ""trivials"" 1) efficacy 2) cost 3) safety https:‚Ä¶SFTW Investor long-term stock recommendation: $AMGN Amgen Inc. (SS: 82) https://t.co/ajLDr7suct@techwhitepapers and LASTLY $AFMD convenience. 4 trivials. BTW Blincyto is the 10th biggest driver f growth for $AMGN ,sales over 500mill/yr$JNJ $AMGN:

Analyst Recent Price Target Update: Johnson &amp; Johnson (NYSE ‚Ä¶:

https://t.co/lhBeN1baAYso ya $AFMD vs CAR-T vs $AMGN Blincyto .. it boils down to few ""small"" ""trivials"" 1) efficacy 2) cost 3) safety https://t.co/9V3cohyxQzRT @barronsonline: 5 potential blockbuster drugs https://t.co/obFbpOVmyf $RHHBY $SHPG $AGN $ANAC $PFE $NVS $REGN $AMGN $GILD $BMY $MRK http‚Ä¶RT @barronsonline: 5 potential blockbuster drugs https://t.co/obFbpOVmyf $RHHBY $SHPG $AGN $ANAC $PFE $NVS $REGN $AMGN $GILD $BMY $MRK http‚Ä¶RT @barronsonline: 5 potential blockbuster drugs https://t.co/obFbpOVmyf $RHHBY $SHPG $AGN $ANAC $PFE $NVS $REGN $AMGN $GILD $BMY $MRK http‚Ä¶RT @barronsonline: 5 potential blockbuster drugs https://t.co/obFbpOVmyf $RHHBY $SHPG $AGN $ANAC $PFE $NVS $REGN $AMGN $GILD $BMY $MRK http‚Ä¶5 potential blockbuster drugs https://t.co/obFbpOVmyf $RHHBY $SHPG $AGN $ANAC $PFE $NVS $REGN $AMGN $GILD $BMY $MRK https://t.co/VUA3sMo2spCommented on: ""Why The Rally Is Topping Out"" https://t.co/r0TG9y9j8c $ABBV $AMGN $CLDT $MRT SeekingAlpha: Following Up On My Radius Short https://t.co/RzpHhVUWkA $AMGN $RDUSFollowing Up On My Radius Short https://t.co/iq5Y8pLhGN $AMGN $RDUSFollowing Up On My Radius Short https://t.co/xpYMMDH93f $AMGN $RDUSRT SeekingAlpha: Gilead Sciences Vs. Its Peers https://t.co/mJuZxej6FN $ABBV $AMGN $CELG $IBB $XBI $GILDGilead Sciences Vs. Its Peers https://t.co/7aY4ER5B8S $ABBV $AMGN $CELG $IBB $XBI $GILDGilead Sciences Vs. Its Peers https://t.co/x8jnIFLiu7 $ABBV $AMGN $CELG $IBB $XBI $GILD$AMGN:

Analysts Rating updates about two Stocks: Amgen Inc. (NASDAQ ‚Ä¶:

https://t.co/1dBqtnyot9Traders Sell Amgen, Inc. $AMGN on Strength $AMGN https://t.co/OuJ1Qumpl0Traders Sell Amgen, Inc. $AMGN on Strength $AMGN https://t.co/c8fOmbjPPXAmgen, Inc. $AMGN Given Overweight Rating at Morgan Stanley https://t.co/8XxPPzYUkhAMGN Bid
See Here ---&gt; https://t.co/uVrgtaPyiG

$AMGN $SIMO $HTLF #shareShort Setups - If There Was Ever Going To Be A Sell-Off $AER $AGN $AL $AOS $BKS $F $HRS $NFX $URI $WES $TREE $AMGN https://t.co/SaUQg40XE0Three Penny Stock Picks More Than QUADRUPLED In Value! More Big Things On The Way: https://t.co/fctN9sytfZ $CMCSA $INTC $AMGNL Investor Opinions
See Here ---&gt; https://t.co/nJwBpukAgA

$L $PFE $AMGN #pennystocksOver 1,466% Gains On Our Top Stock Picks Lately! See Our Big New Pick Early: https://t.co/4FeNl8zbvO $CMCSA $INTC $AMGN$AMGN #Options OI chart. #option #invest More with #OptionsPro FREE app at https://t.co/xF6JpJ7ztu https://t.co/ogsJ49dV3ZLEI Day High
See Here ---&gt; https://t.co/1SvqjC4NWD

$LEI $CEO $AMGN #stockmarketTrading Strategies Partners: https://t.co/Upddhj47pY $AAPL $NFLX $QQQ $SPY $DJIA $VZ $GS $INTC $AA $INTC $NFLX $GS $JPM $T $MMM $AMGN$AMGN high open interest range is 148.00 to 150.00 for option expiration 04/01/2016.  https://t.co/cx0ElgkkXr https://t.co/BE1QqriWfY$AMGN Statement of Changes in Beneficial Ownership (4)‚Ä¶ https://t.co/nhWd4egl1o$AMGN Statement of Changes in Beneficial Ownership (4)‚Ä¶ https://t.co/iXrwmnwpZY$AMGN Statement of Changes in Beneficial Ownership (4)‚Ä¶ https://t.co/E229eCSQmY$AMGN Statement of Changes in Beneficial Ownership (4)‚Ä¶ https://t.co/JOGKLex6Ul$AMGN Statement of Changes in Beneficial Ownership (4)‚Ä¶ https://t.co/sdvlYhzWQ0$AMGN Statement of Changes in Beneficial Ownership (4)‚Ä¶ https://t.co/2hiE08l2Pc$AMGN Neulasta ""on-body"" IMS sales appear solid: February was $71M, representing 26% of total Neulasta IMS sales now.$AMGN Statement of Changes in Beneficial Ownership (4)‚Ä¶ https://t.co/gZjaBbJsOG$AMGN Statement of Changes in Beneficial Ownership (4)‚Ä¶ https://t.co/kInEvoWm8xTime to worry about $AMGN? https://t.co/EnHZeW1i8dRT @Taarriqq: Bullish  options /patterns, levels to watch $NFLX $FB $BIDU $SPY $IWM $BWLD $AMGN $XBI $SPLS  $FEYE $AMGN $TWTR  https://t.co‚Ä¶",2016-03-30,AMGN,1
3,"Over 1,466% Gains On Our Top Stock Picks Lately! See Our Big New Pick Early: https://t.co/4FeNl8zbvO $CMCSA $INTC $AMGN#Amgen Will SCOTUS take up Sandoz' pivotal biosim case? New briefs call on court to weigh in. Read more: https://t.co/wspUOTbTWZ $AMGN$AMGN:

New Insider Transaction on AMGN by Director:

https://t.co/wol2DVy5eD https://t.co/cscFvdcQdXAmgen Inc. director just picked up 3,312 shares  https://t.co/cEXpcyyhHi $AMGN$AMGN ALERT: New Amgen SEC Filing
From our Stock News Alerts App$AMGN - Statement of Changes in Beneficial Ownership (4) https://t.co/6USJcWyG8xBRIEFJanssen Pharmaceuticals terminates licensing agreement with #Amgen for Fulranumab. Read more: https://t.co/nqw3d5Kmzs $AMGNRT @Street_Insider: Janssen R&amp;D to Discontinue Fulranumab Phase 3; Terminates Agreement with Amgen $AMGN $JNJ $$ https://t.co/9E3ScMAEPIBRIEF-Janssen Pharmaceuticals terminates licensing agreement with #Amgen for Fulranumab. Read more: https://t.co/JEERj9RapI $AMGN$JNJ ditches fulranumab &amp; $AMGN deal. @ByJonGardner story about this troubled drug class from a year ago https://t.co/YDlY4Irouq $PFE $REGNNew insights on T cell bispecifics and how we can improve on blinatumomab https://t.co/x1uGX5AaZZ $amgn $rhhby $mgnx $regnRT @Street_Insider: Janssen R&amp;D to Discontinue Fulranumab Phase 3; Terminates Agreement with Amgen $AMGN $JNJ $$ https://t.co/9E3ScMAEPIJ&amp;J backs out of fulranumab development for osteoarthritis pain https://t.co/pmKhVSRHmu $JNJ $AMGNJ&amp;J backs out of fulranumab development for osteoarthritis pain https://t.co/8cecxTzcBl $JNJ $AMGNJ&amp;J backs out of fulranumab development for osteoarthritis pain https://t.co/g2EGtiJV59 $JNJ $AMGNRT @Street_Insider: Janssen R&amp;D to Discontinue Fulranumab Phase 3; Terminates Agreement with Amgen $AMGN $JNJ $$ https://t.co/9E3ScMAEPIJanssen R&amp;amp;D to Discontinue Fulranumab Phase 3; Terminates Agreement with Amgen $AMGN $JNJ $$ https://t.co/ee5FfenjRl via ‚Üí @AlertTradeRT @zbiotech: $JNJ returning NGF rights to $AMGNJanssen R&amp;D to Discontinue Fulranumab Phase 3; Terminates Agreement with Amgen $AMGN $JNJ $$ https://t.co/9E3ScMAEPIAnchor Capital Advisors LLC Has $37,264,000 Position in Amgen, Inc. $AMGN https://t.co/gCKVBAW9g3$JNJ returning NGF rights to $AMGNMetLife Securities Inc Has $3,070,000 Position in Amgen, Inc. $AMGN https://t.co/8AXENDzIvaTealwood Asset Management Inc. Lowers Position in Amgen, Inc. $AMGN https://t.co/rd29qqXExDStoneridge Investment Partners LLC Has $3,087,000 Position in Amgen, Inc. $AMGN https://t.co/MzVS33OuoRADMP Investor Opinions
See Here ---&gt; https://t.co/OtmEeCgw59

$ADMP $DIN $AMGN #investingMedivation is beating 'em off with a stick, but how much is it worth?: https://t.co/WPDD9viDWW $MDVN $SNY $AZN $RHHBY $BAYRY $AMGN$IBB $CELG $XBI $BBC $GILD $NBIX $AMGN https://t.co/k6ZkTYHMFoCMCSA Volume
See Here ---&gt; https://t.co/RlcmVKZMfk

$CMCSA $AMGN $MYRG #share$MCO $RAD $CAG $BBBY $STZ $ISCA $DRI $AMGN $MON:

Fed Minutes, U.S. Services, Masters Golf: Week Ahead April 2-9:

https://t.co/k7siDUbuEh$IBB $.SPX $VRTX $REGN $ALXN $BIIB $CELG $GILD $AMGN:

Can biotech recover from big slide?:

https://t.co/uP5kvz4wVFRT @3NT: What to know why $AMGN Blincyto sales are poor and how it can be improved? Read @MaverickNY on @BiotechStrategy https://t.co/NP30T‚Ä¶What to know why $AMGN Blincyto sales are poor and how it can be improved? Read @MaverickNY on @BiotechStrategy https://t.co/NP30T7Sy4AWhy The Rally Is Topping Out - Bret Jensen | Seeking Alpha https://t.co/mRwXjWn828 via @salphatrending $ABBV $AMGN $CLDT $MBiotech Investors: Here's How To Respond To The Bursting Bubble https://t.co/xsTZC7fTDA $AMGN $BIIB $CELG $GILD $SHPG $IBBMedivation: Let the M&amp;A Speculation Begin https://t.co/fK0LrhiK0H via @barronsonline $GILD $MDVN $AMGN $AZN $SNY$IBB wrv 263.18 last week $GILD (held wrv9013)  wrv 9087 $AMGN wrv 14844@amitkjolly @jimcramer @barbara_ryan12 Jim ask How Dosing Schedule can compete w Monthly Rx by $AMGN in same space? $RDUS dosing Achill HeelMy 74 Stock Portfolio Quarterly Update Review For Income, Sectors And Value https://t.co/HacadAvI6P $AAPL $ABBV $ADP $AMGN $BA $BCE $BDXYesterday We Made $94,000 In Just One Trade More Info Here https://t.co/ZMvOsK1CVa .. $CMCSA $INTC $AMGNRT @Lin_ling_88: $CYTK: $AMGN's R&amp;D Chief Expresses Great Optimism About Omecamtiv Mecarbil for Treating Congestive Heart Failure  https://‚Ä¶AMGN Top news - Mar 31st, 2016 $AMGN https://t.co/hS0bNP6poBRT @techwhitepapers: $AFMD $MRK partnership is more interesting if y read this https://t.co/hHTXwItbia .. $AMGN Blincyto allready partners‚Ä¶RT @Trading_Analyst: {NEW POST} 3/30/16 MARKET ANALYSIS: $AAPL $AA $AKAM $AMBA $AMGN $ABBV - CLICK THE LINK &gt; https://t.co/LiijRA7xw3 https‚Ä¶Biotech Investors: Here's How To Respond To The Bursting Bubble https://t.co/JrlIohhHZd $AMGN $BIIB $CELG $GILD $SHPG $IBBCNCR: Investing In The Cancer Immunotherapy Industry https://t.co/dxFRA90OI9 $ADAP $ADRO $AGEN $AMGN $ATRA $AZN $BLCM $BLUE $BMY $CELGBiotech Investors: Here's How To Respond To The Bursting Bubble https://t.co/8wO3jWKpCK $AMGN $BIIB $CELG $GILD $SHPG $IBBBiotech Investors: Here's How To Respond To The Bursting Bubble https://t.co/Ab1xlgGMHK $AMGN $BIIB $CELG $GILD $SHPG $IBB#Amgen, Inc. Lowered to ""Hold"" at Zacks Investment Research. Read more: https://t.co/Iz9SX1ffFP $AMGNThree Penny Stock Picks More Than QUADRUPLED In Value! More Big Things On The Way: https://t.co/fctN9sgRRp $CMCSA $INTC $AMGN$AMGN $AZN:

Overview of Analyst‚Äôs Recommendations: Amgen Inc. (NASDAQ ‚Ä¶:

https://t.co/TdOzA9mD9X@techwhitepapers why would $MRK partner w $AFMD for the same indication for which already has $AMGN ? UNLESSSSSS! $MRK knows.?$AFMD $MRK partnership is more interesting if y read this https://t.co/hHTXwItbia .. $AMGN Blincyto allready partners w $MRK in HL! what?Over 1,466% Gains On Our Top Stock Picks Lately! See Our Big New Pick Early: https://t.co/4FeNl8QMnm $CMCSA $INTC $AMGNAmgen, Inc. $AMGN Lowered to ‚ÄúHold‚Äù at Zacks Investment Research https://t.co/gOK1eve2k6AMGN Company Info
See Here ---&gt; https://t.co/jT9UrwoZBY

$AMGN $SIEN $HRS #stock20 Of The Best Yielding Healthcare Growth Stocks For The Next Years - https://t.co/6KYj4jZUeD - $PLDI $ABBV $MSA $AMGN $WLP $STJ $DGX $VIVO$AMGN:

Analyst update:Amgen Inc was rated by Citigroup to Initiates ‚Ä¶:

https://t.co/6bOYnqD2P7Citigroup, Amgen Are Trading With Wide Margin of Safety $LUV $PKG $AMGN $EMN $JAZZ $C https://t.co/fB8VWGrv8mTrading Strategies Partners: https://t.co/Upddhj47pY $AAPL $NFLX $QQQ $SPY $DJIA $VZ $GS $INTC $AA $INTC $NFLX $GS $JPM $T $MMM $AMGNRT @scalpthatstock: Stock Market Chart Technical Analysis Video March 30 
  https://t.co/SQxaH9XIM1
  $AA $AAPL $AMBA $AKAM $AMGN $ABBVStock Market Chart Technical Analysis Video March 30 
  https://t.co/SQxaH9XIM1
  $AA $AAPL $AMBA $AKAM $AMGN $ABBVIs The Biotech ETF IBB Forming A Double Bottom Pattern? https://t.co/aLuvEmhNLw $AMGN $BIIB $CELG $GILD $REGN $IBBThree Penny Stock Picks More Than QUADRUPLED In Value! More Big Things On The Way: https://t.co/fctN9sytfZ $CMCSA $INTC $AMGN",2016-03-31,AMGN,1
4,"#Amgen, Inc. Shares Sold by NorthCoast Asset Management LLC. Read more: https://t.co/62ywdOwwWt $AMGNRT @pharmalot: FDA proposes biosimilars labeling that favors generic drug makers.. read it here.. https://t.co/PnSLMkw4WB #pharma #FDA $ABB‚Ä¶These $ITUS Profits Are much Bigger Than $AMGNS&amp;P500 #Stocks Trend $EW $ABBV $ALXN $BSX $ISRG $PFE $CCE $CAH $BCR $VAR $AAPL $TMO $BDX $TWX $GIS $AMGN $MSI  @ https://t.co/RPeaHBHYi0$CYTK start of phase 2 clinical trial of Omecamtiv Mecarbil in collaboration with $AMGN to evaluate Japanese subjects with heart failureNasdaq100 #Stocks Trend $TSLA $ALXN $ISRG $AAPL $ILMN $AMGN $INTU $LBTYA $GILD $BMRN $CTXS $YHOO $FOXA $CHTR  @ https://t.co/YdSIjFJqHfNasdaq100 #Stocks Performance $VRTX $TSLA $ALXN $ISRG $CHTR $SYMC $AAPL $CERN $ADSK $ILMN $AMGN $INCY $INTU more@ https://t.co/YdSIjFJqHfS&amp;P100 #Stocks Trend $ABBV $PFE $AAPL $TWX $AMGN $GILD $PEP $CVS $PM $BMY $MRK $FOXA $MCD $ABT $V $CMCSA $MDT  @ https://t.co/cKkr8cKsjuS&amp;P100 #Stocks Performance $AGN $ABBV $PFE $MDT $AAPL $T $TWX $VZ $SLB $LMT $MCD $AMGN $ABT $V $UTX $BK  more@ https://t.co/cKkr8cKsjuRT @fwpharma: Amgen's PCSK9 inhibitor Repatha more effective than Merck &amp; Co.'s Zetia: study https://t.co/1FZ5o3O3Yy $AMGN $MRL #pharma@adamfeuerstein @matthewherper didnt Schoney suggest $AMGN $AGN tie up?$AMGN would be nice üò¨üò¨üò¨üòâ https://t.co/xqof4Spn1PAmgen's PCSK9 inhibitor Repatha more effective than Merck &amp; Co.'s Zetia: study https://t.co/1FZ5o3O3Yy $AMGN $MRL #pharma$IBB has 190 holdings; top 10 = 57.83% weight; basically you are saying $AMGN $GILD $REGN $BIIB $CELG $ILMN $MYL $ALXN $VRTX $INCYWould be really funny if $PFE dropped $AGN bid then bought $GILD or $AMGN (top 2 holdings of $IBB) sending biotech thru the roof. Haha$AMGN Max Pain = 149.00. Maturity = 04/08/2016.  Previous close = 154.16. bearish  https://t.co/0ccEievDt5 https://t.co/clkrGcJRh8$IBB Inverted hammer outside dly bolli near supply zone/ Careful not best spot long $LABU $BIB $XBI $AMGN $... https://t.co/gvrUvEubYORT @pharmalot: FDA proposes biosimilars labeling that favors generic drug makers.. read it here.. https://t.co/PnSLMkw4WB #pharma #FDA $ABB‚Ä¶RT @pharmalot: FDA proposes biosimilars labeling that favors generic drug makers.. read it here.. https://t.co/PnSLMkw4WB #pharma #FDA $ABB‚Ä¶#Amgen Release: Positive Efficacy And Tolerability Study Of Repatha (evolocumab) In Statin-... Read more: https://t.co/cnX1bIbQLf $AMGNAmgen, Inc. $AMGN Shares Sold by NorthCoast Asset Management LLC https://t.co/wZ4eMhAjjbAmgen, Inc. $AMGN Stake Held by Supplemental Annuity Collective Trust of NJ https://t.co/Yx9fNKWorBAmgen, Inc. $AMGN Position Maintained by Thomas Story &amp; Son LLC https://t.co/Dz30vBxTREAmgen, Inc. $AMGN Stake Held by Supplemental Annuity Collective Trust of NJ https://t.co/cVYqV5qBU1CI Global Investments Inc. Boosts Position in Amgen, Inc. $AMGN https://t.co/rkl2uf5OvLStevens Capital Management LP Has $1,788,000 Stake in Amgen, Inc. $AMGN https://t.co/ZSpDy81NjQRT @pharmalot: FDA proposes biosimilars labeling that favors generic drug makers.. read it here.. https://t.co/PnSLMkw4WB #pharma #FDA $ABB‚Ä¶RT SeekingAlpha: Aeglea Biotherapeutics IPO: Wait For Larger April Deals https://t.co/dS4uqLdDje $AMGN $AZN $BMY $CALA $CELG $CPA $JNJ $LL‚Ä¶Nasdaq100 #Stocks Trend $TSLA $ALXN $ISRG $CHTR $ADSK $AAPL $BMRN $ILMN $AMGN $CELG $GILD $LBTYA $INTU $CTXS  @ https://t.co/YdSIjFJqHfS&amp;P100 #Stocks Trend $ABBV $PFE $MDT $AAPL $TWX $AMGN $CELG $GILD $CVS $PM $BMY $MRK $FOXA $MCD $ABT $MO $V  @ https://t.co/cKkr8cKsjuS&amp;P100 #Stocks Performance $AGN $ABBV $PFE $MDT $AAPL $TWX $AMGN $MCD $VZ $UTX $T $CELG $ABT $LMT $GILD  more@ https://t.co/cKkr8cKsjuAeglea Biotherapeutics IPO: Wait For Larger April Deals https://t.co/8NyHl5FLh4 $AGLE, $AMGN, $AZN, $BMY, $CALA, $CELG, $CPA, $JNJ, $LLY,Aeglea Biotherapeutics IPO: Wait For Larger April Deals https://t.co/s9fWEIBbcU $AMGN $AZN $BMY $CALA $CELG $CPA $JNJ $LLY $NVS $AGLEAeglea Biotherapeutics IPO: Wait For Larger April Deals https://t.co/KoFz6iaxgP $AMGN $AZN $BMY $CALA $CELG $CPA $JNJ $LLY $NVS $AGLEAeglea Biotherapeutics IPO: Wait For Larger April Deals https://t.co/7LX5KL1WYN $AMGN $AZN $BMY $CALA $CELG $CPA $JNJ $LLY $NVS $AGLECheck. Regeneron Pharmaceuticals Is My Top Pick In The Biotech Space https://t.co/nAh91Ou1T4 $ABBV $AMGN $ESRX $GILD $MRK $SNY $REGNClose $AMGN @154.38 from 146.65 entry +5.27% #timestamp #winningtrade https://t.co/rbd8LuvW0k sharing all entries/exits realtime3 Biotech Stocks on the Verge of an Overdue Run $AMGN $GILD $REGN - https://t.co/rHvJgfFccm#AmgenUCB's bone drug romosozumab shines again in PhIII. Read more: https://t.co/9riTJGiR51 $AMGNRT @TracyStaton: Discounts on some top 10 meds cancel out price hikes. Others, not so much https://t.co/RLmPxI2zJ6 $AMGN $JNJ $GSK via @Fie‚Ä¶Discounts on some top 10 meds cancel out price hikes. Others, not so much https://t.co/RLmPxI2zJ6 $AMGN $JNJ $GSK via @FiercePharmaThis Data Signals The End For Merck's Anacetrapib $AMGN $LLY $MRK https://t.co/ZcYV40KwZW#Amgen, UCB Group's Romosozumab Tops Teriparatide in Phase III Osteoporosis Study  . Read more: https://t.co/wfxKvc4DwN $AMGNFDA proposes biosimilars labeling that favors generic drug makers. https://t.co/Xisf7CGomF ‚Ä¶ #pharma #FDA $ABBV $SNY $AMGN #BiolsimilarsRT @pharmalot: FDA proposes biosimilars labeling that favors generic drug makers.. read it here.. https://t.co/PnSLMkw4WB #pharma #FDA $ABB‚Ä¶RT @pharmalot: FDA proposes biosimilars labeling that favors generic drug makers.. read it here.. https://t.co/PnSLMkw4WB #pharma #FDA $ABB‚Ä¶RT @pharmalot: FDA proposes biosimilars labeling that favors generic drug makers.. read it here.. https://t.co/PnSLMkw4WB #pharma #FDA $ABB‚Ä¶RT @pharmalot: FDA proposes biosimilars labeling that favors generic drug makers.. read it here.. https://t.co/PnSLMkw4WB #pharma #FDA $ABB‚Ä¶RT @pharmalot: FDA proposes biosimilars labeling that favors generic drug makers.. read it here.. https://t.co/PnSLMkw4WB #pharma #FDA $ABB‚Ä¶RT @pharmalot: FDA proposes biosimilars labeling that favors generic drug makers.. read it here.. https://t.co/PnSLMkw4WB #pharma #FDA $ABB‚Ä¶FDA proposes biosimilars labeling that favors generic drug makers.. read it here.. https://t.co/PnSLMkw4WB #pharma #FDA $ABBV $SNY $AMGNAMGN Top news - Apr 4th, 2016 $AMGN https://t.co/w8jrosjCs4$AMGN,List:Continuing Bull Trend,Quote:155.39,Change:1.23,Target:187.0These $ITUS Profits Are much Bigger Than $AMGN https://t.co/VHiqzkacqqRT SeekingAlpha: IBB Is About To Break Out With Significant Upside Potential https://t.co/DIlbGmu60G $AMGN $BIIB $CELG $GILD $MDVN $MRK $R‚Ä¶AMGN 154.50 Amgen $AMGN added to my watch list. Right now with AMGN I am watching the last price 154.50 High 1 https://t.co/mQbZzS0qETRT @MomentBreakouts: Watch this one spike its getting started
$brcd $wdc $ip $adbe $brk-b $abt $amgn $nycb $hyd $cag https://t.co/K5LqANBhJ0RT @OpenOutcrier: Why $GILD and $AMGN Can Eye $MDVN As Acquisition Target 

https://t.co/cOR1KIF8g0Why $GILD and $AMGN Can Eye $MDVN As Acquisition Target 

https://t.co/cOR1KIF8g0IBB Is About To Break Out With Significant Upside Potential https://t.co/qj59jVdFzI $AMGN $BIIB $CELG $GILD $MDVN $MRK $REGN $SNY $RHHBYIBB Is About To Break Out With Significant Upside Potential https://t.co/q1uyzabZUK $AMGN $BIIB $CELG $GILD $MDVN $MRK $REGN $SNY $RHHBYIBB Is About To Break Out With Significant Upside Potential https://t.co/fWieiAKyIr $AMGN $BIIB $CELG $GILD $MDVN $MRK $REGN $SNY $RHHBYRT @ScripDonnaDC: Apotex at Fed Circ: Elephant in room is $AMGN wants 12.5 yrs exclusivity &amp; trying to get it through a mouse hole
#biosimi‚Ä¶RT @biotech_sector: #Amgen, Inc. Cut to ""Hold"" at Zacks Investment Research. Read more: https://t.co/r1rG3B9jJu $AMGNRT @matthewherper: Somebody name a single case where a drug failed totally, and another with same mechanism proved effective. #CETP $MRK $A‚Ä¶#Amgen, Inc. Cut to ""Hold"" at Zacks Investment Research. Read more: https://t.co/r1rG3B9jJu $AMGNBetter Buy: Regeneron Pharmaceuticals, Inc. vs. #Amgen. Read more: https://t.co/5JMAAqB4wz $AMGNAmgen Breaks Above 200-Day Moving Average - Bullish for $AMGN $IBB #dividends https://t.co/cSLE0h5lmIWatch this one spike its getting started
$brcd $wdc $ip $adbe $brk-b $abt $amgn $nycb $hyd $cag https://t.co/K5LqANBhJ0RT @ScripDonnaDC: Apotex at Fed Circ: Elephant in room is $AMGN wants 12.5 yrs exclusivity &amp; trying to get it through a mouse hole
#biosimi‚Ä¶Johnson &amp; Johnson's Phase 3 Cancellation: Why It Matters https://t.co/2gr7eofqpM $AMGN $LLY $PFE $REGN $SNY $SPY $JNJApotex at Fed Circ: Elephant in room is $AMGN wants 12.5 yrs exclusivity &amp; trying to get it through a mouse hole
#biosimilars #BPCIA3 Biotech Stocks on the Verge of an Overdue Run $AMGN $GILD $REGN - https://t.co/Io60dl1i8hRT @ stockguy22 ""$IBB doing well today even into this weakness.. #biotech stocks pushed up well since last week 
$JAZZ $AMGN $BIIB $CELG $R‚Ä¶$IBB doing well today even into this weakness.. #biotech stocks pushed up well since last week 
$JAZZ $AMGN $BIIB $CELG $REGN $ALXN etc.S&amp;P500 #Stocks Trend $EW $RRC $ABBV $PFE $ISRG $MDT $TMO $AAPL $BSX $CCE $ADSK $PKI $CAH $CELG $BDX $VAR $AMGN @ https://t.co/RPeaHBHYi0Nasdaq100 #Stocks Trend $TSLA $BMRN $ISRG $AAPL $ADSK $CELG $AMGN $ILMN $GILD $INTU $LBTYA $CTXS $LMCA $YHOO  @ https://t.co/YdSIjFJqHfNasdaq100 #Stocks Performance $VRTX $TSLA $ALXN $BMRN $ISRG $MYL $AAPL $ADSK $SYMC $CHTR $CELG $CERN $AMGN  more@ https://t.co/YdSIjFJqHfS&amp;P100 #Stocks Trend $ABBV $PFE $MDT $AAPL $CELG $AMGN $TWX $GILD $PEP $BMY $MRK $FOXA $ABT $V $MCD $CVS $PM  @ https://t.co/cKkr8cKsjuS&amp;P100 #Stocks Performance $AGN $ABBV $PFE $MDT $AAPL $DVN $ABT $CELG $NSC $XOM $COP $AMGN $UNP $SLB $LMT  more@ https://t.co/cKkr8cKsju$MRK $AMGN:

This Data Signals The End For Merck‚Äôs Anacetrapib:

https://t.co/zhGUxktIiT#Amgen : Positive Efficacy And Tolerability Study Of Repatha¬Æ (evolocumab) In ... https://t.co/q04OlAHvGR $AMGNPositive results for #Amgen's Repatha for high cholesterol patients who can't tolerate stat... Read more: https://t.co/JOk6hXAEa8 $AMGN#Amgen and UCB present positive data for romosozumab with teriparatide in osteoporosis. Read more: https://t.co/oR6THgWPxo $AMGN$AAPL $AMAT $AMGN $AMTD $AMZN $ATVI Trade long or long and short positions from the #NYSE , up to 1500% since 2010. https://t.co/gquyAF9D7u@techwhitepapers beyond NK target AFM13 it has AFM11 clinical a competitor to Blincyto for which $AMGN made the winner of last yr @AACR$IBB very important test for #biotech right now!

$AMGN $GILD $CELG
$BIIB $REGN https://t.co/x8SZ3DWqIgExclusive: Makers took big #price increases on widely used U.S. #drugs  https://t.co/cA8qUmojpq via @Reuters $ABBV $AMGN $TEVAPricey #PCSK9 Inhibitors Require Careful Patient Selection $AMGN $REGN $ESPR's bempedoic acid could b priced at 1/5  https://t.co/iELNsQcurO$xom $JNJ $GOOGL $AMZN $DIS $HD $BAC $GS $AMGN $SPY $QQQ $IWM $NKE $KO $MCD $AXP #Market mixed, $AAPL $FB opposite https://t.co/LOdOEYIrXeRT @asclepiacap: Insights Into Statin Intolerance Roundtable from Clinical Cardiology

$ESPR $AMGN $SNY $REGN $MRK 

https://t.co/1RdeXttC01StockTradeHome's Results: $AMGN opened LONG on 4/01 at $149.50 and closed today's at $154.00 +3.01% https://t.co/sEWpN8FFKR $QQQ $SPY $DJIAApril 4 Biotech Update $AGN $AMGN $ESPR $GILD $PFE https://t.co/JwVxqjkSGa$AMGN:

Market Analyst Recent Rating Update: Amgen Inc. (NASDAQ:AMGN ‚Ä¶:

https://t.co/BzNXhSDqp2@PFOLIOALERT PREDICTED WINNERS APR 4 $ZFGN $JAZZ $AMGN  $OHRP $INCY $HKMPY $AMPH $NVO $ACAD $BMRN $REGN $CASI $FOLD $RGLS $INO
 ALPHACHAOSInsights Into Statin Intolerance Roundtable from Clinical Cardiology

$ESPR $AMGN $SNY $REGN $MRK 

https://t.co/1RdeXttC01$AMGN $AAPL $V $GILD $LULU Couple stocks at the overbought Hourly. All above the 70 Hourly RSI. If you are swinging these, trade cautiously.ProStockSystem's Results: $AMGN opened LONG on 3/31 at $149.50 and closed today's at $154.30 +3.21% https://t.co/4c9AFxqToS $QQQ $SPY $DIA$AMGN C 155 #target 156.22Amgen, Inc. $AMGN Cut to ‚ÄúHold‚Äù at Zacks Investment Research https://t.co/b7MsZKb4xGShire And Baxalta - A Match Made In Heaven? (Part 1) https://t.co/fptCNGln5D $AMGN $BXLT $GILD $SHPGRT @Alexability: Top sentiment for SP1500 stocks at market open: $ALK $CME $SSS $GE $AMGN (2016/04/04) #sentiment #stock #alexandria$AMGN https://t.co/9RRGvlCgHC$AMGN Inside the range, not much going on... https://t.co/vaCby8ptMLRT SeekingAlpha: Shire And Baxalta - A Match Made In Heaven? (Part 1) https://t.co/Ddw6Mrempw $AMGN $BXLT $GILD $SHPG@techwhitepapers Both Nimbus and $VTAE are Atlas Venture companies.. interesting that Micromet bought by $AMGN was too.. 1.4bill!Top #sentiment for #SP1500 #stocks at market open: $ALK $CME $SSS $GE $AMGN (2016/04/04) #stocktrading #predictiveanalytics #bigdataTop sentiment for SP1500 stocks at market open: $ALK $CME $SSS $GE $AMGN (2016/04/04) #sentiment #stock #alexandriaShire And Baxalta - A Match Made In Heaven? (Part 1) https://t.co/d2KWvVkHjL $AMGN $BXLT $GILD $SHPG$AMGN is setup for higher here. chart plan explains key points https://t.co/ZE4wLHvXikThese $ITUS Profits Are much Bigger Than $AMGN$AMGN with a classic buy signal $IBB https://t.co/gygVdAC8FqRT @godmodetrader: #Amgen - Auch dieser Biotech-Wert erwacht #b√∂rse #aktien $AMGN https://t.co/r5N2d3L5O8 https://t.co/NJnwuGXdYrRT @matthewherper: Somebody name a single case where a drug failed totally, and another with same mechanism proved effective. #CETP $MRK $A‚Ä¶These $ITUS Profits Are much Bigger Than $AMGNRT @matthewherper: Somebody name a single case where a drug failed totally, and another with same mechanism proved effective. #CETP $MRK $A‚Ä¶RT @matthewherper: Somebody name a single case where a drug failed totally, and another with same mechanism proved effective. #CETP $MRK $A‚Ä¶$AMGN v Apotex 
#biosimilars #biosimilar #pharma #biotech #BPCIA https://t.co/zInEgdsX3HRT SeekingAlpha: Johnson &amp; Johnson's Phase 3 Cancellation: Why It Matters https://t.co/lmYo8Tcd7t $AMGN $LLY $PFE $REGN $SNY $SPY $JNJ#Amgen - Auch dieser Biotech-Wert erwacht #b√∂rse #aktien $AMGN https://t.co/r5N2d3L5O8 https://t.co/NJnwuGXdYrThese $ITUS Profits Are much Bigger Than $AMGNExclusive: Makers took big price increases on widely used U.S. drugs $VRX $SNY $JNJ $AZN $ABBV $GSK $AMGN $TEVA  https://t.co/SbfcXzIIF9The failure of #Lilly's evacetrapib may prove the final nail in the coffin for #CETP  $LLY $MRK $AMGN https://t.co/kPoYRvCb4m ‚Ä¶Johnson &amp; Johnson's Phase 3 Cancellation: Why It Matters https://t.co/FjsitwPVES $AMGN $LLY $PFE $REGN $SNY $SPY $JNJWhere is congress and the media bashing on these companies? I guess not good politics or news? https://t.co/5xuZbIIWv0. $amgn $azn $abbv$AMGN:

Latest Analysts Tips Update: Amgen Inc. (NASDAQ:AMGN ‚Ä¶:

https://t.co/rjcJtS3SOXRT @matthewherper: Somebody name a single case where a drug failed totally, and another with same mechanism proved effective. #CETP $MRK $A‚Ä¶RT @TradeWithSK: $STUDY TrendLines, Targets Before Open $ES_F https://t.co/xDSiOa4Zq7 . $SPX $SPY $BIB $IBB $LABU $GOOG $CRPT $CL_F $GC_F $‚Ä¶RT @TradeWithSK: $STUDY TrendLines, Targets Before Open $ES_F https://t.co/BcsVD2C21f . $SPX $SPY $BIB $IBB $LABU $GOOG $CRPT $CL_F $GC_F $‚Ä¶$STUDY TrendLines, Targets Before Open $ES_F https://t.co/BcsVD2C21f . $SPX $SPY $BIB $IBB $LABU $GOOG $CRPT $CL_F $GC_F $AMGN $AMZN $TWTR$STUDY TrendLines, Targets Before Open $ES_F https://t.co/xDSiOa4Zq7 . $SPX $SPY $BIB $IBB $LABU $GOOG $CRPT $CL_F $GC_F $AMGN $AMZN $TWTRQuarterly updates keep this index of 30 dividend stocks fresh!  https://t.co/eurVlwpFpE $ADM $AGU $AMGN $AMP $ARCC $CMI $GM $IP $IVZRT @MarketCurrents: Pfizer's PCSK9 inhibitor bococizumab successful in late-stage cholesterol study https://t.co/5fhIZB4Mub $PFE $AMGN $REG‚Ä¶.@Reuters Exclusive: Makers took big price increases on widely used U.S. drugs  https://t.co/0nDtjiWQl3 $VRX $ABBV $TEVA $AMGN $JNJ $GSKBRIEF-#Amgen Canada - announces new study results of Repatha in statin-intolerant patients. Read more: https://t.co/PW02bV3y2F $AMGNRT @theflynews: On The Fly: Top five weekend stock stories $TSLA $SUNE $EW $MDT $AMGN $IRMD $YHOO $TIME $SFTBF $TWX $UTX $MTW ... https://t‚Ä¶Weekly Nasdaq100 #Stocks Trend $ILMN $DLTR $AMAT $LBTYA $TSLA $SBAC $AAPL $CTXS $FISV $TSCO $VRSK $AMGN $DISCA  @ https://t.co/YdSIjFJqHfWeekly S&amp;P100 #Stocks Trend $V $MA $AAPL $SPG $ABT $AMGN $IBM $CMCSA $GILD $PEP $CSCO $CL $HD $MCD $LOW $SO  @ https://t.co/cKkr8cKsjuWeekly S&amp;P100 #Stocks Performance $MET $SBUX $V $COST $GS $MA $TWX $AAPL $SPG $AIG $MO $ABT $HD $AMGN $LLY more@ https://t.co/cKkr8cKsju$AMGN Positive Efficacy And Tolerability Study Of Repatha¬Æ  Published In Journal of the American Medical Association https://t.co/NzihwsGwXERT @MarketCurrents: Amgen's Repatha shows greater cholesterol reduction than ezetimibe https://t.co/bF5xAQGTPZ $AMGN $MRK $AMGN$AMGN: Amgen reports positive efficacy and tolerability study Of Repatha published in JAMA https://t.co/mlKrLq4RM8Better Buy: Amgen Inc. vs. Celgene Corp. $AMGN , $CELG https://t.co/f4irsA6sQF https://t.co/cqz1sTPOtFRT @MarketCurrents: Amgen's Repatha shows greater cholesterol reduction than ezetimibe https://t.co/bF5xAQGTPZ $AMGN $MRK $AMGNRT @theflynews: On The Fly: Top five weekend stock stories $TSLA $SUNE $EW $MDT $AMGN $IRMD $YHOO $TIME $SFTBF $TWX $UTX $MTW ... https://t‚Ä¶These $ITUS Profits Are much Bigger Than $AMGNRT @matthewherper: Somebody name a single case where a drug failed totally, and another with same mechanism proved effective. #CETP $MRK $A‚Ä¶RT @theflynews: On The Fly: Top five weekend stock stories $TSLA $SUNE $EW $MDT $AMGN $IRMD $YHOO $TIME $SFTBF $TWX $UTX $MTW ... https://t‚Ä¶RT @theflynews: On The Fly: Top five weekend stock stories $TSLA $SUNE $EW $MDT $AMGN $IRMD $YHOO $TIME $SFTBF $TWX $UTX $MTW ... https://t‚Ä¶RT @JohnCFierce: Interesting: Seamus Fernandez at Leerink believes that $AMGN will now drop its recently acquired cetp program (Dezima). $M‚Ä¶RT @matthewherper: Somebody name a single case where a drug failed totally, and another with same mechanism proved effective. #CETP $MRK $A‚Ä¶$AMGN high open interest range is 147.00 to 155.00 for option expiration 04/08/2016.  https://t.co/t6XWBsPsX7 https://t.co/xFQQaTuxkF$AMGN:

Company Shares of Amgen (NASDAQ:AMGN) Rally 3.3%:

https://t.co/cX3oyOaKmWOn The Fly: Top five weekend stock stories $TSLA $SUNE $EW $MDT $AMGN $IRMD $YHOO $TIME $SFTBF $TWX $UTX $MTW ... https://t.co/enffREf7LDTrading Strategies Partners: https://t.co/Upddhj47pY $AAPL $NFLX $QQQ $SPY $DJIA $VZ $GS $INTC $AA $INTC $NFLX $GS $JPM $T $MMM $AMGNRT @matthewherper: Somebody name a single case where a drug failed totally, and another with same mechanism proved effective. #CETP $MRK $A‚Ä¶RT @matthewherper: Somebody name a single case where a drug failed totally, and another with same mechanism proved effective. #CETP $MRK $A‚Ä¶RT @matthewherper: Somebody name a single case where a drug failed totally, and another with same mechanism proved effective. #CETP $MRK $A‚Ä¶RT @matthewherper: Somebody name a single case where a drug failed totally, and another with same mechanism proved effective. #CETP $MRK $A‚Ä¶RT @matthewherper: Somebody name a single case where a drug failed totally, and another with same mechanism proved effective. #CETP $MRK $A‚Ä¶Somebody name a single case where a drug failed totally, and another with same mechanism proved effective. #CETP $MRK $AMGN $PFEWas $MRK simply stuck with cetp, or was it the old hubris shining through? $AMGN investors may have some questions for R&amp;D.Interesting: Seamus Fernandez at Leerink believes that $AMGN will now drop its recently acquired cetp program (Dezima). $MRK - RIPFour Best #Biotech #Stocks of the First Quarter of 2016 $KIN $CRMD $ALIOF $MESO Also $AMGN $GILD $SHPG $BXLT https://t.co/xu3NT8MYjF",2016-04-04,AMGN,0
5,"Nasdaq100 #Stocks Trend $TSLA $GILD $CELG $ALXN $EBAY $NFLX $ISRG $FOXA $BMRN $INCY $AMGN $ILMN $GRMN $ADP $TXN @ https://t.co/YdSIjFJqHfS&amp;P100 #Stocks Trend $PFE $GILD $CELG $LMT $PM $MRK $BMY $ABBV $FOXA $AMGN $JNJ $PEP $MCD $TXN $CL $LOW $ABT  @ https://t.co/cKkr8cKsju$AMGN takes issue with yet-to-be published #MultipleMyeloma drug report. #myeloma #drugcosts https://t.co/mxapX2hHyc https://t.co/ZoqYRqpRcdInvestment Analysts‚Äô Updated EPS Estimates for April, 5th $AMGN, BIIB, BMA, BSET, CEB, CELG, CFMS, DLR, EDR, EGO https://t.co/ggqZ6DO2A1RT @pharmalot: FDA proposes biosimilars labeling that favors generic drug makers.. read it here.. https://t.co/PnSLMkw4WB #pharma #FDA $ABB‚Ä¶RT @seeitmarket: New Post -  5 Large Cap Biotech Stocks With Upside https://t.co/1X6jpQSUsX by @OphirGottlieb $GILD $BIIB $AMGN $REGN https‚Ä¶Amgen initiated by BMO Capital Markets at outperform. https://t.co/y5gMTpj5m2 $AMGN #AMGNAmgen Inc Initiated Coverage by BMO Capital Markets (Ranked 12th) to Outperform $AMGN #AMGN https://t.co/bqjkWr2ARAAmgen, Inc. $AMGN Now Covered by BMO Capital Markets https://t.co/gLHZVDNaw4$AMGN Max Pain = 150.00. Maturity = 04/08/2016.  Previous close = 154.66. bearish  https://t.co/K9LYWYS5rZ https://t.co/1DV7haaXFvAmgen initiated by BMO Capital Markets at outperform. https://t.co/msriUZYP9I $AMGN #AMGNRT @seeitmarket: New Post -  5 Large Cap Biotech Stocks With Upside https://t.co/1X6jpQSUsX by @OphirGottlieb $GILD $BIIB $AMGN $REGN https‚Ä¶#Evolocumab Cuts Cholesterol for #Statin Intolerant‚Äîbut #JAMA Says Cost Too High $AMGN $SNY $REGN https://t.co/ccQ2OaLA1n via @ajmc_journal@tgtxdough $AMGN AMGN; OP; $183 PT)
Very Little Has to Go Right for AMGN to Move HigherBMO April 05, 2016
Research Report
 M. Ian Somaiya
BMO Capital Markets Corp.Initiating Coverage of $CELG $AMGN $GILD and $BIIBNew Post -  5 Large Cap Biotech Stocks With Upside https://t.co/1X6jpQSUsX by @OphirGottlieb $GILD $BIIB $AMGN $REGN https://t.co/aEVMYkWYpjAmgen, Inc. $AMGN Position Held by Texas Yale Capital Corp. https://t.co/kZ8WTou4hzNasdaq100 #Stocks Trend $TSLA $GILD $CELG $ALXN $ADP $ISRG $BMRN $EBAY $NFLX $TXN $FOXA $INCY $CHTR $AAPL $AMGN @ https://t.co/YdSIjFJqHfAmgen, Inc. $AMGN Shares Sold by New York State Common Retirement Fund https://t.co/wZdrPLK99QIntermede Investment Partners Ltd Invests $23,103,000 in Amgen, Inc. $AMGN https://t.co/vVBS0kBvoFIntermede Investment Partners Ltd Invests $23,103,000 in Amgen, Inc. $AMGN https://t.co/oaplkTQlmXAmgen, Inc. $AMGN Stake Held by Sivik Global Healthcare LLC https://t.co/lxUAedwrjNAmgen, Inc. $AMGN Stake Held by Sivik Global Healthcare LLC https://t.co/hrgu4YYOxLS&amp;P100 #Stocks Trend $PFE $GILD $CELG $LMT $MRK $BMY $PM $ABBV $JNJ $TXN $PEP $HD $FOXA $CL $AAPL $AMGN $MCD  @ https://t.co/cKkr8cKsjuVan Strum &amp; Towne Inc. Has $6,578,000 Position in Amgen, Inc. $AMGN https://t.co/AkjEv5XXSYAmgen, Inc. $AMGN Position Held by Texas Yale Capital Corp. https://t.co/QwzCdECJcYAmgen, Inc. $AMGN Position Held by Texas Yale Capital Corp. https://t.co/FL4ay3ooV2These $ITUS Profits Are much Bigger Than $AMGN@BioDctr good chance the company that helped $HALO develop its 1st Non enzymatic Rx - a mAb-has interest- see HALO CEO history w $AMGN -ONXX$AMGN:

Amgen, Inc. (NASDAQ:AMGN) Given Average Recommendation of ‚Ä¶:

https://t.co/3P7UoMwfj1$AMGN:

Amgen, Inc. (NASDAQ:AMGN) Receives Average Recommendation ‚Ä¶:

https://t.co/JT3qakvkSnKyprolis was $ONXX's 1st Protesome Inhibitor- $HALO CEO nurtured it for $AMGNAmgen Inc Reiterated Rating by Leerink Swann (Ranked 71st) to Market Perform $AMGN #AMGN https://t.co/bqjkWr2ARAAmgen, Inc. $AMGN Given ‚ÄúMarket Perform‚Äù Rating at Leerink Swann https://t.co/MCWzPKgcAxAmgen's market perform rating reiterated at Leerink Swann. https://t.co/lFqbwH8mzs $AMGN #AMGNAmgen, Inc. $AMGN Given ‚ÄúMarket Perform‚Äù Rating at Leerink Swann https://t.co/vhPcMpxswIAmgen's market perform rating reiterated at Leerink Swann. https://t.co/na6Gkomnsy $AMGN #AMGNAMGN Top news - Apr 5th, 2016 $AMGN https://t.co/zVlcQsfFKo$HALO was exclusively an Enzyme Co. under CEO's Lim &amp; Frost-now Torley ex $BMY ex $AMGN ex ONXX has it making mAbs-for whom? Itself? Buyer?Analysis shows pharma companies aggressively increased prices on widely used drugs $ABBV $AMGN $TEVA https://t.co/ekXJUC8py6#Amgen takes issue with yet-to-be published multiple-myeloma drug report. Read more: https://t.co/fw58Sp3vfs $AMGNRT @ScripDonnaDC: ICYMI: Court Probes Rationale For Biosimilars' 180-Day Notice 
https://t.co/JY28QAEsKe
$AMGN $NVS #BPCIA #biosimilars #bi‚Ä¶RT @ScripDonnaDC: ICYMI: Court Probes Rationale For Biosimilars' 180-Day Notice 
https://t.co/JY28QAEsKe
$AMGN $NVS #BPCIA #biosimilars #bi‚Ä¶Nasdaq100 #Stocks Trend $GILD $ALXN $ISRG $TSLA $BMRN $FOXA $INCY $EBAY $NFLX $SPLS $AMGN $ILMN $ADP $TXN $SBAC @ https://t.co/YdSIjFJqHfS&amp;P100 #Stocks Trend $GILD $PFE $LMT $MRK $BMY $PM $ABBV $JNJ $PEP $FOXA $HD $AMGN $CL $TXN $ABT $MCD $AAPL  @ https://t.co/cKkr8cKsjuI'm checking out $AMGN #thinkorswim@investFeed https://t.co/Mg4qkUpZI4RT @BreakoutStocks: A Biotech Breakout? https://t.co/fA97Kf4Vsh $IBB $XBI $AMGN $REGNBiotech: Time To Buy Or Sell? Surprising Stock Tips $BSX $IBB $AMGN https://t.co/c76HnkMDje$AMGN takes issue with yet-to-be published #MultipleMyeloma drug report. #myeloma #drugcosts https://t.co/mxapX2hHyc https://t.co/GIMchwtHyNWho will experience the most EPS growth next year? $BXLT@34.4%, $PFE@44%, $AMGN@5% https://t.co/yvS3uiaZrp https://t.co/02bFbBV9FDRT @pharmalot: FDA proposes biosimilars labeling that favors generic drug makers.. read it here.. https://t.co/PnSLMkw4WB #pharma #FDA $ABB‚Ä¶CYDY running, FLKS is just starting: https://t.co/lwSyWTxOEB $AMBS $AMG.DE $AMGN $AMGN.BA $AMGN.MX $AMGN34.SA $AMGN34F.SA $AMPEPerspective: YTD Losses:

$AGN ‚¨áÔ∏è 26%
$PFE ‚¨áÔ∏è 4.1%
$XLV ‚¨áÔ∏è 4.6%
$MRK ‚¨ÜÔ∏è 3.3%
$CELG ‚¨áÔ∏è 15%
$AMGN ‚¨áÔ∏è 5%
$IBB ‚¨áÔ∏è 19.5%

$AGN Value ? warranted?A Biotech Breakout? $IBB $XBI $AMGN $REGN https://t.co/S6DviHMrfm https://t.co/T4L3ZfvWUc https://t.co/tli9FCHdT7Trending #Biotech topics include $AMGN, $REGN, #Norvasc #stocks #invest See more https://t.co/EpbbdqDEG1RT @BreakoutStocks: A Biotech Breakout? https://t.co/fA97Kf4Vsh $IBB $XBI $AMGN $REGNA Biotech Breakout? https://t.co/fA97Kf4Vsh $IBB $XBI $AMGN $REGN$AMGN: At/Above 200DaySMA[-154.69]:2M, cl:+19, 0NearHi:BrkPLo[+1.3%], AtPivPt, tf:1110111, ch:+0.1%, bigFlt:751M; TLM:1.2; ILM:1.5$AMGN $MDT $MMM:

Trade of the Day: Nautilus, Inc. (NYSE:NLS):

https://t.co/dbiaCsfmxCAMGN Message Board Posts
See Here ---&gt; https://t.co/dswStpcUIZ

$AMGN $BK $HOG #investingRT @fwpharma: Amgen's PCSK9 inhibitor Repatha more effective than Merck &amp; Co.'s Zetia: study https://t.co/1FZ5o3O3Yy $AMGN $MRL #pharmaICYMI: Court Probes Rationale For Biosimilars' 180-Day Notice 
https://t.co/JY28QAEsKe
$AMGN $NVS #BPCIA #biosimilars #biosimilar #pharmaRT @pharmalot: FDA proposes biosimilars labeling that favors generic drug makers.. read it here.. https://t.co/PnSLMkw4WB #pharma #FDA $ABB‚Ä¶RT @pharmalot: FDA proposes biosimilars labeling that favors generic drug makers.. read it here.. https://t.co/PnSLMkw4WB #pharma #FDA $ABB‚Ä¶RT @pharmalot: FDA proposes biosimilars labeling that favors generic drug makers.. read it here.. https://t.co/PnSLMkw4WB #pharma #FDA $ABB‚Ä¶RT @pharmalot: FDA proposes biosimilars labeling that favors generic drug makers.. read it here.. https://t.co/PnSLMkw4WB #pharma #FDA $ABB‚Ä¶RT @pharmalot: FDA proposes biosimilars labeling that favors generic drug makers.. read it here.. https://t.co/PnSLMkw4WB #pharma #FDA $ABB‚Ä¶Weekly S&amp;P500 #Stocks Trend $EW $ALXN $ZTS $MNK $BSX $ISRG $GIS $AAPL $ABBV $VAR $CRM $BMY $YHOO $AMT $AMGN  @ https://t.co/RPeaHBHYi0Weekly Nasdaq100 #Stocks Trend $ALXN $ILMN $TSLA $BMRN $ISRG $LBTYA $AAPL $YHOO $AMGN $CTXS $INTU $FOXA $GILD  @ https://t.co/YdSIjFJqHfWeekly S&amp;P100 #Stocks Trend $AAPL $ABBV $BMY $AMGN $PFE $MRK $PEP $CVS $PM $FOXA $GILD $TWX $V $MCD $ABT  @ https://t.co/cKkr8cKsjuWeekly S&amp;P100 #Stocks Performance $AAPL $ABBV $BMY $V $BIIB $MDLZ $AMGN $MA $LLY $MCD $MSFT $ABT $COST  more@ https://t.co/cKkr8cKsjuAmgen, Inc. $AMGN Lowered to Hold at Zacks Investment Research https://t.co/sS4Q1aAFT3Biotech: Time To Buy Or Sell? Surprising Stock Tips $BSX $IBB $AMGN https://t.co/PWEwCXIhgYAeglea Biotherapeutics IPO: Wait For Larger April Deals $AGLE Also $AZN $BMY $JNJ $LLY $NVS $AMGN $CELG https://t.co/D9Fw7YKUpJThese $ITUS Profits Are much Bigger Than $AMGN$AMGN:

Shares of Amgen (NASDAQ:AMGN) Sees Large Outflow of Money:

https://t.co/PnIko6vEilCYDY running, FLKS is just starting: https://t.co/lwSyWTxOEB $AMDA $AME $AMED $AMFW $AMG $AMGN $AMH $AMH-A$AMGN:

AMGEN INC (NASDAQ:AMGN): Target Price of 181.7 expected:

https://t.co/7TaIuATFWMCommented on Gilead Sciences Vs. Its Peers https://t.co/nFKc2XmY45 $ABBV $AMGN $CELG $IBB $XBI $GILDRT @ScripDonnaDC: Court Probes Rationale For Biosimilars' 180-Day Notice 
https://t.co/JY28QAEsKe
$AMGN #BPCIA #biosimilars #biosimilar #ph‚Ä¶EPRS 52Wk Low
See Here ---&gt; https://t.co/mkMfBafeFt

$EPRS $AMGN $ZFGN #financeCourt Probes Rationale For Biosimilars' 180-Day Notice 
https://t.co/JY28QAEsKe
$AMGN #BPCIA #biosimilars #biosimilar #pharmaRT @Sandro_power: $AMGN is setup for higher here. chart plan explains key points https://t.co/ZE4wLHvXikBiotech: Time To Buy Or Sell? Surprising Stock Tips $BSX $IBB $AMGN https://t.co/c76HnkMDje$AMGN high open interest range is 148.00 to 155.00 for option expiration 04/08/2016.  https://t.co/GWTSKbUlk8 https://t.co/QlNUPETbAOAeglea Biotherapeutics IPO: Wait For Larger April Deals $AGLE Also $AZN $BMY $JNJ $LLY $NVS $AMGN $CELG https://t.co/kRI4SpPxo8Aeglea Biotherapeutics IPO: Wait For Larger April Deals $AGLE Also $AZN $BMY $JNJ $LLY $NVS $AMGN $CELG https://t.co/j6g9N575hWRT @G_Commish: @pinsky6 faith is not subjective. Do your diligence. How do you think $Amgn sellers feel 30 years later? I'm a buyer. Look a‚Ä¶NE Ideas
See Here ---&gt; https://t.co/rEKw6Mdxkg

$NE $AMGN $ZEUS #pennystocksTrading Strategies Partners: https://t.co/Upddhj47pY $AAPL $NFLX $QQQ $SPY $DJIA $VZ $GS $INTC $AA $INTC $NFLX $GS $JPM $T $MMM $AMGNRT @pharmalot: FDA proposes biosimilars labeling that favors generic drug makers.. read it here.. https://t.co/PnSLMkw4WB #pharma #FDA $ABB‚Ä¶After looking at $AGN compared to other biotechs like $AMGN, only thing keeping $AGN afloat is the promise of a $PFE buyout$CYTK Announces Start of Ph2 Clinical Trial of Omecamtiv Mecarbil in Japan for Heart Failure #partnering with $AMGN https://t.co/ZlcRC0xvs9",2016-04-05,AMGN,1
6,"VLO Last Trade
See Here ---&gt; https://t.co/8GWKoYK85s

$VLO $CYBE $AMGN #tradeideasRT @pharmalot: Amgen balks at meeting to review cost of bone #cancer drugs.. read statement here &amp; ICER response.. https://t.co/CoP09jlJmZ‚Ä¶Muchas noticias P/ $IBB!: La princ es la especulaci√≥n sobre q empresa va a comprar  $AGN: $BIIB $CELG $AMGN $ABBV https://t.co/H9xvF10xUXS&amp;P500 #Stocks Trend $ALXN $CELG $STZ $REGN $OI $MCK $BIIB $PFE $AMGN $MNK $EBAY $KMX $EW $CAH $ZTS $SEE $MLM  @ https://t.co/RPeaHBHYi0Nasdaq100 #Stocks Trend $INCY $BMRN $ILMN $ALXN $CELG $REGN $BIIB $AMGN $EBAY $TSLA $ISRG $GILD $FOXA $ADP  @ https://t.co/YdSIjFJqHfNasdaq100 #Stocks Performance $INCY $VRTX $BMRN $ILMN $ALXN $CELG $REGN $MYL $BIIB $AMGN $EBAY $TSLA $AKAM  more@ https://t.co/YdSIjFJqHfS&amp;P100 #Stocks Trend $CELG $BIIB $PFE $AMGN $MRK $MDT $ABT $ABBV $GILD $FOXA $TWX $BMY $PM $LMT $V $MO $PG  @ https://t.co/cKkr8cKsjuS&amp;P100 #Stocks Performance $CELG $HAL $BIIB $PFE $DVN $AMGN $COP $OXY $APC $KMI $AGN $HPQ $AMZN $MRK $MDT  more@ https://t.co/cKkr8cKsju@Sharma1981N @VM1409 Looking at # and enrollment # of/in $AMGN $TEVA $LLY p3 CGRPi trials maybe $ALDR needs more $ than we think?23:35-&gt;https://t.co/vqaokSKgmf

Also,see:https://t.co/Tx8cJJUe7g

$AMGN $SNY $LLY $BAYRY $GILD $BIIB $CELG $REGN https://t.co/GOUhn7Y5HI180 Bullish https://t.co/j5Ufe4aNwK $SRPT $EWM $ERIC $ACAD $FISV $ANTM $MDVN $CCE $BSX $HIMX $ABC $GERN $AKRX $ARRY $MGM $AMGN $LKQ $MDYA battle that will come to seem all too familiar in the near future... #drugpricing $AMGN https://t.co/qORguvUcXW$AMGN maturity 04/08/2016 oi CallPutRatio of 1.33 puts 2,534 &amp; calls 1,906 bearish. https://t.co/t6XWBsPsX7 https://t.co/XrumQ7P9SW$es_f $spx $nasdaq $xom $GOOGL $AMZN $DIS $HD $BAC $GS $AMGN $QQQ $IWM $NKE $KO $MCD $AXP Understanding Order Flow https://t.co/GruJJPOA3S$AMGN posted on my stream april 04 so far the options I have mentioned in my plan are up 130% from my confirmation. https://t.co/mrQD3hd8xqCalamos Advisors LLC Purchases 1,400 Shares of Amgen, Inc. $AMGN https://t.co/l7YtqRQlCHBig day for #biotechs , 5% pop for the sector , help #nasdaq gain 76 points for the day. $BBH $AMGN $ALXN $REGN $VRTX $JAZZTeacher Retirement System of Texas Increases Stake in Amgen, Inc. $AMGN https://t.co/2PBYLKpccSOppenheimerFunds Inc. Sells 111,815 Shares of Amgen, Inc. $AMGN https://t.co/iZ5c8SM2oeToday's Top 5 Technical Gainers among Large Caps: $ILMN, $BXLT, $AMGN, $PFE, $CELG https://t.co/ctFzkw6tom #sccrankings #stockchartsS&amp;P500 #Stocks Trend $VRTX $CELG $REGN $BIIB $OI $ALXN $STZ $PFE $MCK $EBAY $AMGN $EW $KMX $ZTS $CAH $UA $MLM  @ https://t.co/RPeaHBHYi0Nasdaq100 #Stocks Trend $INCY $VRTX $BMRN $CELG $ILMN $REGN $BIIB $ALXN $EBAY $AMGN $TSLA $ISRG $FOXA $GILD  @ https://t.co/YdSIjFJqHfNasdaq100 #Stocks Performance $INCY $VRTX $BMRN $CELG $ILMN $REGN $BIIB $ALXN $MYL $EBAY $AMGN $TSLA $AKAM  more@ https://t.co/YdSIjG11yNS&amp;P100 #Stocks Trend $CELG $BIIB $PFE $AMGN $MRK $ABT $ABBV $MDT $FOXA $GILD $TWX $BMY $PM $LMT $HAL $CMCSA  @ https://t.co/cKkr8csQUUS&amp;P100 #Stocks Performance $HAL $CELG $BIIB $PFE $COP $AMGN $DVN $KMI $OXY $AGN $APC $MRK $HPQ $ABT $AMZN  more@ https://t.co/cKkr8cKsjuRT @pharmalot: Amgen balks at meeting to review cost of bone #cancer drugs.. read statement here &amp; ICER response.. https://t.co/CoP09jlJmZ‚Ä¶Noteworthy Wednesday Option Activity: $GOGO  $YHOO  $AMGN #stockoptions https://t.co/zOAs45UDGyNEW POST: Painting the Picture  https://t.co/YWk5BYwEqv $AMGN $BIS $GILD $IBB $XBIRT @StockTwits: Whoa. Biotech is having a monster day.

$CELG +6%
$BIIB +5%
$REGN +5%
$AMGN +4%

Now look at the sector ETF $IBB: https://t‚Ä¶$AMGN #Options volume chart in animation. More with #OptionsPro FREE app at https://t.co/K8PrRVM20E https://t.co/xvMaPnwnAO$AMGN she down and $BIIB declining too, I am done for today traders seriously this time.RT @pharmalot: Amgen balks at meeting to review cost of bone #cancer drugs.. read statement here &amp; ICER response.. https://t.co/CoP09jlJmZ‚Ä¶RT @pharmalot: Amgen balks at meeting to review cost of bone #cancer drugs.. read statement here &amp; ICER response.. https://t.co/CoP09jlJmZ‚Ä¶RT @pharmalot: Amgen balks at meeting to review cost of bone #cancer drugs.. read statement here &amp; ICER response.. https://t.co/CoP09jlJmZ‚Ä¶Unicorn Bay rating for $AMGN is 3.33 out of 5. https://t.co/KGl3e8T4UOAmgen balks at meeting to review cost of bone #cancer drugs.. read statement here &amp; ICER response.. https://t.co/CoP09jlJmZ #pharma $AMGNRT @StockTwits: Whoa. Biotech is having a monster day.

$CELG +6%
$BIIB +5%
$REGN +5%
$AMGN +4%

Now look at the sector ETF $IBB: https://t‚Ä¶Wondering about #sentiment indicator for $AMGN? The Short Ratio is 2.96% https://t.co/HcLgB2rjNX$AMGN sentiment rise to: 0.89, change: +0.75, sdr: 1.78, 1H, 3:00 PM, #nasdaq $NDX $SPY$AMGN nope not going to do it, see you guys tomorrow https://t.co/GaE8VIpjyS$IBB Looking at the strength in leading bio names $CELG $AMGN $GILD $REGN, it doesn't look like this rally is going to run out steam here$AMGN nominated the big tease of the day, acts like it wants to die but never does $159.29 currentlyRT @sanglucci: $IBB and the dog pharmas are finally doing it. Nice moves thus far lotta juice here $AMGNRT @StockTwits: Whoa. Biotech is having a monster day.

$CELG +6%
$BIIB +5%
$REGN +5%
$AMGN +4%

Now look at the sector ETF $IBB: https://t‚Ä¶RT @StockTwits: Whoa. Biotech is having a monster day.

$CELG +6%
$BIIB +5%
$REGN +5%
$AMGN +4%

Now look at the sector ETF $IBB: https://t‚Ä¶StockTwits: Whoa. Biotech is having a monster day.

$CELG +6%
$BIIB +5%
$REGN +5%
$AMGN +4%

Now look at the secto‚Ä¶ https://t.co/spbUBQVbPvRT @StockTwits: Whoa. Biotech is having a monster day.

$CELG +6%
$BIIB +5%
$REGN +5%
$AMGN +4%

Now look at the sector ETF $IBB: https://t‚Ä¶RT @StockTwits: Whoa. Biotech is having a monster day.

$CELG +6%
$BIIB +5%
$REGN +5%
$AMGN +4%

Now look at the sector ETF $IBB: https://t‚Ä¶RT StockTwits: Whoa. Biotech is having a monster day.

$CELG +6%
$BIIB +5%
$REGN +5%
$AMGN‚Ä¶ https://t.co/2TLhE1deMQ https://t.co/unKBV0NM78Trending #Biotech topics include $REGN, $AMGN, #Propecia #stocks #invest See more https://t.co/EpbbdqDEG1RT @StockTwits: Whoa. Biotech is having a monster day.

$CELG +6%
$BIIB +5%
$REGN +5%
$AMGN +4%

Now look at the sector ETF $IBB: https://t‚Ä¶RT @StockTwits: Whoa. Biotech is having a monster day.

$CELG +6%
$BIIB +5%
$REGN +5%
$AMGN +4%

Now look at the sector ETF $IBB: https://t‚Ä¶Rotation into biotech is happening, especially the long over suppressed names $IBB $SNY $GILD $AMGN $REGN $NK $OPHTRT @StockTwits: Whoa. Biotech is having a monster day.

$CELG +6%
$BIIB +5%
$REGN +5%
$AMGN +4%

Now look at the sector ETF $IBB: https://t‚Ä¶RT @StockTwits: Whoa. Biotech is having a monster day.

$CELG +6%
$BIIB +5%
$REGN +5%
$AMGN +4%

Now look at the sector ETF $IBB: https://t‚Ä¶RT @StockTwits: Whoa. Biotech is having a monster day.

$CELG +6%
$BIIB +5%
$REGN +5%
$AMGN +4%

Now look at the sector ETF $IBB: https://t‚Ä¶RT @StockTwits: Whoa. Biotech is having a monster day.

$CELG +6%
$BIIB +5%
$REGN +5%
$AMGN +4%

Now look at the sector ETF $IBB: https://t‚Ä¶RT @StockTwits: Whoa. Biotech is having a monster day.

$CELG +6%
$BIIB +5%
$REGN +5%
$AMGN +4%

Now look at the sector ETF $IBB: https://t‚Ä¶RT @StockTwits: Whoa. Biotech is having a monster day.

$CELG +6%
$BIIB +5%
$REGN +5%
$AMGN +4%

Now look at the sector ETF $IBB: https://t‚Ä¶RT @StockTwits: Whoa. Biotech is having a monster day.

$CELG +6%
$BIIB +5%
$REGN +5%
$AMGN +4%

Now look at the sector ETF $IBB: https://t‚Ä¶RT @StockTwits: Whoa. Biotech is having a monster day.

$CELG +6%
$BIIB +5%
$REGN +5%
$AMGN +4%

Now look at the sector ETF $IBB: https://t‚Ä¶Whoa. Biotech is having a monster day.

$CELG +6%
$BIIB +5%
$REGN +5%
$AMGN +4%

Now look at the sector ETF $IBB: https://t.co/ukIc5C5Q2lEyes wide open now for most peeps. Will be more telling if this move continues next week $IBB $GILD $CELG $AMGN $REGN $BIIB $JAZZ $ILKM $VRXRT SeekingAlpha: U.S. Biosimilar Space Reaches Its Inflectra Point https://t.co/vpJsSVTwbq $JNJ $AMGN $CHRS $PFE$NVS $AMGN:

US Biosimilar Space Reaches Its Inflectra Point:

https://t.co/gTXswJ1aqd$AMGN takes issue with yet-to-be published #MultipleMyeloma drug report. #myeloma #drugcosts https://t.co/mxapX2hHyc https://t.co/Nxm06TzOcO$AMGN like watching paint dry https://t.co/HHb7pjCvMBU.S. Biosimilar Space Reaches Its Inflectra Point https://t.co/56w9VfthCo $JNJ $AMGN $CHRS $PFERT @pharmalot: FDA proposes biosimilars labeling that favors generic drug makers.. read it here.. https://t.co/PnSLMkw4WB #pharma #FDA $ABB‚Ä¶Trading Strategies Partners: https://t.co/UpddhiMw1o $AAPL $NFLX $QQQ $SPY $DJIA $VZ $GS $INTC $AA $INTC $NFLX $GS $JPM $T $MMM $AMGNBiotech Sector Outlook (video + static charts) - https://t.co/8GlXA7UHZ2 $XBI $IBB $PBE $GILD $AMGN $ABBV $CELG $BIIB $REGN$AMGN #VALUE Agreed nancy tengler on @cnbcQQQTradingTip‚Äôs Results: $AMGN opened LONG on 4/05 at $153.00 and closed today's at $158.50 +3.59% https://t.co/tHKkaFyUHg $QQQ $DJIA $SPYAMGN Top news - Apr 6th, 2016 $AMGN https://t.co/Zx4HXJaAf5RT @EquityClock: Biotech ETFs $IBB $BBH are streaming higher thanks to intermediate breakouts this morning by $AMGN,$BIIB and $CELG https:/‚Ä¶RT @herostick: $CYTK big upside move over the last week or so. I don't like this company, but it has been long rumored that $AMGN will acqu‚Ä¶$AMGN $158.57 looking at the hourly I just knew she was ready to call it quits but I am not sure going watch her7 Healthcare Stocks to Buy for Your Retirement $AMGN $BDX $MDT ... https://t.co/vs6Ck1UEAB https://t.co/G1yBvqaz6sRT @sanglucci: $IBB and the dog pharmas are finally doing it. Nice moves thus far lotta juice here $AMGN@MaverickNY forgot $AMGNFacing a new assessment of Kyprolis, Amgen castigates cost-effectiveness team's methods https://t.co/KZaPjImQrH $AMGN #pharma @CarlyHFierceFacing a new assessment of Kyprolis, Amgen castigates cost-effectiveness team's methods: https://t.co/GeXWDE47KY $AMGN #pharmaRT @PersonsPlanet: Heads up for remaining positions in $AMGN profit target is 159 now at 158.11 and $IBB target is 283 now at 281 exit all‚Ä¶RT @PersonsPlanet: Heads up for remaining positions in $AMGN profit target is 159 now at 158.11 and $IBB target is 283 now at 281 exit all‚Ä¶RT @PersonsPlanet: Heads up for remaining positions in $AMGN profit target is 159 now at 158.11 and $IBB target is 283 now at 281 exit all‚Ä¶$es_f $spx $nasdaq $xom $GOOGL $AMZN $DIS $HD $BAC $GS $AMGN $v $QQQ $IWM $NKE $KO $MCD $AXP 04-06-2016 Trader Bite https://t.co/4xZjtXhhvlRT @PersonsPlanet: Heads up for remaining positions in $AMGN profit target is 159 now at 158.11 and $IBB target is 283 now at 281 exit all‚Ä¶FNMA Exchange
See Here ---&gt; https://t.co/KsIxb6luKu

$FNMA $AMGN $PNFP #nasdaqRT @PersonsPlanet: Heads up for remaining positions in $AMGN profit target is 159 now at 158.11 and $IBB target is 283 now at 281 exit all‚Ä¶ABX Exchange
See Here ---&gt; https://t.co/U2aiyFfNVg

$ABX $AMGN $JEC #nasdaqRT @EquityClock: Biotech ETFs $IBB $BBH are streaming higher thanks to intermediate breakouts this morning by $AMGN,$BIIB and $CELG https:/‚Ä¶RT @PersonsPlanet: Heads up for remaining positions in $AMGN profit target is 159 now at 158.11 and $IBB target is 283 now at 281 exit all‚Ä¶RT @PersonsPlanet: Heads up for remaining positions in $AMGN profit target is 159 now at 158.11 and $IBB target is 283 now at 281 exit all‚Ä¶RT @PersonsPlanet: Heads up for remaining positions in $AMGN profit target is 159 now at 158.11 and $IBB target is 283 now at 281 exit all‚Ä¶RT @PersonsPlanet: Heads up for remaining positions in $AMGN profit target is 159 now at 158.11 and $IBB target is 283 now at 281 exit all‚Ä¶Biotech ETFs $IBB $BBH are streaming higher thanks to intermediate breakouts this morning by $AMGN,$BIIB and $CELG https://t.co/E5zAbBNJE5RT @PersonsPlanet: Heads up for remaining positions in $AMGN profit target is 159 now at 158.11 and $IBB target is 283 now at 281 exit all‚Ä¶S&amp;P500 #Stocks Trend $CELG $STZ $KMX $ALXN $PFE $EBAY $EW $AMGN $ISRG $MDT $BMY $ABBV $MRK $GILD $FOXA $CCE  @ https://t.co/RPeaHBHYi0Heads up for remaining positions in $AMGN profit target is 159 now at 158.11 and $IBB target is 283 now at 281 exit all 260/65 call spreadsNasdaq100 #Stocks Trend $CELG $ILMN $ALXN $EBAY $AMGN $ISRG $TSLA $GILD $FOXA $BMRN $INCY $NFLX $LMCA $AAPL  @ https://t.co/YdSIjFJqHfNasdaq100 #Stocks Performance $INCY $VRTX $CELG $ILMN $BMRN $ALXN $MYL $EBAY $BIIB $AMGN $AKAM $ISRG $TSLA  more@ https://t.co/YdSIjFJqHfS&amp;P100 #Stocks Trend $CELG $PFE $AMGN $MDT $BMY $ABBV $MRK $GILD $FOXA $PM $LMT $ABT $PG $HAL $MO $AAPL $BIIB  @ https://t.co/cKkr8cKsjuS&amp;P100 #Stocks Performance $HAL $DVN $CELG $AGN $PFE $COP $BIIB $AMGN $KMI $MDT $ABT $OXY $BMY $ABBV $MRK  more@ https://t.co/cKkr8cKsju$CYTK big upside move over the last week or so. I don't like this company, but it has been long rumored that $AMGN will acquire them.$IBB $CELG $GILD $BIIB $AMGN $REGN MY TOP 10 POSITIONS BIOTECHNOLOGY, $VRTX $ALXN 
(Giant company) , https://t.co/borQWNNOrxGet ready to squeeze $SRPT shorts!
$ACAD $CPXX $AMGN $BLRX $ICPT $CELGRT @seeitmarket: New Post -  5 Large Cap Biotech Stocks With Upside https://t.co/1X6jpQSUsX by @OphirGottlieb $GILD $BIIB $AMGN $REGN https‚Ä¶KST EOD Data
See Here ---&gt; https://t.co/BS2tXH7LAQ

$KST $AMGN $TSO #stocks$PFE -about a year behind $AMGN in anti PCSK9 - needs to turn a dosing disadvantage into a dosing advantage -needs $HALO Enhanze &amp; knows it$AMGN high open interest range is 152.50 to 155.00 for option expiration 04/08/2016.  https://t.co/t6XWBsPsX7 https://t.co/SBNcTTdq5fRT @pharmalot: FDA proposes biosimilars labeling that favors generic drug makers.. read it here.. https://t.co/PnSLMkw4WB #pharma #FDA $ABB‚Ä¶With death of inversions like $AGN $PFE other stocks like $CELG $GILD $ABBV $AMGN benefit from less political focus on Biotech/Pharma sectorOn The Fly: Top five analyst initiations  $AMGN $AAPL $BIIB $LMCA $WPX: Full Story https://t.co/qc4ncQIIlOBMO analyst Ian Somaiya initiated coverage: Amgen $AMGN with an ‚Äúoutperform‚Äù rating and $183 price target.$IBB and the dog pharmas are finally doing it. Nice moves thus far lotta juice here $AMGNRT @seeitmarket: New Post -  5 Large Cap Biotech Stocks With Upside https://t.co/1X6jpQSUsX by @OphirGottlieb $GILD $BIIB $AMGN $REGN https‚Ä¶Amgen Inc Valuation - February 2016 $AMGN https://t.co/MlQB8b9oqUTop + Initiations 4/6: $AAPL $AMGN $CEA $CELG $CSTE $LMCA $MDVN $TKAI $WPX

Top - Initiations 4/6: $KS$AMGN takes issue with yet-to-be published #MultipleMyeloma drug report. #myeloma #drugcosts https://t.co/mxapX2hHyc https://t.co/l6cVs2EUKu$JNJ $AMGN:

The FDA Endorses Celltrion‚Äôs Biosimilar Version From Johnson ‚Ä¶:

https://t.co/PBVZpPv1q5Re: previous tweet on $TSRO $JNJ deal, I thought $JNJ learned its lesson on indication-specific deals with $AMGN a few decades ago?@adamfeuerstein i think $AMGN becomes a target for $PFE$AMGN initiated at outperform @ BMO Cap target 183.... Biotech coming back.Weekly Nasdaq100 #Stocks Trend $TSLA $ALXN $GILD $CELG $ISRG $EBAY $NFLX $BMRN $FOXA $INCY $ILMN $AMGN $GRMN  @ https://t.co/YdSIjFJqHfWeekly S&amp;P100 #Stocks Trend $PFE $GILD $ABBV $BMY $LMT $CELG $MRK $PM $FOXA $AMGN $PEP $JNJ $MCD $CL $TXN  @ https://t.co/cKkr8cKsjuWeekly S&amp;P100 #Stocks Performance $PFE $BIIB $GILD $RTN $MCD $ABBV $BMY $MDLZ $AMGN $LMT $V $CELG $AAPL  more@ https://t.co/cKkr8cKsju$AMGN:

On the move Healthcare Stocks trend: Amgen Inc. (NASDAQ:AMGN ‚Ä¶:

https://t.co/FYRE2kSMLW$AMGN FDA Approves Rheumatoid Arthritis Biosimilar‚Ä¶ https://t.co/6UyO9NiIxw$AMGN FDA Approves Rheumatoid Arthritis Biosimilar‚Ä¶ https://t.co/qsLsIGqlH44 types f CD19 targeting mechanisms  CAR-T $JUNO etc. bispecifics $AFMD $AMGN , FC eng Morphosys , ADCs $SGEN https://t.co/HHW9NaX9qfIntermede Investment Partners Ltd Invests $23,103,000 in #Amgen, Inc. (). Read more: https://t.co/jbx9ssBkfB $AMGN#Amgen, Inc. Receives New Coverage from Analysts at BMO Capital Markets. Read more: https://t.co/qZq1jGMyQG $AMGN$AMGN:

Leerink Swann rated Amgen Inc (NASDAQ:AMGN) to ,Initiates ‚Ä¶:

https://t.co/hWWSxxVwFTAMGN E.P.S.
See Here ---&gt; https://t.co/faeLjSneXJ

$AMGN $FLT $DAL #invest$CELG $GILD $AMGN nice price targets set @BMOSTBZ Message Board Posts
See Here ---&gt; https://t.co/87mr3rHQrg

$STBZ $AMGN $TIVO #nasdaqWho will experience the most EPS growth next year? $PFE (43.6%) vs $JNJ (6%) vs $AMGN (5%) https://t.co/TDRaEC8EYn https://t.co/jYkFdibM4F$AMGN Max Pain is 150.00 for maturity 04/08/2016.  Price = 154.66. bearish https://t.co/0ccEievDt5 https://t.co/KtEdIaM139$AMGN OI for maturity 04/08/2016. 152.50 Highest put. 155.00 Highest call.  https://t.co/GWTSKbUlk8 https://t.co/47oip5cvPwTrading Strategies Partners: https://t.co/Upddhj47pY $AAPL $NFLX $QQQ $SPY $DJIA $VZ $GS $INTC $AA $INTC $NFLX $GS $JPM $T $MMM $AMGNRT @tgtxdough: IMHO best slide I tweet all weekend Free cash flow for the larger cap biotechs 2014-2020E $AMGN $CELG $GILD  M&amp;A ?? https://‚Ä¶RT @seeitmarket: New Post -  5 Large Cap Biotech Stocks With Upside https://t.co/1X6jpQSUsX by @OphirGottlieb $GILD $BIIB $AMGN $REGN https‚Ä¶@G_Commish 1 yr ago ""How do you think $Amgn sellers feel 30 years later?"" why don't u answer your SH now. U were very positive then. $ambs",2016-04-06,AMGN,0
7,"$AMGN $CELG $FSLR options have the largest change in price. Free options screener. https://t.co/EiI9SxdKaBICER publishes new report on effectiveness and value of myeloma drugs $AMGN $BMY $CELG https://t.co/UswhXfF2SpS&amp;P500 #Stocks Trend $CAG $CAH $MRK $PFE $CELG $WYNN $COG $SHW $LMT $ZTS $AMGN $MNK $STZ $HAL $SBUX $MHK $NEM  @ https://t.co/RPeaHBHYi0Nasdaq100 #Stocks Trend $CELG $BMRN $INCY $WYNN $AMGN $SBUX $TSLA $GILD $CHKP $ILMN $REGN $BIIB $ADP $CMCSA  @ https://t.co/YdSIjFJqHfS&amp;P100 #Stocks Trend $MRK $PFE $CELG $LMT $AMGN $HAL $SBUX $UTX $MMM $ABBV $BMY $GILD $MCD $JNJ $MO $PEP $V  @ https://t.co/cKkr8cKsjuStochastic Sell https://t.co/gVcxSjhPf1 $IBB $XLV $BDSI $BIIB $GILD $ABBV $NMBL $MRK $EXEL $ILMN $PDLI $AMGN $GRMN $TWX $INCY $COMM $BIBAMGN EOD Data
See Here ---&gt; https://t.co/LOJSdYNnpj

$AMGN $TNXP $WRLD #stocksRT @SRportfolio: #DividendGrowers down 1.6% 1 week after inception but $AMGN up 5%. https://t.co/zBlJNmC1Tl #dividends #portfolioCLGX Stock Forum
See Here ---&gt; https://t.co/kNqblf8CsA

$CLGX $AMGN $CRAI #invest#DividendGrowers down 1.6% 1 week after inception but $AMGN up 5%. https://t.co/zBlJNmC1Tl #dividends #portfolioLam Research Corporation Leads Our Nasdaq Top-Ten List $AMGN $ATVI $AVGO $CSCO $GILD $INTC $LRCX $MSFT $NTES https://t.co/9gxNgdMVYzGamco Investors INC. ET AL Has $6,359,000 Stake in Amgen, Inc. $AMGN https://t.co/epriXomklaGabelli Funds LLC Sells 3,000 Shares of Amgen, Inc. $AMGN https://t.co/IF7X1LRJ2uAmgen, Inc. $AMGN Stake Increased by Bank of Hawaii https://t.co/0ivKOrI5WI$JUNO in #China $AMGN https://t.co/2fDe2KOli0Gamco Investors INC. ET AL Has $6,359,000 Stake in Amgen, Inc. $AMGN https://t.co/FDkyA8Cva7Gabelli Funds LLC Sells 3,000 Shares of Amgen, Inc. $AMGN https://t.co/OM4g3sIOaXRT @pharmalot: Docs won't prescribe new cholesterol meds unless they lower heart risk sufficiently: survey https://t.co/YnaBXeuedV #pharma‚Ä¶$AMGN sum put oi=3,391 sum call oi=4,277 CallPutRatio=0.79 expiration 04/08/2016 bullish. https://t.co/t6XWBsPsX7 https://t.co/6S7a69swNRAmgen, Inc. $AMGN Stake Increased by Bank of Hawaii https://t.co/dVDwusJwPg$AMGN:

New SEC Filing for AMGN: Form DEFA14A (No. 0001193125-16-533807):

https://t.co/aLxFetQGvi https://t.co/C26FLRiNf1$AMGN ALERT: New Amgen SEC Filing
From our Stock News Alerts AppRT @alexandriatech: Top #sentiment for #SP1500 #stocks at market close: $PFE $ADP $AGN $AMGN $AYI (2016/04/07) #stocktrading #predictiveana‚Ä¶RT @DozenStocks: Nasdaq100 #Stocks Trend $BMRN $CELG $WYNN $AMGN $INCY $TSLA $GILD $ILMN $REGN $BIIB $CHKP $ADP $CMCSA $AVGO  @ https://t.c‚Ä¶S&amp;P500 #Stocks Trend $CAG $MRK $PFE $CELG $WYNN $NEM $SHW $LMT $ZTS $AMGN $LEN $CAH $OI $STZ $COG $UTX $EW  @ https://t.co/RPeaHBHYi0Top #sentiment for #SP1500 #stocks at market close: $PFE $ADP $AGN $AMGN $AYI (2016/04/07) #stocktrading #predictiveanalytics #bigdataTop sentiment for SP1500 stocks at market close: $PFE $ADP $AGN $AMGN $AYI (2016/04/07) #sentiment #stock #alexandriaNasdaq100 #Stocks Trend $BMRN $CELG $WYNN $AMGN $INCY $TSLA $GILD $ILMN $REGN $BIIB $CHKP $ADP $CMCSA $AVGO  @ https://t.co/YdSIjFJqHfS&amp;P100 #Stocks Trend $MRK $PFE $CELG $LMT $AMGN $UTX $GILD $MO $PEP $ABBV $ABT $BIIB $BMY $HAL $COP $MCD  @ https://t.co/cKkr8cKsjuJohnson &amp; Johnson, Merck &amp; Co, Amgen : Remicade‚Äôs Potential Competitor? - $JNJ $MRK $AMGN https://t.co/BuwJTw1Ubm https://t.co/LcPOYM1SaH#clinicaltrials &amp; quality of life parameter QALY
$AMGN review cost of bone cancer drugs https://t.co/NcdiTlqp6I via @statnewsRT @sanglucci: $IBB and the dog pharmas are finally doing it. Nice moves thus far lotta juice here $AMGN&lt;snark&gt; Good look for $AMGN given current #drugpricing and #value debate! &lt;/snark&gt; https://t.co/mi0HW92jSR$AMGN balks over meeting to review cost of bone cancer drugs https://t.co/E8fCswjkQK by @pharmalot via @statnewsRT @StockTwits: What biotech did today, how to play @howardlindzon in golf, and the remarkable Tesla rally: https://t.co/oAYH9HR2Gg

$TSLA‚Ä¶$AMGN $CELG $FSLR options have the largest change in price. Free options screener. https://t.co/EiI9Sxvl29AMGN Top news - Apr 7th, 2016 $AMGN https://t.co/EoKPB0pI3HDocs won't prescribe new cholesterol meds unless they lower heart risk sufficiently: survey https://t.co/YnaBXeuedV #pharma $AMGN $REGN $SNYAMGN 158.90 Amgen $AMGN added to my watch list. Right now with AMGN I am watching the last price 158.90 High 1 https://t.co/6NeYHSrW26Top #sentiment for #SP1500 #stocks at midday: $PFE $ADP $AGN $AMGN $AYI (2016/04/07) #stocktrading #predictiveanalytics #bigdataTop sentiment for SP1500 stocks at midday: $PFE $ADP $AGN $AMGN $AYI (2016/04/07) #sentiment #stock #alexandriaRT @fezziwig2008: The recent CTEP failure https://t.co/2x5BenL7mj should provide $PFE greater incentive to press their $HALO dosing advanta‚Ä¶The recent CTEP failure https://t.co/2x5BenL7mj should provide $PFE greater incentive to press their $HALO dosing advantage over $REGN $AMGNRT @pharmalot: ICYMI: Amgen balks over meeting to review cost of myeloma drugs.. read statement &amp; ICER response here https://t.co/CoP09jlJm‚Ä¶Nasdaq100 #Stocks Trend $BBBY $CHKP $CELG $REGN $BMRN $TSLA $INCY $WYNN $AMGN $ALXN $SBUX $SPLS $GILD $ILMN  @ https://t.co/YdSIjFJqHfS&amp;P100 #Stocks Trend $PFE $MRK $CELG $LMT $AMGN $HAL $SBUX $GILD $UTX $MO $BIIB $PEP $PM $V $TWX $CMCSA $ABT  @ https://t.co/cKkr8cKsju@Drchik23 @TimCarmichael3 @Sharma1981N $ALDR, with small trials going against huge &amp; numerous trials of $AMGN, $LLY, $TEVA s/b aquiredVetr users have downgraded Amgen Inc. to a HOLD Rating (3 stars), giving $AMGN a target price of $165.73 https://t.co/sgyPwK93LkAs healthcare stocks rally. We buy The 4 Horsemen of #Biotech https://t.co/zqRpeLXzF1 #aviateUS $AMGN $GILD $BIIB $CELG Capital At Risk$AMGN high open interest range is 152.50 to 160.00 for option expiration 04/08/2016.  https://t.co/t6XWBsPsX7 https://t.co/z7OFBwlLjQ$AMGN $GSK:

Amgen, Inc. (NASDAQ:AMGN) Criticizes The Methods Used To ‚Ä¶:

https://t.co/BLtLRuaBh2Mittelfristiges Signal! $AMGN: Ein Trendkanal wurde bei 159.409 USD nach oben durchbrochen:  https://t.co/yqeJs2WtKNAmgen balks over a meeting to review the cost of myeloma drugs. https://t.co/4BFw6AmZDh ‚Ä¶ #pharma $AMGN #myeloma #amgen$amgn lower lowsRT @pharmalot: ICYMI: Amgen balks over meeting to review cost of myeloma drugs.. read statement &amp; ICER response here https://t.co/CoP09jlJm‚Ä¶Top #sentiment for #SP1500 #stocks at market open: $PFE $ADP $AGN $AMGN $AYI (2016/04/07) #stocktrading #predictiveanalytics #bigdataTop sentiment for SP1500 stocks at market open: $PFE $ADP $AGN $AMGN $AYI (2016/04/07) #sentiment #stock #alexandriaTrading Strategies Partners: https://t.co/Upddhj47pY $AAPL $NFLX $QQQ $SPY $DJIA $VZ $GS $INTC $AA $INTC $NFLX $GS $JPM $T $MMM $AMGNRT @pharmalot: ICYMI: Amgen balks over meeting to review cost of myeloma drugs.. read statement &amp; ICER response here https://t.co/CoP09jlJm‚Ä¶ICYMI: Amgen balks over meeting to review cost of myeloma drugs.. read statement &amp; ICER response here https://t.co/CoP09jlJmZ #pharma $AMGNRT @ByJonGardner: ICER, the ""American NICE,"" has some interesting meetings coming up. The OCA one is new to me. $ICPT $AMGN https://t.co/3j‚Ä¶RT @ByJonGardner: ICER, the ""American NICE,"" has some interesting meetings coming up. The OCA one is new to me. $ICPT $AMGN https://t.co/3j‚Ä¶Amgen, Inc. $AMGN Downgraded to Hold at Vetr Inc. https://t.co/oGNaztxFr1Amgen, Inc. $AMGN Rating Reiterated by Leerink Swann https://t.co/63AlcLgM7uBMO Capital Markets Initiates Coverage on Amgen, Inc. $AMGN https://t.co/vutnQiupOFSRG Bid
See Here ---&gt; https://t.co/rkn1TxjDRc

$SRG $AMGN $AMD #tradeideasTraders Sell Amgen, Inc. $AMGN on Strength $AMGN https://t.co/KYG5JNVLiQTraders Sell Amgen, Inc. $AMGN on Strength $AMGN https://t.co/sJiXvvtv36RT @1MinuteStock: Not sure what to do with $AMGN? Explore our #fundamental pros and cons.  https://t.co/ZW5e637quV$AMGN: Analyst action by BMO Capital on Amgen: https://t.co/FgzHssL44X https://t.co/kFv7zpxi6GNot sure what to do with $AMGN? Explore our #fundamental pros and cons.  https://t.co/ZW5e637quV@PFOLIOALERT RESULTS APR 6 $PFE (+3.8%) $MRK (+2%) $GILD (+1.2%) $IMMU (+3.4%) $ADXS (+10.8%) $AMGN (+3.2%)
https://t.co/mUqg3vekdd@PFOLIOALERT PREDICTS WINNERS APRIL 7 $GILD $REGN $ADXS $PTLA
$AMGN $IMMU $MRK $MDVN $CELG $CELG
USING CHAOS THEORY
https://t.co/mUqg3vekddRT @ByJonGardner: ICER, the ""American NICE,"" has some interesting meetings coming up. The OCA one is new to me. $ICPT $AMGN https://t.co/3j‚Ä¶Weekly S&amp;P500 #Stocks Trend $EW $REGN $ALXN $BIIB $CELG $PFE $MNK $ZTS $AMGN $GILD $MLM $EBAY $STZ $ABBV $BMY  @ https://t.co/RPeaHBHYi0Weekly S&amp;P500 #Stocks Performance $EW $REGN $ALXN $VRTX $BIIB $CELG $PFE $MNK $ZTS $AMGN $GILD $HES $MLM  more@ https://t.co/RPeaHBHYi0Weekly Nasdaq100 #Stocks Trend $INCY $REGN $TSLA $ALXN $BMRN $ILMN $BIIB $CELG $AMGN $GILD $EBAY $ISRG $FOXA  @ https://t.co/YdSIjFJqHfWeekly Nasdaq100 #Stocks Performance $INCY $REGN $TSLA $ALXN $VRTX $BMRN $ILMN $BIIB $CELG $AMGN $GILD  more@ https://t.co/YdSIjFJqHfWeekly S&amp;P100 #Stocks Trend $BIIB $CELG $PFE $AMGN $GILD $ABBV $BMY $MRK $FOXA $ABT $MDT $TWX $PM $LMT $V $MO  @ https://t.co/cKkr8cKsjuWeekly S&amp;P100 #Stocks Performance $BIIB $CELG $PFE $AMGN $GILD $DVN $ABBV $BMY $MRK $LLY $MDLZ $FOXA $ABT  more@ https://t.co/cKkr8cKsjuInterview with Connor Bruggeman SchoolTrader Extraordinaire!: https://t.co/DgrNThhkJM $NFLX $HIMX $INO $AMGN $GOOGLRT @ByJonGardner: ICER, the ""American NICE,"" has some interesting meetings coming up. The OCA one is new to me. $ICPT $AMGN https://t.co/3j‚Ä¶Do you know that #WallStreet price for $AMGN is $180.71 https://t.co/jyn12gp3cIRT @ByJonGardner: ICER, the ""American NICE,"" has some interesting meetings coming up. The OCA one is new to me. $ICPT $AMGN https://t.co/3j‚Ä¶ICER, the ""American NICE,"" has some interesting meetings coming up. The OCA one is new to me. $ICPT $AMGN https://t.co/3jxaygJ79gUnicorn Bay rating for $AMGN is 3.33 out of 5. https://t.co/KGl3e8T4UOResearch Analysts‚Äô Recent Ratings Changes for Amgen $AMGN https://t.co/XhFqUn2QHkRT @pharmalot: FDA proposes biosimilars labeling that favors generic drug makers.. read it here.. https://t.co/PnSLMkw4WB #pharma #FDA $ABB‚Ä¶$AMGN:

Key Stocks of the Day: Amgen Inc. (NASDAQ:AMGN):

https://t.co/wprmeU4xY8$AMGN:US Amgen, Inc. (AMGN) Downgraded to Hold at Vetr Inc. #AMGEN INC  https://t.co/e4ycbTzNPu #SP500RT @BioBounce: $IBB has 190 holdings; top 10 = 57.83% weight; basically you are saying $AMGN $GILD $REGN $BIIB $CELG $ILMN $MYL $ALXN $VRTX‚Ä¶1/2
#MadMoneyEspresso
$AGN$PFE$REGN$BIIB$CELG
$AMGN$VRX$VRTX$GILD$HAL$BHI ‚Äîüëç
$KBH‚Äîüëç
$AVGO‚Äîüëç
$CFMS‚ÄîüëçAMGN EOD Data
See Here ---&gt; https://t.co/EhTb9qH6Qv

$AMGN $YRD $XLY #stockDelta between Humira in US and CH interesting; EU pricing of $AMGN's #ABP501 will be biggest Ab-market event in yrs https://t.co/9QeYs8YepEAmgen downgraded by Vetr Inc. to hold. $165.73 PT. https://t.co/JXHMQlLkfG $AMGN #AMGN@Sharma1981N @bradloncar I'm hoping to get answers on the @Slingshot_Invst CGRPi expert call. Does $ALDR stand a chance v $TEVA $LLY $AMGN$es_f $spx $nasdaq $mcd $GOOGL $AMZN $DIS $ma $BAC $GS $AMGN $QQQ $IWM $NKE $KO
Linda Raschke on Day Trading E-minis https://t.co/ZPKiyFIJIo$AMGN: Analyst action by BMO Capital on Amgen: https://t.co/FgzHssL44X https://t.co/yRa5zJON9oRT @StockTwits: What biotech did today, how to play @howardlindzon in golf, and the remarkable Tesla rally: https://t.co/oAYH9HR2Gg

$TSLA‚Ä¶RT @herostick: $CYTK big upside move over the last week or so. I don't like this company, but it has been long rumored that $AMGN will acqu‚Ä¶RT @StockTwits: What biotech did today, how to play @howardlindzon in golf, and the remarkable Tesla rally: https://t.co/oAYH9HR2Gg

$TSLA‚Ä¶RT @sanglucci: $IBB and the dog pharmas are finally doing it. Nice moves thus far lotta juice here $AMGNRT @StockTwits: What biotech did today, how to play @howardlindzon in golf, and the remarkable Tesla rally: https://t.co/oAYH9HR2Gg

$TSLA‚Ä¶$AMGN Max Pain is 152.50 for maturity 04/08/2016.  Price = 152.95. bearish https://t.co/0ccEievDt5 https://t.co/bus8gPUK9lRT @StockTwits: What biotech did today, how to play @howardlindzon in golf, and the remarkable Tesla rally: https://t.co/oAYH9HR2Gg

$TSLA‚Ä¶RT @StockTwits: What biotech did today, how to play @howardlindzon in golf, and the remarkable Tesla rally: https://t.co/oAYH9HR2Gg

$TSLA‚Ä¶RT @StockTwits: What biotech did today, how to play @howardlindzon in golf, and the remarkable Tesla rally: https://t.co/oAYH9HR2Gg

$TSLA‚Ä¶RT @StockTwits: What biotech did today, how to play @howardlindzon in golf, and the remarkable Tesla rally: https://t.co/oAYH9HR2Gg

$TSLA‚Ä¶What biotech did today, how to play @howardlindzon in golf, and the remarkable Tesla rally: https://t.co/oAYH9HR2Gg

$TSLA $SPY $AMGN $GILDJefferies Global Equity Adds Risk, Rotates Into EM, Cyclicals $AMGN $BA $GD https://t.co/qCGZ862w7H https://t.co/tFAFPI36yUJefferies Global Equity Adds Risk, Rotates Into EM, Cyclicals $AMGN $BA $GD #wlst https://t.co/ZNnh0i50UO https://t.co/xnKjLEFYL7Jefferies‚Äô Global Equity Adds Risk, Rotates Into EM, Cyclicals https://t.co/U4PTJGhBKu via @barronsonline $AMGN $BA $GD$amgn &gt; 200 SMA  $AMGN https://t.co/8FXwW3hbSc$AMGN chart: $amgn &gt; 200 SMA . https://t.co/6qiRpcWB4i",2016-04-07,AMGN,0
8,"RT SeekingAlpha: How I Determine My 'Buy Range' For DGI Stocks https://t.co/FOhkVrRmFV $ABBV $ABT $AMGN $BXLT $CLX $JNJ $MRK $NVSHow I Determine My 'Buy Range' For DGI Stocks https://t.co/dIReLsOXIL $ABBV $ABT $AMGN $BXLT $CLX $JNJ $MRK $NVSHow I Determine My 'Buy Range' For DGI Stocks https://t.co/VH0YxJ9C7H $ABBV $ABT $AMGN $BXLT $CLX $JNJ $MRK $NVS$AMGN:US Amgen, Inc. (AMGN) Now Covered by BMO Capital Markets #AMGEN INC  https://t.co/ipuszJGRc0 #NASDAQ$AMGN still holding above d/t. All bio whacked but when they bounce, this one could go https://t.co/UkBiTfSMynDrugs and Biotech Getting Perky https://t.co/mODxkK063u via @barronsonline $IBB $MRK $GILD $AMGN $GSKNext call this week is on #CGRP in general &amp; $ALDR Max cost is $65 &amp; it gets cheaper if more join: https://t.co/a2ICFZUHZF  $AMGN $LLY $TEVABig year at #Amgen delivers $2M pay hike for CEO Bradway, to $16M. Read more: https://t.co/4o6t6MJI1V $AMGN$AMGN Max Pain is 150.00 for maturity 04/15/2016.  Price = 156.46. bearish https://t.co/fQ0spJZLAN https://t.co/AlwsDSLlnM$IBB wrv 270.03   lg at wrv cross 263.18    $AMGN lg wrv 14747   wrv 152.66Be funny if $amgn bought $rlyp oh the irony!Ranks #1 with over 80% in alert gains today. Click here https://t.co/ewcYkLb72h .. $AMGN $GLNG $PZZA#Amgen, Inc. Shares Sold by Seizert Capital Partners LLC. Read more: https://t.co/VJsJqBgJ1K $AMGNAMGN Top news - Apr 11th, 2016 $AMGN https://t.co/PuOZ7iZauPThese $ITUS Profits Are much Bigger Than $AMGNFollow #Nasdaq 100 traders &amp; track their tweets under one watchlist $AMGN $QCOM https://t.co/W1OB9ZtUgi https://t.co/l4EZGbq0wTAMG National Trust Bank Has $1,582,000 Position in #Amgen, Inc. (). Read more: https://t.co/pEc6uLThSJ $AMGNOut of $AMGN one year later. I'm tired of waiting here. The story of Q2 will be long $REGN and small NASH m&amp;a pickups. #biotechRT @FiercePharma: Big year at $AMGN delivers $2M pay hike for CEO Bradway, to $16M https://t.co/ON6Hy0Thxr #pharma by @TracyStatonBig year at $AMGN delivers $2M pay hike for CEO Bradway, to $16M https://t.co/ON6Hy0Thxr #pharma by @TracyStatonRT SeekingAlpha: Pfizer: Master Of Diversity https://t.co/bOi5IfpOhA $AGN $GILD $AAPL $AMGN $AXP $CSCO $ETN $MSFT $SHPG $PFE$AMGN sum put oi=27,282 sum call oi=22,377 CallPutRatio=1.22 expiration 04/15/2016 bearish. https://t.co/8nvi1JWS2W https://t.co/rqpRgH33kDPfizer: Master Of Diversity https://t.co/bQEmprsDfG $AGN $GILD $AAPL $AMGN $AXP $CSCO $ETN $MSFT $SHPG $PFEAMGN News
See Here ---&gt; https://t.co/2vfpydl1vQ

$AMGN $TISI $CPGX #investingLR ""The slow PCSK9 initial launch is primarily due to formulary access,
patient reluctance to use injectables, our survey shows"" $AMGN $REGN$AMGN: Analyst action by BMO Capital on Amgen: https://t.co/FgzHssL44X https://t.co/wJJ3mWN5yzRT @SA_Portfolio: Valuation Dashboard: Healthcare - Update https://t.co/ciyYRcXcHt $ABBV $AMGN $BAX $BIIB $ENTA $EW $GILD $HCA $IBB $ISRG $‚Ä¶RT SeekingAlpha: Valuation Dashboard: Healthcare - Update https://t.co/MA5jJjNNUA $ABBV $AMGN $BAX $BIIB $ENTA $EW $GILD $HCA $IBB $ISRG $‚Ä¶Valuation Dashboard: Healthcare - Update https://t.co/TXxdomJsbF $ABBV $AMGN $BAX $BIIB $ENTA $EW $GILD $HCA $IBB $ISRG $LCI $MASI $MCKValuation Dashboard: Healthcare - Update https://t.co/ciyYRcXcHt $ABBV $AMGN $BAX $BIIB $ENTA $EW $GILD $HCA $IBB $ISRG $LCI $MASI $MCKValuation Dashboard: Healthcare - Update https://t.co/VhN5NgbuxC $ABBV $AMGN $BAX $BIIB $ENTA $EW $GILD $HCA $IBB $ISRG $LCI $MASI $MCKWetherby Asset Management Inc. Sells 1,083 Shares of #Amgen, Inc. (). Read more: https://t.co/PLaEO4ZNUn $AMGNERIC Quotes
See Here ---&gt; https://t.co/2m5nutnGJc

$ERIC $AMGN $AMZN #shareRT @AndysCycles: $IBB components sorted by RS (23d 130d 260d weighted): 
$AMGN $CELG $ILMN $GILD $BIIB $MYL $ALXN $BMRN $REGN $VRTX https:/‚Ä¶Amgen, Inc. $AMGN Position Decreased by Wellington Shields Capital Management LLC https://t.co/FuFFgxbjTlRT @OwensAssetFund: Slingshot Bullish  $CNL $LABU $TSLA $BIIB $PFE $XBI $DDD $MDVN $ABBV $ACAD $BMRN $NBIX $CAH $AMGN $CELG $INCY $CERS htt‚Ä¶Amgen, Inc. $AMGN Shares Sold by Seizert Capital Partners LLC https://t.co/mfgOc1ZIlGSlingshot Bullish  $CNL $LABU $TSLA $BIIB $PFE $XBI $DDD $MDVN $ABBV $ACAD $BMRN $NBIX $CAH $AMGN $CELG $INCY $CERS https://t.co/Cg7Yk4msrIRT SeekingAlpha: U.K. Portfolio Update: Q1 2016 And Lessons Learned https://t.co/Us6mLG7NJn $AAPL #APPLE $AGN $AMGN $AZN $BA $BBL $BHP $CV‚Ä¶U.K. Portfolio Update: Q1 2016 And Lessons Learned https://t.co/XWoyIHCM7N $AAPL #APPLE $AGN $AMGN $AZN $BA $BBL $BHP $CVS $DIS $GILD $GSKU.K. Portfolio Update: Q1 2016 And Lessons Learned https://t.co/DYx7SLu7bO $AAPL #APPLE $AGN $AMGN $AZN $BA $BBL $BHP $CVS $DIS $GILD $GSKSlingshot Bullish https://t.co/LEPjhYXFYj   $CNL $LABU $TSLA $BIIB $PFE $XBI $DDD $MDVN $ABBV $ACAD $BMRN $NBIX $CAH $AMGN $CELG $INCY $CERSWhere were you (invested) when the biotech sector woke up?
$IBB $CELG $REGN $GILD $BMY $AMGN

Invest wisely with https://t.co/iClE4419yP3 Cheap Dividend Stocks To Buy And Hold $BA $MPC $AMGN https://t.co/qrOPDEVqIW$AMGN: Analyst action by BMO Capital on Amgen: https://t.co/FgzHssL44X https://t.co/tNmhVZTrSYAmgen, Inc. $AMGN Price Target Raised to $195.00 at Morgan Stanley https://t.co/gnVo5X6nbCDoc Day Boston - Key Summaries from 20 physicians
$VRTX, $CELG, $GILD, $BIIB, $AMGN, $ICPT, $KITE, $ACOR, $PRTA https://t.co/YvRxtefIv3@techwhitepapers $AFMD CSO presentation is followed by $AMGN on Blincyto  .. thinking myself AFM11RT @DailyStockPlays: Slingshot Bullish https://t.co/LEPjhYXFYj   $CNL $LABU $TSLA $BIIB $PFE $XBI $DDD $MDVN $ABBV $ACAD $BMRN $NBIX $CAH $‚Ä¶3 Cheap Dividend Stocks To Buy And Hold $BA $MPC $AMGN https://t.co/Po2HdKcigySlingshot Bullish https://t.co/LEPjhYXFYj   $CNL $LABU $TSLA $BIIB $PFE $XBI $DDD $MDVN $ABBV $ACAD $BMRN $NBIX $CAH $AMGN $CELG $INCY $CERSZEUS Chart
See Here ---&gt; https://t.co/3G2N11jQxu

$ZEUS $ILMN $AMGN #stocks$AMGN OI for maturity 04/15/2016. 135.00 Highest put. 155.00 Highest call. bearish https://t.co/8nvi1JWS2W https://t.co/5SIDUJegLzRT @StockWebTrading: Trading Strategies Partners: https://t.co/Upddhj47pY $AAPL $NFLX $QQQ $SPY $DJIA $VZ $GS $INTC $AA $INTC $NFLX $GS $JP‚Ä¶RT @StockWebTrading: Trading Strategies Partners: https://t.co/Upddhj47pY $AAPL $NFLX $QQQ $SPY $DJIA $VZ $GS $INTC $AA $INTC $NFLX $GS $JP‚Ä¶23:15-&gt;https://t.co/vqaokSKgmf

Also,see:https://t.co/Tx8cJJUe7g

$AMGN $SNY $LLY $BAYRY $GILD $BIIB $CELG $REGN https://t.co/yMnOK5Po1wTrading Strategies Partners: https://t.co/Upddhj47pY $AAPL $NFLX $QQQ $SPY $DJIA $VZ $GS $INTC $AA $INTC $NFLX $GS $JPM $T $MMM $AMGNRT @DailyStockPlays: Slingshot Bullish https://t.co/LEPjhYXFYj   $CNL $LABU $TSLA $BIIB $PFE $XBI $DDD $MDVN $ABBV $ACAD $BMRN $NBIX $CAH $‚Ä¶RT @DailyStockPlays: Slingshot Bullish https://t.co/LEPjhYXFYj   $CNL $LABU $TSLA $BIIB $PFE $XBI $DDD $MDVN $ABBV $ACAD $BMRN $NBIX $CAH $‚Ä¶Slingshot Bullish https://t.co/LEPjhYXFYj   $CNL $LABU $TSLA $BIIB $PFE $XBI $DDD $MDVN $ABBV $ACAD $BMRN $NBIX $CAH $AMGN $CELG $INCY $CERS",2016-04-11,AMGN,1
9,"Mastrapasqua Asset Management Inc. Has $10,996,000 Position in Amgen, Inc. $AMGN https://t.co/OA7eVHZRYYVaughan David Investments Inc. IL Acquires 425 Shares of #Amgen, Inc. (). Read more: https://t.co/jzNsj0CBxM $AMGNFishman Jay A Ltd. MI Increases Stake in Amgen, Inc. $AMGN https://t.co/L6C2uu66UTFishman Jay A Ltd. MI Increases Stake in Amgen, Inc. $AMGN https://t.co/l1PB58RBctRT @Benzinga: Cancer Drug Stocks Are The Picture Of Health $AMGN $AZN $GILD $SNY https://t.co/gXaoMEa8PF via @MotifInvestingMedivation: Biotech‚Äôs Most Wanted?  https://t.co/7tD8Hx5sUX via @barronsonline $MDVN $SNY $GILD $AMGN $AZNVaughan David Investments Inc. IL Acquires 425 Shares of Amgen, Inc. $AMGN https://t.co/ctgfqJPmcC$AMGN high open interest range is 135.00 to 155.00 for option expiration 04/15/2016. bearish https://t.co/8nvi1JWS2W https://t.co/l7kEvyItj0Is $ALDR 's CGRP therapy best positioned to dominate the market for migraine treatments? $TEVA $AMGN #ALD403 https://t.co/D1MC2t5XVvCancer Drug Stocks Are The Picture Of Health $AMGN $AZN $GILD $SNY https://t.co/gXaoMEa8PF via @MotifInvesting$XLV, $GRPN, $BMY, $JWN, $TMUS, $LLY, $ACAD, $AMGN, bullish engulfing patterns, https://t.co/iz6m7HqU3523:15-&gt;https://t.co/vqaokSKgmf

Also,see:https://t.co/Tx8cJJUe7g

$AMGN $SNY $LLY $BAYRY $GILD $BIIB $CELG $REGN https://t.co/cElatJ5arL$MDVN $AMGN $SNY:

Cancer Drug Stocks Are The Picture Of Health:

https://t.co/jIO3nLZzKxCrash in $VRX makes other biotech such as $ABBV , $AMGN , &amp; $GILD much more interesting &amp; safe...BMY Ideas
See Here ---&gt; https://t.co/vUPj3irKM9

$BMY $VA $AMGN #tradeideasNRG Message Board Posts
See Here ---&gt; https://t.co/vEfuCQ5M1A

$NRG $AMGN $HII #investingThese $ITUS Profits Are much Bigger Than $AMGNTrending #Biotech topics include $AMGN, $ABBV, #Evista #stocks #invest See more https://t.co/EpbbdqDEG1$AMGN Max Pain is 150.00 for maturity 04/15/2016.  Price = 156.39. bearish https://t.co/fQ0spJZLAN https://t.co/0FyLKeWhvEFollow #Nasdaq 100 traders &amp; track their tweets under one watchlist $AMGN $QCOM https://t.co/W1OB9ZtUgi https://t.co/9LbDnFCmOnRT @Slingshot_Invst: Our project on #CGRP &amp; $ALDR needs at least 3 more folks chipping in @WilliamGerber1 https://t.co/D1MC2tnzk5 Expert co‚Ä¶@WilliamGerber1 I'm long $ALDR but nervous may not be able to catch up/ compete w/ $TEVA $AMGN $LLY. My hope 4 call is to get sense of thisRT @SheffStation: $IBB $XBI..interesting to be reminded of top 3 $XBI holdings $ACAD $MDVN $NBIX. $IBB top 3 has $AMGN $GILD $BIIB https://‚Ä¶These $ITUS Profits Are much Bigger Than $AMGN$ALDR ALD403 has advantages over comps from $LLY, $AMGN, $TEVA migraine drugs, mainly longer duration between treatments. Look for tutes....Amgen, Inc. $AMGN Lowered to ‚ÄúHold‚Äù at Vetr Inc. https://t.co/egBfMXPewdOur project on #CGRP &amp; $ALDR needs at least 3 more folks chipping in @WilliamGerber1 https://t.co/D1MC2tnzk5 Expert consults 4 $AMGN &amp; $LLYAEM Ask Size
See Here ---&gt; https://t.co/7bjyo2HgzJ

$AEM $OA $AMGN #investThese $ITUS Profits Are much Bigger Than $AMGN$AMGN:

Short Sellers Run for Cover From Major Biotechs:

https://t.co/g0CSFMkCRaSFTW Investor long-term stock recommendation: $AMGN Amgen Inc. (SS: 81) https://t.co/ajLDr7suctAMGN Top news - Apr 12th, 2016 $AMGN https://t.co/rdqCcQ5YXCRT @SheffStation: $IBB $XBI..interesting to be reminded of top 3 $XBI holdings $ACAD $MDVN $NBIX. $IBB top 3 has $AMGN $GILD $BIIB https://‚Ä¶$IBB $XBI..interesting to be reminded of top 3 $XBI holdings $ACAD $MDVN $NBIX. $IBB top 3 has $AMGN $GILD $BIIB https://t.co/QGwmYudqFA$AMGN maturity 04/15/2016 oi CallPutRatio of 1.23 puts 27,894 &amp; calls 22,606 bearish. https://t.co/8nvi1JWS2W https://t.co/9d4Juygg1zValuation Dashboard: Healthcare - Update https://t.co/6xptvA2ptr $ABBV $AMGN $BAX $BIIB $ENTA $EW $GILD $HCA $IBB $ISRG $LCI $MASI $MCKThese $ITUS Profits Are much Bigger Than $AMGNWeekly S&amp;P100 #Stocks Performance $HAL $COP $PFE $OXY $KMI $CELG $MDLZ $CVX $UTX $SLB $GILD $BA $MRK $AMGN more@ https://t.co/cKkr8cKsjuAmgen, Inc. $AMGN Position Lowered by Marco Investment Management LLC https://t.co/KTOlL6JsPMAmgen, Inc. $AMGN Position Lowered by Marco Investment Management LLC https://t.co/lNCUYzXjmkAmgen, Inc. $AMGN Shares Bought by Aviance Capital Management LLC https://t.co/vmMmSMYMcL$AMGN:

Amgen Inc. (NASDAQ:AMGN) Latest Broker Coverage:

https://t.co/YfcyjHzXLU14,426 Shares in Amgen, Inc. $AMGN Acquired by Roundview Capital LLC https://t.co/yorjDOLefiFoster Dykema Cabot &amp; Co. Inc. MA Sells 1,430 Shares of Amgen, Inc. $AMGN https://t.co/5PbsStam5cConnor Clark &amp; Lunn Investment Management Ltd. Has $42,656,000 Position in Amgen, Inc. $AMGN https://t.co/sjJN08vdlcAmgen, Inc. $AMGN Shares Sold by Calvert Investment Management Inc. https://t.co/inrFgnUNClConnor Clark &amp; Lunn Investment Management Ltd. Has $42,656,000 Position in Amgen, Inc. $AMGN https://t.co/TRJeUEeSzEAmgen, Inc. $AMGN Shares Sold by Calvert Investment Management Inc. https://t.co/7vShV307TjTrading Strategies Partners: https://t.co/Upddhj47pY $AAPL $NFLX $QQQ $SPY $DJIA $VZ $GS $INTC $AA $INTC $NFLX $GS $JPM $T $MMM $AMGNUnited Capital Financial Advisers LLC Sells 1,678 Shares of Amgen, Inc. $AMGN https://t.co/WYPcjzPnv4Nasdaq100 #Stocks Trend $ULTA $LBTYA $ILMN $ISRG $FOXA $MXIM $SRCL $CELG $VOD $NXPI $SBUX $CTRP $AMGN $BMRN  @ https://t.co/YdSIjFJqHfS&amp;P100 #Stocks Trend $HAL $PEP $UTX $MRK $MO $KO $ABT $FOXA $V $TWX $PFE $CELG $MDT $OXY $COP $SBUX $AMGN $BMY @ https://t.co/cKkr8cKsjuPCSK9 Drugs Are Overhyped -  https://t.co/hUiDKgPxNq $AMGN, $ALNY, $AZN, $CATB, $ESPR, $LLY, $MDCO, $MRK, $PFE, $REGN, $SNY$AMGN OI for maturity 04/15/2016. 135.00 Highest put. 155.00 Highest call. bearish https://t.co/8nvi1JWS2W https://t.co/gTa7gDiRe6These $ITUS Profits Are much Bigger Than $AMGN",2016-04-12,AMGN,1
10,"I am bullish on $AMGN with a target price of $168.06 in 6 mos. on Vetr! https://t.co/d1ITy96HrwRT @StockMatusow: Affimed Science Explained - Technical Breakdown https://t.co/0wIUBBxSH5 (Open to Public) $AFMD $JUNO $KITE $AMGN ##immuno‚Ä¶RT @StockMatusow: Affimed Science Explained - Technical Breakdown https://t.co/0wIUBBxSH5 (Open to Public) $AFMD $JUNO $KITE $AMGN ##immuno‚Ä¶JBEM pick FLKS data release on 4/19. Read here: https://t.co/RJhHbIwnlX $AMDA $AME $AMED $AMFW $AMG $AMGN $AMH $AMH-A$IBB  Biotech stocks (setups)

$BIIB $KITE $BLUE $JUNO $CARA $SGEN $BIB $AMGN $CELG $LABU

#Trading #Biotech #Stocks https://t.co/xgh0CZHypZOver Keltner https://t.co/U0HyGG7CEe $PFE $AAPL $FOXA $NVDA $SLB $MRK $RIO $GWB $MGM $MDVN $BSX $BMY $AMZN $ABT $AMGN $DHI $NUE $ARWRRT @tgtxdough: February IMS Sales Analysis For Large-Cap Biotech $AMGN $GILD $CELG https://t.co/Jjddo5gS0FFebruary IMS Sales Analysis For Large-Cap Biotech $AMGN $GILD $CELG https://t.co/Jjddo5gS0FRT @UOTApp: Last Minutes of Trading: $AMGN $BAC $CME $GS $YHOO via https://t.co/4JB9SJl4KQ https://t.co/NUmKgwjvuTLast Minutes of Trading: $AMGN $BAC $CME $GS $YHOO via https://t.co/4JB9SJl4KQ https://t.co/NUmKgwjvuT$AMGN high open interest range is 135.00 to 155.00 for option expiration 04/15/2016. bearish https://t.co/8nvi1JWS2W https://t.co/3f98jfz6tA@AOTtrades $AMGN pinned right at 160, they're good!RT @StockMatusow: Affimed Science Explained - Technical Breakdown https://t.co/0wIUBBxSH5 (Open to Public) $AFMD $JUNO $KITE $AMGN ##immuno‚Ä¶$AMGN:

Key Stocks of the Day: Amgen Inc. (NASDAQ:AMGN):

https://t.co/7KNdaYkN7H$AMGN:

Will Amgen Inc. (NASDAQ:AMGN) beat earning estimates again?:

https://t.co/yfTJBR5hmZ$AMGN 160 Puts BUYING Activity expiring on 20th May, Vol 293 @ IntermarketSweepThis is Why Everyone Wants to Buy Medivation https://t.co/767642JvYI via @barronsonline $MDVN $SNY $GILD $AZN $AMGNAffimed Science Explained - Technical Breakdown https://t.co/0wIUBBxSH5 (Open to Public) $AFMD $JUNO $KITE $AMGN ##immunotherapy #biotech$AMGN 3 Safe Blue Chip Stocks with Growing Dividends https://t.co/tPPCtRYDxS https://t.co/xT5aGHb282RT @valuewalk: Aristotle Value Equity 1Q16 Commentary ‚Äì Amgen https://t.co/IWIe1wXeQ8 $AMGN https://t.co/j9fjibMRbGHere are the top three undervalued #dividend stocks that you can now buy for cheap $BA $MPC $AMGN #DividendStocks https://t.co/zXlilVIQ8VRT @valuewalk: Aristotle Value Equity 1Q16 Commentary ‚Äì Amgen https://t.co/IWIe1wXeQ8 $AMGN https://t.co/j9fjibMRbGAristotle Value Equity 1Q16 Commentary ‚Äì Amgen https://t.co/IWIe1wXeQ8 $AMGN https://t.co/j9fjibMRbGThese $ITUS Profits Are much Bigger Than $AMGN""valuations in the sector are particularly attractive and for large caps at a decade low"" #biotech $IBB $AMGN $BIIB $CELG $GILD $REGN ...Trending #Biotech topics include $MRK, $AMGN, #Rociletinib #stocks #invest See more https://t.co/EpbbdqDEG1Looks like consolidation on the monthly $AMGN https://t.co/csIC5qnAIT$AMGN chart: Looks like consolidation on the monthly. https://t.co/s2HJUNhAn3$AMGN hmm my entry here is 137$. Time to trim a bit. We'll prob get to 164$These $ITUS Profits Are much Bigger Than $AMGN$MDVN $AMGN $AZN:

SunTrust: Medivation M&amp;A Chatter Highlights Value, Company‚Äôs ‚Ä¶:

https://t.co/I5YRJ754q0AMGN Top news - Apr 13th, 2016 $AMGN https://t.co/j6oYQoG6HpFollow #Nasdaq 100 traders &amp; track their tweets under one watchlist $AMGN $QCOM https://t.co/W1OB9ZtUgi https://t.co/VVqmDCEVufWeekly Nasdaq100 #Stocks Performance $VOD $STX $INCY $ULTA $ILMN $ALXN $AMGN $MDLZ $LBTYA $CERN $MAR $AMZN  more@ https://t.co/YdSIjG11yNWeekly S&amp;P100 #Stocks Performance $COP $KMI $HAL $OXY $CVX $SLB $AMGN $MDLZ $BA $GD $XOM $AMZN $PFE $BMY  more@ https://t.co/cKkr8cKsjuSunTrust: 9 Biotech Companies are Profitable. Medivation is the only midcap. https://t.co/20dMzgKTn5 @barronsonline $MDVN $SNY $GILD $AMGN$VRX , $GILD and $AMGN have done more to improve the lives of AIDS patients than any other companies. We respect that.Nasdaq100 #Stocks Trend $ALXN $MAT $ISRG $LBTYA $ILMN $GILD $STX $TXN $CTXS $AAPL $ULTA $QCOM $TSLA $AMGN $AMZN @ https://t.co/YdSIjFJqHfS&amp;P100 #Stocks Performance $COP $KMI $CVX $OXY $MS $CAT $BMY $SLB $BA $FB $MET $DOW $C $AMGN $COF $MDT  more@ https://t.co/cKkr8cKsjuRT @BioPharmaDive: Biosimilars gain momentum ‚Äî and pharma leaders are noticing https://t.co/W9KJLtWMbB $NVS $PFE $AMGNBiosimilars gain momentum ‚Äî and pharma leaders are noticing https://t.co/W9KJLtWMbB $NVS $PFE $AMGN$AMGN Max Pain = 150.00. Maturity = 04/15/2016.  Previous close = 158.60. bearish  https://t.co/fQ0spJZLAN https://t.co/XcuZRtHtyOMorgan Stanley Raises #Amgen, Inc. Price Target to $195.00. Read more: https://t.co/e3gpJKG82H $AMGNMorgan Stanley Raises Amgen, Inc. $AMGN Price Target to $195.00 https://t.co/jZZrnP5Ab5Morgan Stanley Raises Amgen, Inc. $AMGN Price Target to $195.00 https://t.co/8WlekNGUhcThese $ITUS Profits Are much Bigger Than $AMGNRT @StockMatusow: Statement of bullishness. Prediction - I got $VRX dead right and $KERX on bear end. $AFMD IMO - 7 to 10 years = another $‚Ä¶$AMGN Blincyto results in various ALL settings to be presented at conference in April. https://t.co/pKiUenYysGInterview with Connor Bruggeman SchoolTrader Extraordinaire!: https://t.co/DgrNThhkJM $NFLX $HIMX $INO $AMGN $GOOGLWant automatic email alerts for $AMGN $CNI $ISRG $ILMN $EOG? Subscribe to MarketBeat Daily https://t.co/nSJuDsYidjThese $ITUS Profits Are much Bigger Than $AMGNOarsman Capital Inc. Decreases Stake in #Amgen, Inc. (). Read more: https://t.co/eSKrFNadlC $AMGN$MRK $AMGN:

Analyst‚Äôs Focused Stocks: Merck &amp; Company, Inc. (NYSE:MRK ‚Ä¶:

https://t.co/Z7GYFF2BksAmgen, Inc. $AMGN Shares Sold by I.G. Investment Management LTD. https://t.co/MlnW3DZCCQ$AMGN:

Healthcare Stocks News Review: Amgen, (NASDAQ:AMGN), Arena ‚Ä¶:

https://t.co/4NgGH0JXBLHealthcare Stocks News Review: $AMGN $ARNA https://t.co/gBfeuM50AXAirain ltd Purchases 36,225 Shares of Amgen, Inc. $AMGN https://t.co/1P8KDTRBIIAmgen, Inc. $AMGN Stake Decreased by Bbva Compass Bancshares Inc. https://t.co/2Le79pNAqUAMGN Yield
See Here ---&gt; https://t.co/1UbK6M3pvQ

$AMGN $AXDX $UFPI #stocksRT @StockMatusow: Statement of bullishness. Prediction - I got $VRX dead right and $KERX on bear end. $AFMD IMO - 7 to 10 years = another $‚Ä¶These $ITUS Profits Are much Bigger Than $AMGNThese $ITUS Profits Are much Bigger Than $AMGNRT @StockMatusow: Statement of bullishness. Prediction - I got $VRX dead right and $KERX on bear end. $AFMD IMO - 7 to 10 years = another $‚Ä¶These $ITUS Profits Are much Bigger Than $AMGN@ScripMikeWard for me interesting is that $AMGN Blincyto got through breakthrough designation. could $AFMD AFM11 go through t same ?Statement of bullishness. Prediction - I got $VRX dead right and $KERX on bear end. $AFMD IMO - 7 to 10 years = another $AMGN$AMGN sum put oi=27,894 sum call oi=22,606 CallPutRatio=1.23 expiration 04/15/2016 bearish. https://t.co/8nvi1JFhbo https://t.co/nbMlhH8VsXSell-signal detected for 12 stocks: $EBAY $CMCSA $RDC $EOG $SLB $MCK $AMGN $VAR $DNR $SE $HRB $CHKHUN Company Info
See Here ---&gt; https://t.co/9XTJ9I749K

$HUN $AMGN $DVN #pennystocksTrading Strategies Partners: https://t.co/Upddhj47pY $AAPL $NFLX $QQQ $SPY $DJIA $VZ $GS $INTC $AA $INTC $NFLX $GS $JPM $T $MMM $AMGNBoston Partners Lowers Position in #Amgen, Inc. (). Read more: https://t.co/kvytP5zLUl $AMGNRT SeekingAlpha: A Few Key Points I Am Focusing On From Gilead Sciences' Upcoming Earnings Release https://t.co/jAR8DtaO9u $ABBV $AMGN $IB‚Ä¶A Few Key Points I Am Focusing On From Gilead Sciences' Upcoming Earnings Release https://t.co/oNGYvZaP4h $ABBV $AMGN $IBB $MRK $PFE $GILDA Few Key Points I Am Focusing On From Gilead Sciences' Upcoming Earnings Release https://t.co/iSxBZmIrGS $ABBV $AMGN $IBB $MRK $PFE $GILDFishman Jay A Ltd. MI Increases Stake in #Amgen, Inc. (). Read more: https://t.co/TIzOwQ4kA4 $AMGN",2016-04-13,AMGN,1
11,"$AMGN:

Best stocks of the day: Amgen Inc. (NASDAQ:AMGN):

https://t.co/grtfrceTtv$AMGN:US Amgen, Inc. (AMGN) Stake Boosted by GAM Holding AG #AMGEN INC  https://t.co/NcScGa0vsU #NASDAQRotating Into Health Care $BSX $VRX $IBB $REGN $AMGN $BIIB $CELG $GILD $ABBV https://t.co/RSXWjVeRxWWATT Open
See Here ---&gt; https://t.co/aWRsYsyBVw

$WATT $AMGN $HEMP #share$DLTR $AMGN $WMT:

The Best And Worst Stocks Of The 2008 Crash: What We Learned:

https://t.co/HDTV5asiZ8These $ITUS Profits Are much Bigger Than $AMGN$AMGN OI for maturity 04/15/2016. 135.00 Highest put. 155.00 Highest call. bearish https://t.co/8nvi1JWS2W https://t.co/7ZWsac6Zf6AMGN Quotes
See Here ---&gt; https://t.co/KmdqMwPzoD

$AMGN $MDT $JCOM #shareRT @ben_levisohn: Gilead Sciences: Maybe It‚Äôll Beat After All? https://t.co/1ve2r7WgM7 via @barronsonline $GILD $AMGN $CELG $BIIB $IBBAWH Ask
See Here ---&gt; https://t.co/h4h0ETS8wt

$AWH $HES $AMGN #stockRT @BioPharmaDive: ICER questions cost effectiveness of multiple myeloma therapies https://t.co/Uur67m087U $AMGN $ABBV $BMYLTXB News
See Here ---&gt; https://t.co/nmRHes959s

$LTXB $AMGN $GHL #tradeideasTraders Sell Shares of Amgen, Inc. $AMGN on Strength $AMGN https://t.co/KUu5ns9nESTraders Sell Shares of Amgen, Inc. $AMGN on Strength $AMGN https://t.co/TS2M5nVAA4Gilead Sciences: Maybe It‚Äôll Beat After All? https://t.co/vU2x49wQGE via @barronsonline $GILD $CELG $AMGN $BIIB $IBBGilead Sciences: Maybe It‚Äôll Beat After All? https://t.co/1ve2r7WgM7 via @barronsonline $GILD $AMGN $CELG $BIIB $IBBAMGN Top news - Apr 14th, 2016 $AMGN https://t.co/rVcVc7vP3XThese $ITUS Profits Are much Bigger Than $AMGNRT @SAlphaTrending: Allergan: Life After Pfizer https://t.co/f1nO44beQj $AAPL #APPLE $AMGN $AXP $BA $CMI $CSCO $ETN $EV $FCF $GILD $IBM $IN‚Ä¶Allergan: Life After Pfizer https://t.co/f1nO44beQj $AAPL #APPLE $AMGN $AXP $BA $CMI $CSCO $ETN $EV $FCF $GILD $IBM $INTC $MSFT $ORCL $PFEICER questions cost effectiveness of multiple myeloma therapies https://t.co/Uur67m087U $AMGN $ABBV $BMYleahanne: Volume Alert - AMGN 159.83 Amgen $AMGN Hit a high https://t.co/vNasH1hhj1leahanne: Volume Alert - AMGN 159.83 Amgen $AMGN Hit a high https://t.co/qwl8MSSpasVolume Alert - AMGN 159.83 Amgen $AMGN Hit a high today of 160.67 Closing the day 10:30 at 159.83 -0.23 -0.14% https://t.co/8IIci3ZVgW$HALO - making preparations to Test/Treat Solid Tumors for HA/KRAS/BRAF-will @RHHBY $MRK/ $BMY/ $GILD/ $AMGN follow? https://t.co/zxhCAAe701#US #Aktien im Fokus: FIRST SOLAR, #Jinkosolar, AMGEN $AMGN https://t.co/NwY9H1PZe7Rotating Into Health Care $BSX $VRX $IBB $REGN $AMGN $BIIB $CELG $GILD $ABBV https://t.co/ryU7n7HbtZ$AMGN:US Amgen, Inc. (AMGN) Stake Boosted by GAM Holding AG #AMGEN INC  https://t.co/WVxjJmOaGN #NASDAQ$AMGN Max Pain = 150.00. Maturity = 04/15/2016.  Previous close = 160.06. bearish  https://t.co/fQ0spJZLAN https://t.co/IUEV5SnmOK@benmat07 ‚ÄúChanging a biochemical marker is not the same as improving the outcome for patients‚Äù #biotech $ESPR $AMGN $REGN $MDCO $MRKResurrected a great article as this cont. to be a hot button topic: Cholesterol Conundrum https://t.co/pAIUJJmKrJ #science $AMGN $REGN $ESPROpus Investment Management Inc. Has $4,951,000 Stake in Amgen, Inc. $AMGN https://t.co/8DF72Y7y94Stephens Inc. AR Raises Position in Amgen, Inc. $AMGN https://t.co/KzlmjHDTc1Why is $AMGN in InvestRica's robo-stock spot light?  Medium Return, Medium Risk, 2 yr Time. https://t.co/AypsAT67VwMTU News
See Here ---&gt; https://t.co/ajV2yORrYP

$MTU $LUV $AMGN #investJBEM pick CYDY runng hard, FLKS is nxt: https://t.co/RJhHbIwnlX $AMBS $AMG.DE $AMGN $AMGN.BA $AMGN.MX $AMGN34.SA $AMGN34F.SA $AMPEWhen the #tide comes into your #circle, all #ships should also #rise. $FB $AMGN $DAL $WYNN $KMX $BLUE $EXPE $MPWR $TRMB $SSYS $LSCC $FRC $FLStock Chart Technical Analysis Video 4/13/16 
  https://t.co/MbYVn7T0Bb
  $AAPL $AMGN $IDU $CMG $COST $DIS $GILD $GPRO $FB $TWTRSFL Short Sales
See Here ---&gt; https://t.co/wKonlYnX47

$SFL $AMGN $WPX #investing$VRX $AMGN:

Analysts Actions to Focus: Valeant Pharmaceuticals International ‚Ä¶:

https://t.co/t8tmcYCTLD@perrone_ken JMO. I tried to include SCap, mid &amp; large. $amgn has some activist HF mgnrs (Loeb), good growth &amp; pipe/That makes it attractive@Drchik23 @DrSManian @bret_jensen $AMGN?????? Seriously???? $120B mkt cap. Seriously???Unifying On Immunotherapy: Will It Pay Off?
https://t.co/9BFqPH6H6A
#pharma #biotech #CancerMoonShot $ABBV $AMGN $BMY $CELG $LLY $MRK $PFERT @valuewalk: Aristotle Value Equity 1Q16 Commentary ‚Äì Amgen https://t.co/IWIe1wXeQ8 $AMGN https://t.co/j9fjibMRbGBaird Financial Group Inc. Sells 951 Shares of Amgen, Inc. $AMGN https://t.co/XNzww2deYXBaird Financial Group Inc. Sells 951 Shares of Amgen, Inc. $AMGN https://t.co/ApEqWiCSSs#Amgen : U.S. Patents Awarded to Inventors in Washington (April 13). Read more: https://t.co/lvC7vuR0Yt $AMGNMorningstar Gives A Credit Rating to Amgen, Inc. $AMGN https://t.co/cxTC4QH7Jh$AMGN:US Amgen, Inc. (AMGN) Stake Boosted by GAM Holding AG #AMGEN INC  https://t.co/aNi64NyFvy #NASDAQ$AMGN:US Amgen, Inc. (AMGN) Stake Boosted by GAM Holding AG #AMGEN INC  https://t.co/2GvbNncUyF #SP500$AMGN chart looks so choppy so how in the world has it managed to close abv the daily 5 EMA for 20 cons trading days?GG 52Wk Low
See Here ---&gt; https://t.co/5yiklCg0WG

$GG $ADC $AMGN #shareThese $ITUS Profits Are much Bigger Than $AMGNRT @Drchik23: @DrSManian @bret_jensen I think these bios could be bought out in 2016: $ardx $fold $cpxx $rlyp $arwr $amgn $cemp. That would‚Ä¶@DrSManian @bret_jensen I think these bios could be bought out in 2016: $ardx $fold $cpxx $rlyp $arwr $amgn $cemp. That would be my list:))$AMGN maturity 04/15/2016 oi CallPutRatio of 1.26 puts 27,868 &amp; calls 22,048 bearish. https://t.co/8nvi1JFhbo https://t.co/z7c7L9VVJ4#Amgen, Inc. Stake Boosted by GAM Holding AG. Read more: https://t.co/Pf3a1fAtn1 $AMGNCAM Group Holding A S Has $38,462,000 Position in Amgen, Inc. $AMGN https://t.co/1mUQ0vMtNyAmgen, Inc. $AMGN Stake Raised by Todd Asset Management LLC https://t.co/fuWXSTSwlsSouth Dakota Investment Council Has $26,655,000 Stake in #Amgen, Inc. (). Read more: https://t.co/iXh5vabkor $AMGN",2016-04-14,AMGN,1
12,"Morgan Stanley Has $1,187,772,000 Stake in Amgen, Inc. $AMGN https://t.co/xjdCA5H8QGFinancial Counselors Inc. Purchases 281 Shares of Amgen, Inc. $AMGN https://t.co/PpQq5RwtgaFinancial Counselors Inc. Purchases 281 Shares of Amgen, Inc. $AMGN https://t.co/Gllaamv144RT SeekingAlpha: 4 Great Dividend Stocks Found In The Biotech Rubble https://t.co/giK7wBwuwZ $ABBV $AMGN $AZN $GRFS4 Great Dividend Stocks Found In The Biotech Rubble https://t.co/l8qopAWBqD $ABBV $AMGN $AZN $GRFS4 Great Dividend Stocks Found In The Biotech Rubble https://t.co/iGy07ToyBZ $ABBV $AMGN $AZN $GRFS4 Great Dividend Stocks Found In The Biotech Rubble https://t.co/AIACPAtrFC $ABBV $AMGN $AZN $GRFS4 Great Dividend Stocks Found In The Biotech Rubble https://t.co/ZTqaTzi74r $ABBV $AMGN $AZN $GRFS$AMGN maturity 04/22/2016 oi CallPutRatio of 1.53 puts 3,015 &amp; calls 1,971 bearish. https://t.co/yETjKVV8ke https://t.co/OushbPoHyY$WAT #biotech stock breaking long term resistance

$IBB $REGN $AMGN $GILD https://t.co/WVoeoeixZxInterview with Connor Bruggeman SchoolTrader Extraordinaire!: https://t.co/DgrNThhkJM $NFLX $HIMX $INO $AMGN $GOOGLWeekly Research Analysts' Ratings Updates for #Amgen (). Read more: https://t.co/D2otW2MJpG $AMGNWeekly Research Analysts' Ratings Updates for #Amgen (). Read more: https://t.co/ON5IFMfAyv $AMGN#Amgen, Inc. Receives ""A"" Credit Rating from Morningstar. Read more: https://t.co/1gIEgxMCsr $AMGN$AMGN has had a great earnings performance in the last few years https://t.co/B45yU18S2N https://t.co/PMa0qqGLhL$NVS, $AMGN,  Long term  $FB $TWTR medium term $CBS Medium Term https://t.co/V5OzJl4vVpPrice Target Alert: Trading the Zacks price target change for AMGEN¬†$AMGN https://t.co/StoTrIV9Qs https://t.co/wu0hnK7TrNRT @StockMatusow: Affimed Science Explained - Technical Breakdown https://t.co/0wIUBBxSH5 $AFMD $KITE $JUNO $FATE $AMGN $PIRS #immunotherap‚Ä¶Amgen, Inc. $AMGN Receives ‚ÄúA‚Äù Credit Rating from Morningstar https://t.co/Ys5nB1fZ06RT @StockMatusow: AACR $AFMD AFM 13 Abstract https://t.co/QRX6Ys2JjH #cancer #oncology #immunotherapy $FATE $KITE $JUNO $PIRS $AMGN $AGN #B‚Ä¶RT @StockMatusow: Affimed Science Explained - Technical Breakdown https://t.co/0wIUBBxSH5 $AFMD $KITE $JUNO $FATE $AMGN $PIRS #immunotherap‚Ä¶AMGN Top news - Apr 18th, 2016 $AMGN https://t.co/qTIaSagLI0What do $GILD, $AMGN, $CELG, $BIIB and $REGN have in common?  https://t.co/1HCajBGEJFWhat do $GILD, $AMGN, $CELG, $BIIB and $REGN have in common?  https://t.co/iStSv03lAvAffimed Science Explained - Technical Breakdown https://t.co/0wIUBBxSH5 $AFMD $KITE $JUNO $FATE $AMGN $PIRS #immunotherapy #biotech #cancerAACR $AFMD AFM 13 Abstract https://t.co/QRX6Ys2JjH #cancer #oncology #immunotherapy $FATE $KITE $JUNO $PIRS $AMGN $AGN #Biotech $RUT #stock3 Cheap #Dividend Stocks To Buy Today
https://t.co/Fyi2BeWWZ1 #investing #DividendStocks $BA $MPC $AMGNPepsi's Q1 - Flat At Best: No 'Alpha' Here, And What Looks Better https://t.co/BuwfwQekjv $ABBV $AMGN $BIIB $CELG $GILD $KO $NVO $PG $SPYRT SeekingAlpha: Pepsi's Q1 - Flat At Best: No 'Alpha' Here, And What Looks Better https://t.co/Wh9SvxqOE9 $ABBV $AMGN $BIIB $CELG $GILD $‚Ä¶@JacobPlieth @AmyEPVantage Perhaps the bigger price $AMGN paid was losing a sizable portion of their oncology team to $KITE.Pepsi's Q1 - Flat At Best: No 'Alpha' Here, And What Looks Better https://t.co/OfLkjcJ8Gj $ABBV $AMGN $BIIB $CELG $GILD $KO $NVO $PG $SPY@DavidWetherell @AmyEPVantage I would argue that $AMGN's committment has been relatively small so far, in up-front financial terms anyway@techwhitepapers $AFMD 10-100 times more potent than $AMGN based @bmo .. WHICH is conservative w only 7$ PT . new analyst. no testosterone$AMGN:

Amgen Inc. (NASDAQ:AMGN) Checking on Earnings:

https://t.co/NC5kArD1UfFlatiron Health Announces Strategic Relationships with $CELG &amp; $AMGN
https://t.co/4gpBGdmwPv
$IBB $XBIJBEM releases new pick 'MBVX'.Full DD here:  https://t.co/BXfT4dyvo5 $AMDA $AME $AMED $AMFW $AMG $AMGN $AMH $AMH-A$AMGN OI for maturity 04/22/2016. 148.00 Highest put. 160.00 Highest call. bearish https://t.co/yETjKVV8ke https://t.co/GODojc5O27$AMGN First-in-human study of AMG 820, a monoclonal anti-CSF-1R (c-fms) antibody, in patients (pts) with advanced solid tumors$AMGN:

Hot stocks: Amgen Inc. (NASDAQ:AMGN) , Astrazeneca PLC (NYSE ‚Ä¶:

https://t.co/SNj8GX5jnwAmgen, Inc. $AMGN Shares Sold by Swedbank https://t.co/MGhu1Xiq7C#Amgen, Inc. Assigned A Credit Rating. Read more: https://t.co/Pq0apWfXfp $AMGNMassachusetts Financial Services Co. MA Sells 707 Shares of Amgen, Inc. $AMGN https://t.co/s7wjYT7F3m$AMGN received a new alert. Find out why at https://t.co/nZwqReM0tj #stocks #daytrading #trading #mkt  #NYSE #NASDAQ #markets 31Massachusetts Financial Services Co. MA Sells 707 Shares of Amgen, Inc. $AMGN https://t.co/NmE8YXez2uKCM Investment Advisors LLC Sells 404 Shares of Amgen, Inc. $AMGN https://t.co/mVF89gcSyKDana Investment Advisors Inc. Has $3,678,000 Position in Amgen, Inc. $AMGN https://t.co/06ORcuVSrx23:15--&gt; https://t.co/vqaokSKgmf

Also, see: https://t.co/Tx8cJJUe7g

$AMGN $SNY $LLY $BAYRY $GILD $BIIB $CELG $REGN https://t.co/pE353zRirt$LLY $GSK $ABBV $AMGN:

Pharma Sector Q1 Earnings Preview: What To Expect From Top ‚Ä¶:

https://t.co/euDVsV9eST$AMGN:

Analysts See Decrease of Amgen, Inc. (AMGN) Earnings Per Share:

https://t.co/hsj09ISNARAmgen Inc Reiterated Rating by Cowen &amp; Co (Ranked 53rd) to Buy $AMGN #AMGN https://t.co/bqjkWr2ARA$AMGN Max Pain = 152.50. Maturity = 04/22/2016.  Previous close = 160.13. bearish  https://t.co/n9lGNXUQ2J https://t.co/q3Ounk5bWCRT @ACInvestorBlog: $AMGN setting up nicely. Go long on a close above 160.89 https://t.co/upCoLToih7Trading Strategies Partners: https://t.co/Upddhj47pY $AAPL $NFLX $QQQ $SPY $DJIA $VZ $GS $INTC $AA $INTC $NFLX $GS $JPM $T $MMM $AMGN",2016-04-18,AMGN,1
13,"Amgen, Inc. $AMGN Stake Boosted by BHF Kleinwort Benson Group S.A. https://t.co/HqB5mJgA0TAmgen, Inc. $AMGN Position Increased by Haverford Trust Co. https://t.co/U4g5R7EUNZRT @bret_jensen: Commented on Biotech: The Rally Could Just Be Beginning https://t.co/kLEee0nLui $ABBV $AGN $AMGN $AZN $CELG $GILD $MDVN $P‚Ä¶RT @JacobPlieth: AMG820 DLTs &amp; AEs in phase I study $AMGN #AACR16 https://t.co/RRrwncg113#Amgen, Inc. Stake Raised by Burney Co. Read more: https://t.co/gWpsBtzVoj $AMGNRT @JacobPlieth: AMG820 best tumour responses $AMGN #AACR16 https://t.co/YeQi980Qgw#Amgen, Inc. Stake Lowered by Plancorp LLC. Read more: https://t.co/djHKtQ8jdx $AMGNBearish Doji https://t.co/iMcLZuWVEv $BKD $WMT $LVLT $SSO $PPL $LUV $BXLT $GGP $ETSY $RES $PCG $GPS $SWFT $HCP $MCD $AMGN $VTI $ACASAmgen, Inc. $AMGN Stake Lowered by Plancorp LLC https://t.co/AWnjwoKWNwAmgen, Inc. $AMGN Stake Raised by Burney Co. https://t.co/1IIkEMKr3Q$AMGN - Amgen, Inc. #AMGN Stake Raised by Burney Co. https://t.co/K8E8lVqE9P$AMGN - Amgen, Inc. #AMGN Stake Raised by Burney Co. https://t.co/LDUp4M9SQ0$AMGN: Amgen announces that The Lancet published results from a Phase 3 study of Nplate; study met the primary... https://t.co/OoMeLh57KcRT @JacobPlieth: AMG820 best tumour responses $AMGN #AACR16 https://t.co/YeQi980QgwAMG820 best tumour responses $AMGN #AACR16 https://t.co/YeQi980QgwAMG820 DLTs &amp; AEs in phase I study $AMGN #AACR16 https://t.co/RRrwncg113RT @HumbleBioTrader: $AMGN Says Study in The Lancet Shows Nplate Significantly Increases Durable Platelet Response https://t.co/I4FlVjDvxM‚Ä¶RT MarketCurrents: Amgen's Nplate successful in late-stage pediatric ITP study https://t.co/wdIaNlxhVK $AMGN,https://t.co/Q0pEHTMLieAmgen's Nplate successful in late-stage pediatric ITP study $AMGN https://t.co/WuHumPMxfOAmgen's Nplate successful in late-stage pediatric ITP study https://t.co/i23KUXg5OG $AMGNAmgen's Nplate successful in late-stage pediatric ITP study https://t.co/tirPPr0R6D $AMGNAmgen's Nplate successful in late-stage pediatric ITP study https://t.co/xK1Xtf4BUZ $AMGNRT @SA_HealthInvest: Biotech: The Rally Could Just Be Beginning https://t.co/uFITPjZgzg $ABBV $AGN $AMGN $AZN $CELG $GILD $MDVN $PFE $SNY $‚Ä¶$AMGN:

New SEC Filing for AMGN: Form DEFA14A (No. 0001193125-16-546504):

https://t.co/atJY4m4gra https://t.co/BmB1O4KXTp$AMGN ALERT: New Amgen SEC Filing
From our Stock News Alerts App$AMGN - Additional Proxy Soliciting Materials (definitive) (defa14a) https://t.co/jvs3l04jDb$AMGN Nplate¬Æ (Romiplostim) Study In The Lancet Shows Significant Increase In Durable Platelet Response Among
From our Stock News Alerts App$AMGN Says Study in The Lancet Shows Nplate Significantly Increases Durable Platelet Response https://t.co/I4FlVjDvxM via @Street_Insider$AMGN: announces that Lancet published results from a Phase 3 study of Nplate; study met the primary endpoint of durable platelet response$AMGN - Nplate¬Æ (Romiplostim) Study In The Lancet Shows Significant Increase In Durable Platelet Response https://t.co/6d6CbDo7cF$amgn 52% of Nplate patients achieved durable platelet responseCommented on Biotech: The Rally Could Just Be Beginning https://t.co/kLEee0nLui $ABBV $AGN $AMGN $AZN $CELG $GILD $MDVN $PFE $SNY $SGYP $VRXAmgen Inc Valuation - February 2016 $AMGN https://t.co/MlQB8b9oqUWhy Johnson &amp; Johnson‚Äôs Earnings are Good News for Big Biotech https://t.co/r02N0gTs19 via @barronsonline $JNJ $BIIB $AMGN $GILD $IBB#Amgen - Gewinne mitnehmen? #b√∂rse #aktien $AMGN https://t.co/D13cSg6mNo https://t.co/ZXuTPR5zDPRT @bs2537: Commented on Biotech: The Rally Could Just Be Beginning https://t.co/Rnw8VHXVKw $ABBV $AGN $AMGN $AZN $CELG $GILD $MDVN $PFE $S‚Ä¶Commented on Biotech: The Rally Could Just Be Beginning https://t.co/Rnw8VHXVKw $ABBV $AGN $AMGN $AZN $CELG $GILD $MDVN $PFE $SNY $SGYP $VRX$AMGN Rapatha dropped my cholesterol down to 100, LDL 20 amazing and no side effects This is amazing if you don't like the statins, who doesBiotech: The Rally Could Just Be Beginning https://t.co/gKroXrjQdh $ABBV, $AGN, $AMGN, $AZN, $CELG, $GILD, $MDVN, $PFE, $SNY, $SGYP, $VRXBiotech: The Rally Could Just Be Beginning https://t.co/SZngMNCfq6 $ABBV $AGN $AMGN $AZN $CELG $GILD $MDVN $PFE $SNY $SGYP $VRXRT SeekingAlpha: Biotech: The Rally Could Just Be Beginning https://t.co/XL6qNoRfSX $ABBV $AGN $AMGN $AZN $CELG $GILD $MDVN $PFE $SNY $SGY‚Ä¶Biotech: The Rally Could Just Be Beginning https://t.co/uFITPjZgzg $ABBV $AGN $AMGN $AZN $CELG $GILD $MDVN $PFE $SNY $SGYP $VRXJohnson &amp; Johnson‚Äôs earnings are good news for big biotechs Gilead Sciences, Biogen, Amgen
https://t.co/LZVFybMLA4 $JNJ $GILD $BIIB $AMGN$AMGN:

How Amgen Inc. (NASDAQ:AMGN) trades after earning ‚Ä¶:

https://t.co/KtyTxsGfVFRT @tgtxdough: RBC Doc day $AMGN $RDUS $PRTA https://t.co/e9WQGW7JqtRBC Doc day $AMGN $RDUS $PRTA https://t.co/e9WQGW7JqtToo Cheap To Buy Expensive Alcohol Stocks? Try Kirin Holdings https://t.co/GCCMDa3OYc $AMGN $BF.B $BUD $KO $PEP $TAP $KNBWY $BF.ART @ChinaInvest: RT SeekingAlpha: Too Cheap To Buy Expensive Alcohol Stocks? Try Kirin Holdings https://t.co/3OprQr5lOW $AMGN $BF.B $BUD $K‚Ä¶RT SeekingAlpha: Too Cheap To Buy Expensive Alcohol Stocks? Try Kirin Holdings https://t.co/3OprQr5lOW $AMGN $BF.B $BUD $KO $PEP $TAP $KNB‚Ä¶Too Cheap To Buy Expensive Alcohol Stocks? Try Kirin Holdings https://t.co/H1mwyelZPw $AMGN $BF.B $BUD $KO $PEP $TAP $KNBWY $BF.AToo Cheap To Buy Expensive Alcohol Stocks? Try Kirin Holdings https://t.co/0mb6ZYhlNt $AMGN $BF.B $BUD $KO $PEP $TAP $KNBWY $BF.AToo Cheap To Buy Expensive Alcohol Stocks? Try Kirin Holdings https://t.co/Dv9gNrUUfI $AMGN $BF.B $BUD $KO $PEP $TAP $KNBWY $BF.A$AMGN out with a new #biosimilars report: 
https://t.co/Os0yVRQKvP 
#biosimilar #FDA #pharma #biotech$AMGN Bearish. Return: 8.4%  Days Held: 96   https://t.co/A8Y7VOpzQS https://t.co/ISrsPsXAwCbispecific antibodies are a fascinating therapeutic class

$MGNX $AMGN $XNGN Ablynx F-Star many more, v active
 https://t.co/aisP2l5b4e$AMGN high open interest range is 148.00 to 160.00 for option expiration 04/22/2016. bearish https://t.co/yETjKVV8ke https://t.co/0nD18VNM684 Great Dividend Stocks Found In The Biotech Rubble https://t.co/H1Pxv5iYGp $ABBV $AMGN $AZN $GRFSAMGN Top news - Apr 19th, 2016 $AMGN https://t.co/Hqd1W7hjm7RT @vlad33301: @AndyBiotech Hats off to Forbion for selling Dezima to $AMGN at just the right time...@AndyBiotech Hats off to Forbion for selling Dezima to $AMGN at just the right time...Over Keltner https://t.co/yQVnYY5ix9 ‚Ä¶ $IWM $GILD $AZN $FOX $BAX $VER $TNA $HCP $HON $CBG $ACN $PLD $AMGN $CRM $GOOG $ILMN $MDY $IWNVetr users have downgraded Amgen Inc. to a HOLD Rating (3 stars), giving $AMGN a target price of $167.71 https://t.co/sgyPwK93LkAmgen, Inc. $AMGN Stake Raised by Martingale Asset Management L P https://t.co/qXrlFHkByIJohnson Investment Counsel Inc. Lowers Position in Amgen, Inc. $AMGN https://t.co/CAR5PWnHN0#Amgen, Inc. Lowered to Hold at Vetr Inc. Read more: https://t.co/mf4KsC3zsP $AMGNAmgen, Inc. $AMGN Lowered to Hold at Vetr Inc. https://t.co/K4XCexmQiCAmgen, Inc. $AMGN Lowered to Hold at Vetr Inc. https://t.co/b6Y0WfvLip$IBB base still looks good,needs 2move up soon 2keep symmetry. $BIIB eps 4/21, $GILD $CELG $AMGN eps 4/28. $LABU https://t.co/Rf3KvBgWHhRT @Festivus159: Looks like some of the late-breaking #AACR16 abstracts are up:
Roche OX40: https://t.co/RJSYDnQSIu
$AMGN CSF1R: https://t.‚Ä¶$IBB Biotech stocks ...setup on the weekly is sweet here. $BIB $LABU $XBI $BIIB $AMGN $CELG $JUNO $BLUE Bul... https://t.co/jHDuNQMY0pAmgen, Inc. $AMGN Lowered to Hold at Vetr Inc. https://t.co/NnbDxWMTAr$IBB  Biotech stocks  ...setup on the weekly is sweet here.

$BIB $LABU $XBI $BIIB $AMGN $CELG $JUNO $BLUE

#Trading https://t.co/CDxw3vETybAmgen downgraded by Vetr Inc. to hold. $167.71 PT. https://t.co/m8cozJevgL $AMGN #AMGNAmgen downgraded by Vetr Inc. to hold. $167.71 PT. https://t.co/6mxsNq1rus $AMGN #AMGNRT @Drchik23: @DrSManian @bret_jensen I think these bios could be bought out in 2016: $ardx $fold $cpxx $rlyp $arwr $amgn $cemp. That would‚Ä¶Pinnacle Associates Ltd. Has $13,543,000 Stake in #Amgen, Inc. (). Read more: https://t.co/UFeoSAOlul $AMGNSumitomo Mitsui Trust Holdings Inc. Has $354,157,000 Stake in #Amgen, Inc. (). Read more: https://t.co/WVzUDse3G6 $AMGN$AMGN Max Pain = 155.00. Maturity = 04/22/2016.  Previous close = 160.13. bearish  https://t.co/n9lGNXUQ2J https://t.co/Zb6AfWV8OtAmgen Inc $AMGN preserves 8.67 b of current liabilities:  https://t.co/gW19hCxEwaPinnacle Associates Ltd. Has $13,543,000 Stake in Amgen, Inc. $AMGN https://t.co/0giwQwaUrPFinancial Counselors Inc. Purchases 281 Shares of #Amgen, Inc. (). Read more: https://t.co/jWxH80kaOl $AMGNOver Keltner https://t.co/yQVnYYmTVJ $IWM $GILD $AZN $FOX $BAX $VER $TNA $HCP $HON $CBG $ACN $PLD $AMGN $CRM $GOOG $ILMN $MDY $IWN",2016-04-19,AMGN,1
14,"Ameritas Investment Partners Inc. Buys 141 Shares of Amgen, Inc. $AMGN https://t.co/Gov0SGMdkoAmeritas Investment Partners Inc. Buys 141 Shares of Amgen, Inc. $AMGN https://t.co/uQQtHsAeiEStudy: #Amgen's Nplate Effective for Child Patients
. Read more: https://t.co/SNEcxRHpmT $AMGN(6/10) 

$IBB Here Comes a Biotech Chart Storm

$AMGN Revenue (TTM)

Story --&gt; https://t.co/LwvR17k08k https://t.co/LyZVtZgUKURT @adamfeuerstein: Ignoring Criticism, Drug Companies Still Raising Prices, Making More Money https://t.co/sJNpmTgy1R $JNJ $AMGN $CELG $GI‚Ä¶These $ITUS Profits Are much Bigger Than $AMGNRT @StockNews_: $AMGN - Additional Proxy Soliciting Materials (definitive) (defa14a) https://t.co/4y20gZj6MP$AMGN - Additional Proxy Soliciting Materials (definitive) (defa14a) https://t.co/4y20gZj6MP$AMGN ALERT: New Amgen SEC Filing
From our Stock News Alerts App$AMGN - Additional Proxy Soliciting Materials (definitive) (defa14a) https://t.co/qmUAOBLWQM$AMGN posted this plan april 06 on my stream this hit above my targets today strong profits on those options. https://t.co/Iu3lhNcfjH$AMGN high open interest range is 148.00 to 165.00 for option expiration 04/22/2016.  https://t.co/2UfRbMVCXm https://t.co/SAqTTs4a4eToo Cheap To Buy Expensive Alcohol Stocks? Try Kirin Holdings https://t.co/3HM9gNJigM $AMGN $BF.B $BUD $KO $PEP $TAP $KNBWY $BF.AInvestors Sell Amgen, Inc. $AMGN on Strength $AMGN https://t.co/zLIcVI8RX4Investors Sell Amgen, Inc. $AMGN on Strength $AMGN https://t.co/ncQFKAYF99#Amgen Insurers, Doctors Making It Hard To Get Breakthrough Cholesterol-Lowering Drugs. Read more: https://t.co/5enNvy8RoF $AMGNMittelfristiges Signal! $AMGN: Ein steigender Keil wurde bei 162.706 USD nach oben durchbrochen:  https://t.co/b25QgfRY9F$JNJ $GILD $AMGN ""we have been impressed by magnitude of price increases taken by large brand biopharmaceutical..."" https://t.co/M9eHomLxTjRT @adamfeuerstein: Ignoring Criticism, Drug Companies Still Raising Prices, Making More Money https://t.co/sJNpmTgy1R $JNJ $AMGN $CELG $GI‚Ä¶#Amgen's Phase III Study Results on Nplate Published . Read more: https://t.co/4BDO63KB1B $AMGNRT @adamfeuerstein: Ignoring Criticism, Drug Companies Still Raising Prices, Making More Money https://t.co/sJNpmTgy1R $JNJ $AMGN $CELG $GI‚Ä¶AMGN Top news - Apr 20th, 2016 $AMGN https://t.co/2wsSxCO8NI2 Winners From #AACR Flying Under The Radar $AMGN $FPRX $JUNO  https://t.co/q8U0KhilTP via @benzinga20 Reasons to Buy #Amgen and Never Sell. Read more: https://t.co/bT6YG1yeHs $AMGNRT @ChinaInvest: RT SeekingAlpha: The Stock Market Leadership Transformation Has Continued https://t.co/QcNjCdoZua $AAPL #APPLE $AEP $AMGN‚Ä¶RT SeekingAlpha: The Stock Market Leadership Transformation Has Continued https://t.co/QcNjCdoZua $AAPL #APPLE $AEP $AMGN $AMZN $COST $D $‚Ä¶Sad if true....Drug prices to continue upward march according to bullish analyst https://t.co/T7wB093A1p $JNJ $AMGN $GILD $BIIBRT @bret_jensen: Commented on: ""Drug prices to continue upward march according to bullish analyst"" https://t.co/DN6lEzcBYp $JNJ $AMGN $GILD‚Ä¶RT @adamfeuerstein: Ignoring Criticism, Drug Companies Still Raising Prices, Making More Money https://t.co/sJNpmTgy1R $JNJ $AMGN $CELG $GI‚Ä¶The Stock Market Leadership Transformation Has Continued https://t.co/lrUh3yScZr $AAPL #APPLE $AEP $AMGN $AMZN $COST $D $DUK $EEM $EWAThe Stock Market Leadership Transformation Has Continued https://t.co/JQ5M2kAwHB $AAPL #APPLE $AEP $AMGN $AMZN $COST $D $DUK $EEM $EWABreakthrough cholesterol drugs fizzle amid price pushback $AMGN $REGN $SNY https://t.co/dxL7IhgTgLDrug prices to continue upward march according t... $JNJ $AMGN $GILD $BIIB $LLY $BXLT $ABBV $CELG $BMY $SHPG https://t.co/2BAA3pyxhNRT @adamfeuerstein: Ignoring Criticism, Drug Companies Still Raising Prices, Making More Money https://t.co/sJNpmTgy1R $JNJ $AMGN $CELG $GI‚Ä¶Commented on: ""Drug prices to continue upward march according to bullish analyst"" https://t.co/DN6lEzcBYp $JNJ $AMGN $GILD $BIIBRT @adamfeuerstein: Ignoring Criticism, Drug Companies Still Raising Prices, Making More Money https://t.co/sJNpmTgy1R $JNJ $AMGN $CELG $GI‚Ä¶RT @adamfeuerstein: Ignoring Criticism, Drug Companies Still Raising Prices, Making More Money https://t.co/sJNpmTgy1R $JNJ $AMGN $CELG $GI‚Ä¶RT @adamfeuerstein: Ignoring Criticism, Drug Companies Still Raising Prices, Making More Money https://t.co/sJNpmTgy1R $JNJ $AMGN $CELG $GI‚Ä¶RT @adamfeuerstein: Ignoring Criticism, Drug Companies Still Raising Prices, Making More Money https://t.co/sJNpmTgy1R $JNJ $AMGN $CELG $GI‚Ä¶Amgen, Inc. $AMGN Rating Lowered to Hold at Vetr Inc. https://t.co/Iuts8nCsIOOn which planet is making money a bad thing? Bernie-land? Bizarro-topia? $JNJ $AMGN $CELG $GILD $BIIBDrug prices to continue upward march according to bullish analyst https://t.co/387j3fne6x $JNJ, $AMGN, $GILD, $BIIB, $LLY, $BXLT, $ABBVRT @adamfeuerstein: Ignoring Criticism, Drug Companies Still Raising Prices, Making More Money https://t.co/sJNpmTgy1R $JNJ $AMGN $CELG $GI‚Ä¶RT @adamfeuerstein: Ignoring Criticism, Drug Companies Still Raising Prices, Making More Money https://t.co/sJNpmTgy1R $JNJ $AMGN $CELG $GI‚Ä¶RT @adamfeuerstein: Ignoring Criticism, Drug Companies Still Raising Prices, Making More Money https://t.co/sJNpmTgy1R $JNJ $AMGN $CELG $GI‚Ä¶RT @adamfeuerstein: Ignoring Criticism, Drug Companies Still Raising Prices, Making More Money https://t.co/sJNpmTgy1R $JNJ $AMGN $CELG $GI‚Ä¶RT @adamfeuerstein: Ignoring Criticism, Drug Companies Still Raising Prices, Making More Money https://t.co/sJNpmTgy1R $JNJ $AMGN $CELG $GI‚Ä¶Drug prices to continue upward march according to bullish analyst https://t.co/NFrExlJjHu $JNJ $AMGN $GILD $BIIBDrug prices to continue upward march according to bullish analyst https://t.co/ho36OtNYMF $JNJ $AMGN $GILD $BIIBDrug prices to continue upward march according to bullish analyst https://t.co/UcFpuFuK7p $JNJ $AMGN $GILD $BIIBRT @adamfeuerstein: Ignoring Criticism, Drug Companies Still Raising Prices, Making More Money https://t.co/sJNpmTgy1R $JNJ $AMGN $CELG $GI‚Ä¶RT @adamfeuerstein: Ignoring Criticism, Drug Companies Still Raising Prices, Making More Money https://t.co/sJNpmTgy1R $JNJ $AMGN $CELG $GI‚Ä¶$AMGN:

Amgen‚Äôs (AMGN) Phase III Study Results on Nplate Published:

https://t.co/7I5isYffxcRT @adamfeuerstein: Ignoring Criticism, Drug Companies Still Raising Prices, Making More Money https://t.co/sJNpmTgy1R $JNJ $AMGN $CELG $GI‚Ä¶RT @adamfeuerstein: Ignoring Criticism, Drug Companies Still Raising Prices, Making More Money https://t.co/sJNpmTgy1R $JNJ $AMGN $CELG $GI‚Ä¶RT @adamfeuerstein: Ignoring Criticism, Drug Companies Still Raising Prices, Making More Money https://t.co/sJNpmTgy1R $JNJ $AMGN $CELG $GI‚Ä¶$AMGN Max Pain is 157.50 for maturity 04/22/2016. Price = 162.10. bearish https://t.co/fH1QBITJwv https://t.co/uV15jVNdIBRT @adamfeuerstein: Ignoring Criticism, Drug Companies Still Raising Prices, Making More Money https://t.co/sJNpmTgy1R $JNJ $AMGN $CELG $GI‚Ä¶RT @adamfeuerstein: Ignoring Criticism, Drug Companies Still Raising Prices, Making More Money https://t.co/sJNpmTgy1R $JNJ $AMGN $CELG $GI‚Ä¶RT @adamfeuerstein: Ignoring Criticism, Drug Companies Still Raising Prices, Making More Money https://t.co/sJNpmTgy1R $JNJ $AMGN $CELG $GI‚Ä¶RT @adamfeuerstein: Ignoring Criticism, Drug Companies Still Raising Prices, Making More Money https://t.co/sJNpmTgy1R $JNJ $AMGN $CELG $GI‚Ä¶RT @adamfeuerstein: Ignoring Criticism, Drug Companies Still Raising Prices, Making More Money https://t.co/sJNpmTgy1R $JNJ $AMGN $CELG $GI‚Ä¶Call/Put Highest % volume changes:  Calls: $XOP, $CREE, $LPX, $HBAN, $CELG.  Puts: $UAL, $WNR, $ITB, $SMH, $AMGN.Ignoring Criticism, Drug Companies Still Raising Prices, Making More Money https://t.co/sJNpmTgy1R $JNJ $AMGN $CELG $GILD $BIIBBiotech: The Rally Could Just Be Beginning https://t.co/7pMn9274WM $ABBV $AGN $AMGN $AZN $CELG $GILD $MDVN $PFE $SNY $SGYP $VRXRT @Benzinga: 2 Winners From AACR Flying Under The Radar $AMGN $FPRX $JUNO https://t.co/AOCLKeX79o2 Winners From AACR Flying Under The Radar $AMGN $FPRX $JUNO https://t.co/AOCLKeX79o#Amgen Release: Nplate (Romiplostim) Study In The Lancet Shows Significant Increase In Dura... Read more: https://t.co/qisZGIZ2MW $AMGN$AMGN Additional Proxy Soliciting Materials (definitive) (defa‚Ä¶ https://t.co/cKioROSS2Q$AMGN Nplate¬Æ (Romiplostim) Study In The Lancet Shows Signific‚Ä¶ https://t.co/mhveKTg9vxCommented on Biotech: The Rally Could Just Be Beginning https://t.co/kLEee0nLui $ABBV $AGN $AMGN $AZN $CELG $GILD $MDVN $PFE $SNY $SGYP $VRX$DFS $LXK $AMGN is around its 60 day high here. What do you think? Will it head higher? https://t.co/5pmVMf42jD‚Ä¶ https://t.co/om9ZLPU3UvBiotech Forum Daily Digest: Biotech Stalwarts Start To Report Results, Kite Pharma Gets Som... https://t.co/nBRb2CMllF $ABBV $AGN $AMGNBiotech Forum Daily Digest: Biotech Stalwarts Start To Report Results, Kite Pharma Gets Som... https://t.co/NsWgBXhBza $ABBV $AGN $AMGNBiotech Forum Daily Digest: Biotech Stalwarts Start To Report Results, Kite Pharma Gets Som... https://t.co/aoTXMdrjb0 $ABBV $AGN $AMGNBiotech Forum Daily Digest: Biotech Stalwarts Start To Report Results, Kite Pharma Gets Som... https://t.co/Ru99XF5dpd $ABBV $AGN $AMGNBiotech Forum Daily Digest: Biotech Stalwarts Start To Report Results, Kite Pharma Gets Som... https://t.co/K96iJ4BvrV $ABBV $AGN $AMGN$AMGN:

Top moving stocks: Amgen Inc. (NASDAQ:AMGN) , Gilead Sciences ‚Ä¶:

https://t.co/9jAiTbQAOI$AMGN‚Äôs Nplate succeeds in late-stage¬†study https://t.co/i20uh5XRTrICYMI: Will 2016 Bring US Biosimilar Reimbursement Clarity? 
https://t.co/x8xdLPs9Eh 
$AMGN $NVS #biosimilars #biosimilar #pharma #biotechAMGN Last Trade
See Here ---&gt; https://t.co/tIJ1fqmIiL

$AMGN $AXE $XBIT #investStelliam Investment Management LP Sells 7,200 Shares of Amgen, Inc. $AMGN https://t.co/JoVRzfUwYbRT @JacobPlieth: AMG820 DLTs &amp; AEs in phase I study $AMGN #AACR16 https://t.co/RRrwncg113Follow #Nasdaq 100 traders &amp; track their tweets under one watchlist $AMGN $QCOM https://t.co/W1OB9ZtUgi https://t.co/fjC1eGfMpFRT @Terri1618: $IBB base still looks good,needs 2move up soon 2keep symmetry. $BIIB eps 4/21, $GILD $CELG $AMGN eps 4/28. $LABU https://t.c‚Ä¶$AMGN sum put oi=3,299 sum call oi=2,107 CallPutRatio=1.57 expiration 04/22/2016 bearish. https://t.co/2UfRbMVCXm https://t.co/MbDZPxo0oART @ScripDonnaDC: Will 2016 Bring US Biosimilar Reimbursement Clarity?
https://t.co/lyRyjFgwM0
$AMGN $NVS $PFE #biosimilars #biosimilar #bi‚Ä¶THC Ex-Div Date
See Here ---&gt; https://t.co/2Go7ho2kz6

$THC $NVEE $AMGN #stockWho will meet these growth rate targets? $MRK 41.5% vs $GE 921% vs $AMGN 6% https://t.co/4rUCpFTyY0 https://t.co/hkPUQ5eI2o23:15--&gt; https://t.co/vqaokSKgmf

Also, see: https://t.co/Tx8cJJUe7g

$AMGN $SNY $LLY $BAYRY $GILD $BIIB $CELG $REGN https://t.co/crmPzU2HGUTTPH Message Board Posts
See Here ---&gt; https://t.co/4nJQg6iHL3

$TTPH $RTRX $AMGN #pennystocksWill 2016 Bring US Biosimilar Reimbursement Clarity?
https://t.co/lyRyjFgwM0
$AMGN $NVS $PFE #biosimilars #biosimilar #biotech #pharmaRemember $AMGN with $300 mil upfront for Dezima‚Ä¶this past Sep. https://t.co/Slng7VHwrW?‚Ä¶  https://t.co/qDuhnu1yCp#Amgen, Inc. Position Increased by Haverford Trust Co. Read more: https://t.co/nis5IHktlI $AMGN",2016-04-20,AMGN,1
15,"GBX Stock Message Board
See Here ---&gt; https://t.co/47b6UY8eDb

$GBX $AVXL $AMGN #finance#InterestingStrength

#biomedical 

$BXLT
$BMY
$A
$WAT
$AMGN
$ABBV
$LH$AMGN:US Doheny Asset Management CA Has $1,586,000 Position in Amgen, Inc. (AMGN) #AMGEN INC  https://t.co/CWx2BNmm0C #NASDAQThese $ITUS Profits Are much Bigger Than $AMGN32 #breakout 2 #breakdown $AGIO $ALXN $AMGN $BMY $CELG $JCI $NEM $SWK $TYC $UNP $DF https://t.co/Rt46yZWIaD https://t.co/lwQBaBYQuH$AMGN (Amgen Inc) secures 0.95 in downside deviation:  https://t.co/wWt0iequsmInvestors Sell Amgen, Inc. $AMGN on Strength $AMGN https://t.co/cEDnj3nZ7fInvestors Sell Amgen, Inc. $AMGN on Strength $AMGN https://t.co/EKdXUJXytM$AMGN:US Doheny Asset Management CA Has $1,586,000 Position in Amgen, Inc. (AMGN) #AMGEN INC  https://t.co/PheeGuOGrr #SP500$AMGN is nearing a huge pivot at 165RT @OpenOutcrier: Biotechs closing on highs $GILD $AMGN $FOLD $BIIB $CELG$AMGN #uptrend continuation detected around 3:30 PM, Apr 21 EDT; use 163.29, 162.03 as stop #bullishBiotechs closing on highs $GILD $AMGN $FOLD $BIIB $CELG$ABBV $AMGN $CELG:

2 Small Biotech Stocks Poised For Substantial Upside:

https://t.co/Rjm1C5aUNJThese $ITUS Profits Are much Bigger Than $AMGNRT @ChinaInvest: RT SeekingAlpha: Rotating Into Health Care https://t.co/9Mj0xg935p $ABBV $AMGN $BIIB $BSX $CELG $GILD $GLD $IBB $REGN $TMO‚Ä¶$AMGN OI for maturity 04/22/2016. 148.00 Highest put. 165.00 Highest call.  https://t.co/LSl5wpOJkV https://t.co/KZgW7VX33lRT SeekingAlpha: Rotating Into Health Care https://t.co/9Mj0xg935p $ABBV $AMGN $BIIB $BSX $CELG $GILD $GLD $IBB $REGN $TMO $VRXThese $ITUS Profits Are much Bigger Than $AMGNAMGN Top news - Apr 21st, 2016 $AMGN https://t.co/WMaIdG6EaJRT @adamfeuerstein: Ignoring Criticism, Drug Companies Still Raising Prices, Making More Money https://t.co/sJNpmTgy1R $JNJ $AMGN $CELG $GI‚Ä¶These $ITUS Profits Are much Bigger Than $AMGNRT SeekingAlpha: Can Humira Still Dominate In 2022? https://t.co/Ev9YbEQdy8 $GILD $AMGN $PFE $JNJ $CHRS $NVS $RHHBY $SNY $ICPT $BMY $ABBV$AMGN Amgen is a 5 star üí∞ dividend üí∞ stock with a 2.5% yield: https://t.co/e49hziwaEN https://t.co/6WqNqC6qzS$AMGN,List:Continuing Bull Trend,Quote:163.82,Change:1.06,Target:194.0Can Humira Still Dominate In 2022? https://t.co/u9h83U0FYu $GILD $AMGN $PFE $JNJ $CHRS $NVS $RHHBY $SNY $ICPT $BMY $ABBVAmgen hits a 1 quarter high https://t.co/TovnXmaIlp $AMGN #Amgen https://t.co/mQd7h4Si3iThese $ITUS Profits Are much Bigger Than $AMGN$IBB catching a bid -- may finally benefit from rotating bull market. Big biotech ER a catalyst...

$AMGN $REGN $GILD $CELG$XBI $AMGN $REGN $GILD WOW$AMGN:US Doheny Asset Management CA Has $1,586,000 Position in Amgen, Inc. (AMGN) #AMGEN INC  https://t.co/hMxgpoS3WI #NASDAQ$AMGN:US Doheny Asset Management CA Has $1,586,000 Position in Amgen, Inc. (AMGN) #AMGEN INC  https://t.co/L3t48OvwqF #SP500The Stock Market Leadership Transformation Has Continued https://t.co/FfpRSK6okn $AAPL $AEP $AMGN $AMZN $COST $D $DUK $EEM $EWA $EWC $EXC$IBB trading tight

$GILD $AMGN
$REGN https://t.co/AlQYclu5TW$AMGN Max Pain = 157.50. Maturity = 04/22/2016. Previous close = 162.76. bearish https://t.co/CypQFarV94 https://t.co/aUdwIqeX0cWho will experience the most EPS growth next year? $MRK 41.5%, $GE 921%, $AMGN 6% https://t.co/g5jc0P42EY https://t.co/4NgBEIj4I1RT @bret_jensen: Commented on Biotech: The Rally Could Just Be Beginning https://t.co/kLEee0nLui $ABBV $AGN $AMGN $AZN $CELG $GILD $MDVN $P‚Ä¶$AMGN Additional Proxy Soliciting Materials (definitive) (defa‚Ä¶ https://t.co/o6AFD4ofuQ$AMGN Additional Proxy Soliciting Materials (definitive) (defa‚Ä¶ https://t.co/DM7b3i3JEOExcept every stock I own that's killing it last few years is layoffs, cost cuts sell debt raise dividend $PEP $AMGNüò≥ https://t.co/HyQLIKAq9C#Amgens drug reduces rates of bleeding in rare childhood disorder. Read more: https://t.co/N53A5fv6fu $AMGNRT @adamfeuerstein: Ignoring Criticism, Drug Companies Still Raising Prices, Making More Money https://t.co/sJNpmTgy1R $JNJ $AMGN $CELG $GI‚Ä¶RT @adamfeuerstein: Ignoring Criticism, Drug Companies Still Raising Prices, Making More Money https://t.co/sJNpmTgy1R $JNJ $AMGN $CELG $GI‚Ä¶Commented on Biotech: The Rally Could Just Be Beginning https://t.co/kLEee0nLui $ABBV $AGN $AMGN $AZN $CELG $GILD $MDVN $PFE $SNY $SGYP $VRXFederated Investors Inc. PA Has $60,157,000 Stake in Amgen, Inc. $AMGN https://t.co/nUh3l6cvXONew heart drugs struggle to win sales as doctors hold back - #PCSK9 $AMGN $REGN $NVS #entresto $ESPR https://t.co/3T8nWAiSWpChemical Bank Sells 232 Shares of Amgen, Inc. $AMGN https://t.co/yOcf4FwsOzChemical Bank Sells 232 Shares of Amgen, Inc. $AMGN https://t.co/nVT2dya4uLAmgen, Inc. $AMGN is Third Point LLC‚Äôs 3rd Largest Position https://t.co/SFjs3AAHMUAmgen, Inc. $AMGN Shares Sold by Santa Fe Partners LLC https://t.co/lJuA5Ge1fVAmgen, Inc. $AMGN Shares Sold by BRYN MAWR TRUST Co https://t.co/k5VX5x3dLl$AMGN ""white mamba√É¬¢√¢¬Ç¬¨√Ç¬¶."" on Yahoo! Finance message boards: https://t.co/aee8yq6EfzFollow #Nasdaq 100 traders &amp; track their tweets under one watchlist $AMGN $QCOM https://t.co/W1OB9ZtUgi https://t.co/j95jIN5VoLRT @adamfeuerstein: Ignoring Criticism, Drug Companies Still Raising Prices, Making More Money https://t.co/sJNpmTgy1R $JNJ $AMGN $CELG $GI‚Ä¶RT @Maximum_Pain_cm: $AMGN maturity 04/22/2016 oi CallPutRatio of 1.42 puts 3,377 &amp; calls 2,376 bearish. https://t.co/LSl5wpOJkV https://t.‚Ä¶Interview with Connor Bruggeman SchoolTrader Extraordinaire!: https://t.co/DgrNThhkJM $NFLX $HIMX $INO $AMGN $GOOGLThese $ITUS Profits Are much Bigger Than $AMGNBig Pharma earnings:

Earnings/sales estimates according to Yahoo:

C  $AMGN $BMY $BIIB $MRK $ABBV $PFE $GILD $CELG https://t.co/TM6BY3HlRRTrading Strategies Partners: https://t.co/UpddhiMw1o $AAPL $NFLX $QQQ $SPY $DJIA $VZ $GS $INTC $AA $INTC $NFLX $GS $JPM $T $MMM $AMGN$AMGN maturity 04/22/2016 oi CallPutRatio of 1.42 puts 3,377 &amp; calls 2,376 bearish. https://t.co/LSl5wpOJkV https://t.co/J4GzsWAdO1$AMGN:

Vanguard Group Inc. Buys 953984 Shares of Amgen, Inc. (AMGN):

https://t.co/MwRFnkx2NFDoheny Asset Management CA Has $1,586,000 Position in Amgen, Inc. $AMGN https://t.co/ATCTnehEq7Doheny Asset Management CA Has $1,586,000 Position in Amgen, Inc. $AMGN https://t.co/VqNGAKieUi$AMGN:

Doheny Asset Management CA Has $1586000 Position in Amgen ‚Ä¶:

https://t.co/6wid3uZZIEAmgen, Inc. $AMGN Shares Sold by GSA Capital Partners LLP https://t.co/irNRFFn8VEThese $ITUS Profits Are much Bigger Than $AMGN",2016-04-21,AMGN,0
16,"$BA $AMGN $INTC.. why wouldn't they want to stay in PNW socialist paradise? https://t.co/JnPbtgyMlLRT @StockTwits: EARNINGS

Mon - $HAL
Tue - $AAPL $TWTR $CMG $MMM $T
Wed - $FB $BA $PYPL
Thu - $AMZN $GILD $AMGN
Fri - $XOM $CVX

https://t.‚Ä¶Nasdaq100 #Stocks Trend $TMUS $TSCO $MXIM $BIIB $CHTR $ULTA $FOXA $GILD $CELG $SIRI $QCOM $CSX $ESRX $AMGN  @ https://t.co/YdSIjFJqHfRT SeekingAlpha: Pfizer Needs To Be Aggressive With M&amp;A Strategies, Or Else https://t.co/yPfQlNsoG1 $ABBV $BIIB $AGN $AMGN $JNJ $PFEPfizer Needs To Be Aggressive With M&amp;A Strategies, Or Else https://t.co/R3oG8Ri2Yv $ABBV $BIIB $AGN $AMGN $JNJ $PFERT @pharmalot: More drug makers are taking hefty price hikes on more drugs.. read how much.. https://t.co/ruynQhbjxo #pharma $JNJ $GILD $CE‚Ä¶RT @tgtxdough: Biotech earnings dates and times $SPY $IBB $AMGN $BMY $CELG $GILD $BMRN https://t.co/EqE3jgKzbPRT @CarolineYLChen: ""'Cure' is starting to feel like something you can get to ... though that won't happen overnight."" -- $AMGN's Sean Harp‚Ä¶RT @HCPG: $IBB at huge area and with $CELG $AMGN $GILD $VRTX earnings on the 27/28th-- should get some resolution. https://t.co/JgPCbde2J6RT @AndyBiotech: Crazy wk ahead!

MON
$SRPT adcom
#SCOTUS IPR

WED
$VRX senate hearing
$VRTX earnings

THU
$ABBV $ALXN $BMY $CELG
$AMGN $BM‚Ä¶$AMGN - Amgen Announces Webcast Of 2016 First Quarter Financial Results https://t.co/xlPtr8hkOj#Amgen CEO Robert Bradway will participate in a fireside chat at #WMIF16 April 26. Find out more at https://t.co/rSSovcNP9C $AMGNRT @AndyBiotech: Crazy wk ahead!

MON
$SRPT adcom
#SCOTUS IPR

WED
$VRX senate hearing
$VRTX earnings

THU
$ABBV $ALXN $BMY $CELG
$AMGN $BM‚Ä¶RT @tgtxdough: Biotech earnings dates and times $SPY $IBB $AMGN $BMY $CELG $GILD $BMRN https://t.co/EqE3jgKzbPRT @StockTwits: Earnings Reports:
Mon $HAL
Tue $AAPL $TWTR $CMG $MMM $T
Wed $FB $BA $PYPL
Thu $AMZN $GILD $AMGN
Fri $XOM $CVXRT @tgtxdough: Biotech earnings dates and times $SPY $IBB $AMGN $BMY $CELG $GILD $BMRN https://t.co/EqE3jgKzbPRT @StockTwits: EARNINGS

Mon - $HAL
Tue - $AAPL $TWTR $CMG $MMM $T
Wed - $FB $BA $PYPL
Thu - $AMZN $GILD $AMGN
Fri - $XOM $CVX

https://t.‚Ä¶RT @biotech_forum: Biotech: The Train Has Left The Station https://t.co/ct5PlUEJCY $ABBV $AGN $AMGN $ANIP $CELG $GILD $PFE $RLYP $S $XNCR $‚Ä¶RT @pharmalot: More drug makers are taking hefty price hikes on more drugs.. read how much.. https://t.co/ruynQhbjxo #pharma $JNJ $GILD $CE‚Ä¶Nasdaq100 #Stocks Trend $TMUS $TSCO $MXIM $BIIB $FOXA $ULTA $GILD $CELG $CHTR $SIRI $NVDA $ESRX $CERN $AMGN  @ https://t.co/YdSIjFJqHfS&amp;P100 #Stocks Trend $BIIB $FOXA $MDT $DIS $GILD $DHR $CELG $TWX $BK $UNP $MON $USB $BMY $AXP $HD $AMGN $ABT  @ https://t.co/cKkr8cKsjuCommented on Biotech: The Train Has Left The Station https://t.co/v0gzOfpMw0 $ABBV $AGN $AMGN $ANIP $CELG $GILD $PFE $RLYP $S $XNCR $IBBRT @tgtxdough: Biotech earnings dates and times $SPY $IBB $AMGN $BMY $CELG $GILD $BMRN https://t.co/EqE3jgKzbPRT @tgtxdough: Biotech earnings dates and times $SPY $IBB $AMGN $BMY $CELG $GILD $BMRN https://t.co/EqE3jgKzbPRT @tgtxdough: Biotech earnings dates and times $SPY $IBB $AMGN $BMY $CELG $GILD $BMRN https://t.co/EqE3jgKzbPRT @tgtxdough: Biotech earnings dates and times $SPY $IBB $AMGN $BMY $CELG $GILD $BMRN https://t.co/EqE3jgKzbPRT @HCPG: $IBB at huge area and with $CELG $AMGN $GILD $VRTX earnings on the 27/28th-- should get some resolution. https://t.co/JgPCbde2J6RT @tgtxdough: Biotech earnings dates and times $SPY $IBB $AMGN $BMY $CELG $GILD $BMRN https://t.co/EqE3jgKzbPBiotech earnings dates and times $SPY $IBB $AMGN $BMY $CELG $GILD $BMRN https://t.co/EqE3jgKzbPRT @HCPG: $IBB at huge area and with $CELG $AMGN $GILD $VRTX earnings on the 27/28th-- should get some resolution. https://t.co/JgPCbde2J6RT @AndyBiotech: Crazy wk ahead!

MON
$SRPT adcom
#SCOTUS IPR

WED
$VRX senate hearing
$VRTX earnings

THU
$ABBV $ALXN $BMY $CELG
$AMGN $BM‚Ä¶RT @biotech_forum: After the longest and deepest bear market since the financial crisis, the biotech sector is back https://t.co/ct5PlUEJCY‚Ä¶$AMGN Amgen To Participate In The 2016 World Medical Innovatio‚Ä¶ https://t.co/RVBRD5qov4RT @HCPG: $IBB at huge area and with $CELG $AMGN $GILD $VRTX earnings on the 27/28th-- should get some resolution. https://t.co/JgPCbde2J6""'Cure' is starting to feel like something you can get to ... though that won't happen overnight."" -- $AMGN's Sean Harper @ #WMIF16This Weeks Earning Candidates $AAPL, $TWTR, $BP, AMZN, $FB,¬†$AMGN https://t.co/8Az3ETUjfg https://t.co/SftYeKJg5pRT @StockTwits: EARNINGS

Mon - $HAL
Tue - $AAPL $TWTR $CMG $MMM $T
Wed - $FB $BA $PYPL
Thu - $AMZN $GILD $AMGN
Fri - $XOM $CVX

https://t.‚Ä¶AMGN Tick
See Here ---&gt; https://t.co/wtlNpXzmWD

$AMGN $WPRT $EBAY #tradeideasFULT Chart
See Here ---&gt; https://t.co/4eAB6ob7bT

$FULT $RY $AMGN #shareAMGN Top news - Apr 25th, 2016 $AMGN https://t.co/siSEgmSrWuRT @AndyBiotech: Crazy wk ahead!

MON
$SRPT adcom
#SCOTUS IPR

WED
$VRX senate hearing
$VRTX earnings

THU
$ABBV $ALXN $BMY $CELG
$AMGN $BM‚Ä¶RT @HCPG: $IBB at huge area and with $CELG $AMGN $GILD $VRTX earnings on the 27/28th-- should get some resolution. https://t.co/JgPCbde2J6RT @HCPG: $IBB at huge area and with $CELG $AMGN $GILD $VRTX earnings on the 27/28th-- should get some resolution. https://t.co/JgPCbde2J6RT @HCPG: $IBB at huge area and with $CELG $AMGN $GILD $VRTX earnings on the 27/28th-- should get some resolution. https://t.co/JgPCbde2J6$IBB at huge area and with $CELG $AMGN $GILD $VRTX earnings on the 27/28th-- should get some resolution. https://t.co/JgPCbde2J6RT @AndyBiotech: Crazy wk ahead!

MON
$SRPT adcom
#SCOTUS IPR

WED
$VRX senate hearing
$VRTX earnings

THU
$ABBV $ALXN $BMY $CELG
$AMGN $BM‚Ä¶#DividendGrowers earnings events this week. It's about to get interesting. $LEA $AMGN $ROP estimates revised up. https://t.co/wnodZAdkvVAfter the longest and deepest bear market since the financial crisis, the biotech sector is back https://t.co/ct5PlUEJCY $ABBV $AMGN $IBBRT @StockTwits: EARNINGS

Mon - $HAL
Tue - $AAPL $TWTR $CMG $MMM $T
Wed - $FB $BA $PYPL
Thu - $AMZN $GILD $AMGN
Fri - $XOM $CVX

https://t.‚Ä¶Upcoming Earnings $AAPL $XOM $FB $AMZN $T $PG $BUD $PFE $BABA $CVX $FMX $MRK $CMCSA $NVO $GILD $PTR $HSBC $AMGN $TOT https://t.co/Cg7Yk4msrIStrong Product Portfolio Drove Biogen‚Äôs 1Q16 Profit Margins $AMGN $BIIB $CELG $GILD https://t.co/vI6KpsUpBVRT @StockTwits: EARNINGS

Mon - $HAL
Tue - $AAPL $TWTR $CMG $MMM $T
Wed - $FB $BA $PYPL
Thu - $AMZN $GILD $AMGN
Fri - $XOM $CVX

https://t.‚Ä¶RT @DozenStocks: Nasdaq100 #Stocks Trend $TMUS $MXIM $BIIB $CELG $TSCO $FOXA $GILD $ALXN $CSX $TSLA $CTXS $AMGN $QCOM $LLTC  @ https://t.co‚Ä¶Nasdaq100 #Stocks Trend $TMUS $MXIM $BIIB $CELG $TSCO $FOXA $GILD $ALXN $CSX $TSLA $CTXS $AMGN $QCOM $LLTC  @ https://t.co/YdSIjFJqHfBillionaire Dan Loeb‚Äôs Top Picks Register Disappointing Returns
$MHK, $DOW, $AMGN, $AGN, $BAX
https://t.co/wmKQc61OWXBillionaire Dan Loeb‚Äôs Top Picks Register Disappointing Returns
$MHK, $DOW, $AMGN, $AGN, $BAX
https://t.co/xpIR9WfWN0Commented on Biotech: The Train Has Left The Station https://t.co/ZkGDll5v4K $ABBV $AGN $AMGN $ANIP $CELG $GILD $PFE $RLYP $S $XNCR $IBBRT @pharmalot: More drug makers are taking hefty price hikes on more drugs.. read how much.. https://t.co/ruynQhbjxo #pharma $JNJ $GILD $CE‚Ä¶RT @AndyBiotech: Crazy wk ahead!

MON
$SRPT adcom
#SCOTUS IPR

WED
$VRX senate hearing
$VRTX earnings

THU
$ABBV $ALXN $BMY $CELG
$AMGN $BM‚Ä¶Biotech: The Train Has Left The Station https://t.co/ct5PlUEJCY $ABBV $AGN $AMGN $ANIP $CELG $GILD $PFE $RLYP $S $XNCR $IBBRT @AndyBiotech: Crazy wk ahead!

MON
$SRPT adcom
#SCOTUS IPR

WED
$VRX senate hearing
$VRTX earnings

THU
$ABBV $ALXN $BMY $CELG
$AMGN $BM‚Ä¶RT @StockTwits: EARNINGS

Mon - $HAL
Tue - $AAPL $TWTR $CMG $MMM $T
Wed - $FB $BA $PYPL
Thu - $AMZN $GILD $AMGN
Fri - $XOM $CVX

https://t.‚Ä¶RT @StockTwits: EARNINGS

Mon - $HAL
Tue - $AAPL $TWTR $CMG $MMM $T
Wed - $FB $BA $PYPL
Thu - $AMZN $GILD $AMGN
Fri - $XOM $CVX

https://t.‚Ä¶RT @StockTwits: EARNINGS

Mon - $HAL
Tue - $AAPL $TWTR $CMG $MMM $T
Wed - $FB $BA $PYPL
Thu - $AMZN $GILD $AMGN
Fri - $XOM $CVX

https://t.‚Ä¶RT @StockTwits: EARNINGS

Mon - $HAL
Tue - $AAPL $TWTR $CMG $MMM $T
Wed - $FB $BA $PYPL
Thu - $AMZN $GILD $AMGN
Fri - $XOM $CVX

https://t.‚Ä¶RT @pharmalot: More drug makers are taking hefty price hikes on more drugs.. read how much.. https://t.co/ruynQhbjxo #pharma $JNJ $GILD $CE‚Ä¶RT @BPGAG: Have great day. Tons of #earnings coming. Don't get bombed in those #stocks. $AAPL $FB $TWTR $GILD $CELG $AMGN $BIIB https://t.c‚Ä¶RT @StockTwits: EARNINGS

Mon - $HAL
Tue - $AAPL $TWTR $CMG $MMM $T
Wed - $FB $BA $PYPL
Thu - $AMZN $GILD $AMGN
Fri - $XOM $CVX

https://t.‚Ä¶RT @AndyBiotech: Crazy wk ahead!

MON
$SRPT adcom
#SCOTUS IPR

WED
$VRX senate hearing
$VRTX earnings

THU
$ABBV $ALXN $BMY $CELG
$AMGN $BM‚Ä¶MON $SRPT adcom #SCOTUS IPR WED $VRX senate hearing $VRTX earnings THU $ABBV $ALXN $BMY $CELG $AMGN $BMRN $GILD FRI CHMPRT @BPGAG: Have great day. Tons of #earnings coming. Don't get bombed in those #stocks. $AAPL $FB $TWTR $GILD $CELG $AMGN $BIIB https://t.c‚Ä¶Have great day. Tons of #earnings coming. Don't get bombed in those #stocks. $AAPL $FB $TWTR $GILD $CELG $AMGN $BIIB https://t.co/l5a9NSFtWhRT @AndyBiotech: Crazy wk ahead!

MON
$SRPT adcom
#SCOTUS IPR

WED
$VRX senate hearing
$VRTX earnings

THU
$ABBV $ALXN $BMY $CELG
$AMGN $BM‚Ä¶RT @AndyBiotech: Crazy wk ahead!

MON
$SRPT adcom
#SCOTUS IPR

WED
$VRX senate hearing
$VRTX earnings

THU
$ABBV $ALXN $BMY $CELG
$AMGN $BM‚Ä¶RT @ChinaInvest: RT SeekingAlpha: Biotech: The Train Has Left The Station https://t.co/igt6tYyXAp $ABBV $AGN $AMGN $ANIP $CELG $GILD $PFE $‚Ä¶RT SeekingAlpha: Biotech: The Train Has Left The Station https://t.co/igt6tYyXAp $ABBV $AGN $AMGN $ANIP $CELG $GILD $PFE $RLYP $S $XNCR $I‚Ä¶Biotech: The Train Has Left The Station https://t.co/zyGDgavWAM $ABBV $AGN $AMGN $ANIP $CELG $GILD $PFE $RLYP $S $XNCR $IBBBiotech: The Train Has Left The Station https://t.co/gYfP0vJM7w $ABBV $AGN $AMGN $ANIP $CELG $GILD $PFE $RLYP $S $XNCR $IBBRT @StockTwits: EARNINGS

Mon - $HAL
Tue - $AAPL $TWTR $CMG $MMM $T
Wed - $FB $BA $PYPL
Thu - $AMZN $GILD $AMGN
Fri - $XOM $CVX

https://t.‚Ä¶Commented on Biotech: The Train Has Left The Station https://t.co/v0gzOfpMw0 $ABBV $AGN $AMGN $ANIP $CELG $GILD $PFE $RLYP $S $XNCR $IBBRT @AndyBiotech: Crazy wk ahead!

MON
$SRPT adcom
#SCOTUS IPR

WED
$VRX senate hearing
$VRTX earnings

THU
$ABBV $ALXN $BMY $CELG
$AMGN $BM‚Ä¶RT @stocktrader300: Earnings this week $AAPL $T $CMG $TWTR $FB $FSLR $PYPL $AMZN $LNKD $AMGN $GILD $XOM $CVX $EBAY $GRPN $JBLU $DPZ $UPS ht‚Ä¶RT @StockTwits: EARNINGS

Mon - $HAL
Tue - $AAPL $TWTR $CMG $MMM $T
Wed - $FB $BA $PYPL
Thu - $AMZN $GILD $AMGN
Fri - $XOM $CVX

https://t.‚Ä¶Biotech: The Train Is Leaving The Station https://t.co/5wPGVlk3YM $ABBV $AGN $AMGN $ANIP $CELG $GILD $PFE $RLYP $S $XNCR $IBBAmgen has smashed the lights out over the last few years with EPS growth $AMGN https://t.co/P7lG6DFShm https://t.co/LP2RdvIAqERT @SAlphaTrending: Biotech Forum Daily Digest: Critical Earnings Week Ahead, Decision Time For Sarepta, Anavex... https://t.co/7VAK5JIGro‚Ä¶Biotech Forum Daily Digest: Critical Earnings Week Ahead, Decision Time For Sarepta, Anavex... https://t.co/7VAK5JIGro $ABBV $AGN $AMGNRT @StockTwits: EARNINGS

Mon - $HAL
Tue - $AAPL $TWTR $CMG $MMM $T
Wed - $FB $BA $PYPL
Thu - $AMZN $GILD $AMGN
Fri - $XOM $CVX

https://t.‚Ä¶Biotech Forum Daily Digest: Critical Earnings Week Ahead, Decision Time For Sarepta, Anavex... https://t.co/35IkkbyDBu $ABBV $AGN $AMGNBiotech Forum Daily Digest: Critical Earnings Week Ahead, Decision Time For Sarepta, Anavex... https://t.co/ZlWilit5cj $ABBV $AGN $AMGNBiotech Forum Daily Digest: Critical Earnings Week Ahead, Decision Time For Sarepta, Anavex... https://t.co/NCruAEELTj $ABBV $AGN $AMGNBiotech Forum Daily Digest: Critical Earnings Week Ahead, Decision Time For Sarepta, Anavex... https://t.co/5NQMxiBDEY $ABBV $AGN $AMGNRT @StockTwits: EARNINGS

Mon - $HAL
Tue - $AAPL $TWTR $CMG $MMM $T
Wed - $FB $BA $PYPL
Thu - $AMZN $GILD $AMGN
Fri - $XOM $CVX

https://t.‚Ä¶#Biotech #stocks ... everybody on the tee-vee ""wanted"" it on Fri ...are they still right up against resistance? $IBB $CELG $GILD $AMGN $BIIBRT @StockTwits: EARNINGS

Mon - $HAL
Tue - $AAPL $TWTR $CMG $MMM $T
Wed - $FB $BA $PYPL
Thu - $AMZN $GILD $AMGN
Fri - $XOM $CVX

https://t.‚Ä¶$AMGN - Amgen To Participate In The 2016 World Medical Innovation Forum‚Ñ¢ On Cancer https://t.co/PW0VtnjP7G$AMGN Amgen To Participate In The 2016 World Medical Innovation ForumTM On Cancer
From our Stock News Alerts AppRT @StockTwits: EARNINGS

Mon - $HAL
Tue - $AAPL $TWTR $CMG $MMM $T
Wed - $FB $BA $PYPL
Thu - $AMZN $GILD $AMGN
Fri - $XOM $CVX

https://t.‚Ä¶RT @StockTwits: EARNINGS

Mon - $HAL
Tue - $AAPL $TWTR $CMG $MMM $T
Wed - $FB $BA $PYPL
Thu - $AMZN $GILD $AMGN
Fri - $XOM $CVX

https://t.‚Ä¶Notable Earnings for the week April 25-29

26 $AAPL $EBAY $TWTR $PNRA $BWLD $CMG
27 $FB
28 $AMGN $BMRN $CELG, $AMZN $LNKD $EXPE $BIDU $WDCRT @StockTwits: EARNINGS

Mon - $HAL
Tue - $AAPL $TWTR $CMG $MMM $T
Wed - $FB $BA $PYPL
Thu - $AMZN $GILD $AMGN
Fri - $XOM $CVX

https://t.‚Ä¶April 25-29
26   $AAPL $EBAY $TWTR $PNRA   $BWLD $CMG
27   $FB
28 $AMGN  $BMRN  $CELG, $AMZN  $LNKD  $EXPE $BIDU  $WDCRT @StockTwits: EARNINGS

Mon - $HAL
Tue - $AAPL $TWTR $CMG $MMM $T
Wed - $FB $BA $PYPL
Thu - $AMZN $GILD $AMGN
Fri - $XOM $CVX

https://t.‚Ä¶RT @StockTwits: EARNINGS

Mon - $HAL
Tue - $AAPL $TWTR $CMG $MMM $T
Wed - $FB $BA $PYPL
Thu - $AMZN $GILD $AMGN
Fri - $XOM $CVX

https://t.‚Ä¶$AAPL $AMAT $AMGN $AMTD $AMZN $ATVI Trade long or long+short positions from the #NASDAQ, up to 1500% since 2010. https://t.co/ldcTl0HsrK$IBB under the ""keep it simple"" banner, this ETF is only selling at 18X.  Heavy exposure to $AMGN, $BIIB, $CELG $GILD $REGN. Down from $400.RT @StockTwits: EARNINGS

Mon - $HAL
Tue - $AAPL $TWTR $CMG $MMM $T
Wed - $FB $BA $PYPL
Thu - $AMZN $GILD $AMGN
Fri - $XOM $CVX

https://t.‚Ä¶RT @StockTwits: EARNINGS

Mon - $HAL
Tue - $AAPL $TWTR $CMG $MMM $T
Wed - $FB $BA $PYPL
Thu - $AMZN $GILD $AMGN
Fri - $XOM $CVX

https://t.‚Ä¶RT @StockTwits: EARNINGS

Mon - $HAL
Tue - $AAPL $TWTR $CMG $MMM $T
Wed - $FB $BA $PYPL
Thu - $AMZN $GILD $AMGN
Fri - $XOM $CVX

https://t.‚Ä¶RT @StockTwits: EARNINGS

Mon - $HAL
Tue - $AAPL $TWTR $CMG $MMM $T
Wed - $FB $BA $PYPL
Thu - $AMZN $GILD $AMGN
Fri - $XOM $CVX

https://t.‚Ä¶RT @tgtxdough: $AMGN new Phase III trial (NCT02739984) to study Repatha patients with type 2 Diabetes Mellitus with Hypercholesterolemia/Mi‚Ä¶RT @StockTwits: EARNINGS

Mon - $HAL
Tue - $AAPL $TWTR $CMG $MMM $T
Wed - $FB $BA $PYPL
Thu - $AMZN $GILD $AMGN
Fri - $XOM $CVX

https://t.‚Ä¶RT @StockTwits: EARNINGS

Mon - $HAL
Tue - $AAPL $TWTR $CMG $MMM $T
Wed - $FB $BA $PYPL
Thu - $AMZN $GILD $AMGN
Fri - $XOM $CVX

https://t.‚Ä¶RT @StockTwits: EARNINGS

Mon - $HAL
Tue - $AAPL $TWTR $CMG $MMM $T
Wed - $FB $BA $PYPL
Thu - $AMZN $GILD $AMGN
Fri - $XOM $CVX

https://t.‚Ä¶RT @StockTwits: EARNINGS

Mon - $HAL
Tue - $AAPL $TWTR $CMG $MMM $T
Wed - $FB $BA $PYPL
Thu - $AMZN $GILD $AMGN
Fri - $XOM $CVX

https://t.‚Ä¶RT @StockTwits: EARNINGS

Mon - $HAL
Tue - $AAPL $TWTR $CMG $MMM $T
Wed - $FB $BA $PYPL
Thu - $AMZN $GILD $AMGN
Fri - $XOM $CVX

https://t.‚Ä¶RT @StockTwits: EARNINGS

Mon - $HAL
Tue - $AAPL $TWTR $CMG $MMM $T
Wed - $FB $BA $PYPL
Thu - $AMZN $GILD $AMGN
Fri - $XOM $CVX

https://t.‚Ä¶RT @StockTwits: EARNINGS

Mon - $HAL
Tue - $AAPL $TWTR $CMG $MMM $T
Wed - $FB $BA $PYPL
Thu - $AMZN $GILD $AMGN
Fri - $XOM $CVX

https://t.‚Ä¶RT @StockTwits: EARNINGS

Mon - $HAL
Tue - $AAPL $TWTR $CMG $MMM $T
Wed - $FB $BA $PYPL
Thu - $AMZN $GILD $AMGN
Fri - $XOM $CVX

https://t.‚Ä¶RT @StockTwits: EARNINGS

Mon - $HAL
Tue - $AAPL $TWTR $CMG $MMM $T
Wed - $FB $BA $PYPL
Thu - $AMZN $GILD $AMGN
Fri - $XOM $CVX

https://t.‚Ä¶RT @StockTwits: EARNINGS

Mon - $HAL
Tue - $AAPL $TWTR $CMG $MMM $T
Wed - $FB $BA $PYPL
Thu - $AMZN $GILD $AMGN
Fri - $XOM $CVX

https://t.‚Ä¶RT @StockTwits: EARNINGS

Mon - $HAL
Tue - $AAPL $TWTR $CMG $MMM $T
Wed - $FB $BA $PYPL
Thu - $AMZN $GILD $AMGN
Fri - $XOM $CVX

https://t.‚Ä¶RT @StockTwits: EARNINGS

Mon - $HAL
Tue - $AAPL $TWTR $CMG $MMM $T
Wed - $FB $BA $PYPL
Thu - $AMZN $GILD $AMGN
Fri - $XOM $CVX

https://t.‚Ä¶StockTwits: EARNINGS

Mon - $HAL
Tue - $AAPL $TWTR $CMG $MMM $T
Wed - $FB $BA $PYPL
Thu - $AMZN $GILD $AMGN
Fri - ‚Ä¶ https://t.co/BrkIxn94JiRT @StockTwits: EARNINGS

Mon - $HAL
Tue - $AAPL $TWTR $CMG $MMM $T
Wed - $FB $BA $PYPL
Thu - $AMZN $GILD $AMGN
Fri - $XOM $CVX

https://t.‚Ä¶RT @StockTwits: EARNINGS

Mon - $HAL
Tue - $AAPL $TWTR $CMG $MMM $T
Wed - $FB $BA $PYPL
Thu - $AMZN $GILD $AMGN
Fri - $XOM $CVX

https://t.‚Ä¶RT @StockTwits: EARNINGS

Mon - $HAL
Tue - $AAPL $TWTR $CMG $MMM $T
Wed - $FB $BA $PYPL
Thu - $AMZN $GILD $AMGN
Fri - $XOM $CVX

https://t.‚Ä¶RT @StockTwits: EARNINGS

Mon - $HAL
Tue - $AAPL $TWTR $CMG $MMM $T
Wed - $FB $BA $PYPL
Thu - $AMZN $GILD $AMGN
Fri - $XOM $CVX

https://t.‚Ä¶RT @StockTwits: EARNINGS

Mon - $HAL
Tue - $AAPL $TWTR $CMG $MMM $T
Wed - $FB $BA $PYPL
Thu - $AMZN $GILD $AMGN
Fri - $XOM $CVX

https://t.‚Ä¶EARNINGS

Mon - $HAL
Tue - $AAPL $TWTR $CMG $MMM $T
Wed - $FB $BA $PYPL
Thu - $AMZN $GILD $AMGN
Fri - $XOM $CVX

https://t.co/46TicoBGufRT @AndyBiotech: Crazy wk ahead!

MON
$SRPT adcom
#SCOTUS IPR

WED
$VRX senate hearing
$VRTX earnings

THU
$ABBV $ALXN $BMY $CELG
$AMGN $BM‚Ä¶RT @AndyBiotech: Crazy wk ahead!

MON
$SRPT adcom
#SCOTUS IPR

WED
$VRX senate hearing
$VRTX earnings

THU
$ABBV $ALXN $BMY $CELG
$AMGN $BM‚Ä¶RT @AndyBiotech: Crazy wk ahead!

MON
$SRPT adcom
#SCOTUS IPR

WED
$VRX senate hearing
$VRTX earnings

THU
$ABBV $ALXN $BMY $CELG
$AMGN $BM‚Ä¶$AMGN new Phase III trial (NCT02739984) to study Repatha patients with type 2 Diabetes Mellitus with Hypercholesterolemia/Mixed DyslipidemiaRT @AndyBiotech: Crazy wk ahead!

MON
$SRPT adcom
#SCOTUS IPR

WED
$VRX senate hearing
$VRTX earnings

THU
$ABBV $ALXN $BMY $CELG
$AMGN $BM‚Ä¶RT @AndyBiotech: Crazy wk ahead!

MON
$SRPT adcom
#SCOTUS IPR

WED
$VRX senate hearing
$VRTX earnings

THU
$ABBV $ALXN $BMY $CELG
$AMGN $BM‚Ä¶RT @AndyBiotech: Crazy wk ahead!

MON
$SRPT adcom
#SCOTUS IPR

WED
$VRX senate hearing
$VRTX earnings

THU
$ABBV $ALXN $BMY $CELG
$AMGN $BM‚Ä¶RT @AndyBiotech: Crazy wk ahead!

MON
$SRPT adcom
#SCOTUS IPR

WED
$VRX senate hearing
$VRTX earnings

THU
$ABBV $ALXN $BMY $CELG
$AMGN $BM‚Ä¶RT @AndyBiotech: Crazy wk ahead!

MON
$SRPT adcom
#SCOTUS IPR

WED
$VRX senate hearing
$VRTX earnings

THU
$ABBV $ALXN $BMY $CELG
$AMGN $BM‚Ä¶RT @AndyBiotech: Crazy wk ahead!

MON
$SRPT adcom
#SCOTUS IPR

WED
$VRX senate hearing
$VRTX earnings

THU
$ABBV $ALXN $BMY $CELG
$AMGN $BM‚Ä¶RT @AndyBiotech: Crazy wk ahead!

MON
$SRPT adcom
#SCOTUS IPR

WED
$VRX senate hearing
$VRTX earnings

THU
$ABBV $ALXN $BMY $CELG
$AMGN $BM‚Ä¶RT @AndyBiotech: Crazy wk ahead!

MON
$SRPT adcom
#SCOTUS IPR

WED
$VRX senate hearing
$VRTX earnings

THU
$ABBV $ALXN $BMY $CELG
$AMGN $BM‚Ä¶RT @AndyBiotech: Crazy wk ahead!

MON
$SRPT adcom
#SCOTUS IPR

WED
$VRX senate hearing
$VRTX earnings

THU
$ABBV $ALXN $BMY $CELG
$AMGN $BM‚Ä¶RT @AndyBiotech: Crazy wk ahead!

MON
$SRPT adcom
#SCOTUS IPR

WED
$VRX senate hearing
$VRTX earnings

THU
$ABBV $ALXN $BMY $CELG
$AMGN $BM‚Ä¶Crazy wk ahead!

MON
$SRPT adcom
#SCOTUS IPR

WED
$VRX senate hearing
$VRTX earnings

THU
$ABBV $ALXN $BMY $CELG
$AMGN $BMRN $GILD

FRI
CHMPRT @stocktrader300: Lots of earnings next week $AAPL $T $CMG $TWTR $FB $FSLR $PYPL $AMZN $LNKD $AMGN $GILD $XOM $CVX $EBAY $GRPN $JBLU http‚Ä¶Delta Lloyd NV Boosts Stake in Amgen, Inc. $AMGN https://t.co/8DlORz8BcRHighTower Advisors LLC Increases Stake in Amgen, Inc. $AMGN https://t.co/kqG3DKIPWSRT @biotech_forum: Biotech Daily Digest: Sarepta Implodes! Biotech In Rally Mode. Biogen Beats! Spotlight On H... https://t.co/DnmHinDHKw $‚Ä¶Amgen, Inc. $AMGN Shares Bought by Fiduciary Group LLC https://t.co/ze8woCWza6Ally Financial Inc. Acquires 4,900 Shares of Amgen, Inc. $AMGN https://t.co/oCvlb84yOzAlly Financial Inc. Acquires 4,900 Shares of Amgen, Inc. $AMGN https://t.co/A0x6b3AsGbVantage Investment Advisors LLC Buys 1,775 Shares of Amgen, Inc. $AMGN https://t.co/GfKySQlE9xJD Prev Close
See Here ---&gt; https://t.co/YIgdJZIBbw

$JD $AMGN $PCBK #financeRT @stocktrader300: Lots of earnings next week $AAPL $T $CMG $TWTR $FB $FSLR $PYPL $AMZN $LNKD $AMGN $GILD $XOM $CVX $EBAY $GRPN $JBLU http‚Ä¶The Most Accurate Stock Alert Service Made $240,000 Yesterday https://t.co/ewcYkLb72h .. $AMGN $GLNG $PZZART @TomSilver39: Very interesting week, my watch list: $SRPT $MSTX $CYTR $FB $AAPL $TSLA $CELG $ABBV $AMZN $AMGN $BMRN $GILD ..... Good luckRT @TomSilver39: Very interesting week, my watch list: $SRPT $MSTX $CYTR $FB $AAPL $TSLA $CELG $ABBV $AMZN $AMGN $BMRN $GILD ..... Good luckVery interesting week, my watch list: $SRPT $MSTX $CYTR $FB $AAPL $TSLA $CELG $ABBV $AMZN $AMGN $BMRN $GILD ..... Good luckWeekly Market Strategies (Apr 25-29) $CVX, $T, $COF, $SAN, $RTN, $AMGN, $AKS, $UNM, $NVAX, $UMC, $AGR, $AMZN, $BSBR https://t.co/OKRkH5ylkEExplore #fundamental numbers and pros and cons for $AMGN https://t.co/olJdqsNFGs$AMGN:

Were Analysts Bullish Amgen, Inc. (NASDAQ:AMGN) This Week?:

https://t.co/aP9bKeyBMV$ADAP @Adaptimmune Therapeutics

$MDT $BSX $TMO $EW $DXCM $IDXX $NVTA $AMGN $SNY $LLY $BAYRY $GILD $BIIB $CELG $REGN https://t.co/1skbYLsG8yRT @StockWebTrading: Trading Strategies Partners: https://t.co/Upddhj47pY $AAPL $NFLX $QQQ $SPY $DJIA $VZ $GS $INTC $AA $INTC $NFLX $GS $JP‚Ä¶Trading Strategies Partners: https://t.co/Upddhj47pY $AAPL $NFLX $QQQ $SPY $DJIA $VZ $GS $INTC $AA $INTC $NFLX $GS $JPM $T $MMM $AMGNRT @GotSanctuary: notable earnings this week
LargeCaps: $CVX $CMCSA $GILD $TOT $AMGN $MO $BMY $NVO $SNY $MA $GSK $MMM $BP $ABBV $DCM https:‚Ä¶RT @Terri1618: $LABU $IBB tight,abstracts on 5/19 for 6/9 biotech conf. $CELG $GILD $AMGN eps 4/28. $TSLA $YRD tight,sto oversold https://t‚Ä¶$LABU $IBB tight,abstracts on 5/19 for 6/9 biotech conf. $CELG $GILD $AMGN eps 4/28. $TSLA $YRD tight,sto oversold https://t.co/DA5FcKS96WRT @stocktrader300: Earnings this week $AAPL $T $CMG $TWTR $FB $FSLR $PYPL $AMZN $LNKD $AMGN $GILD $XOM $CVX $EBAY $GRPN $JBLU $DPZ $UPS ht‚Ä¶Earnings this week $HAL $MMM $JBLU $PG $EBAY $SNDK $BP $AAPL $TWTR $GILD $AMZN $LNKD $BA $PYPL $UPS $AMGN $DOW $RCL https://t.co/DEeU6n5QAwEarnings this week $AAPL $T $CMG $TWTR $FB $FSLR $PYPL $AMZN $LNKD $AMGN $GILD $XOM $CVX $EBAY $GRPN $JBLU $DPZ $UPS https://t.co/Wb8Y0nGCniRT @stocktrader300: Lots of earnings next week $AAPL $T $CMG $TWTR $FB $FSLR $PYPL $AMZN $LNKD $AMGN $GILD $XOM $CVX $EBAY $GRPN $JBLU http‚Ä¶",2016-04-25,AMGN,0
17,"RT @Amgen: CEO Robert Bradway highlights importance of internal &amp; external innovation in oncology at #Amgen #WMIF2016 $AMGN https://t.co/4t‚Ä¶@OphirGottlieb $AMGN ?$AMGN - Statement of Changes in Beneficial Ownership (4) https://t.co/sQEWTSfBTx$AMGN ALERT: New Amgen SEC Filing
From our Stock News Alerts App$AMGN - Statement of Changes in Beneficial Ownership (4) https://t.co/diu8eu2NsZRT @Amgen: CEO Robert Bradway highlights importance of internal &amp; external innovation in oncology at #Amgen #WMIF2016 $AMGN https://t.co/4t‚Ä¶#Amgen, Coca-Cola re-up sponsorship of California's largest cycling event. Read more: https://t.co/9RsE19fsLW $AMGNRT @princetongb: National Kidney Foundation award for Veltassa. $RLYP + $AMGN makes sense. https://t.co/HrYFit3ffiParabolic SAR Sell https://t.co/NU8SgYcG2a $IBB $AMGN $ALXN $TMO $IHE $TARO $WAT $LGND $TNH $LQD $BBH $CRED $CIU $FICO $FBT $TECH $VCITRT @princetongb: National Kidney Foundation award for Veltassa. $RLYP + $AMGN makes sense. https://t.co/HrYFit3ffiRT @princetongb: National Kidney Foundation award for Veltassa. $RLYP + $AMGN makes sense. https://t.co/HrYFit3ffiRT @princetongb: National Kidney Foundation award for Veltassa. $RLYP + $AMGN makes sense. https://t.co/HrYFit3ffiRT @princetongb: National Kidney Foundation award for Veltassa. $RLYP + $AMGN makes sense. https://t.co/HrYFit3ffiNational Kidney Foundation award for Veltassa. $RLYP + $AMGN makes sense. https://t.co/HrYFit3ffiRT @Amgen: CEO Robert Bradway highlights importance of internal &amp; external innovation in oncology at #Amgen #WMIF2016 $AMGN https://t.co/4t‚Ä¶$ADAP @Adaptimmune Therapeutics

$MDT $BSX $TMO $EW $DXCM $IDXX $NVTA $AMGN $SNY $LLY $BAYRY $GILD $BIIB $CELG $REGN https://t.co/C6i5caNlE3RT @Amgen: CEO Robert Bradway highlights importance of internal &amp; external innovation in oncology at #Amgen #WMIF2016 $AMGN https://t.co/4t‚Ä¶CEO Robert Bradway highlights importance of internal &amp; external innovation in oncology at #Amgen #WMIF2016 $AMGN https://t.co/4tYaqDk1bDCrystal Ball Gazing: Amgen $AMGN‚Äôs Q1 Financials, What to Look For https://t.co/lyjNk6Urft https://t.co/o7e5nG5MteRT @Amgen: #Amgen CEO discusses @ProjDataSphere with @Bloomberg‚Äôs @CarolineYLChen #WMIF2016 $AMGN https://t.co/Zt3hbEJoOfRT @tgtxdough: Biotech earnings dates and times $SPY $IBB $AMGN $BMY $CELG $GILD $BMRN https://t.co/EqE3jgKzbPRT @tgtxdough: Biotech earnings dates and times $SPY $IBB $AMGN $BMY $CELG $GILD $BMRN https://t.co/EqE3jgKzbP#Amgen CEO discusses @ProjDataSphere with @Bloomberg‚Äôs @CarolineYLChen #WMIF2016 $AMGN https://t.co/Zt3hbEJoOfRT @psuvafan007: From 2016 TIDES Oligo meeting brochure $ALNY $IONS $BMRN #Moderna $AZN $AMGN #Roche It seems $ARWR data is ""new""? https://‚Ä¶AMGN Ideas
See Here ---&gt; https://t.co/rOqSuIzwsc

$AMGN $LPI $ENH #investingFrom 2016 TIDES Oligo meeting brochure $ALNY $IONS $BMRN #Moderna $AZN $AMGN #Roche It seems $ARWR data is ""new""? https://t.co/YrvpAU3WYhAMGN Top news - Apr 26th, 2016 $AMGN https://t.co/1npPcNWhcD5 NASDAQ 100 Stocks for Momentum Investors $FOX $GILD $QVCA $AMGN $ULTA https://t.co/tdyP2tD0xd https://t.co/cWNiF5gAX8#Amgen Announces Webcast Of 2016 First Quarter Financial Results  . Read more: https://t.co/ZlPXehJSzW $AMGN$IBB big week - 5 large cap biotechs reporting $VRTX 27th, $ALXN 28th, CELG 28th $AMGN 28th, GILD 28th watch $IBB 285 level for a breakoutRT @ccduong: $AMGN CEO: #ProjectDataSphere has a goal of 100K patient lives; currently at 30K patients #WMIF16 #cancer @CarolineYLChen @Amg‚Ä¶Commented on Biotech: The Train Has Left The Station https://t.co/v0gzOfpMw0 $ABBV $AGN $AMGN $ANIP $CELG $GILD $PFE $RLYP $S $XNCR $IBB$AMGN's Reese: challenge w/IO diagnostics is evolution of microenvironment over time--looks diff under treatment #WMIF16RT @ccduong: $AMGN CEO: intrigued by #liquidbiopsy and pretty optimistic about it. #WMIF16 #cancer @AmgenRT @ccduong: $AMGN CEO: #ProjectDataSphere has a goal of 100K patient lives; currently at 30K patients #WMIF16 #cancer @CarolineYLChen @Amg‚Ä¶$AMGN CEO: intrigued by #liquidbiopsy and pretty optimistic about it. #WMIF16 #cancer @Amgen$AMGN CEO: #ProjectDataSphere has a goal of 100K patient lives; currently at 30K patients #WMIF16 #cancer @CarolineYLChen @Amgen$AMGN CEO: Innovation is an expensive challenge but it needs to generate enough benefit for society #cancer #WMIF16 @amgen @CarolineYLChen$AMGN CEO: we‚Äôre excited about #multiplemyeloma but won‚Äôt touch signal transduction (dialing down) #WMIF16 #cancerUp next @ #WMIF16, @CarolineYLChen interviewing $AMGN's CEO Bob Bradway#Amgen CEO Robert Bradway to participate in fireside chat today with @Bloomberg‚Äôs @CarolineYLChen at #WMIF16. $AMGNTransports, Biotechs, And Small-Caps Spring Back To Life https://t.co/UzT4KtWxlk $ADM $ALK $ALXN $AMGN $BHP $BIIB $CDE $CELG $CHRW $CLFRT @Amgen: #Amgen CEO Robert Bradway will participate in a fireside chat at #WMIF16 April 26. Find out more at https://t.co/rSSovcNP9C $AMGN$AAPL $AMAT $AMGN $AMTD $AMZN $ATVI Trade long or long+short positions from the #NASDAQ, up to 1500% since 2010. https://t.co/ldcTl0HsrKRT @CarolineYLChen: ""'Cure' is starting to feel like something you can get to ... though that won't happen overnight."" -- $AMGN's Sean Harp‚Ä¶Medivation still an attractive takeover opportunity, says William Blair $MDVN $SNY $AZN $RHHBY $ABBV $AMGN: F... https://t.co/iBF4xlD1DT$AMGN  Symm. Triangle Breakout https://t.co/yFDnmBSUKD$AMGN     $ BIIB     $IMMY$AMGN Amgen Announces Webcast Of 2016 First Quarter Financial ‚Ä¶ https://t.co/mGRfKSKsMcRT @Benzinga: Big #Biotech In The Earnings Spotlight $AMGN $CELG $GILD https://t.co/5ccwKEVKLrBig #Biotech In The Earnings Spotlight $AMGN $CELG $GILD https://t.co/5ccwKEVKLr$AMGN Since last ER, stock gained 10%. Reporting Earnings on 4/28 After Close (Confirmed). https://t.co/GXS8iisPAeRT @StockTwits: EARNINGS

Mon - $HAL
Tue - $AAPL $TWTR $CMG $MMM $T
Wed - $FB $BA $PYPL
Thu - $AMZN $GILD $AMGN
Fri - $XOM $CVX

https://t.‚Ä¶BLUE Day Low
See Here ---&gt; https://t.co/ojXgDQUfIj

$BLUE $AMGN $ELP #stockmarketGeneral Electric Co. Cuts Position in Amgen, Inc. $AMGN https://t.co/1FDCZ3R8yaAmgen, Inc. $AMGN Position Decreased by Boston Private Wealth LLC https://t.co/KvpyKhG3KvAmgen, Inc. $AMGN Earns ‚ÄúA‚Äù Credit Rating https://t.co/HxItFkrIpXRT @bret_jensen: Commented on Biotech: The Train Has Left The Station https://t.co/v0gzOfHnUA $ABBV $AGN $AMGN $ANIP $CELG $GILD $PFE $RLYP‚Ä¶Commented on Biotech: The Train Has Left The Station https://t.co/v0gzOfHnUA $ABBV $AGN $AMGN $ANIP $CELG $GILD $PFE $RLYP $S $XNCR $IBBRT @AndyBiotech: Crazy wk ahead!

MON
$SRPT adcom
#SCOTUS IPR

WED
$VRX senate hearing
$VRTX earnings

THU
$ABBV $ALXN $BMY $CELG
$AMGN $BM‚Ä¶#Amgen Announces Webcast Of 2016 First Quarter Financial Results. Read more: https://t.co/PHlwp3ulnU $AMGNDG Capital Management Inc. Lowers Position in #Amgen, Inc. (). Read more: https://t.co/4IfmnpoAR0 $AMGN$CELG, $AMGN, $ALXN, $GILD reporting #earnings this week. Trade #Biotech #options to realize high profits. #stocks https://t.co/oQEwZcVBc8RT @AndyBiotech: Crazy wk ahead!

MON
$SRPT adcom
#SCOTUS IPR

WED
$VRX senate hearing
$VRTX earnings

THU
$ABBV $ALXN $BMY $CELG
$AMGN $BM‚Ä¶#Amgen, Inc. Shares Bought by Mizuho Trust &amp; Banking Co. Ltd. Read more: https://t.co/QI7rqPqrxl $AMGN""Resistance"" $AMGN https://t.co/TYfQmwp0if$AMGN chart: ""Resistance"". https://t.co/uyId8h0ti6RT @tgtxdough: Biotech earnings dates and times $SPY $IBB $AMGN $BMY $CELG $GILD $BMRN https://t.co/EqE3jgKzbPDG Capital Management Inc. Lowers Position in Amgen, Inc. $AMGN https://t.co/6heEnuEdyKHunter Associates inc. Sells 2,755 Shares of #Amgen, Inc. (). Read more: https://t.co/4Qzfa2kpaY $AMGNDG Capital Management Inc. Lowers Position in Amgen, Inc. $AMGN https://t.co/Tb5T60ElO9Amgen, Inc. $AMGN Shares Bought by LS Investment Advisors LLC https://t.co/ZGUZm4Bi1cGulf International Bank UK Ltd Acquires 5,500 Shares of Amgen, Inc. $AMGN https://t.co/csoi98I8jG",2016-04-26,AMGN,0
18,"More '16 MA biotech job commitments on MLSC list: Takeda in for 75, $SHPG in for 150, $AMGN in for 52, @emulatebio said 30, $ABBV said 351234 Bullish https://t.co/dezFYTL5UM $SJNK $GLNG $ETP $CX $EWS $ABBV $MMC $AEM $FBHS $IBB $BKD $TEVA $IBN $ZIOP $ENB $AMGN $FITNotable earnings after Thursday‚Äôs close https://t.co/DodyOlZK3u $ABAX, $ACHC, $AEM, $AIV, $AJG, $ALDR, $ALGN, $AMCC, $AMGN, $AMZN, $YRCWPretty safe to call this resistance $AMGN https://t.co/KEQgpr3qGI$AMGN chart: Pretty safe to call this resistance. https://t.co/PqhooFNJds@CNBCFastMoney $AMGN makes money on anti-inflammatory-diseases for $4600 per dose when nat. products work better. @GuyAdami -$AMGN is #FRAUDEarnings I'm watching tomorrow: $AMZN (expecting a miss) and $AMGN &amp; $GILDMittelfristiges Signal! $AMGN: Ein Trendkanal wurde bei 162.785 USD nach unten durchbrochen:  https://t.co/f5dMURW3rE#Earnings expected Thurs: $AMZN $GILD $AMGN $MO $BMY- 5 largest U.S. companies by market cap. 5 things to consider: https://t.co/YpCN9gqRyX#Earnings Tomorrow-P1
$ABAX $ACHC $AIV $AJG $ALDR $AMCC $AMGN $AMZN $ARII $ATEC $ATEN $ATHN $ATR $ATRC 
https://t.co/wkf0X8RupsEarnings After Close 4-28-2016 https://t.co/cfPzyqf5TS $ENVA $ATEN $ABAX $AEM $AIV $ALGN $AMZN $AMGN $AJG $AZPN $ATRC $BGS $BIDU $BMRN $BOFIRT @SheffStation: Key Anti-CD19 Bispecific T-Cell Engager &amp; CAR-T Programs. $AMGN $AFMD $MGNX $NVS $KITE $JUNO/$CELG $CLLS $BLCM $CBMG http‚Ä¶Algo trading: OPEN signals Apr/27
BUY: $ALB $MMM $AMGN $ASH $ACM $AN$IBB components were easy to setup 4 max profit by MMs to hedge 2morrow big ER day. $CELG $AMGN $GILD $ALXN. Going upRT @AndyBiotech: Crazy wk ahead!

MON
$SRPT adcom
#SCOTUS IPR

WED
$VRX senate hearing
$VRTX earnings

THU
$ABBV $ALXN $BMY $CELG
$AMGN $BM‚Ä¶Market Outlook: Landmines to Avoid https://t.co/bcpWY91Gi2 $ABBV $AMGN $CELG $GILD $LGIH $TMHCRT @Amgen: CEO Robert Bradway highlights importance of internal &amp; external innovation in oncology at #Amgen #WMIF2016 $AMGN https://t.co/4t‚Ä¶@AdamSinger @JuliaSkripkaSer this company has quite a history- $JNJ, $Amgn...who's next?AMGN Top news - Apr 27th, 2016 $AMGN https://t.co/YXlKIeKfceWill Impressive 1Q16 Earnings for Regeneron Be Enough? $AMGN $BIIB $CELG $IBB https://t.co/DPdaOltDFL@ErikNeelsen doesn't  $amgn report tomorrow?  Same as $rlyp presentation?  Interesting@BioRunUp any thoughts on $amgn heading into earnings? Positive est. but this seasons reactions seem negative regardless#Amgen Big Biotech In The Earnings Spotlight. Read more: https://t.co/G2ZcIoNes0 $AMGNRT @ErikNeelsen: $RLYP $AMGN is the new rumor!$RLYP $AMGN is the new rumor!$RLYP https://t.co/tXeIPZGi9e  $AMGN bought $RLYP (Ilypsa) for $420M in 2007. Buy company back for $3.75B?$AMGN has been heading south on no news and day away from earning ? 
Wondering if this is a buy opportunity or sell and wait post earningGet daily event reports like these for your watchlist w/ Enchilada https://t.co/6N2XyRnNXx, $GILD $CELG $ABBV $AMGN https://t.co/FVYOHQ9igYVideo: $FVD  $LMBS  Big ETF Inflows $ENB $AMGN $IEF $TLT #stocks https://t.co/O2RFatEKI5$AMGN:US Amgen, Inc. (AMGN) Shares Sold by FineMark National Bank &amp; Trust #AMGEN INC  https://t.co/1i02dFxFci #NASDAQ$AMGN:US Amgen, Inc. (AMGN) Shares Sold by FineMark National Bank &amp; Trust #AMGEN INC  https://t.co/B8A0p2WQko #SP500AMGN P/E Ratio
See Here ---&gt; https://t.co/1B2Z5p1OAm

$AMGN $MSCC $JHX #financeRT @Amgen: #Amgen CEO discusses @ProjDataSphere with @Bloomberg‚Äôs @CarolineYLChen #WMIF2016 $AMGN https://t.co/Zt3hbEJoOfRT @princetongb: National Kidney Foundation award for Veltassa. $RLYP + $AMGN makes sense. https://t.co/HrYFit3ffiRT @SashaDamouni: Drug Prices Keep Rising Despite Intense Criticism https://t.co/sen5K1EeqZ $JNJ $GILD $AMGN $CELGRT @AndyBiotech: Crazy wk ahead!

MON
$SRPT adcom
#SCOTUS IPR

WED
$VRX senate hearing
$VRTX earnings

THU
$ABBV $ALXN $BMY $CELG
$AMGN $BM‚Ä¶Drug Prices Keep Rising Despite Intense Criticism https://t.co/sen5K1EeqZ $JNJ $GILD $AMGN $CELGRT @princetongb: National Kidney Foundation award for Veltassa. $RLYP + $AMGN makes sense. https://t.co/HrYFit3ffi$AMGN:US Amgen, Inc. (AMGN) Shares Sold by FineMark National Bank &amp; Trust #AMGEN INC  https://t.co/Y4grdrDj2P #SP500RT @SheffStation: Key Anti-CD19 Bispecific T-Cell Engager &amp; CAR-T Programs. $AMGN $AFMD $MGNX $NVS $KITE $JUNO/$CELG $CLLS $BLCM $CBMG http‚Ä¶$AMGN Statement of Changes in Beneficial Ownership (4)‚Ä¶ https://t.co/jABdUXSYMc$AMGN Statement of Changes in Beneficial Ownership (4)‚Ä¶ https://t.co/q24A7MeJlTA List Of The Top Dividend Payer From The Nasdaq 100 - https://t.co/LIABSZp2Ob - $AMGN $CSCO $VIA $VOD $WDC $KHC $MAT $INTC $TXN5 Nasdaq 100 Stocks For Momentum Investors - April 26, 2016 $AMGN $GILD $ULTA $FOX $QVCA https://t.co/iCY2MSU0i5Amgen, Inc. $AMGN Position Lowered by Waddell &amp; Reed Financial Inc. https://t.co/M0i6SNXQtxVLO Tick
See Here ---&gt; https://t.co/v0xg6I1JOQ

$VLO $VIVO $AMGN #investing7 Undervalued Stocks To Buy And 3 To Sell $AMGN $CELG $GILD $MSFT $NFLX $XHB $ABBV $GOOGL $TPH $LGIH $TMHC $SCWX https://t.co/4Hd61D9b8PAmgen, Inc. $AMGN Stake Raised by The Manufacturers Life Insurance Company https://t.co/BZmezLOJ1vThe Stock Market Leadership Transformation Has Continued https://t.co/troSSKKJoC $AAPL $AEP $AMGN $AMZN $COST $D $DUK $EEM $EWA $EWC $EXCA List Of The Top Dividend Payer From The Nasdaq 100 - https://t.co/ERb9BgVFnn - $AMGN $CSCO $VIA $VOD $STX $WDC $KHC $MAT $INTC $TXN $MXIMAmgen, Inc. $AMGN Set to Announce Quarterly Earnings on Thursday https://t.co/pYy6u1RDEn$AMGN:US Amgen, Inc. (AMGN) Shares Sold by FineMark National Bank &amp; Trust #AMGEN INC  https://t.co/TCOHNY2Hj7 #NASDAQ$AMGN:US Amgen, Inc. (AMGN) Shares Sold by FineMark National Bank &amp; Trust #AMGEN INC  https://t.co/NmUHPK2NGa #SP500Bp Plc Sells 6,000 Shares of #Amgen, Inc. (). Read more: https://t.co/GAs0cHVFhD $AMGN$AMGN Amgen is a 5 star üí∞ dividend üí∞ stock with a 2.5% yield: https://t.co/e49hziwaEN https://t.co/ttRCia43Q1Big Biotech In The Earnings Spotlight $AMGN $CELG $GILD https://t.co/aliuhFtcDXEMC Tick
See Here ---&gt; https://t.co/qhsLyle9IR

$EMC $CHMA $AMGN #stock5 Nasdaq 100 Stocks For Momentum Investors - April 26, 2016 $AMGN $GILD $ULTA $FOX $QVCA https://t.co/3F4Z5x6Uoo7 Undervalued Stocks To Buy And 3 To Sell $AMGN $CELG $GILD $MSFT $NFLX $XHB $ABBV $GOOGL $TPH $LGIH $TMHC $SCWX https://t.co/TwXw8o5mzZKey Anti-CD19 Bispecific T-Cell Engager &amp; CAR-T Programs. $AMGN $AFMD $MGNX $NVS $KITE $JUNO/$CELG $CLLS $BLCM $CBMG https://t.co/QVJYqgNdnN$CELG $GILD $AMGN https://t.co/nR9eSFTrJw$AAPL $AMAT $AMGN $AMTD $AMZN $ATVI Trade long or long+short positions from the #NASDAQ, up to 1500% since 2010. https://t.co/ldcTl0HsrKRT @tgtxdough: Biotech earnings dates and times $SPY $IBB $AMGN $BMY $CELG $GILD $BMRN https://t.co/EqE3jgKzbPRT @princetongb: National Kidney Foundation award for Veltassa. $RLYP + $AMGN makes sense. https://t.co/HrYFit3ffiRT @tgtxdough: Biotech earnings dates and times $SPY $IBB $AMGN $BMY $CELG $GILD $BMRN https://t.co/EqE3jgKzbP$AMGN:

New Insider Transaction on AMGN by SVP, Business Development:

https://t.co/DuufnJkzM7 https://t.co/fdXLCrQD5E",2016-04-27,AMGN,0
19,"RT @StockTwits: Earnings TODAY after the market closes include

‚Ä¢ $AMZN
‚Ä¢ $LNKD
‚Ä¢ $GILD
‚Ä¢ $P
‚Ä¢ $AMGN
‚Ä¢ $BIDU
‚Ä¢ $GRPN
‚Ä¢ $EXPE

https://t.co/‚Ä¶RT @StockTwits: Another one of the biggest biotech stocks just reported earnings. But this time it's a beat. Amgen: https://t.co/YjnqXsScTn‚Ä¶RT @IBD_ECarson: After Hours: Amazon, LinkedIn, Baidu, Expedia Soar, Gilead Flops https://t.co/LJ7yFdWKFz $AMZN $LNKD $BIDU $EXPE $GILD $AM‚Ä¶With a yield of 2.5% Amgen is a üí∞ dividend üí∞ stock worth a look $AMGN https://t.co/E1K0p1xh4E https://t.co/sDp1EUZqFdRT @CNBC: EARNINGS: Amgen Q1 EPS $2.90 Adj. vs. $2.60 Est.; Q1 Revs. $5.53B vs. $5.32B Est. ‚Ä¢ $AMGN https://t.co/PWVqduPADB https://t.co/Jp‚Ä¶1234 Bullish https://t.co/pS6dQofeYd $SMFG $NCR $IBN $FHN $ALKS $STNG $SNY $LPLA $RSPP $PLUG $BXLT $AMGN $FOXA $SHPG $LLY $UL $AMAG$AMGN - Amgen Profit Rises 17%, Guidance Raised--Update https://t.co/Ryq6hY6gLzRT @CNBCClosingBell: After hours earnings movers: $AMZN $LNKD $GILD $AMGN https://t.co/mbxj4RWOnzRT @IBD_ECarson: After Hours: Amazon, LinkedIn, Baidu, Expedia Soar, Gilead Flops https://t.co/LJ7yFdWKFz $AMZN $LNKD $BIDU $EXPE $GILD $AM‚Ä¶RT @Amgen: $AMGN ‚Äò16 Q1 Earnings: #Amgen is off to a strong start in 2016. Read more in the PR here: https://t.co/T5UfaTXndk https://t.co/Z‚Ä¶Scan results - 1,2,3 Pullback Bullish today: $OUTR $CVT $GILD $LGND $KFY $PTC $ALKS $SCLN $AMGN $AOS ... https://t.co/o96iIkvaq0They've always been boring. But somehow, other cos in the cohort have been -ve'ly interesting,so its all good. $AMGN https://t.co/JzoibiKuXT@joncon3325 I was listening to the $AMGN call$AMGN maybe the most boring call I‚Äôve been on this season. Please stop talking so we can get to questionsRT @Amgen: $AMGN ‚Äò16 Q1 Earnings: #Amgen is off to a strong start in 2016. Read more in the PR here: https://t.co/T5UfaTXndk https://t.co/Z‚Ä¶RT @LeanneBMiller: $GILD &amp; $AMGN report in less than 1 hour!

Why biotech‚Äôs biggest names could rally the sector ¬ª 

https://t.co/FxtLdZTclvRT @IBD_ECarson: After Hours: Amazon, LinkedIn, Baidu, Expedia Soar, Gilead Flops https://t.co/LJ7yFdWKFz $AMZN $LNKD $BIDU $EXPE $GILD $AM‚Ä¶$AMGN Q1 EPS of $2.90 beats by $0.30.  Rev of $5.5B (+9.3% Y/Y) beats by $180M.  Very bullish on AMGN!!!RT @IBD_ECarson: After Hours: Amazon, LinkedIn, Baidu, Expedia Soar, Gilead Flops https://t.co/LJ7yFdWKFz $AMZN $LNKD $BIDU $EXPE $GILD $AM‚Ä¶After Hours: Amazon, LinkedIn, Baidu, Expedia Soar, Gilead Flops https://t.co/LJ7yFdWKFz $AMZN $LNKD $BIDU $EXPE $GILD $AMGNlet's play, ""how many earnings stories can i write in a day""... $BMY $ABBV $AMGN #howdoyoulikemenowNoteworthy Thursday Option Activity: $CRWN  $IPGP  $AMGN #stockoptions https://t.co/qyN2MUt06dRT @chartsmarter: ChartSmarter Friday Game Plan: https://t.co/DNJkZSmngN ""tech earnings overload"" $AMZN $LNKD $EXPE $GILD $SYMC $AMGN https‚Ä¶ChartSmarter Friday Game Plan: https://t.co/DNJkZSmngN ""tech earnings overload"" $AMZN $LNKD $EXPE $GILD $SYMC $AMGN https://t.co/Sl00vVABCd$AMGN CC slides:

https://t.co/l7RbaN3FuH$AMGN ‚Äò16 Q1 Earnings: #Amgen is off to a strong start in 2016. Read more in the PR here: https://t.co/T5UfaTXndk https://t.co/ZRnOCzYgb5RT SeekingAlpha: Amgen (AMGN) Q1 2016 Results - Earnings Call Webcast https://t.co/fx3xomyuQB $AMGNConference call: (17:30): $AMGN -- Amgen Inc Earnings (Q1 2016)Amgen (AMGN) Q1 2016 Results - Earnings Call Webcast https://t.co/P9CgQdjfeb $AMGNAmgen (AMGN) Q1 2016 Results - Earnings Call Webcast https://t.co/HmDmDETIut $AMGNAmgen (AMGN) Q1 2016 Results - Earnings Call Webcast https://t.co/4u1rT9DCH2 $AMGN@StockTwits Trending via @Stocks_Live $AMZN $GILD $LNKD $GRPN $AAPL $WLL $BIDU $QQQ $CLF $EXPE $AMGN $SWKS $UVXY https://t.co/nQhPVL0Ze1@Vtradz @blerghhh $AMGN $EXPD $LNKD$AMGN BUY SRPT WILL GO $60 - ACCORDING TO OPENHIMMER@CT_Morrison @AndyBiotech Innovative pricing models, maybe. $AMGN #Enbrel$AMGN:

New SEC Filing for AMGN: Form 8-K (No. 0001193125-16-563872):

https://t.co/vqNIIWNPGa https://t.co/qT3T8H0TPgRT @AndyBiotech: $AMGN Enbrel grew 24% YoY  while volume down 5%,  you know what that means... https://t.co/P50K3cY57vRT @StockTwits: Another one of the biggest biotech stocks just reported earnings. But this time it's a beat. Amgen: https://t.co/YjnqXsScTn‚Ä¶Catch our live updates from $AMGN's Q1 2016 #earnings conference call @ 5 p.m. ET. Join here: https://t.co/EoJaQCAJEPPopular: $GILD, $AMGN, $SWKS, $P, $OUTR, $WDC, $BABA, $TLGT, $LOGM, $SGEN, $PRLB, $BZH, $ATHN, $NUSRT @Amgen: #Amgen Announces Q1 2016 Earnings https://t.co/T5UfaTXndk $AMGNRT @BioStocks: $AMGN raises FY16 EPS  from $10.60-$11.00 to $10.85-$11.20RT @CNBC: EARNINGS: Amgen Q1 EPS $2.90 Adj. vs. $2.60 Est.; Q1 Revs. $5.53B vs. $5.32B Est. ‚Ä¢ $AMGN https://t.co/PWVqduPADB https://t.co/Jp‚Ä¶RT @AndyBiotech: $AMGN Enbrel grew 24% YoY  while volume down 5%,  you know what that means... https://t.co/P50K3cY57v$AMGN Mixed qtr but overall descent. Enbrel beats Eopgen miss. Raise guidance helped by lower R&amp;D and lower tax rate. Call 5.30RT @CNBCnow: EARNINGS: Amgen Q1 EPS $2.90 Adj. vs. $2.60 Est.; Q1 Revs. $5.53B vs. $5.32B Est. ‚Ä¢ $AMGN https://t.co/Zi7ik1vD54 https://t.co‚Ä¶Amgen, Inc. $AMGN Announces  Earnings Results, Beats Estimates By $0.30 EPS https://t.co/tozaYpJdV8Why Medivation Will Likely Reject Sanofi's $52.50/Share Buyout Offer $MDVN $SNY $ABBV $AMGN $AZN https://t.co/WHk4MLJeAw$AMGN - Current Report Filing (8-k) https://t.co/H4GeF4Pkn6Amgen Q1 top line up 10%; net income up 17%; CF Ops up 40% https://t.co/ywNyaxdPv6 $AMGNAmgen Q1 top line up 10%; net income up 17%; CF Ops up 40% https://t.co/4mmuTInztA $AMGNAmgen Q1 top line up 10%; net income up 17%; CF Ops up 40% https://t.co/hlDwztV7zT $AMGNRT @AndyBiotech: $AMGN Enbrel grew 24% YoY  while volume down 5%,  you know what that means... https://t.co/P50K3cY57vAmgen, Inc. $AMGN Releases Quarterly  Earnings Results https://t.co/wxZyHVxp1pRT @fwpharma: Amgen lifts annual guidance as first-quarter profit, sales rise https://t.co/oaL8yq5FuS $AMGN #pharma$AMGN - Amgen Profit Rises 17%, Guidance Raised https://t.co/dYTCxZwKrN$AMGN trading down slightly after hours. Enbrel sales up 24% on increased pricing, declining inventory. Neulasta up 4% on price &amp; volume.RT @BioStocks: $AMGN raises FY16 EPS  from $10.60-$11.00 to $10.85-$11.20RT @CalConfidence: Why Medivation Will Likely Reject Sanofi's $52.50/Share Buyout Offer $ABBV $AMGN $AZN  https://t.co/R3ZAXYBAy8 via @benz‚Ä¶Amgen lifts annual guidance as first-quarter profit, sales rise https://t.co/oaL8yq5FuS $AMGN #pharmaWhy Medivation Will Likely Reject Sanofi's $52.50/Share Buyout Offer $ABBV $AMGN $AZN  https://t.co/R3ZAXYBAy8 via @benzingaRT @StockTwits: Another one of the biggest biotech stocks just reported earnings. But this time it's a beat. Amgen: https://t.co/YjnqXsScTn‚Ä¶RT @CNBCClosingBell: After hours earnings movers: $AMZN $LNKD $GILD $AMGN https://t.co/mbxj4RWOnz$AMGN $5.5bn revenue up 10% in 1Q16; consensus was $5.3bn. EPS up 17% to $2.90. FY16 Guidance raised $22.2bn-$22.6bn rev, $10.85-$11.20 EPS.RT @AndyBiotech: $AMGN Enbrel grew 24% YoY  while volume down 5%,  you know what that means... https://t.co/P50K3cY57vRT @CNBC: EARNINGS: Amgen Q1 EPS $2.90 Adj. vs. $2.60 Est.; Q1 Revs. $5.53B vs. $5.32B Est. ‚Ä¢ $AMGN https://t.co/PWVqduPADB https://t.co/Jp‚Ä¶RT @StockTwits: Another one of the biggest biotech stocks just reported earnings. But this time it's a beat. Amgen: https://t.co/YjnqXsScTn‚Ä¶RT @CNBCClosingBell: After hours earnings movers: $AMZN $LNKD $GILD $AMGN https://t.co/mbxj4RWOnz$AMGN - Amgen Profit Rises 17%, Guidance Raised https://t.co/WxhHn2e7CQRT @AndyBiotech: $AMGN Enbrel grew 24% YoY  while volume down 5%,  you know what that means... https://t.co/P50K3cY57v$AMGN trading down off some good headline numbers. 
$GILD trading down on some bad ones. 

Such is the muddled world of biotech.RT @CNBC: EARNINGS: Amgen Q1 EPS $2.90 Adj. vs. $2.60 Est.; Q1 Revs. $5.53B vs. $5.32B Est. ‚Ä¢ $AMGN https://t.co/PWVqduPADB https://t.co/Jp‚Ä¶RT @CNBCnow: EARNINGS: Amgen Q1 EPS $2.90 Adj. vs. $2.60 Est.; Q1 Revs. $5.53B vs. $5.32B Est. ‚Ä¢ $AMGN https://t.co/Zi7ik1vD54 https://t.co‚Ä¶Amgen $AMGN Stock Higher in After-Hours Trading on Q1 Beat, Guidance https://t.co/tXZpDNxVtmAmgen $AMGN Stock Higher in After-Hours Trading on Q1 Beat, Guidance https://t.co/fi1Ydbwgqi #StockAction$AMGN 16M Repatha .... Maybe if they get $REGN kicked off the market, they can get closer to consensusAmgen (AMGN) Stock Higher in After-Hours Trading on Q1 Beat, Guidance $AMGN https://t.co/J5ALBxGmUz https://t.co/AmEEzvN9iKRT @StockTwits: Another one of the biggest biotech stocks just reported earnings. But this time it's a beat. Amgen: https://t.co/YjnqXsScTn‚Ä¶Trade-Ideas: Amgen $AMGN Is Today's Post-Market Leader Stock $AMGN https://t.co/0IP45CLEkNanyone know why $amgn stock is so flat, earning beat + rasised expectations, WTF?RT @AndyBiotech: $AMGN Enbrel grew 24% YoY  while volume down 5%,  you know what that means... https://t.co/P50K3cY57vRT @AndyBiotech: $AMGN Enbrel grew 24% YoY  while volume down 5%,  you know what that means... https://t.co/P50K3cY57vListen Live at 5:30pm ET: #Amgen $AMGN Q1 2016 Earnings Webcast: https://t.co/4G80T42WlORT @AndyBiotech: $AMGN Enbrel grew 24% YoY  while volume down 5%,  you know what that means... https://t.co/P50K3cY57v@AndyBiotech Pearson giving counsel to $AMGN?RT @OrangeTrader: So if market acts correctly, $EXPE $AMZN and $AMGN crushed earnings, so should be a red day tomorrow, right? Up is down,‚Ä¶RT @AndyBiotech: $AMGN Enbrel grew 24% YoY  while volume down 5%,  you know what that means... https://t.co/P50K3cY57vRT @AndyBiotech: $AMGN Enbrel grew 24% YoY  while volume down 5%,  you know what that means... https://t.co/P50K3cY57vRT @AndyBiotech: $AMGN Enbrel grew 24% YoY  while volume down 5%,  you know what that means... https://t.co/P50K3cY57v$AMGN This just got even cheaper. Ridiculously so. Problem is, it's a bio. In another time, this would have flown higher.RT CNBC ""EARNINGS: Amgen Q1 EPS $2.90 Adj. vs. $2.60 Est.; Q1 Revs. $5.53B vs. $5.32B Est. ‚Ä¢ $AMGN ‚Ä¶ https://t.co/q3bavFg5pU""RT @CNBCClosingBell: After hours earnings movers: $AMZN $LNKD $GILD $AMGN https://t.co/mbxj4RWOnz$AMGN Enbrel grew 24% YoY  while volume down 5%,  you know what that means... https://t.co/P50K3cY57vRT @CNBC: EARNINGS: Amgen Q1 EPS $2.90 Adj. vs. $2.60 Est.; Q1 Revs. $5.53B vs. $5.32B Est. ‚Ä¢ $AMGN https://t.co/PWVqduPADB https://t.co/Jp‚Ä¶RT @CNBCClosingBell: After hours earnings movers: $AMZN $LNKD $GILD $AMGN https://t.co/mbxj4RWOnzRT @CNBCnow: EARNINGS: Amgen Q1 EPS $2.90 Adj. vs. $2.60 Est.; Q1 Revs. $5.53B vs. $5.32B Est. ‚Ä¢ $AMGN https://t.co/Zi7ik1vD54 https://t.co‚Ä¶After hours earnings movers: $AMZN $LNKD $GILD $AMGN https://t.co/mbxj4RWOnzRT @Amgen: #Amgen Announces Q1 2016 Earnings https://t.co/T5UfaTXndk $AMGN#Amgen Announces Q1 2016 Earnings https://t.co/T5UfaTXndk $AMGN$AMGN sentiment rise to: 0.9, change: +0.73, sdr: 1.69, 1H, 4:00 PM, #nasdaq $SPY $NDX$AMGN beats, raises guidanceRT @CNBCnow: EARNINGS: Amgen Q1 EPS $2.90 Adj. vs. $2.60 Est.; Q1 Revs. $5.53B vs. $5.32B Est. ‚Ä¢ $AMGN https://t.co/Zi7ik1vD54RT @everytimeicash: $AMGN: Amgen beats by $0.29, beats on revs; raises FY16 EPS guidance, issues inline revenue guidanceAmgen beats by $0.30, beats on revenue $AMGN https://t.co/6voGVAYKpART @CNBCnow: EARNINGS: Amgen Q1 EPS $2.90 Adj. vs. $2.60 Est.; Q1 Revs. $5.53B vs. $5.32B Est. ‚Ä¢ $AMGN https://t.co/Zi7ik1vD54 https://t.co‚Ä¶$EXPE $AMZN $AMGN All beat the numbers!! Second straight day with 3 strikes! #StockMarket https://t.co/ZULEXWzAVuRT @CNBCnow: EARNINGS: Amgen Q1 EPS $2.90 Adj. vs. $2.60 Est.; Q1 Revs. $5.53B vs. $5.32B Est. ‚Ä¢ $AMGN https://t.co/Zi7ik1vD54 https://t.co‚Ä¶RT @CNBC: EARNINGS: Amgen Q1 EPS $2.90 Adj. vs. $2.60 Est.; Q1 Revs. $5.53B vs. $5.32B Est. ‚Ä¢ $AMGN https://t.co/PWVqduPADB https://t.co/Jp‚Ä¶RT @StockTwits: Another one of the biggest biotech stocks just reported earnings. But this time it's a beat. Amgen: https://t.co/YjnqXsScTn‚Ä¶RT @StockTwits: Another one of the biggest biotech stocks just reported earnings. But this time it's a beat. Amgen: https://t.co/YjnqXsScTn‚Ä¶RT @CNBCnow: EARNINGS: Amgen Q1 EPS $2.90 Adj. vs. $2.60 Est.; Q1 Revs. $5.53B vs. $5.32B Est. ‚Ä¢ $AMGN https://t.co/Zi7ik1vD54RT @CNBCnow: EARNINGS: Amgen Q1 EPS $2.90 Adj. vs. $2.60 Est.; Q1 Revs. $5.53B vs. $5.32B Est. ‚Ä¢ $AMGN https://t.co/Zi7ik1vD54 https://t.co‚Ä¶party time again AH $AMZN $LNKD $AMGN$AMGN: Amgen beats by $0.29, beats on revs; raises FY16 EPS guidance, issues inline revenue guidanceEntre las 10 primeras empresas por capitalizaci√≥n del #Nasdaq hay 2 #Biotech $GLD $AMGN, todo y la volatilidad el sector va cogiendo fuerza.RT @CNBCnow: EARNINGS: Amgen Q1 EPS $2.90 Adj. vs. $2.60 Est.; Q1 Revs. $5.53B vs. $5.32B Est. ‚Ä¢ $AMGN https://t.co/Zi7ik1vD54 https://t.co‚Ä¶RT @CNBCnow: EARNINGS: Amgen Q1 EPS $2.90 Adj. vs. $2.60 Est.; Q1 Revs. $5.53B vs. $5.32B Est. ‚Ä¢ $AMGN https://t.co/Zi7ik1vD54 https://t.co‚Ä¶RT @CNBCnow: EARNINGS: Amgen Q1 EPS $2.90 Adj. vs. $2.60 Est.; Q1 Revs. $5.53B vs. $5.32B Est. ‚Ä¢ $AMGN https://t.co/Zi7ik1vD54 https://t.co‚Ä¶RT @StockTwits: Another one of the biggest biotech stocks just reported earnings. But this time it's a beat. Amgen: https://t.co/YjnqXsScTn‚Ä¶Another one of the biggest biotech stocks just reported earnings. But this time it's a beat. Amgen: https://t.co/YjnqXsScTn

$AMGNRT @CNBC: EARNINGS: Amgen Q1 EPS $2.90 Adj. vs. $2.60 Est.; Q1 Revs. $5.53B vs. $5.32B Est. ‚Ä¢ $AMGN https://t.co/PWVqduPADB https://t.co/Jp‚Ä¶RT @CNBCnow: EARNINGS: Amgen Q1 EPS $2.90 Adj. vs. $2.60 Est.; Q1 Revs. $5.53B vs. $5.32B Est. ‚Ä¢ $AMGN https://t.co/Zi7ik1vD54 https://t.co‚Ä¶RT @CNBC: EARNINGS: Amgen Q1 EPS $2.90 Adj. vs. $2.60 Est.; Q1 Revs. $5.53B vs. $5.32B Est. ‚Ä¢ $AMGN https://t.co/PWVqduPADB https://t.co/Jp‚Ä¶RT @CNBC: EARNINGS: Amgen Q1 EPS $2.90 Adj. vs. $2.60 Est.; Q1 Revs. $5.53B vs. $5.32B Est. ‚Ä¢ $AMGN https://t.co/PWVqduPADB https://t.co/Jp‚Ä¶RT @CNBC: EARNINGS: Amgen Q1 EPS $2.90 Adj. vs. $2.60 Est.; Q1 Revs. $5.53B vs. $5.32B Est. ‚Ä¢ $AMGN https://t.co/PWVqduPADB https://t.co/Jp‚Ä¶RT @CNBC: EARNINGS: Amgen Q1 EPS $2.90 Adj. vs. $2.60 Est.; Q1 Revs. $5.53B vs. $5.32B Est. ‚Ä¢ $AMGN https://t.co/PWVqduPADB https://t.co/Jp‚Ä¶RT @CNBCnow: EARNINGS: Amgen Q1 EPS $2.90 Adj. vs. $2.60 Est.; Q1 Revs. $5.53B vs. $5.32B Est. ‚Ä¢ $AMGN https://t.co/Zi7ik1vD54 https://t.co‚Ä¶RT @BioStocks: $AMGN raises FY16 EPS  from $10.60-$11.00 to $10.85-$11.20EARNINGS: Amgen Q1 EPS $2.90 Adj. vs. $2.60 Est.; Q1 Revs. $5.53B vs. $5.32B Est. ‚Ä¢ $AMGN https://t.co/PWVqduPADB https://t.co/JpuwpTSOBWEARNINGS: Amgen Q1 EPS $2.90 Adj. vs. $2.60 Est.; Q1 Revs. $5.53B vs. $5.32B Est. ‚Ä¢ $AMGN https://t.co/Zi7ik1vD54 https://t.co/AXFFjl0wAI$AMGN up a nice small amount.RT @bradloncar: $AMGN listed BLINCYTO ($27 million) and Repatha ($16 million) revenue. https://t.co/HUFAHnl0dqRT @CNBCnow: EARNINGS: Amgen Q1 EPS $2.90 Adj. vs. $2.60 Est.; Q1 Revs. $5.53B vs. $5.32B Est. ‚Ä¢ $AMGN https://t.co/Zi7ik1vD54RT @CNBCnow: EARNINGS: Amgen Q1 EPS $2.90 Adj. vs. $2.60 Est.; Q1 Revs. $5.53B vs. $5.32B Est. ‚Ä¢ $AMGN https://t.co/Zi7ik1vD54Amgen $AMGN Tops Q1 EPS by 30c, Raises FY Guidance https://t.co/WO75q69QCb via ‚Üí @AlertTradeRT @OptionsHawk: $GILD ugly miss and $AMGN crushed #'s..same story..different quarterRT @BioStocks: $AMGN raises FY16 EPS  from $10.60-$11.00 to $10.85-$11.20RT @bradloncar: $AMGN listed BLINCYTO ($27 million) and Repatha ($16 million) revenue. https://t.co/HUFAHnl0dqAmgen beats by $0.30, beats on revenue https://t.co/BhrU13ExQl $AMGN$AMGN Amgen's First Quarter 2016 Revenues Increased 10 Percent To $5.5 Billion And Adjusted Earnings Per Shar
From our Stock News Alerts AppRT @BioStocks: $AMGN raises FY16 EPS  from $10.60-$11.00 to $10.85-$11.20$AMGN listed BLINCYTO ($27 million) and Repatha ($16 million) revenue. https://t.co/HUFAHnl0dq$AMGN raises FY16 EPS  from $10.60-$11.00 to $10.85-$11.20$AMGN
Amgen Raises FY16 Sales Outlook from $22B-$22.5B to $22.2B-$22.6B vs $22.3B Est.$AMGN
Amgen Reports Q1 Adj. EPS $2.90 vs $2.60 Est., Sales $5.527B vs $5.32B Est.RT @OrangeTrader: So if market acts correctly, $EXPE $AMZN and $AMGN crushed earnings, so should be a red day tomorrow, right? Up is down,‚Ä¶So if market acts correctly, $EXPE $AMZN and $AMGN crushed earnings, so should be a red day tomorrow, right? Up is down, down is up? K, thx.RT @MarketCurrents: Amgen beats by $0.30, beats on revenue https://t.co/YedLy7G5Jn $AMGNRT @CNBCnow: EARNINGS: Amgen Q1 EPS $2.90 Adj. vs. $2.60 Est.; Q1 Revs. $5.53B vs. $5.32B Est. ‚Ä¢ $AMGN https://t.co/Zi7ik1vD54$AMGN: Amgen sees FY16 $10.85-$11.20 vs $10.82 Consensus Estimate; sees revs $22.2-22.6 bln vs $22.27 bln Consensus EstimateAmgen beats by $0.30, beats on revenue https://t.co/oudLZH71oh $AMGNAmgen beats by $0.30, beats on revenue https://t.co/CVzTisjNAw $AMGNAmgen beats by $0.30, beats on revenue https://t.co/YedLy7G5Jn $AMGNAmgen $AMGN Tops Q1 EPS by 30c, Raises FY Guidance https://t.co/6Q3vL2YHlM$AMGN: Amgen prelim Q1 $2.90 vs $2.61 Capital IQ Consensus Estimate; revs $5.53 bln vs $5.32 bln Capital IQ Consensus EstimateRT @CNBCnow: EARNINGS: Amgen Q1 EPS $2.90 Adj. vs. $2.60 Est.; Q1 Revs. $5.53B vs. $5.32B Est. ‚Ä¢ $AMGN https://t.co/Zi7ik1vD54$GILD miss. 
$AMGN beat &amp; raise$GILD ugly miss and $AMGN crushed #'s..same story..different quarterRT @CNBCnow: EARNINGS: Amgen Q1 EPS $2.90 Adj. vs. $2.60 Est.; Q1 Revs. $5.53B vs. $5.32B Est. ‚Ä¢ $AMGN https://t.co/Zi7ik1vD54RT @CNBCnow: EARNINGS: Amgen Q1 EPS $2.90 Adj. vs. $2.60 Est.; Q1 Revs. $5.53B vs. $5.32B Est. ‚Ä¢ $AMGN https://t.co/Zi7ik1vD54$AMGN - Amgen's First Quarter 2016 Revenues Increased 10 Percent To $5.5 Billion And Adjusted Earnings Per https://t.co/zYvQxStvqtRT @bradloncar: $AMGN and $GILD up tonight. The former has $31+ billion cash on hand and the latter $26+ billion.RT @CNBCnow: EARNINGS: Amgen Q1 EPS $2.90 Adj. vs. $2.60 Est.; Q1 Revs. $5.53B vs. $5.32B Est. ‚Ä¢ $AMGN https://t.co/Zi7ik1vD54RT @CNBCnow: EARNINGS: Amgen Q1 EPS $2.90 Adj. vs. $2.60 Est.; Q1 Revs. $5.53B vs. $5.32B Est. ‚Ä¢ $AMGN https://t.co/Zi7ik1vD54$AMZN $LNKD $AMGN $BIDU https://t.co/at2DIYcdedRT @CNBCnow: EARNINGS: Amgen Q1 EPS $2.90 Adj. vs. $2.60 Est.; Q1 Revs. $5.53B vs. $5.32B Est. ‚Ä¢ $AMGN https://t.co/Zi7ik1vD54RT @CNBCnow: EARNINGS: Amgen Q1 EPS $2.90 Adj. vs. $2.60 Est.; Q1 Revs. $5.53B vs. $5.32B Est. ‚Ä¢ $AMGN https://t.co/Zi7ik1vD54RT @CNBCnow: EARNINGS: Amgen Q1 EPS $2.90 Adj. vs. $2.60 Est.; Q1 Revs. $5.53B vs. $5.32B Est. ‚Ä¢ $AMGN https://t.co/Zi7ik1vD54EARNINGS: Amgen Q1 EPS $2.90 Adj. vs. $2.60 Est.; Q1 Revs. $5.53B vs. $5.32B Est. ‚Ä¢ $AMGN https://t.co/Zi7ik1vD54$AMGN and $AMZN coming out nowNasdaq100 #Stocks Performance $FB $VRTX $MNST $CELG $MU $CHTR $WFM $REGN $MAR $LMCA $TRIP $BIIB $AMGN $TMUS more@ https://t.co/YdSIjFJqHfS&amp;P100 #Stocks Performance $FB $F $BMY $CELG $CL $ABBV $COP $MO $BIIB $GM $HAL $AMGN $MDT $SO $MON $PEP  more@ https://t.co/cKkr8cKsjuRT @CarolineYLChen: *Deep breath* 
Next up, $AMGN and $GILD.*Deep breath* 
Next up, $AMGN and $GILD.Shorts had been covering $AMGN since mid-March but I see a 14% increase in shorts, over $200mm,  since April 20th https://t.co/jkDwQm5Kn0RT @bradloncar: $AMGN and $GILD up tonight. The former has $31+ billion cash on hand and the latter $26+ billion.$ADAP @Adaptimmune Therapeutics

$MDT $BSX $TMO $EW $DXCM $IDXX $NVTA $AMGN $SNY $LLY $BAYRY $GILD $BIIB $CELG $REGN https://t.co/ohahHU90zZRT @bradloncar: $AMGN and $GILD up tonight. The former has $31+ billion cash on hand and the latter $26+ billion.RT @bradloncar: $AMGN and $GILD up tonight. The former has $31+ billion cash on hand and the latter $26+ billion.RT @bradloncar: $AMGN and $GILD up tonight. The former has $31+ billion cash on hand and the latter $26+ billion.RT @bradloncar: $AMGN and $GILD up tonight. The former has $31+ billion cash on hand and the latter $26+ billion.RT @bradloncar: $AMGN and $GILD up tonight. The former has $31+ billion cash on hand and the latter $26+ billion.$AMGN and $GILD up tonight. The former has $31+ billion cash on hand and the latter $26+ billion.Amgen tonight. It has beat 12 qtrs in a row. $AMGN https://t.co/7opZjFmw3ORT @LeanneBMiller: $GILD &amp; $AMGN report in less than 1 hour!

Why biotech‚Äôs biggest names could rally the sector ¬ª 

https://t.co/FxtLdZTclv$AMGN lotto pick - earnings tonight  https://t.co/fYEtNQNzZh via https://t.co/11Wpw9y7t1Today's Slots  https://t.co/YTMU7PBZx6 Daily #Earnings Trades $AMZN $BIDU $WDC $SWKS $JNPR $GILD $AMGNRT @LeanneBMiller: $GILD &amp; $AMGN report in less than 1 hour!

Why biotech‚Äôs biggest names could rally the sector ¬ª 

https://t.co/FxtLdZTclvRT @LeanneBMiller: $GILD &amp; $AMGN report in less than 1 hour!

Why biotech‚Äôs biggest names could rally the sector ¬ª 

https://t.co/FxtLdZTclv$GILD &amp; $AMGN report in less than 1 hour!

Why biotech‚Äôs biggest names could rally the sector ¬ª 

https://t.co/FxtLdZTclvPutting on ICs for earning on $WDC $AMZN $AMGN and $LNKD.  1/2 today with two scratches@RedDogT3 $CELG had a big reversal today off ""light"" earnings.  $GILD and $AMGN earnings tonight so maybe the same or better for those twoRT @StockTwits: Earnings TODAY after the market closes include

‚Ä¢ $AMZN
‚Ä¢ $LNKD
‚Ä¢ $GILD
‚Ä¢ $P
‚Ä¢ $AMGN
‚Ä¢ $BIDU
‚Ä¢ $GRPN
‚Ä¢ $EXPE

https://t.co/‚Ä¶RT @StockTwits: Earnings TODAY after the market closes include

‚Ä¢ $AMZN
‚Ä¢ $LNKD
‚Ä¢ $GILD
‚Ä¢ $P
‚Ä¢ $AMGN
‚Ä¢ $BIDU
‚Ä¢ $GRPN
‚Ä¢ $EXPE

https://t.co/‚Ä¶RT @HCPG: 290 huge area -- 3/4 largest components of $IBB report today $AMGN $GILD $CELG https://t.co/B7y4silu15290 huge area -- 3/4 largest components of $IBB report today $AMGN $GILD $CELG https://t.co/B7y4silu15RT @eWhispers: #earnings after close $AMZN $GILD $LNKD $SWKS $BIDU $EXPE $AMGN $GRPN $WDC $P $YRCW $GIMO    https://t.co/lObOE0uRjZ https:/‚Ä¶RT @StockTwits: Earnings TODAY after the market closes include

‚Ä¢ $AMZN
‚Ä¢ $LNKD
‚Ä¢ $GILD
‚Ä¢ $P
‚Ä¢ $AMGN
‚Ä¢ $BIDU
‚Ä¢ $GRPN
‚Ä¢ $EXPE

https://t.co/‚Ä¶@CTLTrading1 $AMGN and $GILD ER tonight fyi.RT @StockTwits: Earnings TODAY after the market closes include

‚Ä¢ $AMZN
‚Ä¢ $LNKD
‚Ä¢ $GILD
‚Ä¢ $P
‚Ä¢ $AMGN
‚Ä¢ $BIDU
‚Ä¢ $GRPN
‚Ä¢ $EXPE

https://t.co/‚Ä¶AMGN Top news - Apr 28th, 2016 $AMGN https://t.co/5gUQNILaUHRT @StockTwits: Earnings TODAY after the market closes include

‚Ä¢ $AMZN
‚Ä¢ $LNKD
‚Ä¢ $GILD
‚Ä¢ $P
‚Ä¢ $AMGN
‚Ä¢ $BIDU
‚Ä¢ $GRPN
‚Ä¢ $EXPE

https://t.co/‚Ä¶RT @StockTwits: Earnings TODAY after the market closes include

‚Ä¢ $AMZN
‚Ä¢ $LNKD
‚Ä¢ $GILD
‚Ä¢ $P
‚Ä¢ $AMGN
‚Ä¢ $BIDU
‚Ä¢ $GRPN
‚Ä¢ $EXPE

https://t.co/‚Ä¶RT @StockTwits: Earnings TODAY after the market closes include

‚Ä¢ $AMZN
‚Ä¢ $LNKD
‚Ä¢ $GILD
‚Ä¢ $P
‚Ä¢ $AMGN
‚Ä¢ $BIDU
‚Ä¢ $GRPN
‚Ä¢ $EXPE

https://t.co/‚Ä¶RT @StockTwits: Earnings TODAY after the market closes include

‚Ä¢ $AMZN
‚Ä¢ $LNKD
‚Ä¢ $GILD
‚Ä¢ $P
‚Ä¢ $AMGN
‚Ä¢ $BIDU
‚Ä¢ $GRPN
‚Ä¢ $EXPE

https://t.co/‚Ä¶RT @CBOE: Earnings Next Week https://t.co/gS9k8PmhMn reporting after the close $AMZN $AMGN $ATHN $BIDU $LNG $EXPE $GNW $GILD $HIG $JNPR $LN‚Ä¶Do you know that #Book Value for $AMGN is $37.24 https://t.co/OLko7AooWnRT @StockTwits: Earnings TODAY after the market closes include

‚Ä¢ $AMZN
‚Ä¢ $LNKD
‚Ä¢ $GILD
‚Ä¢ $P
‚Ä¢ $AMGN
‚Ä¢ $BIDU
‚Ä¢ $GRPN
‚Ä¢ $EXPE

https://t.co/‚Ä¶RT @StockTwits: Earnings TODAY after the market closes include

‚Ä¢ $AMZN
‚Ä¢ $LNKD
‚Ä¢ $GILD
‚Ä¢ $P
‚Ä¢ $AMGN
‚Ä¢ $BIDU
‚Ä¢ $GRPN
‚Ä¢ $EXPE

https://t.co/‚Ä¶RT @StockTwits: Earnings TODAY after the market closes include

‚Ä¢ $AMZN
‚Ä¢ $LNKD
‚Ä¢ $GILD
‚Ä¢ $P
‚Ä¢ $AMGN
‚Ä¢ $BIDU
‚Ä¢ $GRPN
‚Ä¢ $EXPE

https://t.co/‚Ä¶My top #earning picks for today are $AMZN $EXPE $AMGN We are looking at June $115 calls @ $3.70 for $EXPE &amp; June $170 call @ $2.15 for $AMGNRT @StockTwits: Earnings TODAY after the market closes include

‚Ä¢ $AMZN
‚Ä¢ $LNKD
‚Ä¢ $GILD
‚Ä¢ $P
‚Ä¢ $AMGN
‚Ä¢ $BIDU
‚Ä¢ $GRPN
‚Ä¢ $EXPE

https://t.co/‚Ä¶RT @StockTwits: Earnings TODAY after the market closes include

‚Ä¢ $AMZN
‚Ä¢ $LNKD
‚Ä¢ $GILD
‚Ä¢ $P
‚Ä¢ $AMGN
‚Ä¢ $BIDU
‚Ä¢ $GRPN
‚Ä¢ $EXPE

https://t.co/‚Ä¶RT @CBOE: Earnings Next Week https://t.co/gS9k8PmhMn reporting after the close $AMZN $AMGN $ATHN $BIDU $LNG $EXPE $GNW $GILD $HIG $JNPR $LN‚Ä¶RT @StockTwits: Earnings TODAY after the market closes include

‚Ä¢ $AMZN
‚Ä¢ $LNKD
‚Ä¢ $GILD
‚Ä¢ $P
‚Ä¢ $AMGN
‚Ä¢ $BIDU
‚Ä¢ $GRPN
‚Ä¢ $EXPE

https://t.co/‚Ä¶RT @StockTwits: Earnings TODAY after the market closes include

‚Ä¢ $AMZN
‚Ä¢ $LNKD
‚Ä¢ $GILD
‚Ä¢ $P
‚Ä¢ $AMGN
‚Ä¢ $BIDU
‚Ä¢ $GRPN
‚Ä¢ $EXPE

https://t.co/‚Ä¶RT @StockTwits: Earnings TODAY after the market closes include

‚Ä¢ $AMZN
‚Ä¢ $LNKD
‚Ä¢ $GILD
‚Ä¢ $P
‚Ä¢ $AMGN
‚Ä¢ $BIDU
‚Ä¢ $GRPN
‚Ä¢ $EXPE

https://t.co/‚Ä¶RT @StockTwits: Earnings TODAY after the market closes include

‚Ä¢ $AMZN
‚Ä¢ $LNKD
‚Ä¢ $GILD
‚Ä¢ $P
‚Ä¢ $AMGN
‚Ä¢ $BIDU
‚Ä¢ $GRPN
‚Ä¢ $EXPE

https://t.co/‚Ä¶RT @StockTwits: Earnings TODAY after the market closes include

‚Ä¢ $AMZN
‚Ä¢ $LNKD
‚Ä¢ $GILD
‚Ä¢ $P
‚Ä¢ $AMGN
‚Ä¢ $BIDU
‚Ä¢ $GRPN
‚Ä¢ $EXPE

https://t.co/‚Ä¶Earnings TODAY after the market closes include

‚Ä¢ $AMZN
‚Ä¢ $LNKD
‚Ä¢ $GILD
‚Ä¢ $P
‚Ä¢ $AMGN
‚Ä¢ $BIDU
‚Ä¢ $GRPN
‚Ä¢ $EXPE

https://t.co/35hh05LP1URT @ZenTrends: Hold onto your hats Biotech Longs, $GILD $CELG $AMGN report after the bell. $IBBHold onto your hats Biotech Longs, $GILD $CELG $AMGN report after the bell. $IBBS&amp;P100 #Stocks Performance $FB $F $BMY $AMZN $CL $MDT $GM $MO $COST $CELG $HON $AMGN $CMCSA $MA $MS $GE  more@ https://t.co/cKkr8csQUUEarnings Next Week https://t.co/gS9k8PmhMn reporting after the close $AMZN $AMGN $ATHN $BIDU $LNG $EXPE $GNW $GILD $HIG $JNPR $LNKD $MRVLWaiting on straddles to be filled is exhausting!  $AMGN, $EXPERT @eWhispers: #earnings after close $AMZN $GILD $LNKD $SWKS $BIDU $EXPE $AMGN $GRPN $WDC $P $YRCW $GIMO    https://t.co/lObOE0uRjZ https:/‚Ä¶#Earnings Today-P1
$ABAX $ACHC $AFOP $AIV $AJG $ALDR $AMCC $AMGN $AMZN $ANH $ARII $ARR $ATEC $ATEN 
https://t.co/wkf0X8RupsRT @eWhispers: #earnings after close $AMZN $GILD $LNKD $SWKS $BIDU $EXPE $AMGN $GRPN $WDC $P $YRCW $GIMO    https://t.co/lObOE0uRjZ https:/‚Ä¶Medivation jumps after Sanofi comes public with takeover offer $MDVN $SNY $AZN $ABBV $AMGN $RHHBY: Full Story https://t.co/iHUKLwLEm0$GILD $AMGN Valeant and Sarepta up big, GILD down. I'm sure this makes sense to someone. Who?Which Will Trump: Healthcare M&amp;A, or Earnings? https://t.co/JF2C82OShH
$GILD $AMGN $BMRN all report after the bell. Some quick #s to know.RT @eWhispers: #earnings after close $AMZN $GILD $LNKD $SWKS $BIDU $EXPE $AMGN $GRPN $WDC $P $YRCW $GIMO    https://t.co/lObOE0uRjZ https:/‚Ä¶RT @eWhispers: #earnings after close $AMZN $GILD $LNKD $SWKS $BIDU $EXPE $AMGN $GRPN $WDC $P $YRCW $GIMO    https://t.co/lObOE0uRjZ https:/‚Ä¶RT @eWhispers: #earnings after close $AMZN $GILD $LNKD $SWKS $BIDU $EXPE $AMGN $GRPN $WDC $P $YRCW $GIMO    https://t.co/lObOE0uRjZ https:/‚Ä¶$GILD $AMGN looking for solid beats this evening. Biotech will be back in favor starting tonight. Mark this post!#earnings after close $AMZN $GILD $LNKD $SWKS $BIDU $EXPE $AMGN $GRPN $WDC $P $YRCW $GIMO    https://t.co/lObOE0uRjZ https://t.co/mOH8LeUftXNotable companies reporting #earnings today - $AMZN $GILD $AMGN $BMY $MA $CELG $BIDU $TWC $F &amp; more https://t.co/j5WSqU0OT2 via Scutify$AAPL $AMAT $AMGN $AMTD $AMZN $AMZN Trade long or long+short positions from the #NASDAQ, up to 1500% since 2010. https://t.co/ldcTl0HsrKTop Earnings Thur 4/28 After: $AEM $AMGN $AMZN $ATHN $BIDU $BMRN $CENX $DLR $ELLI $EMN $EXPE $FLEX $GILD $GNW $GRPN $HIG $JNPR $LNKD (1/2)RT @daytradingninja: Notable #Earnings {3/3 AfterHours} 2016.04.28
$AMZN $AMGN $BIDU $CUBE $EXPE $GILD $GRPN $JNPR $LNKD $N $P $QLIK $SWKS‚Ä¶Top gainners today: $ACH, $ADI, $AMGN, $AXP, and $AIGRT @AndyBiotech: Why does every big bio have to report on the same damn day!

PM
$ABBV $ACOR $ALKS $ALXN $BMY $CELG $UTHR

AH
$AMGN $ALDR $‚Ä¶Notable #Earnings {3/3 AfterHours} 2016.04.28
$AMZN $AMGN $BIDU $CUBE $EXPE $GILD $GRPN $JNPR $LNKD $N $P $QLIK $SWKS $STRZA $SNE $VRSN $WDCRT @AndyBiotech: Why does every big bio have to report on the same damn day!

PM
$ABBV $ACOR $ALKS $ALXN $BMY $CELG $UTHR

AH
$AMGN $ALDR $‚Ä¶RT @finsents: $AMGN:US Amgen Urges Ban On Cholesterol Drug Sales After Patent Win #AMGEN INC  https://t.co/NDDI4lBo5w #SP500@cashInsider kenne $AMGN und $SHPG nicht; die ""Sch√∂ne Sicht"" hat ja 200 Target drauf, das w√§ren dann schon mal 30Percento Pr√§mie, CH-Fr√§nkliRT @AndyBiotech: Why does every big bio have to report on the same damn day!

PM
$ABBV $ACOR $ALKS $ALXN $BMY $CELG $UTHR

AH
$AMGN $ALDR $‚Ä¶$AMGN:US Amgen Urges Ban On Cholesterol Drug Sales After Patent Win #AMGEN INC  https://t.co/NDDI4lBo5w #SP500#Amgen,Astellas announce the launch of Repatha in Japan. Read more: https://t.co/7ijwtoHlEU $AMGNRT @AndyBiotech: Why does every big bio have to report on the same damn day!

PM
$ABBV $ACOR $ALKS $ALXN $BMY $CELG $UTHR

AH
$AMGN $ALDR $‚Ä¶#Update US Earnings Release for today: $MO $BMY $MA $ABBV $DCM $UPS $CELG $CL $AMZN $GILD $AMGN $BIDU $AMX $FMX $HIG $EXPEWhy does every big bio have to report on the same damn day!

PM
$ABBV $ACOR $ALKS $ALXN $BMY $CELG $UTHR

AH
$AMGN $ALDR $BMRN $GILD $SGEN$ESPR $AMGN $REGN https://t.co/ku1lWuJD33Polar Capital LLP Reduces Stake in Amgen, Inc. $AMGN https://t.co/FKDi8tGl44RT @AndyBiotech: Biotech and Pharma companies with most Medicare Part B exposure (via GS)

$REGN $AMGN $SGEN $BXLT $BIIB https://t.co/68nii‚Ä¶8 users on Vetr are bullish on Amgen Inc., indicating a BUY Rating (3.5 stars) for $AMGN https://t.co/sgyPwK93LkEarnings-Reaction to Keep an Eye Today $ALXN, $FLS, $AMGN, $BBVA, $CCE, $SNE, $GIMO, $ALLE, $EMN, $CBG, $BOFI, $CAB https://t.co/roaB562ZmVRT @FinSentS_NASDAQ: $AMGN:US Amgen Urges Ban On Cholesterol Drug Sales After Patent Win #AMGEN INC  https://t.co/mmTLT6hMGx #NASDAQ$AMGN:US Amgen Urges Ban On Cholesterol Drug Sales After Patent Win #AMGEN INC  https://t.co/mmTLT6hMGx #NASDAQSeasonal charts of companies reporting earnings today: https://t.co/hqYOaqLyHu $AET $AEM $MO $AMZN $AMGN $BMY $CL $EMN $F $GILD $UPS $VIABAHL Partners LLP Acquires 13,657 Shares of Amgen, Inc. $AMGN https://t.co/nVl16ZOCgdRT @Amgen: CEO Robert Bradway highlights importance of internal &amp; external innovation in oncology at #Amgen #WMIF2016 $AMGN https://t.co/4t‚Ä¶Unicorn Bay rating for $AMGN is 3.76 out of 5. https://t.co/KGl3e8T4UO@_bhaveshpatel I see that. Tomorrow will likely determine where biotech goes in the interim. $AMGN, $CELG and $GILD all report.Amgen upgraded by Vetr Inc. to buy. $168.64 PT. https://t.co/wvQWHjTmoI $AMGN #AMGNAmgen upgraded by Vetr Inc. to buy. $168.64 PT. https://t.co/5MeCSOOFYj $AMGN #AMGNBtw, Estimated #Earnings Per Share for $AMGN is $2.73 it's 1.68% of the current price https://t.co/IfKOfHY5SqWondering about risks of $AMGN? The 63-day volatility is 12.7% https://t.co/08XQBOGBC6$AAPL $AMAT $AMGN $AMTD $AMZN $ATVI Trade long or long+short positions from the #NASDAQ, up to 1500% since 2010. https://t.co/ldcTl0HsrKState of Wisconsin Investment Board Sells 271,780 Shares of Amgen, Inc. $AMGN https://t.co/n0mdAWPhhiAmgen, Inc. $AMGN Shares Bought by Private Advisor Group LLC https://t.co/gXejMMBJSYDo you know that #WallStreet price for $AMGN is $180.94 https://t.co/jyn12gp3cIRT @AndyBiotech: Biotech and Pharma companies with most Medicare Part B exposure (via GS)

$REGN $AMGN $SGEN $BXLT $BIIB https://t.co/68nii‚Ä¶RT @1MinuteStock: Explore #fundamental numbers and pros and cons for $AMGN https://t.co/olJdqsNFGsNot sure what to do with $AMGN? Explore our #fundamental pros and cons.  https://t.co/ZW5e637quVExplore #fundamental numbers and pros and cons for $AMGN https://t.co/olJdqsNFGsRT @StocksMD: $UPS $ABBV $DOW $AMZN $GILD $AMGN $XOM $CVX $SPY $QQQ $FB $AAPL  https://t.co/wPF4ybekUqRT @StocksMD: $UPS $ABBV $DOW $AMZN $GILD $AMGN $XOM $CVX $SPY $QQQ $FB $AAPL  https://t.co/wPF4ybekUqAccumulated $LABU (not D) today, few more in early am (on 'false' dip); Go $CELG $GILD $AMGN (the only decency left in $IBB) :B Nikkei GREENEarnings for Thursday: $AEM, $AMGN, $BMY, $BZH, $CAB, $COP, $F, $JNPR, $LNKD, $MA, $MO, $POT, $QSR, $TMO, $TWC, $TZOO, $VIAB, $WM, $YNDXRT @AndyBiotech: Biotech and Pharma companies with most Medicare Part B exposure (via GS)

$REGN $AMGN $SGEN $BXLT $BIIB https://t.co/68nii‚Ä¶$UPS $ABBV $DOW $AMZN $GILD $AMGN $XOM $CVX $SPY $QQQ $FB $AAPL  https://t.co/wPF4ybekUqThese $ITUS Profits Are much Bigger Than $AMGN https://t.co/IMp4Mn7Fe4RT @PearlF: More '16 MA biotech job commitments on MLSC list: Takeda in for 75, $SHPG in for 150, $AMGN in for 52, @emulatebio said 30, $AB‚Ä¶",2016-04-28,AMGN,0
20,"What Are Analysts Saying About Q1 At Big Biotech? Price increases are v impt. https://t.co/ta7qmN0RwY $AMGN $BIIB $GILD $CELGAside From 1 Eyesore, #Amgen Delivers Another Solid Quarter. Read more: https://t.co/OHHl5qwjyF $AMGN$AMGN ALERT: New Amgen SEC Filing
From our Stock News Alerts App$AMGN:

New SEC Filing for AMGN: Form 10-Q (No. 0000318154-16-000035):

https://t.co/KnrFrLe99c https://t.co/MC1YRknOxp$AMGN - Quarterly Report (10-q) https://t.co/fSR9ERqHZ9Dividend Growth, Safety And Credit Review Of My 76 Dividend Paying Stocks https://t.co/0k1QLA0vz2 $AAPL #APPLE $ABBV $ADP $AMGN $BA $BDXDividend Growth, Safety And Credit Review Of My 76 Dividend Paying Stocks https://t.co/UvN893b0Pg $AAPL #APPLE $ABBV $ADP $AMGN $BA $BDX$AMGN initiatedPhase I trial designed to study effect of  anti-CGRP monoclonal antibody for migraine, AMG 334, on BP when  with  sumatriptanNOK E.P.S.
See Here ---&gt; https://t.co/eEBDJDqRLn

$NOK $AMGN $BABY #shareNE Financials
See Here ---&gt; https://t.co/lsfduPw1lI

$NE $AMGN $MTG #nasdaqAMGN Top news - May 2nd, 2016 $AMGN https://t.co/vyNjLsO00r$AVXL P&amp;D $200K promo campaign due for a 90%+ drop GI's last call $GBSN is down 99.96% in a year https://t.co/LLzZfYUOHj $GE $AMGN $VMW $VRXWhat Drove AbbVie‚Äôs Solid Performance in 1Q16? $ABBV $AMGN $CELG $GILD https://t.co/UBDJr6cPmIWhy Vertex's 1Q16 Earnings Were a Disappointment $AMGN $CELG $GILD $QQQ https://t.co/OK1vzp5xpcCommented on Putting Your Money To Work In The Cancer 'Moonshot' https://t.co/qIXle9sjhw $AMGN $ZIOP $IBB $BBH $CNCRRT @StockSwipe: UPDATE: Trade Ideas - $AMGN, $CGNX, $TSLA, $GRPN, $NFLX, $RIC #StockSwipe

https://t.co/ZxVnn7tLHGRT @StockSwipe: UPDATE: Trade Ideas - $AMGN, $CGNX, $TSLA, $GRPN, $NFLX, $RIC #StockSwipe

https://t.co/ZxVnn7tLHGBiotech Forum Daily Digest: Gilead Post Earnings, ACADIA FDA Nod, Dynavax's Setback https://t.co/gP4H3IYbxx $ABBV $ACAD $ALXN $AMGN $DVAXUPDATE: Trade Ideas - $AMGN, $CGNX, $TSLA, $GRPN, $NFLX, $RIC #StockSwipe

https://t.co/ZxVnn7tLHGRT SeekingAlpha: Why I Bought Friday's Dip In Amgen https://t.co/O5xWMsfGpq $ABBV $JNJ $NVS $PFE $SNY $SPY $AMGNWhy I Bought Friday's Dip In Amgen https://t.co/i7rbgVk9qB $ABBV $JNJ $NVS $PFE $SNY $SPY $AMGNWhy I Bought Friday's Dip In Amgen https://t.co/Vmu0w4DXs9 $ABBV $JNJ $NVS $PFE $SNY $SPY $AMGNWhy I Bought Friday's Dip In Amgen https://t.co/rC0MGvBiQH $ABBV $JNJ $NVS $PFE $SNY $SPY $AMGNBiotech Forum Daily Digest: Gilead Post Earnings, ACADIA FDA Nod, Dynavax's Setback https://t.co/iWvrxmmfuK $ABBV $ACAD $ALXN $AMGN $DVAXBiotech Forum Daily Digest: Gilead Post Earnings, ACADIA FDA Nod, Dynavax's Setback https://t.co/XzDIvDbS1N $ABBV $ACAD $ALXN $AMGN $DVAXBiotech Forum Daily Digest: Gilead Post Earnings, ACADIA FDA Nod, Dynavax's Setback https://t.co/sr3Xe0FS3H $ABBV $ACAD $ALXN $AMGN $DVAXAmgen, Inc. $AMGN Lifted to Buy at Vetr Inc. https://t.co/iBMkd6Y9cwAmgen, Inc. $AMGN Lifted to Buy at Vetr Inc. https://t.co/4kwCNF0SOX$AAPL $AMAT $AMGN $AMTD $AMZN $ATVI Trade long or long+short positions from the #NASDAQ, up to 1500% since 2010. https://t.co/ldcTl0HsrKTrading Strategies Partners: https://t.co/Upddhj47pY $AAPL $NFLX $QQQ $SPY $DJIA $VZ $GS $INTC $AA $INTC $NFLX $GS $JPM $T $MMM $AMGNRT @theflynews: Jefferies 'rose colored glasses' Medivation buyout value hits $90/share $MDVN $AZN $NVS $PFE $AMGN $BAYRY $SN... https://t.‚Ä¶Amgen, Inc. $AMGN Issues FY16 Earnings Guidance https://t.co/qXwaz5JbGuAmgen, Inc. $AMGN Issues FY16 Earnings Guidance https://t.co/2weVCKVks2Changes to Top #Biotech Ratings. $CELG $GILD $BMRN $ALXN $AMGN
https://t.co/iveyMQSfOJRT @theflynews: Jefferies 'rose colored glasses' Medivation buyout value hits $90/share $MDVN $AZN $NVS $PFE $AMGN $BAYRY $SN... https://t.‚Ä¶RT @theflynews: Jefferies 'rose colored glasses' Medivation buyout value hits $90/share $MDVN $AZN $NVS $PFE $AMGN $BAYRY $SN... https://t.‚Ä¶Jefferies 'rose colored glasses' Medivation buyout value hits $90/share $MDVN $AZN $NVS $PFE $AMGN $BAYRY $SN... https://t.co/fBKjCDNqUZAMGN Open
See Here ---&gt; https://t.co/rSlKPrgyOI

$AMGN $CF $DUK #shareWilliam Blair Comments on Amgen, Inc.‚Äôs Q3 2016 Earnings $AMGN https://t.co/5MHPwa3bmvRT SeekingAlpha: Portfolio Update For April 2016 https://t.co/zl4CqPUZNR $ADM $AMGN $AMP $BLK $CAT $CUBE $EOT $FFC $FXI $ICE $IEF $O $OHI ‚Ä¶Portfolio Update For April 2016 https://t.co/ArU6NseKmv $ADM $AMGN $AMP $BLK $CAT $CUBE $EOT $FFC $FXI $ICE $IEF $O $OHI $TLT $TROW $UAPortfolio Update For April 2016 https://t.co/3dqc8VWyIj $ADM $AMGN $AMP $BLK $CAT $CUBE $EOT $FFC $FXI $ICE $IEF $O $OHI $TLT $TROW $UAPortfolio Update For April 2016 https://t.co/PeDrtyUHFA $ADM $AMGN $AMP $BLK $CAT $CUBE $EOT $FFC $FXI $ICE $IEF $O $OHI $TLT $TROW $UAAmgen (AMGN) Earnings Report: Q1 2016 Conference Call Transcript $AMGN https://t.co/LoDfEIUATE https://t.co/H5jl9Mh0lRQ2 2016 EPS Estimates for Amgen, Inc. $AMGN Cut by Jefferies Group https://t.co/EveLDf3HObRT @reviewgal: A few more of interest: $AMBA $ADXS $AAL $AMGN $AMZN $ARIA $ARRY $ASHR http://t.co/bh923uwZvq http://t.co/PRxatXFvYKAmgen, Inc. $AMGN Announces  Earnings Results, Beats Estimates By $0.30 EPS https://t.co/7qkhjZr0cd$AMGN:US Amgen, Inc. (AMGN) Receives Buy Rating from Piper Jaffray #AMGEN INC  https://t.co/ZZxXjp0PJV #SP500RT @AndyBiotech: $REGN $SNY Praluent Q1 $13M vs $16M cons.

$AMGN Repatha Q1 $16M vs $27M cons.

77% prescription rejection rate at the pha‚Ä¶Amgen Inc Reiterated Rating by BMO Capital Markets (Ranked 12th) to Buy $AMGN #AMGN https://t.co/bqjkWr2ARADNAI Day Low
See Here ---&gt; https://t.co/jdJZw3iftM

$DNAI $KMI $AMGN #nasdaq@techwhitepapers the names are $AMGN $BMY $OPK $EBS $NKTR $LGND $MRK $JAZZ ........ $celg and $gild are missing in action.Amgen Inc Reiterated Rating by Piper Jaffray (Ranked 59th) to Buy $AMGN #AMGN https://t.co/bqjkWr2ARA$AMGN,AMZN,DPZ,GILD,LOGM,MA,MERC,NOV,NPTN,SU - Analysts' Updated EPS Estimates for May, 1st #AMGN, AMZN, DPZ, GILD‚Ä¶ https://t.co/1lZ9E0pY3UAnalysts‚Äô Updated EPS Estimates for May, 1st $AMGN, AMZN, DPZ, GILD, LOGM, MA, MERC, NOV, NPTN, SU https://t.co/F1hawI4BxGAmgen, Inc. $AMGN Given ‚ÄúMarket Perform‚Äù Rating at Leerink Swann https://t.co/FMo6Wvdw6c$AMGN - Amgen's #AMGN Market Perform Rating Reiterated at Leerink Swann https://t.co/cAwYhtU8lC$AMGN - Amgen's #AMGN Market Perform Rating Reiterated at Leerink Swann https://t.co/WrAaGwUk85Amgen's market perform rating reiterated at Leerink Swann. $186.00 PT. https://t.co/uKmLC1ZkPW $AMGN #AMGNAmgen‚Äôs $AMGN Market Perform Rating Reiterated at Leerink Swann https://t.co/gORWMPNsPMAmgen‚Äôs $AMGN Market Perform Rating Reiterated at Leerink Swann https://t.co/jyGWN4llZMAmgen, Inc. $AMGN Given ‚ÄúMarket Perform‚Äù Rating at Leerink Swann https://t.co/rpTFTG4FzTAmgen, Inc. $AMGN Stock Rating Reaffirmed by Leerink Swann https://t.co/pMc23ok6IpAmgen, Inc. $AMGN Stock Rating Reaffirmed by Leerink Swann https://t.co/M3OHIfqnWQAmgen, Inc. $AMGN Given ‚ÄúMarket Perform‚Äù Rating at Leerink Swann https://t.co/aaDQRJlcJ1Amgen's market perform rating reiterated at Leerink Swann. $186.00 PT. https://t.co/XyTnLc4Qq2 $AMGN #AMGNAmgen Inc Reiterated Rating by Leerink Swann (Ranked 66th) to Market Perform with 186 PT $AMGN #AMGN https://t.co/bqjkWr2ARA",2016-05-02,AMGN,0
21,"Look who's moving in to an 8-year-old site never occupied by lessee Amgen https://t.co/o3NwV33qLS $AMGN #biotech https://t.co/UJJoHUUctVLook who's moving in to an 8-year-old site never occupied by lessee Amgen https://t.co/ztSr3JHYPc $AMGN #biotech https://t.co/NLm2Bx3b29Look who's moving in to an 8-year-old site never occupied by lessee Amgen https://t.co/nzNmPCrYFU $AMGN #biotech https://t.co/prCdoKRZXeLook who's moving in to an 8-year-old site never occupied by lessee Amgen https://t.co/IbWsblydHY $AMGN #biotech https://t.co/cDzVX4htJeLook who's moving in to an 8-year-old site never occupied by lessee Amgen https://t.co/ZtBWTIoIvr $AMGN #biotech https://t.co/W1DTtgqLNa$AMGN:

New Insider Transaction on AMGN by EVP, Research &amp; Development:

https://t.co/HiISX1FEJ0 https://t.co/bpUSPSa3QF$AMGN ALERT: New Amgen SEC Filing
From our Stock News Alerts App$AMGN - Statement of Changes in Beneficial Ownership (4) https://t.co/k3fzGdZtof$AMGN - Statement of Changes in Beneficial Ownership (4) https://t.co/7Uxf7Y4nVAAmgen Inc. director just disposed of 3,312 shares  https://t.co/TBR9ylszXx $AMGN$AMGN: Amgen announces FDA priority review for the supplemental biologics license application for Blincyto https://t.co/3lXaVYINUn7 Undervalued Stocks To Buy And 3 To Sell $MSFT $NFLX $ABBV $GILD $LGIH $ABBV $AMGN #options #trading            --&gt;https://t.co/qZl6CVQkWpRT @theflynews: On The Fly: Top five analyst downgrades  $ACAD $BIIB $AMGN $SRPT $CYH $UTX $HON $ONDK: Full Story https://t.co/ywdCoVWm93AMGN Investor Opinions
See Here ---&gt; https://t.co/mOaluwmtBn

$AMGN $KELYA $TD #pennystocksThese $ITUS Profits Are much Bigger Than $AMGN https://t.co/llI3Wa0y9eTop ten pharma/drug companies by market cap are $JNJ $RHHBY $PFE $NVS $MRK $NVO $GILD $BMY $AMGN $SNY$AMGN FDA Grants Priority Review For Amgen's Supplemental Biologics License Application For BLINCYTO¬Æ (Blinat
From our Stock News Alerts App$AMGN
FDA Grants Priority Review For Amgen's Supplemental Biologics License Application For BLINCYTO(R) (Blinatumomab) -Dow JonesRT @SFBIZronleuty: Look who's moving in to an 8-year-old bldg never occupied by lessee Amgen https://t.co/scpQRpxJPB $AMGN https://t.co/7hg‚Ä¶$AMGN maturity 05/06/2016 oi CallPutRatio of 0.70 puts 2,230 &amp; calls 3,175 bullish. https://t.co/fWSNp2J3bq https://t.co/Lvt5cJoPVwRT @SFBIZronleuty: Look who's moving in to an 8-year-old bldg never occupied by lessee Amgen https://t.co/scpQRpxJPB $AMGN https://t.co/7hg‚Ä¶RT @SFBIZronleuty: Look who's moving in to an 8-year-old bldg never occupied by lessee Amgen https://t.co/scpQRpxJPB $AMGN https://t.co/7hg‚Ä¶RT @SFBIZronleuty: Look who's moving in to an 8-year-old bldg never occupied by lessee Amgen https://t.co/scpQRpxJPB $AMGN https://t.co/7hg‚Ä¶Emerging biotech company preps fall takeover of never-used #Amgen space. Read more: https://t.co/6Dxw99q2w5 $AMGNEmerging biotech company preps fall takeover of never-used #Amgen space. Read more: https://t.co/Yc8XyNLaA9 $AMGNLook who's moving in to an 8-year-old bldg never occupied by lessee Amgen https://t.co/scpQRpxJPB $AMGN https://t.co/7hgpvD29NKLook who's moving in to an 8-year-old bldg never occupied by lessee Amgen https://t.co/nhaRx5GIyd $AMGN https://t.co/gdQXqWd3EdLook who's moving in to an 8-year-old bldg never occupied by lessee Amgen https://t.co/o4SGFg32fE $AMGN https://t.co/cDy5WZ4fSMRegeneron Nips At Amgen And Pfizer's Heels In Pain Drug Race https://t.co/We63nseGf0 $REGN $PFE $AMGNWhat Will Drive AbbVie's Valuations in 2016? $ABBV $AMGN $CELG $FPX https://t.co/nMYdT8hNTHStock Analysts‚Äô Upgrades for May, 3rd $AMGN, ARNA, BCS, CMA, EMN, F, IPG, ITW, JCI, KEY https://t.co/ajxTRIqUMJRT SeekingAlpha: A Prescription For High Risk Fever https://t.co/Or0kC3P7Qk $ABT $AGN $AKRX $AMGN $BAX $BIIB $BMY $CELG $DEPO $GILD $HRTX ‚Ä¶A Prescription For High Risk Fever https://t.co/gPQCtFDPvM $ABT $AGN $AKRX $AMGN $BAX $BIIB $BMY $CELG $DEPO $GILD $HRTX $IPXL $JNJ $LCIA Prescription For High Risk Fever https://t.co/kkuKlhUXHZ $ABT $AGN $AKRX $AMGN $BAX $BIIB $BMY $CELG $DEPO $GILD $HRTX $IPXL $JNJ $LCIA Prescription For High Risk Fever https://t.co/BDMZC40kWf $ABT $AGN $AKRX $AMGN $BAX $BIIB $BMY $CELG $DEPO $GILD $HRTX $IPXL $JNJ $LCIA Prescription For High Risk Fever https://t.co/2b97FFOfWx $ABT $AGN $AKRX $AMGN $BAX $BIIB $BMY $CELG $DEPO $GILD $HRTX $IPXL $JNJ $LCIAMGN Top news - May 3rd, 2016 $AMGN https://t.co/mQWWLeeyqXRT SeekingAlpha: Regeneron Nips At Amgen And Pfizer's Heels In Pain Drug Race https://t.co/soU0Gm9S5Y $REGN $PFE $AMGNRegeneron Nips At Amgen And Pfizer's Heels In Pain Drug Race https://t.co/cieSzF0kPS $REGN $PFE $AMGN3 Stocks Dragging In The Drugs Industry $AMGN https://t.co/wDteXT37aRRT @tgtxdough: IMHO best slide I tweet all weekend Free cash flow for the larger cap biotechs 2014-2020E $AMGN $CELG $GILD  M&amp;A ?? https://‚Ä¶RT SeekingAlpha: April Showers Bring May Dividends https://t.co/YYFCyF67mr $AAPL #APPLE $AFL $AMGN $AMZN $BBL $CAH $CLX $CMI $CRC $CSCO $C‚Ä¶April Showers Bring May Dividends https://t.co/AgiSMEqPNS $AAPL #APPLE $AFL $AMGN $AMZN $BBL $CAH $CLX $CMI $CRC $CSCO $CSX $DIS $DUK $FBApril Showers Bring May Dividends https://t.co/UPzHYrU0hG $AAPL #APPLE $AFL $AMGN $AMZN $BBL $CAH $CLX $CMI $CRC $CSCO $CSX $DIS $DUK $FB$AMGN Quarterly Report (10-q)‚Ä¶ https://t.co/8SUMcqQ4BSRT @Suttmeier: How To Trade Biotechs $BIIB $AMGN $CELG $GILD $REGN
https://t.co/Bzi86aKo1eHow To Trade Biotechs $BIIB $AMGN $CELG $GILD $REGN
https://t.co/Bzi86aKo1eHow To Trade Biotechs $BIIB $AMGN $CELG $GILD $REGN https://t.co/NGcsEvsqTgRT @AlertTrade: #StockNews ‚Äï On The Fly: Top five analyst downgrades $ACAD $BIIB $AMGN $SRPT $CYH $UTX $HON‚Ä¶ https://t.co/IKHPB6QWgT ‚Üí via‚Ä¶What Are Analysts Saying About Q1 At Big Biotech? Price increases are v impt. https://t.co/mBoLPgxboU $AMGN $BIIB $GILD $CELG via @ldtimme‚Ä¶#StockNews ‚Äï On The Fly: Top five analyst downgrades $ACAD $BIIB $AMGN $SRPT $CYH $UTX $HON‚Ä¶ https://t.co/IKHPB6QWgT ‚Üí via @AlertTradeOn The Fly: Top five analyst downgrades  $ACAD $BIIB $AMGN $SRPT $CYH $UTX $HON $ONDK: Full Story https://t.co/ywdCoVWm93Pfizer forges ahead without Allergan and puts up a good Q1 report and guidance increase: https://t.co/dnswCwgvxq $PFE $AGN $AMGN$AVXL P&amp;D $200K promo campaign due for a 90%+ drop. GI's last call $GBSN is down 99.96% in a year https://t.co/LLzZfYUOHj $GE $AMGN $VMWSFTW Investor long-term stock recommendation: $AMGN Amgen Inc. (SS: 78) https://t.co/ajLDr7aTkVRT @tgtxdough: IMHO best slide I tweet all weekend Free cash flow for the larger cap biotechs 2014-2020E $AMGN $CELG $GILD  M&amp;A ?? https://‚Ä¶RT SeekingAlpha: Amgen Is Even More Attractive After Earnings https://t.co/ejx11bfPDM $AMGNRT SeekingAlpha: Amgen's Pipeline Makes It A Strong Buy https://t.co/SZQhiHixUw $REGN $SNY $VRX $AMGNAmgen Is Even More Attractive After Earnings https://t.co/XpM39X82b8 $AMGNAmgen Is Even More Attractive After Earnings https://t.co/mccJvwmjTf $AMGN$AAPL $AMAT $AMGN $AMTD $AMZN $ALKS Trade long or long+short positions from the #NASDAQ, up to 1500% since 2010. https://t.co/ldcTl0HsrKAmgen's Pipeline Makes It A Strong Buy https://t.co/ns0D0xOhMF $REGN $SNY $VRX $AMGNAmgen's Pipeline Makes It A Strong Buy https://t.co/E5jDdAbUsD $REGN $SNY $VRX $AMGNMorgan Stanley Reiterates Buy Rating for Amgen, Inc. $AMGN https://t.co/aZKCkllVqORT @DomSloane: Why I Bought Friday's Dip In Amgen https://t.co/4aIoTmALt1 $ABBV $JNJ $NVS $PFE $SNY $SPY $AMGNWhy I Bought Friday's Dip In Amgen https://t.co/4aIoTmALt1 $ABBV $JNJ $NVS $PFE $SNY $SPY $AMGNERF News
See Here ---&gt; https://t.co/SjNLmAlnsQ

$ERF $LMT $AMGN #investRT @AlertTrade: #StockNews ‚Äï ACADIA downgraded to Market Perform from Outperform at Leerink $ACAD $BIIB $AMGN:‚Ä¶ https://t.co/DHBjxl5sP9 ‚Üí v‚Ä¶#StockNews ‚Äï ACADIA downgraded to Market Perform from Outperform at Leerink $ACAD $BIIB $AMGN:‚Ä¶ https://t.co/DHBjxl5sP9 ‚Üí via @AlertTradeRT @theflynews: ACADIA downgraded to Market Perform from Outperform at Leerink $ACAD $BIIB $AMGN: Full Story https://t.co/G7dPXVa8iWACADIA downgraded to Market Perform from Outperform at Leerink $ACAD $BIIB $AMGN: Full Story https://t.co/G7dPXVa8iWRT @marketexclusive: Regeneron Pharmaceuticals has Success With Its Arthritis Pain Molecule Trial https://t.co/y4oFITaqO9 $REGN $PFE $LLY $‚Ä¶RT @marketexclusive: Regeneron Pharmaceuticals has Success With Its Arthritis Pain Molecule Trial https://t.co/y4oFITaqO9 $REGN $PFE $LLY $‚Ä¶RT @marketexclusive: Regeneron Pharmaceuticals has Success With Its Arthritis Pain Molecule Trial https://t.co/y4oFITaqO9 $REGN $PFE $LLY $‚Ä¶RT @marketexclusive: Regeneron Pharmaceuticals has Success With Its Arthritis Pain Molecule Trial https://t.co/y4oFITaqO9 $REGN $PFE $LLY $‚Ä¶RT @marketexclusive: Regeneron Pharmaceuticals has Success With Its Arthritis Pain Molecule Trial https://t.co/y4oFITaqO9 $REGN $PFE $LLY $‚Ä¶RT @marketexclusive: Regeneron Pharmaceuticals has Success With Its Arthritis Pain Molecule Trial https://t.co/y4oFITaqO9 $REGN $PFE $LLY $‚Ä¶RT @marketexclusive: Regeneron Pharmaceuticals has Success With Its Arthritis Pain Molecule Trial https://t.co/y4oFITaqO9 $REGN $PFE $LLY $‚Ä¶RT @marketexclusive: Regeneron Pharmaceuticals has Success With Its Arthritis Pain Molecule Trial https://t.co/y4oFITaqO9 $REGN $PFE $LLY $‚Ä¶RT @marketexclusive: Regeneron Pharmaceuticals has Success With Its Arthritis Pain Molecule Trial https://t.co/y4oFITaqO9 $REGN $PFE $LLY $‚Ä¶Regeneron Pharmaceuticals has Success With Its Arthritis Pain Molecule Trial https://t.co/y4oFITaqO9 $REGN $PFE $LLY $JNJ $AMGN #fasinumabBPTH Last Price
See Here ---&gt; https://t.co/Km5UIHuzGz

$BPTH $FULT $AMGN #pennystocksAmgen has smashed the lights out over the last few years with EPS growth $AMGN https://t.co/P7lG6DohpO https://t.co/bsPQJTY26g$UNIS @unilifecorp heard whispers new CEO to be announced with results and its an ex $amgn production managing director!?! Please advise...RT @1stOncology: #Amgen World-Wide Sales for #KYPROLIS was 154m USD in Q1 2016 (Up 59%) $AMGN https://t.co/0jAHqavWtR$GILD $VRTX $CELG $BIIB $AMGN $BMRN
https://t.co/tyTvmEO4b2
RBC #biotech video
$IBB $XBIAMGN Message Board Posts
See Here ---&gt; https://t.co/vxPxyqQUvx

$AMGN $SPN $PTR #stockmarketFollow #Nasdaq 100 traders &amp; track their tweets under one watchlist $AMGN $QCOM https://t.co/W1OB9ZtUgi https://t.co/HKdjeGSY38CVA Short Sales
See Here ---&gt; https://t.co/WrkMmDXt1x

$CVA $ISBG $AMGN #stockmarket$AAPL $AMAT $AMGN $AMTD $AMZN $ATVI Trade long or long+short positions from the #NASDAQ, up to 1500% since 2010. https://t.co/ldcTl0HsrKFreestone Capital Holdings LLC Invests $1,099,000 in Amgen, Inc. $AMGN https://t.co/IFsnx7kftVAmgen, Inc. $AMGN Shares Sold by Meridian Investment Counsel Inc. https://t.co/2luc8eS1wrAmgen, Inc. $AMGN Stake Raised by TCI Wealth Advisors Inc. https://t.co/X2lu1ohEkI",2016-05-03,AMGN,0
22,"RT @KamakuraCo: Kamakura's best value bond trades have been posted, with comments on $AMGN, $T and $BAC https://t.co/3JDTla2Ihs https://t.c‚Ä¶5 #Stocks to Buy for Growth, Value, and #Yield $F $GM $PEB $AMGN $ABBV Also $AAPL $GILD $MSFT $FB https://t.co/kinlWsNcbi$AMGN Statement of Changes in Beneficial Ownership (4)‚Ä¶ https://t.co/Difa14iZaz$AMGN Statement of Changes in Beneficial Ownership (4)‚Ä¶ https://t.co/58dTclg88T#Oncobiologics #IPO: We Suggest Holding Off $ONS Also $PFE $MNTA $AMGN $CHRS https://t.co/wV0SiBT4yrBooming Bay Area Biotech NGM Plans Move to Vacant Site Once Meant for Amgen $AMGN https://t.co/WDnAySAo4O https://t.co/89Ggww8vmbRT @insidermonkey: $MRTN, $AMGN and $PH Witness Striking Insider Selling
https://t.co/PY2Q3kPKci#Amgens Corlanor√Ç can help Reduce the Risk of Hospitalization for Patients with worsening H... Read more: https://t.co/rt1ISDuD8Y $AMGNClosed trades today: $AMGN, $CELG, $HD, $NEM - all returns were aove 50%+ and shorted $FIT.$AMGN high open interest range is 155.00 to 162.50 for option expiration 05/06/2016.  https://t.co/fWSNp2J3bq https://t.co/TX0tVN5aGlRT @KamakuraCo: Kamakura's best value bond trades have been posted, with comments on $AMGN, $T and $BAC https://t.co/3JDTla2Ihs https://t.c‚Ä¶$AMGN - SELL Signal at 154.04 on May 04, 16 By https://t.co/6PpjiKmc9G Trading Robot #Stockstowatch #Stockmarket #trading #trade #investingLook who's moving in to an 8-year-old site never occupied by lessee Amgen https://t.co/ztSr3JHYPc $AMGN #biotech https://t.co/NLm2Bx3b29BKD News
See Here ---&gt; https://t.co/5ULtjRJh6R

$BKD $TCP $AMGN #stocksRT @fezziwig2008: $ABBV in Court wSamsung over   Humira Biosimilar https://t.co/B7hG6eeXpg‚Ä¶ &amp; reformulating w $HALO prior 2 Dec Expir'n $MR‚Ä¶$ABBV in Court wSamsung over   Humira Biosimilar https://t.co/B7hG6eeXpg‚Ä¶ &amp; reformulating w $HALO prior 2 Dec Expir'n $MRK $AMGN $MNTA $BXLTThese $ITUS Profits Are much Bigger Than $AMGNKamakura's best value bond trades have been posted, with comments on $AMGN, $T and $BAC https://t.co/3JDTla2Ihs https://t.co/VaY2uGVyzpAMGN Top news - May 4th, 2016 $AMGN https://t.co/os6JkQCrbt$AMGN Max Pain is 157.50 for maturity 05/06/2016. Price = 156.35. bullish https://t.co/UhZjRt3jqs https://t.co/tc2vk3hUsG$AMGN - Phase III Trial of Regorafenib in Patients with Unresectable Liver Cancer Meets Primary Endpoint of https://t.co/y84amm2OVU$AMGN last 154.24 Amgen: Phase III Trial Of Regorafenib In Patients With Unresectable Liver Cancer Meets Primary Endpoint$AAPL $AMAT $AMGN $AMTD $AMZN $ATVI Trade long or long+short positions from the #NASDAQ, up to 1500% since 2010. https://t.co/ldcTl0HsrK5 #Stocks to Buy for Growth, Value, and #Yield $F $GM $PEB $AMGN $ABBV Also $AAPL $GILD $MSFT $FB https://t.co/Yqf4ZX8e7vRT @WrigleyTom: $AMGN
FDA Grants Priority Review For Amgen's Supplemental Biologics License Application For BLINCYTO(R) (Blinatumomab) -Dow‚Ä¶$MRTN, $AMGN and $PH Witness Striking Insider Selling
https://t.co/PY2Q3kPKci$AMGN dumpRT @insidermonkey_n: $MRTN, $AMGN and $PH Witness Striking Insider Selling
https://t.co/cetwA0MpjO$MRTN, $AMGN and $PH Witness Striking Insider Selling
https://t.co/cetwA0MpjORT @theflynews: ACADIA downgraded to Market Perform from Outperform at Leerink $ACAD $BIIB $AMGN: Full Story https://t.co/G7dPXVa8iW#Oncobiologics #IPO: We Suggest Holding Off $ONS Also $PFE $MNTA $AMGN $CHRS https://t.co/xiCrVcHDPm#Oncobiologics #IPO: We Suggest Holding Off $ONS Also $PFE $MNTA $AMGN $CHRS https://t.co/sZH4IfIcayAmazon $AMZN overtakes Amgen $AMGN as the best performer in #LCCAP #srportfolio https://t.co/EewReQcEQdMMM E.P.S.
See Here ---&gt; https://t.co/Y5xYW4ymUV

$MMM $AMGN $COST #tradeideasRT @ETFChannel: Health Care Select Sector SPDR Fund Experiences Big Inflow $XLV $GILD $UNH $AMGN #etfs: Symbols mentioned in ... https://t.‚Ä¶Health Care Select Sector SPDR Fund Experiences Big Inflow $XLV $GILD $UNH $AMGN #etfs https://t.co/kSoekW90tJHealth Care Select Sector SPDR Fund Experiences Big Inflow $XLV $GILD $UNH $AMGN #etfs: Symbols mentioned in ... https://t.co/lRGQIKZ6jtHealth Care Select Sector SPDR Fund Experiences Big Inflow $XLV $GILD $UNH $AMGN #etfs: Symbols mentioned in ... https://t.co/lRGQIKHuUTRT @WKRBNews: Morgan Stanley Reiterates Buy Rating for Amgen, Inc. $AMGN https://t.co/aZKCkllVqOAmgen's Kyprolis stands its ground against new $JNJ, $BMY rivals: https://t.co/1bzL9YiB26 $AMGN #pharma #marketingLigand Pharma, tiny biopharma and #IBD50 stock, is up after a beat-and-raise: https://t.co/3TnsGRyNyq $LGND $AMGN $NVSEx-Dividend Stocks Of The Next Week May 09 - 15, 2016 - https://t.co/4zJVJgO87y - $XOM $WMT $V $PFE $AMGN $SAP $GSK $STO $WBK $LLY $BA $TJXMorgan Stanley Reaffirms Buy Rating for Amgen, Inc. $AMGN https://t.co/Ir0RHTpXdCAmgen's Kyprolis stands its ground against new $JNJ, $BMY rivals https://t.co/TsXpWqTwr9 $AMGN #pharma #marketing by @carMorgan Stanley Reaffirms Buy Rating for Amgen, Inc. $AMGN https://t.co/UrkO1SlzXUAmgen, Inc. to Post Q3 2016 Earnings of $2.71 Per Share, William Blair Forecasts $AMGN https://t.co/MKyvLRnMdpOn our ""3 buy signals"" list this morning $DOW, $AMGN, $MRK at https://t.co/FZPcGSL2CY$AMGN sum put oi=2,547 sum call oi=3,545 CallPutRatio=0.72 expiration 05/06/2016 bullish. https://t.co/fWSNp2J3bq https://t.co/SjMpn2Jz6aRT @1stOncology: FDA Grants #PriorityReview For #Amgen's #sBLA For #BLINCYTO (#Blinatumomab) $AMGN https://t.co/nUcvyOGueuFDA Grants #PriorityReview For #Amgen's #sBLA For #BLINCYTO (#Blinatumomab) $AMGN https://t.co/nUcvyOGueuRT @princetongb: $RLYP combo with $AMGN nephrology franchise appears an optimal strategic fit.RT @princetongb: $RLYP combo with $AMGN nephrology franchise appears an optimal strategic fit.$AMGN New PDUFA Date 2016-09-01 Amgen Link:https://t.co/P2ja35CG3y Calendar:https://t.co/sCt1qKoMdr$RLYP combo with $AMGN nephrology franchise appears an optimal strategic fit.RT @theflynews: ACADIA downgraded to Market Perform from Outperform at Leerink $ACAD $BIIB $AMGN: Full Story https://t.co/G7dPXVa8iWA Prescription For High Risk Fever https://t.co/44BVuixFzD $ABT $AGN $AKRX $AMGN $BAX $BIIB $BMY $CELG $DEPO $GILD $HRTX $IPXL $JNJ $LCIRT SeekingAlpha: Oncobiologics IPO: We Suggest Holding Off https://t.co/XWeUiWs5jz $ABBV $AMGN $CHRS $MNTA $PFE $ONS8 Best Dividend Stock Bets For 2016 - https://t.co/BT5uGDgNKN - $BA $AMGN $ABBV $NLSN $WEC $MSFTOncobiologics IPO: We Suggest Holding Off https://t.co/dkXUVDgJXn $ABBV $AMGN $CHRS $MNTA $PFE $ONSOncobiologics IPO: We Suggest Holding Off https://t.co/TwRaVINwWp $ABBV $AMGN $CHRS $MNTA $PFE $ONSOncobiologics IPO: We Suggest Holding Off https://t.co/qdAdBNTkhr $ABBV $AMGN $CHRS $MNTA $PFE $ONSAmgen, Inc. $AMGN Director David Baltimore Sells 3,312 Shares https://t.co/sgQXJ0GyYUAmgen, Inc. $AMGN Director David Baltimore Sells 3,312 Shares https://t.co/xt2A23g0k3RT @JPZaragoza1: Comparison of PsiOxus oncolytic virus Enadenoturicev and $AMGN's Imlygic @ImperialInnova @EdisonHealth https://t.co/DtJwTm‚Ä¶5 #Stocks to Buy for Growth, Value, and #Yield $F $GM $PEB $AMGN $ABBV Also $AAPL $GILD $MSFT $FB https://t.co/kinlWsNcbiComparison of PsiOxus oncolytic virus Enadenoturicev and $AMGN's Imlygic @ImperialInnova @EdisonHealth https://t.co/DtJwTmb9T1Amgen, Inc. to Post Q2 2016 Earnings of $2.66 Per Share, Jefferies Group Forecasts $AMGN https://t.co/WyTA35EY9D$AMGN Amgen is a 5 star üí∞ dividend üí∞ stock with a 2.5% yield: https://t.co/QxgdO7WuWq https://t.co/nzYbChpDEo$AMGN high open interest range is 160.00 to 162.50 for option expiration 05/06/2016. bullish https://t.co/fWSNp2J3bq https://t.co/y0AsZIKtRzFollow #Nasdaq 100 traders &amp; track their tweets under one watchlist $AMGN $QCOM https://t.co/W1OB9ZtUgi https://t.co/RJd5DMEh1d$AMGN FDA Grants Priority Review For Amgen's Supplemental Biol‚Ä¶ https://t.co/TbeUv9FFAcRT @theflynews: On The Fly: Top five analyst downgrades  $ACAD $BIIB $AMGN $SRPT $CYH $UTX $HON $ONDK: Full Story https://t.co/ywdCoVWm93Insider Selling: Amgen, Inc. $AMGN EVP Sells 21,875 Shares of Stock https://t.co/U465dYQiok$AMGN - David Baltimore Sells 3,312 Shares of Amgen, Inc. #AMGN Stock https://t.co/hwF1yVSQ71Whittier Trust Co. Has $9,714,000 Stake in Amgen, Inc. $AMGN https://t.co/nucSWFHEHg$AAPL $AMAT $AMGN $AMTD $AMZN $ATVI Trade long or long+short positions from the #NASDAQ, up to 1500% since 2010. https://t.co/ldcTl0HsrKAmgen, Inc. $AMGN Shares Bought by Levin Capital Strategies L.P. https://t.co/sk5tsoIxt4CCI Below -100 https://t.co/m9jd1RohCQ $AYI $AMGN $COHR $STE $TUP $NLSN $JWN $EEMV $PKX $PNFP $WABC $GMT $OPHT $TLTE $ARII $EWX $YHOOAmgen Inc. (NASDAQ: AMGN) Executives are Making Moves with Their Shares $AMGN https://t.co/MaPOiLnxlLRT @theflynews: On The Fly: Top five analyst downgrades  $ACAD $BIIB $AMGN $SRPT $CYH $UTX $HON $ONDK: Full Story https://t.co/ywdCoVWm93$AMGN Max Pain is 157.50 for maturity 05/06/2016. Price = 158.99. bearish https://t.co/UhZjRt3jqs https://t.co/d6uX92paQC",2016-05-04,AMGN,1
23,"$AMGN - Statement of Changes in Beneficial Ownership (4) https://t.co/0uVMycEfT2$AMGN - Statement of Changes in Beneficial Ownership (4) https://t.co/gtMUoWtOzx$AMGN - Statement of Changes in Beneficial Ownership (4) https://t.co/zTs64JHiDD$AMGN ALERT: New Amgen SEC Filing
From our Stock News Alerts App$AMGN - Statement of Changes in Beneficial Ownership (4) https://t.co/xwsfvBTwLr$AMGN - Statement of Changes in Beneficial Ownership (4) https://t.co/zjWJuaTur0Price cut: $14,000 to $5,780 per patient year $AMGN $REGN #PCSK9 $ESPR  https://t.co/7QjTEV0breSanofi, #Amgen cholesterol drugs win UK backing after price cuts. Read more: https://t.co/ZSsw9hiqVD $AMGNAAL Short Sales
See Here ---&gt; https://t.co/vWTx6O8ayQ

$AAL $AMGN $USERX #stockBullish Doji https://t.co/Cw6wkAwWrW $ABC $LC $MBLY $DRII $AVP $TER $ARNA $ARIA $AZN $SCHF $ETFC $EWU $PDLI $SHPG $BIL $ZIOP $AMGN#Amgen May Join Fray to Buy Cancer Therapy Firm
. Read more: https://t.co/FcQPuzN5hy $AMGN$AMGN Max Pain = 157.50. Maturity = 05/06/2016. Previous close = 154.18. bullish https://t.co/UhZjRt3jqs https://t.co/EulOHvA2FX#Amgen Declines as Company Said to be Considering a Bid for Medivation: Bloomberg (NASDAQ:). Read more: https://t.co/0lIGJrIDWB $AMGNGain 50% From This Bidding War https://t.co/i4xNqYgSss $ABT $ALR $AMGN $AQUNF $AZN $BAX $BAYRY $BUD $BXLT $C $CMCSA $CPGX $CSH $DIS $DWAName another SMID cap biotech that has a $1B drug that is expected to grow &gt;50%/year? Hence why $MDVN is a target. $SNY $AZN $PFE $AMGN, etcAfter another day fighting Sanofi, Medivation misses Q1 estimates but affirms guidance: https://t.co/edDBs5qGtU $MDVN $SNY $AZN $NVS $AMGN#Amgen Rumored to be Another Medivation Suitor  . Read more: https://t.co/hmstfrdrVk $AMGNRegeneron Reports Q1; Why I Bought More Despite Some Challenges https://t.co/E14NX4olRa $ABBV $AMGN $BAYRY $IBB $JNJ $LLY $PFE $RHHBYRT @JCMcCracken: #Amgen joins list of companies exploring #Medivation bid. $AMGN $MDVN https://t.co/QGxZdyOzl9RECAP 5/5 Chatter (1/2):
$MDVN - $AMGN $MRK $PFE $NVS $SNY
$GOGO - $AAL deal?, IAG deal
$SAP - $AAPL partnershipLook who's moving in to an 8-year-old site never occupied by lessee Amgen https://t.co/ztSr3JHYPc $AMGN #biotech https://t.co/NLm2Bx3b29Gain 50% From This Bidding War https://t.co/iHEl7mGWCQ $ABT $ALR $AMGN $AQUNF $AZN $BAX $BAYRY $BUD $BXLT $C $CMCSA $CPGX $CSH $DIS $DWART @JCMcCracken: #Amgen joins list of companies exploring #Medivation bid. $AMGN $MDVN https://t.co/QGxZdyOzl9Gain 50% From This Bidding War $PFE  $SNY $AMGN $RHHBY $BAYRY $NVS$AZN $MDVN #pharma #stocks #finance #investing  https://t.co/zSEtDwfNo4RT SeekingAlpha: Gain 50% From This Bidding War https://t.co/uc8hLbmjXJ $ABT $ALR $AMGN $AQUNF $AZN $BAX $BAYRY $BUD $BXLT $C $CMCSA $CPGX‚Ä¶Gain 50% From This Bidding War https://t.co/QJK8p5LH3R $ABT $ALR $AMGN $AQUNF $AZN $BAX $BAYRY $BUD $BXLT $C $CMCSA $CPGX $CSH $DIS $DWAGain 50% From This Bidding War https://t.co/cZXKiJ6u9c $ABT $ALR $AMGN $AQUNF $AZN $BAX $BAYRY $BUD $BXLT $C $CMCSA $CPGX $CSH $DIS $DWAGain 50% From This Bidding War https://t.co/od484V39Ib $ABT $ALR $AMGN $AQUNF $AZN $BAX $BAYRY $BUD $BXLT $C $CMCSA $CPGX $CSH $DIS $DWAGain 50% From This Bidding War https://t.co/HwRa54gY3z $ABT $ALR $AMGN $AQUNF $AZN $BAX $BAYRY $BUD $BXLT $C $CMCSA $CPGX $CSH $DIS $DWATime to get back into #Growth #Biotech
I prefer the steady giants like $AMGN with #Dividends Ex on 05/13/2016 and great #EarningsEAT % Change
See Here ---&gt; https://t.co/BKrM6aAEMY

$EAT $AMGN $TREE #pennystocks#Amgen looking to join the fray mulling Medivation bid  Reports. Read more: https://t.co/IBAuqR4t2p $AMGNDoes anyone trade $FPRX ? $VRX $AMGN $MNK$AMGN maturity 05/06/2016 oi CallPutRatio of 0.75 puts 2,719 &amp; calls 3,641 bullish. https://t.co/fWSNp2J3bq https://t.co/G45o0Sn0XdAmgen hits a 1 month low https://t.co/TVSs33cCO3 $AMGN #Amgen https://t.co/UuND1sUXXRRT @KamakuraCo: Best value bond trades for the day have been posted with focus on $LLL $T $BAC $AMGN https://t.co/enT3AH3hOERT @KamakuraCo: Best value bond trades for the day have been posted with focus on $LLL $T $BAC $AMGN https://t.co/enT3AH3hOEBest value bond trades for the day have been posted with focus on $LLL $T $BAC $AMGN https://t.co/enT3AH3hOEAmgen hits a 1 month low https://t.co/TVSs33cCO3 $AMGN #Amgen https://t.co/Ps4MwrZjPr$AMGN getting nasty https://t.co/vrI9W19jWXRT @JCMcCracken: #Amgen joins list of companies exploring #Medivation bid. $AMGN $MDVN https://t.co/QGxZdyOzl9AMGN Top news - May 5th, 2016 $AMGN https://t.co/YLWURokLK2These $ITUS Profits Are much Bigger Than $AMGN#Amgen, Inc. Cut to ""Hold"" at Zacks Investment Research. Read more: https://t.co/MlwZ1iIEfr $AMGNAmgen, Inc. $AMGN Rating Increased to Buy at Zacks Investment Research https://t.co/bJk2GPGrXKRT SeekingAlpha: Regeneron Reports Q1; Why I Bought More Despite Some Challenges https://t.co/m8Re4lK3Ca $ABBV $AMGN $BAYRY $IBB $JNJ $LLY‚Ä¶RT @TylerHCanalyst: ""Back then they didn't want me now i'm hot they all on me""

- Mike Jones and David Hung

$MDVN $MRK $PFE $SNY $AMGN $AZN""Back then they didn't want me now i'm hot they all on me""

- Mike Jones and David Hung

$MDVN $MRK $PFE $SNY $AMGN $AZNAmgen, Inc. $AMGN Cut to ‚ÄúHold‚Äù at Zacks Investment Research https://t.co/1xadchuKnwRegeneron Reports Q1; Why I Bought More Despite Some Challenges https://t.co/22duoMmqkk $ABBV $AMGN $BAYRY $IBB $JNJ $LLY $PFE $RHHBYRegeneron Reports Q1; Why I Bought More Despite Some Challenges https://t.co/eaoW5zoPnu $ABBV $AMGN $BAYRY $IBB $JNJ $LLY $PFE $RHHBYRegeneron Reports Q1; Why I Bought More Despite Some Challenges https://t.co/Hb9P2dfskO $ABBV $AMGN $BAYRY $IBB $JNJ $LLY $PFE $RHHBYRegeneron secures more insurance coverage for cholesterol drug Praluent; ramp remains sluggish d... https://t.co/2bH7I7xdTA $REGN $SNY $AMGN$AMGN, a U.S. company, has a tax rate of 19%-20%.  Is this unreasonable? Looks reasonable to me. #inversionAmgen downgraded by Zacks Investment Research to hold. https://t.co/eub7ED8Kp7 $AMGN #AMGNAmgen downgraded by Zacks Investment Research to hold. https://t.co/jBSBFf5828 $AMGN #AMGNRT @zbiotech: $AMGN weighing $MDVN offer apparentlyRegeneron secures more insurance coverage for cholesterol drug Praluent; ramp remains sluggish d... https://t.co/m3pAGe5Z0f $REGN $SNY $AMGNRegeneron secures more insurance coverage for cholesterol drug Praluent; ramp remains sluggish d... https://t.co/em2qLGaE83 $REGN $SNY $AMGNRegeneron secures more insurance coverage for cholesterol drug Praluent; ramp remains sluggish d... https://t.co/dQo9bsAuAA $REGN $SNY $AMGN$AMGN reportedly considering bid for $MDVN, joining $AZN, $NVS, $PFE, + $SNY (the only one the make a public offer) https://t.co/2YWgZHFr1R$AMGN nearing 50% retracement after posting solid quarter with beat and raise, wouldn't be surprised to see call action pick up down hereAmgen another possible Medivation suitor $SNY $PFE $AZN $AMGN $MDVN https://t.co/e0PL97WV8AAmgen another possible Medivation suitor https://t.co/WOw7PBd7EC $SNY $PFE $AZN $AMGNAmgen another possible Medivation suitor https://t.co/OUxTep6WYU $SNY $PFE $AZN $AMGNAmgen another possible Medivation suitor https://t.co/qkryX172vC $SNY $PFE $AZN $AMGNAmgen another possible Medivation suitor https://t.co/wkignsn2v9 $SNY $PFE $AZN $AMGNRT @CarolineYLChen: And now $AMGN as well.  https://t.co/Uyux3gdKiZ$AMGN Said to Join Health-Care Pack Weighing $MDVN Bids 
https://t.co/m2v6pbDBON $SNY $PFE $NVSRT @CarolineYLChen: And now $AMGN as well.  https://t.co/Uyux3gdKiZBiotechnology: Entering A Pocket Of Turbulence https://t.co/SyiIEsG55n $AAPL $ABBV $ABT $ACAD $AGN $ALKS $ALNY $ALPMY $ALXN $AMGN $AMZNRT @OpenOutcrier: $MDVN ( $AMGN $PFE $SNY $NVS ) https://t.co/qgq5a7bSzJRT @CarolineYLChen: And now $AMGN as well.  https://t.co/Uyux3gdKiZRT @CarolineYLChen: And now $AMGN as well.  https://t.co/Uyux3gdKiZAnd now $AMGN as well.  https://t.co/Uyux3gdKiZRT @JCMcCracken: #Amgen joins list of companies exploring #Medivation bid. $AMGN $MDVN https://t.co/QGxZdyOzl9RT @JohnCFierce: Sanofi, then Pfizer, now Amgen: Can Medivation's CEO get a bidding war started?
$SNY $PFE $AMGN $MDVN
https://t.co/nXC10wf‚Ä¶RT @JohnCFierce: Sanofi, then Pfizer, now Amgen: Can Medivation's CEO get a bidding war started?
$SNY $PFE $AMGN $MDVN
https://t.co/nXC10wf‚Ä¶RT @JohnCFierce: Sanofi, then Pfizer, now Amgen: Can Medivation's CEO get a bidding war started?
$SNY $PFE $AMGN $MDVN
https://t.co/nXC10wf‚Ä¶RT @JohnCFierce: Sanofi, then Pfizer, now Amgen: Can Medivation's CEO get a bidding war started?
$SNY $PFE $AMGN $MDVN
https://t.co/nXC10wf‚Ä¶RT @JohnCFierce: Sanofi, then Pfizer, now Amgen: Can Medivation's CEO get a bidding war started?
$SNY $PFE $AMGN $MDVN
https://t.co/nXC10wf‚Ä¶Sanofi, then Pfizer, now Amgen: Can Medivation's CEO get a bidding war started?
$SNY $PFE $AMGN $MDVN
https://t.co/nXC10wfNo8RT @JCMcCracken: #Amgen joins list of companies exploring #Medivation bid. $AMGN $MDVN https://t.co/QGxZdyOzl9$AMGN - SELL Signal at 154.18 on May 04, 16 By https://t.co/6PpjiKmc9G Trading Robot #Stockstowatch #Stockmarket #trading #trade #investingRT @JCMcCracken: #Amgen joins list of companies exploring #Medivation bid. $AMGN $MDVN https://t.co/QGxZdyOzl9RT @OpenOutcrier: $MDVN ( $AMGN $PFE $SNY $NVS ) https://t.co/qgq5a7bSzJRT @JCMcCracken: #Amgen joins list of companies exploring #Medivation bid. $AMGN $MDVN https://t.co/QGxZdyOzl9RT @OpenOutcrier: $MDVN ( $AMGN $PFE $SNY $NVS ) https://t.co/qgq5a7bSzJ$MDVN ( $AMGN $PFE $SNY $NVS ) https://t.co/qgq5a7bSzJRT @Stock_Mind1: Too late! $AMGN rumored so now 3 CASH rich co.s @alienmars11: @Stock_Mind1 $MDVN Sanofi better hurry before the company ge‚Ä¶May 5 Biotech Update $AMGN $BIIB $BMRN $MDVN $MRK https://t.co/ahFH4fBl72RT BloombergDeals: RT JCMcCracken: #Amgen joins list of companies exploring #Medivation bid. $AMGN $MDVN https://t.co/K5LhVzOPmwRT @JCMcCracken: #Amgen joins list of companies exploring #Medivation bid. $AMGN $MDVN https://t.co/QGxZdyOzl9RT @JCMcCracken: #Amgen joins list of companies exploring #Medivation bid. $AMGN $MDVN https://t.co/QGxZdyOzl9RT @JCMcCracken: #Amgen joins list of companies exploring #Medivation bid. $AMGN $MDVN https://t.co/QGxZdyOzl9#Amgen joins list of companies exploring #Medivation bid. $AMGN $MDVN https://t.co/QGxZdyOzl9$AMGN high open interest range is 152.50 to 162.50 for option expiration 05/06/2016.  https://t.co/fWSNp2J3bq https://t.co/0Zms2Y56QSToo late! $AMGN rumored so now 3 CASH rich co.s @alienmars11: @Stock_Mind1 $MDVN Sanofi better hurry before the company gets more attentionA Prescription For High Risk Fever https://t.co/Uu9lQOeTW0 $ABT $AGN $AKRX $AMGN $BAX $BIIB $BMY $CELG $DEPO $GILD $HRTX $IPXL $JNJ $LCIRT @zbiotech: $AMGN weighing $MDVN offer apparentlyRegeneron Pharmaceuticals: The Eyleas Have It https://t.co/Rq7vz795SO via @barronsonline $REGN $AMGN $SNY $IBB$AMGN sees itself as a potential buyer for $MDVNRT @OpenOutcrier: $AMGN said to join in fray for $MDVN -BBGRT @zbiotech: $AMGN weighing $MDVN offer apparentlyRT @zbiotech: $AMGN weighing $MDVN offer apparentlyRT @OpenOutcrier: $AMGN said to join in fray for $MDVN -BBGRT @zbiotech: $AMGN weighing $MDVN offer apparently$AMGN said to join in fray for $MDVN -BBG$AMGN weighing $MDVN offer apparentlyUK's NICE supports the use of $AMGN's Repatha#Amgen, Inc. Selectively Eyes Bigger M&amp;As. Read more: https://t.co/WaBUlhTT8x $AMGN$AAPL $AMAT $AMGN $AMTD $AMZN $ATVI Trade long or long+short positions from the #NASDAQ, up to 1500% since 2010. https://t.co/ldcTl0HsrKBiotechnology: Entering A Pocket Of Turbulence https://t.co/JrcEqMdJ92 $AAPL #APPLE $ABBV $ABT $ACAD $AGN $ALKS $ALNY $ALPMY $ALXN $AMGN#Amgen, Inc. Criticizes The Methods Used To Assess Kyprolis. Read more: https://t.co/lbT3ssirLl $AMGNThe Status Of Romosozumab From #Amgen, Inc. Is Yet To Be Known Having Failed To Excite In M... Read more: https://t.co/rZoAIVKPmX $AMGNRT @Lin_ling_88: $rlyp Q&amp;A: scripts rejection rate of #veltassa: 20%, compared to 77% for $AMGN's #Repartha$AMGN Max Pain = 157.50. Maturity = 05/06/2016. Previous close = 154.18. bullish https://t.co/UhZjRt3jqs https://t.co/8fNNTePkLI#Amgen Gets FDA Priority Review For Supplemental Biologics License Application For BLINCYTO... Read more: https://t.co/0s47NQuC6f $AMGN$rlyp Q&amp;A: scripts rejection rate of #veltassa: 20%, compared to 77% for $AMGN's #ReparthaSean E. Harper Sells 21,875 Shares of Amgen, Inc. $AMGN Stock https://t.co/5HcUvCPit7AMGN Investor Opinions
See Here ---&gt; https://t.co/kxPNJz04xr

$AMGN $PRAN $NEM #investNPBC Prev Close
See Here ---&gt; https://t.co/Exwp9NbUJZ

$NPBC $AMGN $DLNG #stockmarket#Oncobiologics #IPO: We Suggest Holding Off $ONS Also $PFE $MNTA $AMGN $CHRS https://t.co/sZH4IfZN26Amgen, Inc. $AMGN Shares Sold by Andra AP fonden https://t.co/k46y7g6NlDRT @theflynews: Jefferies 'rose colored glasses' Medivation buyout value hits $90/share $MDVN $AZN $NVS $PFE $AMGN $BAYRY $SN... https://t.‚Ä¶RT @KamakuraCo: Kamakura's best value bond trades have been posted, with comments on $AMGN, $T and $BAC https://t.co/3JDTla2Ihs https://t.c‚Ä¶RT @Trading_Analyst: ANALYSIS + TRADE IDEAS: $AAPL $AMZN $AMGN $TWTR $BABA $CMG $NFLX $PANW $PG $QCOM click link  https://t.co/A3uzUHqoN1 h‚Ä¶ANALYSIS + TRADE IDEAS: $AAPL $AMZN $AMGN $TWTR $BABA $CMG $NFLX $PANW $PG $QCOM click link  https://t.co/A3uzUHqoN1 https://t.co/25O0VlOTjV$AMGN maturity 05/06/2016 oi CallPutRatio of 0.72 puts 2,547 &amp; calls 3,545 bullish. https://t.co/fWSNp2J3bq https://t.co/7eOJ7g3GJ3",2016-05-05,AMGN,0
24,"Notable AH Movers 05/09: (Up) $MS $C $SNC $AU $NVRO $NUS $VNET $WAGE YUM (Down) $SCTY $AMGN $TTS $MPEL $BLOX $GPS $GS  $INVN $FRGI $RAXS&amp;P100 #Stocks Performance $AGN $BIIB $CELG $ABBV $EMC $TGT $COST $AMGN $LLY $GILD $MO $SPG $WMT $KMI $MRK more@ https://t.co/cKkr8cKsju$AMGN high open interest range is 150.00 to 155.00 for option expiration 05/13/2016.  https://t.co/Q3AjyJ6lrZ https://t.co/HqL8KZcwcVRT @bradloncar: $KITE said they won‚Äôt file an IND from the $AMGN partnership until 2017 (a delay from last update).$KITE said they won‚Äôt file an IND from the $AMGN partnership until 2017 (a delay from last update).Healthcare Industry To Grow By $282 Billion https://t.co/0ml7TCLRJA $AMGN $NVS $RHHBY $IXJ $IYH $JHMHFollow #Nasdaq 100 traders &amp; track their tweets under one watchlist $AMGN $QCOM https://t.co/W1OB9ZtUgi https://t.co/qgmF5wirG7#LargeCap #Biopharmaceuticals Q1 Metrics: #Earnings Show Limited Growth Prospects $BMY $R $RHHBY $IBB $REGN $AMGN... https://t.co/HhxFX4cBdfMT IBD_Areeves: Medivation reportedly caves to the inevitable and cozies up to Pfizer and Amgen https://t.co/N4liamtc55 $MDVN $PFE $AMGNMedivation reportedly caves to the inevitable and cozies up to Pfizer and Amgen to ward off Sanofi: https://t.co/EpUGXMXJGo $MDVN $PFE $AMGNRT @OpenOutcrier: RECAP 5/9 Chatter:
$IOC - $TOT $XOM
$SRNE - Adviser
$MDVN - $PFE $AMGN
$MHGC - SBERECAP 5/9 Chatter:
$IOC - $TOT $XOM
$SRNE - Adviser
$MDVN - $PFE $AMGN
$MHGC - SBEMedivation Signs Non-Disclosure Pacts With Pfizer, #Amgen -Reuters. Read more: https://t.co/mwdGuUlu4F $AMGNRT @MaisaCorp: $MDVN current suitors:

$PFE + $AMGN signed non-disclosure agreements
$SNY offered $9.3BLook who's moving in to an 8-year-old site never occupied by lessee Amgen https://t.co/ztSr3JHYPc $AMGN #biotech https://t.co/NLm2Bx3b29Top #sentiment for #SP1500 #stocks at market close: $TSN $PFE $ANF $AMGN $LUV (2016/05/09) #stocktrading #predictiveanalytics #bigdataTop sentiment for SP1500 stocks at market close: $TSN $PFE $ANF $AMGN $LUV (2016/05/09) #sentiment #stock #alexandriaNasdaq100 #Stocks Performance $INCY $BMRN $VRTX $MYL $BIIB $CERN $ALXN $CELG $REGN $TRIP $ROST $DISH $AMGN  more@ https://t.co/YdSIjFJqHfS&amp;P100 #Stocks Performance $AGN $BIIB $CELG $ABBV $AMGN $TGT $EMC $GILD $AMZN $COST $LLY $RTN $WMT $MO  more@ https://t.co/cKkr8cKsju$MDVN current suitors:

$PFE + $AMGN signed non-disclosure agreements
$SNY offered $9.3BTo win U.K. cost agency approval, $AMGN, $SNY/$REGN offer discounts for new $PCSK9 drugs https://t.co/EzATxr9rwyAMGN Exchange
See Here ---&gt; https://t.co/IoD8jKpVhF

$AMGN $BCOR $TLP #investingICER analysis recommends lower prices for new multiple myeloma drugs, includ. $AMGN's Kyprolis and Takeda's Ninlaro https://t.co/RE06MVqE3E$AMGN Max Pain is 155.00 for maturity 05/13/2016. Price = 153.19. bullish https://t.co/GNw6we6Rbb https://t.co/6eY7Hvl8YvREPORT: Medivation signs NDA with Pfizer and Amgen as it officially moves to explore sale: https://t.co/CocnWkDZc3 $MDVN $SNY $PFE $AMGNRT @TylerHCanalyst: $MDVN signs non-disclosure with $AMGN and $PFE ... exploring sale ... seeing Reuters as sourceTrending #Biotech topics include $ABBV, $AMGN, #Imbruvica #stocks #invest See more https://t.co/EpbbdqDEG1&lt;b&gt;Platelet BioGenesis&lt;/b&gt; Wins #Amgen Golden Ticket For &lt;b&gt;LabCentral&lt;/b&gt;  . Read more: https://t.co/SOQ90UaOi1 $AMGN#Amgen Exclusive: Medivation succumbs to pressure to explore sale - sources . Read more: https://t.co/ucp2JMmqPo $AMGNMedivation is conceding to pressure &amp; exploring sale! $SNY $PFE &amp; $AMGN are front suitors! More interest, higher sale price! $MDVN up &gt; 4%!With @pamela_msg -- Exclusive: Medivation succumbs to pressure to explore sale-sources https://t.co/D3iUgPUHwD via @Reuters $MDVN $PFE $AMGN$AMGN - Medivation Signs Non-Disclosure Pacts With Pfizer, Amgen -Reuters https://t.co/M2eSY9wQxZ$AMGN sentiment rise to: 0.75, change: +0.56, sdr: 1.11, 1H, 2:00 PM, #nasdaq $SPY $NDXAmgen Inc Valuation - February 2016 $AMGN https://t.co/MlQB8b9oqURT @zbiotech: EXCLUSIVE-MEDIVATION DECIDES TO EXPLORE SALE, SIGNS NON-DISCLOSURE AGREEMENTS WITH PFIZER INC, AMGEN INC - SOURCES - RTRS $MD‚Ä¶Medivation signs non-disclosure pacts with Amgern, Pfizer [Reuters]. $MDVN +4.37% at 62.62 $AMGN +1.64% $PFE +0.66% #biotech #mna #stocksRT @TylerHCanalyst: $MDVN signs non-disclosure with $AMGN and $PFE ... exploring sale ... seeing Reuters as source@JoeHsieh24 $AMGN HOD $CELG HOD $BIIB HOD confirmed.RT @WrigleyTom: $IBB strong all day, nHod

Too many to list, across all caps
$BLUE $KITE $JUNO $BPMC
$AMGN $CELG $SAGE $ALNY
$OPHT $XLRN $B‚Ä¶RT @TylerHCanalyst: $MDVN signs non-disclosure with $AMGN and $PFE ... exploring sale ... seeing Reuters as sourceRT @zbiotech: EXCLUSIVE-MEDIVATION DECIDES TO EXPLORE SALE, SIGNS NON-DISCLOSURE AGREEMENTS WITH PFIZER INC, AMGEN INC - SOURCES - RTRS $MD‚Ä¶RT @tsilver_apex: EXCLUSIVE-MEDIVATION DECIDES TO EXPLORE SALE, SIGNS NON-DISCLOSURE AGREEMENTS WITH PFIZER INC, AMGEN INC - SOURCES - RTRS‚Ä¶RT @zbiotech: EXCLUSIVE-MEDIVATION DECIDES TO EXPLORE SALE, SIGNS NON-DISCLOSURE AGREEMENTS WITH PFIZER INC, AMGEN INC - SOURCES - RTRS $MD‚Ä¶RT @WrigleyTom: $IBB strong all day, nHod

Too many to list, across all caps
$BLUE $KITE $JUNO $BPMC
$AMGN $CELG $SAGE $ALNY
$OPHT $XLRN $B‚Ä¶RT @WrigleyTom: $IBB strong all day, nHod

Too many to list, across all caps
$BLUE $KITE $JUNO $BPMC
$AMGN $CELG $SAGE $ALNY
$OPHT $XLRN $B‚Ä¶U.K. cost agency recommends new PCSK9 drugs, but only after further discounts  https://t.co/EzATxr9rwy $AMGN $SNy $REGNRT @zbiotech: EXCLUSIVE-MEDIVATION DECIDES TO EXPLORE SALE, SIGNS NON-DISCLOSURE AGREEMENTS WITH PFIZER INC, AMGEN INC - SOURCES - RTRS $MD‚Ä¶RT @WrigleyTom: $IBB strong all day, nHod

Too many to list, across all caps
$BLUE $KITE $JUNO $BPMC
$AMGN $CELG $SAGE $ALNY
$OPHT $XLRN $B‚Ä¶RT @zbiotech: EXCLUSIVE-MEDIVATION DECIDES TO EXPLORE SALE, SIGNS NON-DISCLOSURE AGREEMENTS WITH PFIZER INC, AMGEN INC - SOURCES - RTRS $MD‚Ä¶AMGN Top news - May 9th, 2016 $AMGN https://t.co/CvU38S4TYyRT @WrigleyTom: $IBB strong all day, nHod

Too many to list, across all caps
$BLUE $KITE $JUNO $BPMC
$AMGN $CELG $SAGE $ALNY
$OPHT $XLRN $B‚Ä¶$IBB strong all day, nHod

Too many to list, across all caps
$BLUE $KITE $JUNO $BPMC
$AMGN $CELG $SAGE $ALNY
$OPHT $XLRN $BIIB $BMRN $SGENRT @zbiotech: EXCLUSIVE-MEDIVATION DECIDES TO EXPLORE SALE, SIGNS NON-DISCLOSURE AGREEMENTS WITH PFIZER INC, AMGEN INC - SOURCES - RTRS $MD‚Ä¶RT @TylerHCanalyst: $MDVN signs non-disclosure with $AMGN and $PFE ... exploring sale ... seeing Reuters as sourceRT @theflynews: Medivation up 4% after said to sign NDA with drugmaking giants $MDVN $SNY $PFE $AMGN: Full Story https://t.co/LHJLMiBUqYRT @zbiotech: EXCLUSIVE-MEDIVATION DECIDES TO EXPLORE SALE, SIGNS NON-DISCLOSURE AGREEMENTS WITH PFIZER INC, AMGEN INC - SOURCES - RTRS $MD‚Ä¶@sharkbiotech $amgn loves to overpay! Come on $85 baby!!RT @zbiotech: EXCLUSIVE-MEDIVATION DECIDES TO EXPLORE SALE, SIGNS NON-DISCLOSURE AGREEMENTS WITH PFIZER INC, AMGEN INC - SOURCES - RTRS $MD‚Ä¶RT @zbiotech: EXCLUSIVE-MEDIVATION DECIDES TO EXPLORE SALE, SIGNS NON-DISCLOSURE AGREEMENTS WITH PFIZER INC, AMGEN INC - SOURCES - RTRS $MD‚Ä¶RT @zbiotech: EXCLUSIVE-MEDIVATION DECIDES TO EXPLORE SALE, SIGNS NON-DISCLOSURE AGREEMENTS WITH PFIZER INC, AMGEN INC - SOURCES - RTRS $MD‚Ä¶RT @theflynews: Medivation up 4% after said to sign NDA with drugmaking giants $MDVN $SNY $PFE $AMGN: Full Story https://t.co/LHJLMiBUqYRT @theflynews: Medivation up 4% after said to sign NDA with drugmaking giants $MDVN $SNY $PFE $AMGN: Full Story https://t.co/LHJLMiBUqYRT @zbiotech: EXCLUSIVE-MEDIVATION DECIDES TO EXPLORE SALE, SIGNS NON-DISCLOSURE AGREEMENTS WITH PFIZER INC, AMGEN INC - SOURCES - RTRS $MD‚Ä¶RT @zbiotech: EXCLUSIVE-MEDIVATION DECIDES TO EXPLORE SALE, SIGNS NON-DISCLOSURE AGREEMENTS WITH PFIZER INC, AMGEN INC - SOURCES - RTRS $MD‚Ä¶Medivation up 4% after said to sign NDA with drugmaking giants $MDVN $SNY $PFE $AMGN: Full Story https://t.co/LHJLMiBUqYRT @tsilver_apex: EXCLUSIVE-MEDIVATION DECIDES TO EXPLORE SALE, SIGNS NON-DISCLOSURE AGREEMENTS WITH PFIZER INC, AMGEN INC - SOURCES - RTRS‚Ä¶RT @zbiotech: EXCLUSIVE-MEDIVATION DECIDES TO EXPLORE SALE, SIGNS NON-DISCLOSURE AGREEMENTS WITH PFIZER INC, AMGEN INC - SOURCES - RTRS $MD‚Ä¶RT @zbiotech: EXCLUSIVE-MEDIVATION DECIDES TO EXPLORE SALE, SIGNS NON-DISCLOSURE AGREEMENTS WITH PFIZER INC, AMGEN INC - SOURCES - RTRS $MD‚Ä¶RT @NatalieGrover: EXCLUSIVE-#Medivation succumbs to pressure to explore #sale -sources via @Reuters $MDVN $PFE $AMGN $SASYEXCLUSIVE-MEDIVATION DECIDES TO EXPLORE SALE, SIGNS NON-DISCLOSURE AGREEMENTS WITH PFIZER INC, AMGEN INC - SOURCES - RTRS $MDVN $PFE $AMGNRT @NatalieGrover: EXCLUSIVE-#Medivation succumbs to pressure to explore #sale -sources via @Reuters $MDVN $PFE $AMGN $SASYRT @tsilver_apex: EXCLUSIVE-MEDIVATION DECIDES TO EXPLORE SALE, SIGNS NON-DISCLOSURE AGREEMENTS WITH PFIZER INC, AMGEN INC - SOURCES - RTRS‚Ä¶RT @TylerHCanalyst: $MDVN signs non-disclosure with $AMGN and $PFE ... exploring sale ... seeing Reuters as sourceRT @tsilver_apex: EXCLUSIVE-MEDIVATION DECIDES TO EXPLORE SALE, SIGNS NON-DISCLOSURE AGREEMENTS WITH PFIZER INC, AMGEN INC - SOURCES - RTRS‚Ä¶EXCLUSIVE-#Medivation succumbs to pressure to explore #sale -sources via @Reuters $MDVN $PFE $AMGN $SASY$MDVN signs non-disclosure with $AMGN and $PFE ... exploring sale ... seeing Reuters as sourceRT @tsilver_apex: EXCLUSIVE-MEDIVATION DECIDES TO EXPLORE SALE, SIGNS NON-DISCLOSURE AGREEMENTS WITH PFIZER INC, AMGEN INC - SOURCES - RTRS‚Ä¶EXCLUSIVE-MEDIVATION DECIDES TO EXPLORE SALE, SIGNS NON-DISCLOSURE AGREEMENTS WITH PFIZER INC, AMGEN INC - SOURCES - RTRS $MDVN $PFE $AMGN#Amgen To Present At The Bank of America Merrill Lynch 2016 Health Care Conference  . Read more: https://t.co/BOIZdwMH6q $AMGNRT SeekingAlpha: Healthcare Industry To Grow By $282 Billion https://t.co/7YgqN1Ag9u $AMGN $NVS $RHHBY $IXJ $IYH $JHMHHealthcare Industry To Grow By $282 Billion https://t.co/39nX7tprrb $AMGN $NVS $RHHBY $IXJ $IYH $JHMHHealthcare Industry To Grow By $282 Billion https://t.co/6p3AR0gFFY $AMGN $NVS $RHHBY $IXJ $IYH $JHMHHealthcare Industry To Grow By $282 Billion https://t.co/1jmes9MCJQ $AMGN $NVS $RHHBY $IXJ $IYH $JHMH$ADAP @Adaptimmune Therapeutics

$MDT $BSX $TMO $EW $DXCM $IDXX $NVTA $AMGN $SNY $LLY $BAYRY $GILD $BIIB $CELG $REGN https://t.co/XNX2HmPtmbBest outperformers ranked 35-40 $BEAV $AMGN $TSO $NYT $MIKICER questions high prices of multiple myeloma meds https://t.co/RE06MVIfse $JNJ $AMGN $BMY $ABBVNasdaq100 #Stocks Performance $CERN $REGN $TRIP $MYL $BMRN $DISH $VRTX $GILD $BIIB $ALXN $CELG $AMGN $COST  more@ https://t.co/YdSIjFJqHfS&amp;P100 #Stocks Performance $AGN $EMC $GILD $BIIB $TGT $CELG $AMGN $LLY $COST $CVS $MRK $PFE $AAPL $MDT  more@ https://t.co/cKkr8cKsjuRT @Taarriqq: Biotech stocks showing strength $GILD  $AMGN $ALXN $XBI $LABU $CELG $BIIB $MNKBiotech stocks showing strength $GILD  $AMGN $ALXN $XBI $LABU $CELG $BIIB $MNK$AMGN From 3 days ago, looking great ! https://t.co/AE8abvYLrRAmgen, Inc. $AMGN Upgraded to ‚ÄúBuy‚Äù at Zacks Investment Research https://t.co/HtmxAwu1f3SAM Ideas
See Here ---&gt; https://t.co/BvokeF9zNt

$SAM $GBX $AMGN #nasdaq$AMGN maturity 05/13/2016 oi CallPutRatio of 1.18 puts 1,358 &amp; calls 1,148 bearish. https://t.co/Q3AjyJ6lrZ https://t.co/s8ud1ZK1uI#LargeCap #Biopharmaceuticals Q1 Metrics: #Earnings Show Limited Growth Prospects $BMY $R $RHHBY $IBB $REGN $AMGN... https://t.co/8ixv4fdMhb$IBB bullish reversal candles on 60 min &amp; daily charts. now see if it can hold. $AMGN $BIIB $CELG $GILD $REGN $ALXN https://t.co/XEUx9LBY2Q$ADAP @Adaptimmune Therapeutics

$MDT $BSX $TMO $EW $DXCM $IDXX $NVTA $AMGN $SNY $LLY $BAYRY $GILD $BIIB $CELG $REGN https://t.co/RNnaSg1m44$AMGN Platelet BioGenesis Wins https://t.co/bDJ7kJG90S #biotechstocks #biotech #stocksvenBio Partners Closes $315M #LifeSciences #VC Fund @Amgen @Merck @Baxalta $MRK $AMGN https://t.co/Pm3ff1Prlu Adelman Goodman @aaronroyston$AMGN: At/Above PivotR1[154.64],200DaySMA 1DyHi50%R[154.45,12m,0.63offHi]:2d, lm:-1, DyRng:2.09, 0NearHi, AtgPivH4, 4:3Accel+$AMGN Platelet BioGenesis Wins Amgen Golden Ticket For LabCentral
From our Stock News Alerts App$AMGN - Platelet BioGenesis Wins Amgen Golden Ticket For LabCentral https://t.co/czBhRJj4MYMerck, Amgen and Baxalta back a $315M biotech fund from venBio: https://t.co/g4EoSxBCT6 $MRK $AMGN via @JohnCFierceMerck, Amgen and Baxalta back a $315M biotech fund from venBio: https://t.co/Qj82nD5Z1X $MRK $AMGN via @JohnCFierceCharts See Possible Value in Apple, Facebook $AAPL $FB $AMGN https://t.co/1XgaP1gpP3Investing In #Biotech: You Have To Hang On Through The Swings https://t.co/9R3Y9dmCTM $ABBV $AMGN $ENDP $MYL $IBB $XBI$ADAP @Adaptimmune Therapeutics

$MDT $BSX $TMO $EW $DXCM $IDXX $NVTA $AMGN $SNY $LLY $BAYRY $GILD $BIIB $CELG $REGN https://t.co/v8NXzrWN5P$AMGN OI for maturity 05/13/2016. 150.00 Highest put. 155.00 Highest call.  https://t.co/Q3AjyJ6lrZ https://t.co/BYpWsPVdewRT @fwpharma: NICE backs use of Sanofi, Amgen's PCSK9 inhibitors https://t.co/3qFixpq5Fi $SNY $AMGN #pharmaRT @CashRocket: Top Upcoming 2016 Biotech Events: $ICPT $BIIB $PRTA $VRTX $ESPR $AMGN $CELG $KITE $INFI $VRTX $GILD $ACOR $FGEN https://t.c‚Ä¶Clearbridge Investments LLC Buys 20,088 Shares of Amgen, Inc. $AMGN https://t.co/pPVRmXw9O4Clearbridge Investments LLC Buys 20,088 Shares of Amgen, Inc. $AMGN https://t.co/pLCMwDQSa6Commented on Investing In Biotech: You Have To Hang On Through The Swings https://t.co/QdOWZySzIc $ABBV $AMGN $ENDP $MYL $IBB $XBIAmgen, Inc. $AMGN Position Decreased by Rock Springs Capital Management LP https://t.co/xX7EBXSTHCRT @CashRocket: Top Upcoming 2016 Biotech Events: $ICPT $BIIB $PRTA $VRTX $ESPR $AMGN $CELG $KITE $INFI $VRTX $GILD $ACOR $FGEN https://t.c‚Ä¶$AMGN - Madhavan Balachandran Sells 30,000 Shares of Amgen, Inc. #AMGN Stock https://t.co/3NyN4LjPn5$AMGN - Madhavan Balachandran Sells 30,000 Shares of Amgen, Inc. #AMGN Stock https://t.co/ibfgsWZcEIhttps://t.co/G9pMgSr1JY &lt; Review of this fantastic traders teaching service!! Try it for FREE! $LLY $DGX $MRK $NVS $AMGN#LargeCap #Biopharmaceuticals Q1 Metrics: #Earnings Show Limited Growth Prospects $BMY $R $RHHBY $IBB $REGN $AMGN... https://t.co/HhxFX4cBdfRT @CashRocket: Top Upcoming 2016 Biotech Events: $ICPT $BIIB $PRTA $VRTX $ESPR $AMGN $CELG $KITE $INFI $VRTX $GILD $ACOR $FGEN https://t.c‚Ä¶These $ITUS Profits Are much Bigger Than $AMGNRT @FierceBiotech: Merck, Amgen and Baxalta back a $315M biotech fund from venBio: https://t.co/rpZkKaVfzM $MRK $AMGN via @JohnCFierceThese $ITUS Profits Are much Bigger Than $AMGNThese $ITUS Profits Are much Bigger Than $AMGNThese $ITUS Profits Are much Bigger Than $AMGNThese $ITUS Profits Are much Bigger Than $AMGNThese $ITUS Profits Are much Bigger Than $AMGNRT @CashRocket: Top Upcoming 2016 Biotech Events: $ICPT $BIIB $PRTA $VRTX $ESPR $AMGN $CELG $KITE $INFI $VRTX $GILD $ACOR $FGEN https://t.c‚Ä¶RT @CashRocket: Top Upcoming 2016 Biotech Events: $ICPT $BIIB $PRTA $VRTX $ESPR $AMGN $CELG $KITE $INFI $VRTX $GILD $ACOR $FGEN https://t.c‚Ä¶These $ITUS Profits Are much Bigger Than $AMGNRT @CashRocket: Top Upcoming 2016 Biotech Events: $ICPT $BIIB $PRTA $VRTX $ESPR $AMGN $CELG $KITE $INFI $VRTX $GILD $ACOR $FGEN https://t.c‚Ä¶RT @CashRocket: Top Upcoming 2016 Biotech Events: $ICPT $BIIB $PRTA $VRTX $ESPR $AMGN $CELG $KITE $INFI $VRTX $GILD $ACOR $FGEN https://t.c‚Ä¶Top Upcoming 2016 Biotech Events: $ICPT $BIIB $PRTA $VRTX $ESPR $AMGN $CELG $KITE $INFI $VRTX $GILD $ACOR $FGEN https://t.co/TVCEkmC851$AMGN Max Pain is 155.00 for maturity 05/13/2016. Price = 153.19. bullish https://t.co/GNw6we6Rbb https://t.co/YMdu6fhZ3AThese $ITUS Profits Are much Bigger Than $AMGNRT @StocksHighAlert: $BILB Massive gains are coming... 
üí• from $.008 to $.10+ üí•

#TRADING #PENNYSTOCKS $AAPL $AMAT $AMGN $AMTD $AMZN
https:‚Ä¶RT @StocksHighAlert: $BILB Massive gains are coming... 
üí• from $.008 to $.10+ üí•

#TRADING #PENNYSTOCKS $AAPL $AMAT $AMGN $AMTD $AMZN
https:‚Ä¶RT @StocksHighAlert: $BILB Massive gains are coming... 
üí• from $.008 to $.10+ üí•

#TRADING #PENNYSTOCKS $AAPL $AMAT $AMGN $AMTD $AMZN
https:‚Ä¶RT @StocksHighAlert: $BILB Massive gains are coming... 
üí• from $.008 to $.10+ üí•

#TRADING #PENNYSTOCKS $AAPL $AMAT $AMGN $AMTD $AMZN
https:‚Ä¶RT @StocksHighAlert: $BILB Massive gains are coming... 
üí• from $.008 to $.10+ üí•

#TRADING #PENNYSTOCKS $AAPL $AMAT $AMGN $AMTD $AMZN
https:‚Ä¶",2016-05-09,AMGN,1
25,"$AMGN Max Pain is 155.00 for maturity 05/13/2016. Price = 155.41. bearish https://t.co/GNw6we6Rbb https://t.co/VNHBCmjKnMHigh Pole https://t.co/jvt7LpScrI $AAWW $ABUS $AGCO $AIRM $AMGN $APOG $ARLP $ASHS $ASR $ATNM $BBH $BETR $CCLP $CCS $CEO $CERN $CERUAmgen Inc. Received its Third Buy in a Row $AMGN https://t.co/K8Q34NnB4FThese $ITUS Profits Are much Bigger Than $AMGNThese $ITUS Profits Are much Bigger Than $AMGN$ADAP @Adaptimmune Therapeutics

$MDT $BSX $TMO $EW $DXCM $IDXX $NVTA $AMGN $SNY $LLY $BAYRY $GILD $BIIB $CELG $REGN https://t.co/vVwW0LSpcH$AMGN:US Amgen, Inc. (AMGN) Shares Bought by BlackRock Investment Management LLC #AMGEN INC  https://t.co/OUuB38WY5Z #NASDAQRT @biospace: Medivation $MDVN Takeover Takes Another Turn, Rumored to Open to Amgen $AMGN, Pfizer $PFE https://t.co/HV2kEr93Bw https://t.c‚Ä¶Medivation $MDVN Takeover Takes Another Turn, Rumored to Open to Amgen $AMGN, Pfizer $PFE https://t.co/HV2kEr93Bw https://t.co/8D3UsRNLwpThese $ITUS Profits Are much Bigger Than $AMGNThese $ITUS Profits Are much Bigger Than $AMGN https://t.co/UstaM7JMj3What Factors Will Drive Celgene‚Äôs Valuations in 2016? $ABBV $AMGN $CELG $GILD https://t.co/3qdqXsGZIsThese $ITUS Profits Are much Bigger Than $AMGNThese $ITUS Profits Are much Bigger Than $AMGNAMGN Market Cap
See Here ---&gt; https://t.co/F2ZR7QIVAX

$AMGN $CPXX $SLV #tradeideas$AMGN maturity 05/13/2016 oi CallPutRatio of 0.96 puts 1,797 &amp; calls 1,864 bullish. https://t.co/Q3AjyJ6lrZ https://t.co/eWy1etgoJgLook who's moving in to an 8-year-old site never occupied by lessee Amgen https://t.co/ztSr3JHYPc $AMGN #biotech https://t.co/NLm2Bx3b29These $ITUS Profits Are much Bigger Than $AMGN@santiagoreba @litenpuppe @pricatti escuch√° a santiago,Ricatti! $GILD, $AMGN $BIIB $CELG $KITE $NVS $JNJ son un ej y mi pollo $JUNO tmb ser√°$AMGN Daily at roughly 50% RT$AMGN close above 5 and 8 ema... lower volume v bottom bounce change in polariatyImpressive turnaround day $IBB
w/some red2green

Top 10 holdings, 9/10 nHod
$AMGN $BIIB $CELG $GILD
$REGN $ALXN $VRTX $ILMN $BMRN

$MYL flatThese $ITUS Profits Are much Bigger Than $AMGN$XLV Healthcare technicals are stabilizing.  $vrtx $BIIB $AMGN $LGND $ARIA https://t.co/zAvkkPlhVMOVAS Ex-Div Date
See Here ---&gt; https://t.co/RHB18iT39m

$OVAS $AMGN $L #stocksApple Vs. China In New Bidding War https://t.co/TXgdPB96BQ $AIQUY $ALR $AMGN $ANCUF $ARG $ATCEY $ATVI $BRCD $BRK.A $BRK.B $CMCSA $COMM#Amgen Medivation succumbs to pressure to explore sale - sources. Read more: https://t.co/E3tYohmSTu $AMGNAMGN Top news - May 10th, 2016 $AMGN https://t.co/UsKJ5kSHJVAMGN 156.60 Amgen $AMGN added to my watch list. Right now with AMGN I am watching the last price 156.60 High 1 https://t.co/Dmn3bgv9wTMedivation opens books to Pfizer, Amgen as bidders circle: Reuters | FiercePharma $MDVN $PFE $AMGN https://t.co/GAMuyg6T5ZApple Vs. China In New Bidding War https://t.co/u92FkOIL1M $AIQUY $ALR $AMGN $ANCUF $ARG $ATCEY $ATVI $BRCD $BRK.A $BRK.B $CMCSA $COMMThese $ITUS Profits Are much Bigger Than $AMGNRT @Taarriqq: Strong again, yesterday had this post  $AMGN $ALXN $XBI $LABU $CELG $BIIB $MNK  #biotechStrong again, yesterday had this post  $AMGN $ALXN $XBI $LABU $CELG $BIIB $MNK  #biotechBest outperformers ranked 35-40 $SATS $BEAV $UTHR $AMGN $TSO$AMGN high open interest range is 150.00 to 157.50 for option expiration 05/13/2016.  https://t.co/Q3AjyJ6lrZ https://t.co/3MGPjbfGbBThese $ITUS Profits Are much Bigger Than $AMGNThese $ITUS Profits Are much Bigger Than $AMGN$ADAP @Adaptimmune Therapeutics

$MDT $BSX $TMO $EW $DXCM $IDXX $NVTA $AMGN $SNY $LLY $BAYRY $GILD $BIIB $CELG $REGN https://t.co/bqja0PGXe0Mittelfristiges Signal! $AMGN: Ein Trendkanal wurde bei 155.281 USD nach oben durchbrochen:  https://t.co/RcoK9bdHDFVetr users have upgraded Amgen Inc. to a STRONG BUY Rating (4.5 stars), giving $AMGN a target price of $175.53 https://t.co/sgyPwK93LkRT @Benzinga: The Market In 5 Minutes: Better Late Than Never $AMGN $DIS $SCTY $TSLA $SPY $USO $LC $RAX $WWE $SODA $GPS https://t.co/twbfmR‚Ä¶Did Regeneron Pharmaceuticals Beat Earnings Estimates in 1Q16? $AMGN $CELG $GILD $IBB https://t.co/or4bylE6jCThe Market In 5 Minutes: Better Late Than Never $AMGN $DIS $SCTY $TSLA $SPY $USO $LC $RAX $WWE $SODA $GPS https://t.co/twbfmRUgmKRT @TalkMarkets: #LargeCap #Biopharmaceuticals Q1 Metrics: #Earnings Show Limited Growth Prospects $BMY $R $RHHBY $IBB $REGN $AMGN... https‚Ä¶Call/Put Highest % volume changes:  Calls: $AUY, $LLY, $LVS, $AKAM, $AMGN.  Puts: $WFM, $SRPT, $WLL, $EBAY, $IBB.Apple Vs. China In New Bidding War https://t.co/KhZyDTkbEE $AIQUY $ALR $AMGN $ANCUF $ARG $ATCEY $ATVI $BRCD $BRK.A $BRK.B $CMCSA $COMMApple Vs. China In New Bidding War https://t.co/fy4rJ5gJ84 $AIQUY $ALR $AMGN $ANCUF $ARG $ATCEY $ATVI $BRCD $BRK.A $BRK.B $CMCSA $COMMRT SeekingAlpha: Apple V China In New Bidding War https://t.co/vjcpTrj4Wo $AIQUY $ALR $AMGN $ANCUF $ARG $ATCEY $ATVI $BRCD $BRK.A $BRK.B $‚Ä¶Apple V China In New Bidding War https://t.co/VnCe5ASUmi $AIQUY $ALR $AMGN $ANCUF $ARG $ATCEY $ATVI $BRCD $BRK.A $BRK.B $CMCSA $COMM $CVCApple V China In New Bidding War https://t.co/2L46D35rKs $AIQUY $ALR $AMGN $ANCUF $ARG $ATCEY $ATVI $BRCD $BRK.A $BRK.B $CMCSA $COMM $CVC@CT_Morrison @JohnCFierce what they have innovated lately?$celg follows $gild $amgn as it gets bigger and fatter.Report: Medivation Committed To Selling Itself $AMGN $MDVN $PFE https://t.co/adopZfJ5ID via @benzingaReport: Medivation Committed To Selling Itself $AMGN $MDVN $PFE $SNY https://t.co/DiVDWe21gl$AAPL $AMAT $AMGN $AMTD $AMZN $ADI Trade long or long+short positions from the #NASDAQ, up to 1500% since 2010. https://t.co/ldcTl0HsrKAmgen, Inc. $AMGN Cut to ‚ÄúHold‚Äù at Zacks Investment Research https://t.co/nHJlkPg1eQ$AMGN Max Pain is 155.00 for maturity 05/13/2016. Price = 155.41. bearish https://t.co/GNw6we6Rbb https://t.co/CXhpZ01WmICommented on Investing In Biotech: You Have To Hang On Through The Swings https://t.co/QdOWZySzIc $ABBV $AMGN $ENDP $MYL $IBB $XBI#Disney Vs. #DreamWorks Showdown https://t.co/AorXNk2c8L $AMGN $APD $APO $APOL $AVNU $AXLL $BUD $CMCSA $CSCO $DISCA $DWA $EA $ETE $ETP $FCLFInvesting In #Biotech: You Have To Hang On Through The Swings https://t.co/9R3Y9dmCTM $ABBV $AMGN $ENDP $MYL $IBB $XBI$AMGN Looks Interesting - Mini Stock ‚Äôn Options Course - https://t.co/Zmuz7XvjqQ
 #stockstowatch #stockmarket https://t.co/CmrJOShsdh$BMY $MRK $ENUM $AMGN https://t.co/Gg6y0xNtgXInsider Selling: Amgen, Inc. $AMGN EVP Sells $4,623,600.00 in Stock https://t.co/77VzxPfZTVInsider Selling: Amgen, Inc. $AMGN EVP Sells $4,623,600.00 in Stock https://t.co/tsYEOEfrwvRT @MaisaCorp: $MDVN current suitors:

$PFE + $AMGN signed non-disclosure agreements
$SNY offered $9.3BRT @MaisaCorp: $MDVN current suitors:

$PFE + $AMGN signed non-disclosure agreements
$SNY offered $9.3BRT @MikeF_trading: $IBB breaking... giving a chance to those who missed it!

$GILD $AMGN $REGN https://t.co/EV4wwKWTfpAmgen, Inc. $AMGN Raised to ‚ÄúStrong-Buy‚Äù at Vetr Inc. https://t.co/ZPHhk769nKAmgen upgraded by Vetr Inc. to strong-buy. $175.53 PT. https://t.co/C88es46Po1 $AMGN #AMGN$AMGN received a new alert. Find out why at https://t.co/nZwqReM0tj #stocks #daytrading #trading #mkt  #NYSE #NASDAQ #markets 713Amgen upgraded by Vetr Inc. to strong-buy. $175.53 PT. https://t.co/LediewhHtN $AMGN #AMGNRT @MikeF_trading: $IBB breaking... giving a chance to those who missed it!

$GILD $AMGN $REGN https://t.co/EV4wwKWTfpRT @MikeF_trading: $IBB breaking... giving a chance to those who missed it!

$GILD $AMGN $REGN https://t.co/EV4wwKWTfp$AMGN sum put oi=1,358 sum call oi=1,148 CallPutRatio=1.18 expiration 05/13/2016 bearish. https://t.co/Q3AjyJ6lrZ https://t.co/wxNrAcllop$AMGN : A Phase I/II trial (NCT02713529) for AMG 820 combined with pembrolizumab in select advanced Solid Tumors started recruiting patients$AAPL $AMAT $AMGN $AMTD $AMZN $ATVI Trade long or long+short positions from the #NASDAQ, up to 1500% since 2010. https://t.co/ldcTl0HsrKRT @MikeF_trading: $IBB breaking... giving a chance to those who missed it!

$GILD $AMGN $REGN https://t.co/EV4wwKWTfpRT @MikeF_trading: $IBB breaking... giving a chance to those who missed it!

$GILD $AMGN $REGN https://t.co/EV4wwKWTfpSchwab Charles Investment Management Inc. Has $527,089,000 Position in Amgen, Inc. $AMGN https://t.co/wc0vJjqdbK$AMGN 10 points above this level@RevDrCook $agn $pfe $amgn $celg real companies with decent pipelines and  actual drug R&amp;DRT @MikeF_trading: $IBB breaking... giving a chance to those who missed it!

$GILD $AMGN $REGN https://t.co/EV4wwKWTfpRT @MikeF_trading: $IBB breaking... giving a chance to those who missed it!

$GILD $AMGN $REGN https://t.co/EV4wwKWTfpRT @MikeF_trading: $IBB breaking... giving a chance to those who missed it!

$GILD $AMGN $REGN https://t.co/EV4wwKWTfpRT @MikeF_trading: $IBB breaking... giving a chance to those who missed it!

$GILD $AMGN $REGN https://t.co/EV4wwKWTfpRT @MikeF_trading: $IBB breaking... giving a chance to those who missed it!

$GILD $AMGN $REGN https://t.co/EV4wwKWTfpRT @MikeF_trading: $IBB breaking... giving a chance to those who missed it!

$GILD $AMGN $REGN https://t.co/EV4wwKWTfp$IBB breaking... giving a chance to those who missed it!

$GILD $AMGN $REGN https://t.co/EV4wwKWTfpRT @CashRocket: Top Upcoming 2016 Biotech Events: $ICPT $BIIB $PRTA $VRTX $ESPR $AMGN $CELG $KITE $INFI $VRTX $GILD $ACOR $FGEN https://t.c‚Ä¶High Pole https://t.co/x1BCImW5he $AAWW $ADP $AIRM $AMG $AMGN $AMSG $APOG $ARLP $ATHM $ATNM $BBH $BBL $BHP $BSTC $CCLP $CCS $CDR",2016-05-10,AMGN,0
26,"Richard Bernstein Advisors LLC Has $6,767,000 Stake in Amgen, Inc. $AMGN https://t.co/T4l7QmZ06R$AMGN Health Insurers Push to Tie Drug Prices to Outcomes--Upd‚Ä¶ https://t.co/wtPvdcVowU$AMGN Hall of Fame Quarterback Joe Montana and Amgen Team Up t‚Ä¶ https://t.co/xkQj8VbA9u$AMGN Health Insurers Push to Tie Drug Prices to Outcomes‚Ä¶ https://t.co/9U5g3MiuVI$AMGN:US Traders Sell Shares of Amgen, Inc. (AMGN) on Strength (AMGN) #AMGEN INC  https://t.co/JQtVwZUj2C #NASDAQRT @stockspastor: Bio-tech stocks sold off today.  Expect a reversal tomorrow going to next week.  $IBB, $GILD, $AMGN $PFE, $MRKParabolic SAR Buy https://t.co/1VYneCUkFR $AYI $SPY $ROP $COO $AMGN $JAZZ $AVGO $BAP $LII $LNKD $LH $SWK $QQQ $HUBB $IGV $TQQQ $THGBio-tech stocks sold off today.  Expect a reversal tomorrow going to next week.  $IBB, $GILD, $AMGN $PFE, $MRKThese $ITUS Profits Are much Bigger Than $AMGN#Biosimilar blocking strategies: $JNJ gets day in court re Remicade, $AMGN seeks FDA docs from Hospira/ $PFE https://t.co/XYUMNGLiZoVetr Inc. Upgrades Amgen, Inc. $AMGN to Strong-Buy https://t.co/JCEvZ4xN5S$AMGN OI for maturity 05/13/2016. 152.50 Highest put. 157.50 Highest call.  https://t.co/Q3AjyJ6lrZ https://t.co/kcWhW69K4NGeneric Stocks Down; Are They Good Buys? Focus On Teva https://t.co/Fx4xwnvrrF $ABC $AGN $AMGN $BIIB $ENDP $MRK $MYL $PRGO $TEVAAMGN Top news - May 11th, 2016 $AMGN https://t.co/bVbGTRYK3QCigna will pay makers of two new, pricey cholesterol drugs based on how well patients respond https://t.co/Ba32hLWDdj $REGN $AMGNRT SeekingAlpha: Generic Stocks Down; Are They Good Buys? Focus On Teva https://t.co/G0wb6jXcIK $ABC $AGN $AMGN $BIIB $ENDP $MRK $MYL $PRG‚Ä¶Generic Stocks Down; Are They Good Buys? Focus On Teva
https://t.co/TYtJkgeZTy $TEVA, $ABC, $AGN, $AMGN, $BIIB, $ENDP, $MRK, $MYL, $PRGOGeneric Stocks Down; Are They Good Buys? Focus On Teva https://t.co/uefIDdqqtG $ABC $AGN $AMGN $BIIB $ENDP $MRK $MYL $PRGO $TEVAGeneric Stocks Down; Are They Good Buys? Focus On Teva https://t.co/puwkyyrPR0 $ABC $AGN $AMGN $BIIB $ENDP $MRK $MYL $PRGO $TEVART @iancassel: Some of the best performing public companies ever including $BRK $WMT $AMGN $NFLX $LUV started as microcap companies
https:/‚Ä¶RT @amancini312: #Cigna signs performance-based contract with $AMGN $SNY for $$$ cholesterol drugs. https://t.co/nXPph9edZ8 via @Reuters$AMGN has just reached a new low at $154.75.  Found with MOMO Stock Breakout App @ https://t.co/1WLje7D8rC#Cigna signs performance-based contract with $AMGN $SNY for $$$ cholesterol drugs. https://t.co/nXPph9edZ8 via @ReutersAmgen Inc Reiterated Rating by Piper Jaffray (Ranked 57th) to Buy $AMGN #AMGN https://t.co/bqjkWr2ARABest outperformers ranked 40-45 $UTHR $AMGN $WEX $TSO $NYT$AMGN Max Pain = 155.00. Maturity = 05/13/2016. Previous close = 157.24. bearish https://t.co/GNw6we6Rbb https://t.co/GXAAf6VCj6#Amgen Cigna inks outcome-based payment contracts with makers of Praluent, Repatha. Read more: https://t.co/WUQsACmBr8 $AMGNCigna makes deals with #Amgen, Sanofi for pricey cholesterol drugs. Read more: https://t.co/wPaCkaV5vW $AMGNCigna inks results-based deals on pricey Amgen, Sanofi PCSK9 meds https://t.co/qRdyfYMR7u $AMGN $SNY #pharma by @TracyStaton@Melikeitalot $HALO CEO ex $BMY $AMGN knows what she's doing-squeeze from Positive data in least promising 202 set @ASCO will be supportiveRT @anky7544: Recap today's buy list: $BIDU, $TSLA, $GS, $AMGN, and $GILD.Recap today's buy list: $BIDU, $TSLA, $GS, $AMGN, and $GILD.#Amgen Teams With Joe Montana On Heart Health Outreach. Read more: https://t.co/gQHrHSDFYC $AMGNHall of Fame Quarterback Joe Montana And #Amgen Team Up To Launch Breakaway From Heart Dise... Read more: https://t.co/kcACnktSfe $AMGN$AMGN has just reached a new high at 155.79.  Found with MOMO Stock Breakout App @ https://t.co/1WLje7D8rC8 users on Vetr are bullish on Amgen Inc., indicating a BUY Rating (4 stars) for $AMGN https://t.co/sgyPwK93LkBuy list to hold for next 2 weeks: $AMGN, $GILD, $GS, and $TSLA. More upside breakout potential. Very attractive entry level here.Cigna makes deals with #Amgen, Sanofi for pricey cholesterol drugs. Read more: https://t.co/kkSujP1OJe $AMGNRT @BMTArmando: $CI Cigna announces coverage deals with both $AMGN Amgen and $REGN Regeneron for their PCSK9 inhibitors https://t.co/Ly77ek‚Ä¶$CI Cigna announces coverage deals with both $AMGN Amgen and $REGN Regeneron for their PCSK9 inhibitors https://t.co/Ly77ekV87rRT @FiercePharma: #ICYMI yesterday: Medivation opens books to Pfizer, Amgen as bidders circle: Reuters https://t.co/VWxvulDxiJ $MDVN $PFE $‚Ä¶$IONS Kynamro reduces cardiovascular events in HoFH #cardiology #biotech #ASO $IBB $AEGR $AMGN $REGN $SNY $MRK https://t.co/zcL3Es454IRT @iancassel: Some of the best performing public companies ever including $BRK $WMT $AMGN $NFLX $LUV started as microcap companies
https:/‚Ä¶Apple Vs. China In New Bidding War https://t.co/Oj6Qi2w0Rm $AIQUY $ALR $AMGN $ANCUF $ARG $ATCEY $ATVI $BRCD $BRK.A $BRK.B $CMCSA $COMMCigna makes deals with #Amgen, Sanofi for pricey cholesterol drugs. Read more: https://t.co/cGdzSZJBX3 $AMGNCigna makes deals with Amgen, Sanofi for pricey cholesterol drugs https://t.co/fdU3JNcgDI via @CarolineHumer $AMGN $SASY $REGNCigna makes deals with #Amgen, Sanofi for pricey cholesterol drugs. Read more: https://t.co/aTDAdFT7rw $AMGN$AMGN maturity 05/13/2016 oi CallPutRatio of 1.10 puts 2,187 &amp; calls 1,990 bearish. https://t.co/Q3AjyJ6lrZ https://t.co/u4u7xYSxiaCigna and Value Based Contracts with $SNY &amp; $AMGN Interesting to see if this model become more widely adopted https://t.co/1o6jWJ94ykRT @FiercePharma: #ICYMI yesterday: Medivation opens books to Pfizer, Amgen as bidders circle: Reuters https://t.co/VWxvulDxiJ $MDVN $PFE $‚Ä¶RT @fwpharma: US health insurer Cigna reaches value-based contracts for PCSK9 inhibitors Repatha, Praluent https://t.co/3kLplutGDe $AMGN $S‚Ä¶$AMGN - Health Insurers Push to Tie Drug Prices to Outcomes--Update https://t.co/jDJ60wSHcoRT @fwpharma: US health insurer Cigna reaches value-based contracts for PCSK9 inhibitors Repatha, Praluent https://t.co/3kLplutGDe $AMGN $S‚Ä¶#ICYMI yesterday: Medivation opens books to Pfizer, Amgen as bidders circle: Reuters https://t.co/VWxvulDxiJ $MDVN $PFE $AMGN #pharmaRT @fwpharma: US health insurer Cigna reaches value-based contracts for PCSK9 inhibitors Repatha, Praluent https://t.co/3kLplutGDe $AMGN $S‚Ä¶Cigna inks value-based contracts with Amgen and Sanofi/Regeneron for high-priced ... https://t.co/C8T1RSBtqc #premarket $CI $AMGN $SNY $REGNCigna inks value-based contracts with Amgen and Sanofi/Regeneron for high-priced ... https://t.co/eUnzXmwauD #premarket $CI $AMGN $SNY $REGNCigna inks value-based contracts with Amgen and Sanofi/Regeneron for high-priced ... https://t.co/YVYeAzM5Ou #premarket $CI $AMGN $SNY $REGNUS health insurer Cigna reaches value-based contracts for PCSK9 inhibitors Repatha, Praluent https://t.co/3kLplutGDe $AMGN $SNY $REGN$CI $AMGN $SNY/$REGN  https://t.co/KUKYf9YDQk$CI targetting discounts for PCSK9 drugs $AMGN $SNY $REGN https://t.co/vZ9Lbzy7rQPharmalot.. Pharmalittle.. Good Morning.. sunshine, coffee &amp; headlines.. https://t.co/GIr7gTjyae #pharma $AMGN $SNY $REGN $MDVN #NIH #FDA$GILD $CELG $BIIB $ALXN $AMGN https://t.co/I2gajuKKdoRT @iancassel: Some of the best performing public companies ever including $BRK $WMT $AMGN $NFLX $LUV started as microcap companies
https:/‚Ä¶RT @iancassel: Some of the best performing public companies ever including $BRK $WMT $AMGN $NFLX $LUV started as microcap companies
https:/‚Ä¶RT @iancassel: Some of the best performing public companies ever including $BRK $WMT $AMGN $NFLX $LUV started as microcap companies
https:/‚Ä¶Some of the best performing public companies ever including $BRK $WMT $AMGN $NFLX $LUV started as microcap companies
https://t.co/E8EKdJJAtr$AMGN Hall of Fame Quarterback Joe Montana and Amgen Team Up to Launch Breakaway from Heart DiseaseTM to Make
From our Stock News Alerts App$AMGN - Hall of Fame Quarterback Joe Montana and Amgen Team Up to Launch Breakaway from Heart Disease‚Ñ¢ to https://t.co/rhAtXa5n39With a yield of 2.6% Amgen is a üí∞ dividend üí∞ stock worth a look $AMGN https://t.co/QxgdO8e6l0 https://t.co/KIndGql7GdThese $ITUS Profits Are much Bigger Than $AMGNThese $ITUS Profits Are much Bigger Than $AMGNThese $ITUS Profits Are much Bigger Than $AMGN@Adaptimmune Therapeutics $ADAP

$MDT $BSX $TMO $EW $DXCM $IDXX $NVTA $AMGN $SNY $LLY $BAYRY $GILD $BIIB $CELG $REGN https://t.co/mMiqzR3mnBThese $ITUS Profits Are much Bigger Than $AMGN$AMGN:US Traders Sell Shares of Amgen, Inc. (AMGN) on Strength (AMGN) #AMGEN INC  https://t.co/AQhKhnN1R7 #NASDAQARGS % Change
See Here ---&gt; https://t.co/u9DqCmT4Zc

$ARGS $AMGN $UAL #stocksThese $ITUS Profits Are much Bigger Than $AMGN https://t.co/n3gUObajU0Amgen, Inc. $AMGN Rating Reiterated by Piper Jaffray https://t.co/ZPFbiJkhdN$AMGN - Health Insurers Push to Tie Drug Prices to Outcomes https://t.co/RVdV7fUUP5$AMGN OI for maturity 05/13/2016. 150.00 Highest put. 157.50 Highest call.  https://t.co/Q3AjyJ6lrZ https://t.co/wrgpAuHR1dAmgen, Inc. $AMGN Shares Bought by Utah Retirement Systems https://t.co/AMdwyucyIRThese $ITUS Profits Are much Bigger Than $AMGN https://t.co/WnVITyU5JFBlackRock Advisors LLC Has $608,126,000 Stake in Amgen, Inc. $AMGN https://t.co/6H1AfHzlYRRT @ChrisNMontoya: Great piece from @WFAssetMgmt. I agree w/ their assessment. Been adding to $AMGN &amp; $NVS in our dividend portfolio. https‚Ä¶PVG Asset Management Purchases Shares of 16,708 Amgen, Inc. $AMGN https://t.co/k6eCplPYxu$AAPL $AMAT $AMGN $AMTD $AMZN $ATVI Trade long or long+short positions from the #NASDAQ, up to 1500% since 2010. https://t.co/ldcTl0HsrKFollow #Nasdaq 100 traders &amp; track their tweets under one watchlist $AMGN $QCOM https://t.co/W1OB9ZciRI https://t.co/NChzaKjfKlGreat piece from @WFAssetMgmt. I agree w/ their assessment. Been adding to $AMGN &amp; $NVS in our dividend portfolio. https://t.co/GkS9v8VWbb3 Things You Need to Know About Kite Pharma's First Quarter -- $KITE $AMGN The Motley Fool https://t.co/Fs7YYkoknWGOOGL Financials
See Here ---&gt; https://t.co/T45NQFY88K

$GOOGL $AVGO $AMGN #stockmarketBreakout alert. Good for $LABU $AMGN https://t.co/NMIpCD7ep5",2016-05-11,AMGN,0
27,"@Adaptimmune Therapeutics $ADAP

$MDT $BSX $TMO $EW $DXCM $IDXX $NVTA $AMGN $SNY $LLY $BAYRY $GILD $BIIB $CELG $REGN https://t.co/LS5cm9bqrS@Adaptimmune Therapeutics $ADAP

$MDT $BSX $TMO $EW $DXCM $IDXX $NVTA $AMGN $SNY $LLY $BAYRY $GILD $BIIB $CELG $REGN https://t.co/N0Dr5FEN61$AMGN Max Pain = 155.00. Maturity = 05/13/2016. Previous close = 154.18. bullish https://t.co/GNw6we6Rbb https://t.co/TlrNxXaCZdAmgen, Inc. $AMGN Shares Sold by QS Investors LLC https://t.co/8OPIHuiESGYancopoulos @regeneron says $REGN invents 50/50 deal‚Ä¶being the company that brought drugs to market‚Ä¶brought in co-partners. $Amgn was first.Unusual Call Activity https://t.co/SxOhF6dfaC   $ALB $JACK $RL $SGYP $JWN $ENDP $MON $IYR $MDLZ $JCP $YY $MET $AMGN $KORS $M $CSCO $PRGOSome names ex dividend tomorrow. $AMGN $SPG and $WYNNBiotechs Entering Pocket of Turbulence. https://t.co/bwiuA59c65
$nvax $gwph $acad $cpxx $srpt $rare $abbv $lgnd $amgn $pfe #biotechs #stocksRT @KamakuraCo: Kamakura best value bond trades have been posted with comments on $GPS $MS $C $BAC $AMGN https://t.co/3JDTla2Ihs https://t.‚Ä¶@EMDSerono's Specialty Digest in @FiercePharma cover of @Cigna's deal #PCSK9inhibitors $AMGN https://t.co/9YwXoN0K8Q https://t.co/E28qleYiwECigna signs value-based pricing deals with $AMGN, $SNY for PCSK9 drugs https://t.co/XNOsx7FY42 $REGN$AMGN ticks the boxes as a dream üí∞ dividend üí∞ stock with 2.6% yield https://t.co/QxgdO8e6l0 https://t.co/TY1ukggQrDBest outperformers ranked 55-60 $SYX $AMGN $IMOS $USNA $CNCKamakura best value bond trades have been posted with comments on $GPS $MS $C $BAC $AMGN https://t.co/3JDTla2Ihs https://t.co/HmBkkVyPMFAMGN Top news - May 12th, 2016 $AMGN https://t.co/A9riMGyThC$AMGN maturity 05/13/2016 oi CallPutRatio of 1.13 puts 2,408 &amp; calls 2,136 bearish. https://t.co/Q3AjyJ6lrZ https://t.co/E013A2WXKvAmgen, Inc. $AMGN Stock Rating Reaffirmed by Piper Jaffray https://t.co/mvanhSVASbAmgen, Inc. $AMGN Upgraded at Vetr Inc. https://t.co/AukCI4qD3nAmgen, Inc. $AMGN Stock Rating Reaffirmed by Piper Jaffray https://t.co/peqbDa3L63Amgen, Inc. $AMGN Stock Rating Reaffirmed by Piper Jaffray https://t.co/5qe3AmHscK8 Best Dividend Stock Bets For 2016 - https://t.co/vesHUE1oHd - $AMGN $HD $NLSN $WEC $CMCSA $JPM $MSFT $BAMedivation $MDVN said to sign non-disclosure with Amgen $AMGN and Pfizer $PFE - https://t.co/TJpAGc6VlR @IntegrationSucc @Medium#Amgen, Regeneron Pharmaceuticals May See Higher PCSK9 Sales Going Forward. Read more: https://t.co/QEJqDptGfI $AMGNRT @OptionsHawk: $AMGN at BAML Conf. yesterday, seems interested, but not in a rush for M&amp;A https://t.co/JhQR5NVssh$AMGN at BAML Conf. yesterday, seems interested, but not in a rush for M&amp;A https://t.co/JhQR5NVsshRT @brendasandburg: #Biosimilar blocking strategies: $JNJ gets day in court re Remicade, $AMGN seeks FDA docs from Hospira/ $PFE https://t.‚Ä¶$AAPL transition to a #SAS #SERVICES #revenue @jimcramer thesis Hold don't trade #APPLE 
Replace #FANG with New #Aok $AAPLE $AMZN $AMGNVetr users have upgraded Amgen Inc. to a STRONG BUY Rating (4.5 stars), giving $AMGN a target price of $175.53 https://t.co/sgyPwK93LkAllstate Corp Invests $4,459,000 in Amgen, Inc. $AMGN https://t.co/awZEGDs3CIOK, I Admit It: There's Life Beyond The Dividend Growth 50! https://t.co/LkLOJ19UFH $ABBV $AMGN $AVA $BA $COST $CVS $D $DUK $HCN $HON $KHCOK, I Admit It: There's Life Beyond The Dividend Growth 50! https://t.co/fFIiwnVJus $ABBV $AMGN $AVA $BA $COST $CVS $D $DUK $HCN $HON $KHC#Cigna Reaches Pay-for-Performance Deals for #PCSK9 Inhibitors $SNY $REGN $AMGN https://t.co/VNywZA9ZDl via @ajmc_journal$AMGN high open interest range is 152.50 to 157.50 for option expiration 05/13/2016.  https://t.co/Q3AjyJ6lrZ https://t.co/jDvG89eJ4UApple Vs. China In New Bidding War https://t.co/Oj6Qi2w0Rm $AIQUY $ALR $AMGN $ANCUF $ARG $ATCEY $ATVI $BRCD $BRK.A $BRK.B $CMCSA $COMMRT @iviewmarkets: Stocks with greatest increase/Decrease in RSI of the Strongest 20 $SPY names $CMG $AGN $AMGN $ADP $MRK $IFF $LLY https://‚Ä¶RT @iviewmarkets: Stocks with greatest increase/Decrease in RSI of the Strongest 20 $SPY names $CMG $AGN $AMGN $ADP $MRK $IFF $LLY https://‚Ä¶RT @chproperties: $BLOX $PBMD $AMGN $ARRY $BTSE $AGN BIO Movers in PM will move the needle for $IBB $XBI $LABU / rest of bio&amp;#39;s https://‚Ä¶$BLOX $PBMD $AMGN $ARRY $BTSE $AGN BIO Movers in PM will move the needle for $IBB $XBI $LABU / rest of bio&amp;#39;s https://t.co/szyMuIwnmTRT @iviewmarkets: Stocks with greatest increase/Decrease in RSI of the Strongest 20 $SPY names $CMG $AGN $AMGN $ADP $MRK $IFF $LLY https://‚Ä¶Tomorrow's ex-dividend dates $AMGN $SPG $BAMXF $CHU $ADDDF and 12 more https://t.co/8K76LaiyrB $$RT @iviewmarkets: Stocks with greatest increase/Decrease in RSI of the Strongest 20 $SPY names $CMG $AGN $AMGN $ADP $MRK $IFF $LLY https://‚Ä¶$AAPL $AMAT $AMGN $AMTD $AMZN $ATVI Trade long or long+short positions from the #NASDAQ, up to 1500% since 2010. https://t.co/ldcTl0HsrKRT @iviewmarkets: Stocks with greatest increase/Decrease in RSI of the Strongest 20 $SPY names $CMG $AGN $AMGN $ADP $MRK $IFF $LLY https://‚Ä¶Stocks with greatest increase/Decrease in RSI of the Strongest 20 $SPY names $CMG $AGN $AMGN $ADP $MRK $IFF $LLY https://t.co/ZiWnadi9oh2/ Antibody Drug Conjugates market includes $RHHBY $PFE $ABBV $AZN $LLY $NVS $SNY $SGEN $IMGN $CLDX $CTMX $IMMU $AMGN $HALO $PGNXOK, I Admit It: There's Life Beyond The Dividend Growth 50! https://t.co/LGgxCvrcri $ABBV $AMGN $AVA $BA $COST $CVS $D $DUK $HCN $HON $KHCBio-tech stocks sold off today.  Expect a reversal tomorrow going to next week.  $IBB, $GILD, $AMGN $PFE, $MRKRT SeekingAlpha: OK, I Admit It: There's Life Beyond The Dividend Growth 50! https://t.co/uf5maAmEX1 $ABBV $AMGN $AVA $BA $COST $CVS $D $D‚Ä¶RT @FiercePharma: Cigna inks results-based deals on pricey Amgen, Sanofi PCSK9 meds https://t.co/qRdyfYMR7u $AMGN $SNY #pharma by @TracySta‚Ä¶OK, I Admit It: There's Life Beyond The Dividend Growth 50! https://t.co/F830waFOyD $ABBV $AMGN $AVA $BA $COST $CVS $D $DUK $HCN $HON $KHCOK, I Admit It: There's Life Beyond The Dividend Growth 50! https://t.co/xTnUDLf46E $ABBV $AMGN $AVA $BA $COST $CVS $D $DUK $HCN $HON $KHCOK, I Admit It: There's Life Beyond The Dividend Growth 50! https://t.co/XoQibUmNpg $ABBV $AMGN $AVA $BA $COST $CVS $D $DUK $HCN $HON $KHCRT @fwpharma: US health insurer Cigna reaches value-based contracts for PCSK9 inhibitors Repatha, Praluent https://t.co/3kLplutGDe $AMGN $S‚Ä¶Interview with Connor Bruggeman SchoolTrader Extraordinaire!: https://t.co/DgrNThhkJM $NFLX $HIMX $INO $AMGN $GOOGLMillennium Management LLC Sells 80,943 Shares of Amgen, Inc. $AMGN https://t.co/DXuSsBJEgsGeneric Stocks Down; Good Buys? #Teva #generics #mAbs #biosimilars https://t.co/fleUIj3wIQ $ABC $AGN $AMGN $BIIB $ENDP $MRK $MYL $PRGO $TEVA$AMGN - Theranos Executive to Exit Amid Probes -- WSJ https://t.co/U5YSyfnV5x$AMGN Max Pain = 155.00. Maturity = 05/13/2016. Previous close = 157.24. bearish https://t.co/GNw6we6Rbb https://t.co/LrkejOJLZd$AMGN - Theranos Executive Sunny Balwani to Depart Amid Regulatory Probes https://t.co/bhp4SfhC4qCounsel Portfolio Services Inc. Has $2,670,000 Position in Amgen, Inc. $AMGN https://t.co/oPihqkvZxv$AMGN - Theranos Executive Sunny Balwani to Depart Amid Regulatory Probes https://t.co/3XQYnSvynX$AMGN - Theranos Executive Sunny Balwani to Depart https://t.co/8KLnTNuL1t$AMGN - Theranos Executive Sunny Balwani to Depart Amid Regulatory Probes https://t.co/bZFwUvUnAN$AAPL $AMAT $AMGN $AMTD $AMZN $ADI Trade long or long+short positions from the #NASDAQ, up to 1500% since 2010. https://t.co/ldcTl0HsrK$AMGN maturity 05/13/2016 oi CallPutRatio of 1.10 puts 2,187 &amp; calls 1,990 bearish. https://t.co/Q3AjyJ6lrZ https://t.co/Um3JYSf62t",2016-05-12,AMGN,0
28,"RT @pharmalot: Drug makers fuming at 'overpriced' values placed on their myeloma drugs.. read why here.. https://t.co/vyV3F03cMq #pharma $A‚Ä¶$IBB $CELG $GILD $AMGN $BIIB https://t.co/Hn58lZIBiC$AMGN:US Amgen, Inc. (AMGN) Receives Buy Rating from Piper Jaffray #AMGEN INC  https://t.co/jL8DB2shmT #NASDAQPacer Advisors Inc. Purchases New Position in Amgen, Inc. $AMGN https://t.co/cppaEsAGtu$AMGN:US Amgen, Inc. (AMGN) Receives Buy Rating from Piper Jaffray #AMGEN INC  https://t.co/yO4MbUk4sx #SP500Pacer Advisors Inc. Purchases New Position in Amgen, Inc. $AMGN https://t.co/iKlCjZEw26RT @insidermonkey: Glaxis Capital All-In on These Two Stocks After Slashing Portfolio
$AMGN, $DAL, $AMZN, $FB, $GOOGL
https://t.co/jl1JCbXy‚Ä¶Glaxis Capital All-In on These Two Stocks After Slashing Portfolio
$AMGN, $DAL, $AMZN, $FB, $GOOGL
https://t.co/jl1JCbXymiGlaxis Capital All-In on These Two Stocks After Slashing Portfolio
$AMGN, $DAL, $AMZN, $FB, $GOOGL
https://t.co/9FqXqgLphWApple Vs. China In New Bidding War https://t.co/Oj6Qi2w0Rm $AIQUY $ALR $AMGN $ANCUF $ARG $ATCEY $ATVI $BRCD $BRK.A $BRK.B $CMCSA $COMMRT @pharmalot: Drug makers fuming at 'overpriced' values placed on their myeloma drugs.. read why here.. https://t.co/vyV3F03cMq #pharma $A‚Ä¶CMLviz: RT Oldie_Records: $IBB $GILD $CELG $AMGN $BIIB $REGN $KITE
Get #Bullish--#BioTech #Stocks?
#StockMarket #T‚Ä¶ https://t.co/P6oQgOZJjTRT @Oldie_Records: $IBB $GILD $CELG $AMGN $BIIB $REGN $KITE
Get #Bullish--#BioTech #Stocks?
#StockMarket #Trading #SwingTrade #Daytrade htt‚Ä¶Ghost Tree Capital LLC Has $12,175,000 Position in Amgen, Inc. $AMGN https://t.co/CzHSRG8SJcGhost Tree Capital LLC Has $12,175,000 Position in Amgen, Inc. $AMGN https://t.co/bi5y4K1MrjDrug makers fuming at 'overpriced' values placed on their myeloma drugs.. read why here.. https://t.co/vyV3F03cMq #pharma $AMGN $NVS $BMYAMGN Top news - May 16th, 2016 $AMGN https://t.co/NlhN0OyUP1#Technical scans $CMI $DRIP  $CERN $ADBE $ATVI $AMGN $VRX $UWTI $NFLX https://t.co/3mOWS1Cjfx #patterns #doji #oversold #breakouts #trading$AMGN Max Pain is 155.00 for maturity 05/20/2016. Price = 152.35. bullish https://t.co/umec75FmpQ https://t.co/zKBXmSXz9MRT @KamakuraCo: #Mexico $AMGN Pemex and Amgen Inc. bond issues rank 1 and 2 on the US fixed rate corporate bond rankings for Friday. https:‚Ä¶AMGN Message Board Posts
See Here ---&gt; https://t.co/86hbHSFSYF

$AMGN $PX $TBRA #stockmarket@Adaptimmune Therapeutics $ADAP

$MDT $BSX $TMO $EW $DXCM $IDXX $NVTA $AMGN $SNY $LLY $BAYRY $GILD $BIIB $REGN $CELG https://t.co/3IUcVhGIx2RT @BioWorld: $AMGN's James Cai: Whether China‚Äôs innovation comes from academic labs, MNCs, local pharma, start-ups, need rich soil to grow‚Ä¶#Mexico $AMGN Pemex and Amgen Inc. bond issues rank 1 and 2 on the US fixed rate corporate bond rankings for Friday. https://t.co/SHl96nweO1#Amgen signs licensing deal for Penn gene therapy technology. Read more: https://t.co/zyolEFhmH6 $AMGNRT @BioWorld: $AMGN's James Cai: Whether China‚Äôs innovation comes from academic labs, MNCs, local pharma, start-ups, need rich soil to grow‚Ä¶$AMGN's James Cai: Whether China‚Äôs innovation comes from academic labs, MNCs, local pharma, start-ups, need rich soil to grow #DIAChinaDr Burry likes $AMGN https://t.co/trx8JLH1hf A former 100 bagger cc:@chriswmayer#Amgen signs licensing deal for Penn gene therapy technology. Read more: https://t.co/vHfipCLIL6 $AMGN$AMGN:US Amgen, Inc. (AMGN) Receives Buy Rating from Piper Jaffray #AMGEN INC  https://t.co/eatPweAOGY #NASDAQBiotech Daily Digest: Array In Spotlight; Pain Continues; Medivation Contest Heats Up https://t.co/nOITtSnakh $AMGN $ARRY $AZN $CI $MDVNSAlphaTrending: Biotech Daily Digest: Array In Spotlight; Pain Continues; Medivation Contest Heats Up https://t.co/M21VN0Tk0Q $AMGN $ARRY ‚Ä¶RT SeekingAlpha: Tracking Dan Loeb's Third Point Portfolio - Q1 2016 Update https://t.co/QBvZT2YOIy $AGN $AMGN $APIC $AVGO $AXTA $BAX $BID‚Ä¶RT SeekingAlpha: Biotech Daily Digest: Array In Spotlight; Pain Continues; Medivation Contest Heats Up https://t.co/lT02jzryiP $AMGN $ARRY‚Ä¶SA_QuickIdeas: Biotech Daily Digest: Array In Spotlight; Pain Continues; Medivation Contest Heats Up https://t.co/ldJwFMs9US $AMGN $ARRY $‚Ä¶SeekingAlpha: Tracking Dan Loeb's Third Point Portfolio - Q1 2016 Update https://t.co/94M2jdgFdH $AGN $AMGN $APIC $AVGO $AXTA $BAX $BID $B‚Ä¶SeekingAlpha: Biotech Daily Digest: Array In Spotlight; Pain Continues; Medivation Contest Heats Up https://t.co/3B3a9vjh72 $AMGN $ARRY $A‚Ä¶$AMGN:US Amgen, Inc. (AMGN) Receives Buy Rating from Piper Jaffray #AMGEN INC  https://t.co/H2WYBszpCk #SP500Amgen Inc Valuation - February 2016 $AMGN https://t.co/MlQB8aRN2kBiotech Daily Digest: Array In Spotlight; Pain Continues; Medivation Contest Heats Up https://t.co/QvCJLX7Hmn $AMGN $ARRY $AZN $CI $MDVNTracking Dan Loeb's Third Point Portfolio - Q1 2016 Update https://t.co/IzM9xgScBB $AGN $AMGN $APIC $AVGO $AXTA $BAX $BID $BUD $BXLT $CBBiotech Daily Digest: Array In Spotlight; Pain Continues; Medivation Contest Heats Up https://t.co/dxonHT6t8w $AMGN $ARRY $AZN $CI $MDVNWill $AMGN be $MDVN‚Äôs white knight? Most of their growth has come from pulling the price lever, and they are in need of revenue.BAML $AMGN Therapeutic areas of focus: Oncology/Hematology, Cardio, Inflammation, Bone Health, Neuroscience, Nephrology.These $ITUS Profits Are much Bigger Than $AMGN$AMGN maturity 05/20/2016 oi CallPutRatio of 0.91 puts 16,432 &amp; calls 18,139 bullish. https://t.co/7PJX1ctrjX https://t.co/0yXONWlsUDRT @OpenOutcrier: Dan Loeb's 3rd Point 13F -Highlights 
Closed: $ACE $AXTA $EBAY $LBTYK $MS $CWEI 
Lowered: $AMGN $SJM 
Holds: $BAX $CHUN Company Info
See Here ---&gt; https://t.co/HYqlxcvmim

$HUN $LOGM $AMGN #pennystocks$AAPL $AMAT $AMGN $AMTD $AMZN $ADI Trade long or long+short positions from the #NASDAQ, up to 1500% since 2010. https://t.co/ldcTl0HsrKRT @OpenOutcrier: Dan Loeb's 3rd Point 13F -Highlights 
Closed: $ACE $AXTA $EBAY $LBTYK $MS $CWEI 
Lowered: $AMGN $SJM 
Holds: $BAX $CDan Loeb's 3rd Point 13F -Highlights 
Closed: $ACE $AXTA $EBAY $LBTYK $MS $CWEI 
Lowered: $AMGN $SJM 
Holds: $BAX $C@biotechnova I think $AZN; emboldened by Tagrisso; how's $AMGN Kyprolis doing (might be feeling overpaid a bit in bio bubble ??)@pbmech I personally don't think it would've been a good play for $PFE. Much better for an $AMGN or $AZN$AMGN:US Amgen, Inc. (AMGN) Receives Buy Rating from Piper Jaffray #AMGEN INC  https://t.co/ND5zNA0Jwt #SP500$IBB $GILD $CELG $AMGN $BIIB $REGN $KITE
Get #Bullish--#BioTech #Stocks?
#StockMarket #Trading #SwingTrade #Daytrade https://t.co/9XMROfJix4$AMGN:US Amgen, Inc. (AMGN) Receives Buy Rating from Piper Jaffray #AMGEN INC  https://t.co/p8sTi6zzfb #NASDAQ$AMGN:US Amgen, Inc. (AMGN) Receives Buy Rating from Piper Jaffray #AMGEN INC  https://t.co/qXZzK7lsAx #SP500$GILD looses title to $AMGN https://t.co/zmSAigPGOx$AMGN OI for maturity 05/20/2016. 150.00 Highest put. 160.00 Highest call.  https://t.co/7PJX1ctrjX https://t.co/u8355teW5aRT @StockWebTrading: $AAPL $AMAT $AMGN $AMTD $AMZN $ATVI Trade long or long+short positions from the #NASDAQ, up to 1500% since 2010. https‚Ä¶$AMGN - Amgen, Inc. #AMGN Receives Buy Rating from Piper Jaffray https://t.co/WUNTplUjw9RT @BursatilBiotech: $GILD GS9883 que lindo, y pensar q estuvieron x venderlo a $AMGN 
Mira @arielsbdar https://t.co/RKj3W9R4qk$AAPL $AMAT $AMGN $AMTD $AMZN $ATVI Trade long or long+short positions from the #NASDAQ, up to 1500% since 2010. https://t.co/ldcTl0HsrK",2016-05-16,AMGN,0
29,"RT @TradeWithSuper: Benzinga: Has A Biotech Recovery Started Yet? $ALXN $AMGN $BIIB $GILD $CELG $REGN https://t.co/c4tS24SE4QRT @Benzinga: Has A Biotech Recovery Started Yet? $ALXN $AMGN $BIIB $GILD $CELG $REGN https://t.co/KshODCHP0nBenzinga: Has A Biotech Recovery Started Yet? $ALXN $AMGN $BIIB $GILD $CELG $REGN https://t.co/c4tS24SE4QHas A Biotech Recovery Started Yet? $ALXN $AMGN $BIIB $GILD $CELG $REGN https://t.co/KshODCHP0nRT @Briefingcom: #Technical scans $CMI $DRIP $CERN $ADBE $ATVI $AMGN $VRX $UWTI $NFLX https://t.co/3mOWS1Cjfx #patterns #doji #oversold #br‚Ä¶#Technical scans $CMI $DRIP $CERN $ADBE $ATVI $AMGN $VRX $UWTI $NFLX https://t.co/3mOWS1Cjfx #patterns #doji #oversold #breakouts #tradingRT @tgtxdough: IMHO best slide I tweet all weekend Free cash flow for the larger cap biotechs 2014-2020E $AMGN $CELG $GILD  M&amp;A ?? https://‚Ä¶Parabolic SAR Sell https://t.co/j2wsWoXPFJ $AZO $LMT $ESS $SPY $MHK $MMM $IJK $STZ $FRT $AMGN $SJM $IEI $IDU $RHS $DST $VMC $GBF$AMGN sum put oi=16,443 sum call oi=18,218 CallPutRatio=0.90 expiration 05/20/2016 bullish. https://t.co/7PJX1ctrjX https://t.co/mo7ZbMdLRr$AMGN:US Wealthfront Inc. Has $2,255,000 Stake in Amgen, Inc. (AMGN) #AMGEN INC  https://t.co/UzExw0sQPx #SP500RT @TalkMarkets: ?2 Undervalued Stocks with Safe and Growing #Dividends $MRK $PFE Also $AGN $ANAC $MDVN $AMGN $GILD $ABBV https://t.co/3efj‚Ä¶?2 Undervalued Stocks with Safe and Growing #Dividends $MRK $PFE Also $AGN $ANAC $MDVN $AMGN $GILD $ABBV https://t.co/3efjKHeDGQRT @pharmalot: Drug makers fuming at 'overpriced' values placed on their myeloma drugs.. read why here.. https://t.co/vyV3F03cMq #pharma $A‚Ä¶Amgen, Inc. $AMGN Earns ‚ÄúHold‚Äù Rating from Robert W. Baird https://t.co/OB8OmSlz1LAmgen, Inc. $AMGN Earns ‚ÄúHold‚Äù Rating from Robert W. Baird https://t.co/KQy7j0U9T8Amgen, Inc. $AMGN Earns ‚ÄúHold‚Äù Rating from Robert W. Baird https://t.co/hfuVj2eVjw$AMGN Amgen's Breakaway from Cancer¬Æ Public Service Announcement Delivers Message That Education, Resources A
From our Stock News Alerts AppBig #BlockTrades in $AMGN at closing tick 1/2 million shares moving up @jimcramerGreat day again- all traders but 1 were green. $TWTR $THC $NFLX &amp;  2- daily dollar winners $AMGN $UVXY Simply follow the trades &amp; make moneyApple Vs. China In New Bidding War https://t.co/Oj6Qi2w0Rm $AIQUY $ALR $AMGN $ANCUF $ARG $ATCEY $ATVI $BRCD $BRK.A $BRK.B $CMCSA $COMMAmgen Inc Reiterated Rating by Robert W. Baird (Ranked 19th) to Hold $AMGN #AMGN https://t.co/bqjkWr2ARA@Robostocks123 ETF effect $AMGN best long to hold on to #DividendWho sells $amgn because loeb sold end of March!  Trimming $endp $vrx trades and adding $amgn here$AMGN OI for maturity 05/20/2016. 150.00 Highest put. 160.00 Highest call.  https://t.co/7PJX1ctrjX https://t.co/jnKZ4VYHgAAMGN Top news - May 17th, 2016 $AMGN https://t.co/b1lXvhXkeVRT @tgtxdough: IMHO best slide I tweet all weekend Free cash flow for the larger cap biotechs 2014-2020E $AMGN $CELG $GILD  M&amp;A ?? https://‚Ä¶These $ITUS Profits Are much Bigger Than $AMGNAmgen hits a 1 month low https://t.co/TVSs33cCO3 $AMGN #Amgen https://t.co/Us7dcN2f8e$AMGN: ApproachingKeyLevel- (150.00), 0NewLo, allTFs-, ch:-2.1%, 1MoLo-, bigFlt:750M, 16DyChgHi:-9%; TLM:1.0; ILM:1.1, 1MoLo-RT @csresearch: Estimated impact of US drug price rises on 2015 net income: $ABBV, $AMGN, $LLY, $SHPG have benefited the most https://t.co/‚Ä¶Lots of choppy weak action today as we continue to look for lower prices. Short $AMGN now &amp; $TSLA from yesterday. https://t.co/oAt5NNRFB5Mittelfristiges Signal! $AMGN: Ein fallendes Dreieck wurde bei 151.149 USD nach unten durchbrochen:  https://t.co/MbHrKRhCQhRT @csresearch: Estimated impact of US drug price rises on 2015 net income: $ABBV, $AMGN, $LLY, $SHPG have benefited the most https://t.co/‚Ä¶RT @csresearch: Estimated impact of US drug price rises on 2015 net income: $ABBV, $AMGN, $LLY, $SHPG have benefited the most https://t.co/‚Ä¶RT @IBD_Areeves: Biosimilar Humira inches closer as the patent board accepts Coherus' review request: https://t.co/diuUg1wXP2 $ABBV $CHRS $‚Ä¶$ABBV $AMGN $IBB Brutal Sentiment On Biotech Is Unwarranted https://t.co/jSNkiROiVQ https://t.co/wXjswtzBQtRT @csresearch: Estimated impact of US drug price rises on 2015 net income: $ABBV, $AMGN, $LLY, $SHPG have benefited the most https://t.co/‚Ä¶RT @csresearch: Estimated impact of US drug price rises on 2015 net income: $ABBV, $AMGN, $LLY, $SHPG have benefited the most https://t.co/‚Ä¶Estimated impact of US drug price rises on 2015 net income: $ABBV, $AMGN, $LLY, $SHPG have benefited the most https://t.co/kmYUV01FGMBiosimilar Humira inches closer as the patent board accepts Coherus' review request: https://t.co/diuUg1wXP2 $ABBV $CHRS $AMGNWhy AbbVie is Getting Hammered https://t.co/FRIdSSCunc via @barronsonline $ABBV $AMGN $CHRS[Barron's] Why AbbVie is getting hammered. https://t.co/IPNVaVFqyf
$ABBV -4.12% at 59.88 $AMGN -0.97% $CHRS +15.09% #biotech #pharma #stocks.@LukeFenek $ABBV has already knocked down several $AMGN challenges who have larger arny of lawyers than $CHRS$AMGN Max Pain is 155.00 for maturity 05/20/2016. Price = 153.27. bullish https://t.co/umec75FmpQ https://t.co/WEt6EljY9W@SashaDamouni rather strange dnt u think $AMGN request wasn't upheld on THE SAME GROUNDS? $ABBV will be fine on this ALONE.@QuoththeRavenSA would be rather strange to give in to the $CHRS patent request &amp; not $AMGN request...think both are invalid..and $ABBV okTracking Dan Loeb's Third Point Portfolio - Q1 2016 Update https://t.co/BEBGK4JEXA $AGN $AMGN $APIC $AVGO $AXTA $BAX $BID $BUD $BXLT $CBRT @BioStocks: Hedge Funds Abandon Ex-Darling $VRX and Other 13F Highlights https://t.co/CwQqykNMnu $AMGN$AMGN sum put oi=16,443 sum call oi=18,218 CallPutRatio=0.90 expiration 05/20/2016 bullish. https://t.co/7PJX1ctrjX https://t.co/1oepTxobIcRT @BioStocks: Hedge Funds Abandon Ex-Darling $VRX and Other 13F Highlights https://t.co/CwQqykNMnu $AMGNLLY Volume
See Here ---&gt; https://t.co/5s66ckRBBv

$LLY $AMGN $WSO #shareEMR Summary
See Here ---&gt; https://t.co/KUCSJ5dRzO

$EMR $CTB $AMGN #tradeideasRT @BioStocks: Hedge Funds Abandon Ex-Darling $VRX and Other 13F Highlights https://t.co/CwQqykNMnu $AMGNHedge Funds Abandon Ex-Darling $VRX and Other 13F Highlights https://t.co/CwQqykNMnu $AMGNAMGN Shares
See Here ---&gt; https://t.co/MTqpRqVn7x

$AMGN $SBGL $AVP #stockRT @biotech_forum: Biotech Daily Digest: Array In Spotlight; Pain Continues; Medivation Contest Heats Up https://t.co/nOITtSnakh $AMGN $ARR‚Ä¶Vident Investment Advisory LLC Increases Position in Amgen, Inc. $AMGN https://t.co/7V42o0BsYv$AAPL $AMAT $AMGN $AMTD $AMZN $ATVI Trade long or long+short positions from the #NASDAQ, up to 1500% since 2010. https://t.co/ldcTl0HsrK#Amgen sues Sandoz over Neulasta biosimilar. Read more: https://t.co/VpZSIMfiir $AMGNTK Current Price
See Here ---&gt; https://t.co/ECOnUzeSUS

$TK $UNG $AMGN #finance$AMGN high open interest range is 150.00 to 160.00 for option expiration 05/20/2016.  https://t.co/7PJX1ctrjX https://t.co/0iLiTV9RF4Covington Capital Management Purchases 1,450 Shares of Amgen, Inc. $AMGN https://t.co/Q206WvKwyKRT @insidermonkey: Glaxis Capital All-In on These Two Stocks After Slashing Portfolio
$AMGN, $DAL, $AMZN, $FB, $GOOGL
https://t.co/jl1JCbXy‚Ä¶RT @pharmalot: Drug makers fuming at 'overpriced' values placed on their myeloma drugs.. read why here.. https://t.co/vyV3F03cMq #pharma $A‚Ä¶Wealthfront Inc. Has $2,255,000 Stake in Amgen, Inc. $AMGN https://t.co/XuvkXR9xTaFNHC Prev Close
See Here ---&gt; https://t.co/tnS7eFhFHs

$FNHC $YY $AMGN #investing$AMGN Amgen is a 5 star üí∞ dividend üí∞ stock with a 2.6% yield: https://t.co/QxgdO8e6l0 https://t.co/msuTD5og3CRT @WarriorNewsFeed: $IBB $CELG $GILD $AMGN $BIIB https://t.co/Hn58lZIBiC",2016-05-17,AMGN,1
30,"RT @AndyBiotech: #ASCO16 $AMGN T-Vec + $MRK Keytruda combo in #Melanoma

14% CR, 48% confirmed ORR
https://t.co/eJPkfQq8U1RT @jonathanrockoff: $AMGN researchers discover genetic variant associated w/ lower heart disease risk, exploring agents https://t.co/m0g3O‚Ä¶RT @kyleserikawa: Wow. @decodegenetics: the gift that keeps on giving to $AMGN #genetics #genomics #drugdevelopment #innovation https://t.c‚Ä¶Wow. @decodegenetics: the gift that keeps on giving to $AMGN #genetics #genomics #drugdevelopment #innovation https://t.co/252lKv5U0u$AMGN: Amgen sub announces discovery of a 'rare' variation in the sequence of the human genome https://t.co/9qmKM07AodRT @AndyBiotech: #ASCO16 $AMGN T-Vec + $MRK Keytruda combo in #Melanoma

14% CR, 48% confirmed ORR
https://t.co/eJPkfQq8U1$AMGN OI for maturity 05/20/2016. 150.00 Highest put. 160.00 Highest call.  https://t.co/7PJX1ctrjX https://t.co/L2CJh4OoyxRT @AndyBiotech: #ASCO16 $AMGN T-Vec + $MRK Keytruda combo in #Melanoma

14% CR, 48% confirmed ORR
https://t.co/eJPkfQq8U1#ASCO16 $AMGN T-Vec + $MRK Keytruda combo in #Melanoma

14% CR, 48% confirmed ORR
https://t.co/eJPkfQq8U1@stanradomski $amgn - watch this video on NAV 1.7  https://t.co/iDoPgM7YINRT @jonathanrockoff: $AMGN researchers discover genetic variant associated w/ lower heart disease risk, exploring agents https://t.co/m0g3O‚Ä¶$AMGN Researchers Find Heart Attack Gene

https://t.co/hrM3jf4d50

https://t.co/MQWdXcRUBjRT @jonathanrockoff: $AMGN researchers discover genetic variant associated w/ lower heart disease risk, exploring agents https://t.co/m0g3O‚Ä¶RT @jonathanrockoff: $AMGN researchers discover genetic variant associated w/ lower heart disease risk, exploring agents https://t.co/m0g3O‚Ä¶$AMGN researchers discover genetic variant associated w/ lower heart disease risk, exploring agents https://t.co/m0g3Oelovf w/ @ronwinslow4 Good Bets For Value &amp; Yield In Biotech &amp; Pharma - Bret Jensen | Seeking Alpha https://t.co/JFa79BOaz6 $ABBV $AMGN $MRK $PFE$AMGN Amgen Data To Be Presented At ASCO 2016 Demonstrates More Insights Into Treatment Options For Patients
From our Stock News Alerts AppCommented on: ""4 Good Bets For Value &amp; Yield In Biotech &amp; Pharma"" https://t.co/NcPoY93He9 $ABBV $AMGN $MRK $PFEInterview with @bret_jensen - Biotechs: Catalysts, Approvals and Takeovers https://t.co/c2Ux4X26KC $MDVN $SNY $AZN $MRK $AMGNHas A #Biotech Recovery Started Yet? $ALXN $AMGN $BIIB $GILD$CELG $REGN  https://t.co/RmLjOqsBNY via @benzinga #stocksRT @MarketCurrents: MacroGenics inks collaboration with Janssen to develop DART-based cancer med; shares up 17% https://t.co/xtrRNNlorN $MG‚Ä¶MacroGenics inks collaboration with Janssen to develop DART-based cancer med; shares up 17% https://t.co/jaOGvfwxhq $MGNX $JNJ $AMGNMacroGenics inks collaboration with Janssen to develop DART-based cancer med; shares up 17% https://t.co/xgQ7mivqjy $MGNX $JNJ $AMGNMacroGenics inks collaboration with Janssen to develop DART-based cancer med; shares up 17% https://t.co/0NbjjjSH7o $MGNX $JNJ $AMGNMacroGenics inks collaboration with Janssen to develop DART-based cancer med; shares up 17% https://t.co/xtrRNNlorN $MGNX $JNJ $AMGN@Adaptimmune Therapeutics $ADAP

$MDT $BSX $TMO $EW $DXCM $IDXX $NVTA $AMGN $SNY $LLY $BAYRY $GILD $BIIB $CELG $REGN https://t.co/m83pkEcmYW$AMGN Max Pain is 155.00 for maturity 05/20/2016. Price = 150.11. bullish https://t.co/umec75FmpQ https://t.co/Op4fxehr95RBC Capital Reiterates ‚ÄúBuy‚Äù Rating for Amgen, Inc. $AMGN https://t.co/qrzvjp0rOpRBC Capital Reiterates ‚ÄúBuy‚Äù Rating for Amgen, Inc. $AMGN https://t.co/GAeix3V9ueRBC Capital Reiterates ‚ÄúBuy‚Äù Rating for Amgen, Inc. $AMGN https://t.co/LjdR5twOqZRBC Capital Reiterates ‚ÄúBuy‚Äù Rating for Amgen, Inc. $AMGN https://t.co/0fTfuDLSHlDividend Growth Portfolios MUST Have 45 (And Only 45) Positions! https://t.co/9hfm0fw9fY $AAPL $ABBV $ACN $ADP $AMGN $AMZN $AVA $BA $BBLPVH Ex-Div Date
See Here ---&gt; https://t.co/zYqSJu6yjw

$PVH $AMGN $ES #investingAMGN Top news - May 18th, 2016 $AMGN https://t.co/S1GrMO0bfBAmgen Inc Reiterated Rating by RBC Capital Mkts (Ranked 56th) to Buy $AMGN #AMGN https://t.co/bqjkWr2ARAAmgen's buy rating reiterated at RBC Capital. https://t.co/oiMZo0GwzZ $AMGN #AMGNAmgen's buy rating reiterated at RBC Capital. https://t.co/PEnRcQEzpl $AMGN #AMGN#Amgen's Breakaway from Cancer Public Service Announcement Delivers Message That Education,... Read more: https://t.co/tKWsuj1mwx $AMGN#Technical scans $CMI $DRIP  $CERN $ADBE $ATVI $AMGN $VRX $UWTI $NFLX https://t.co/3mOWS1Cjfx #patterns #doji #oversold #breakouts #trading$AMGN maturity 05/20/2016 oi CallPutRatio of 0.89 puts 16,418 &amp; calls 18,536 bullish. https://t.co/7PJX1ctrjX https://t.co/jeij7HcBDjHas A Biotech Recovery Started Yet? $ALXN $AMGN $BIIB https://t.co/Ypogpoipzq via @benzinga@akceatx Conclusions $AMGN study
In older high-risk adults, increased Lp(a) levels were assoc with higher CVD risk,especially in those $IONSDividend Growth Portfolios MUST Have 45 (And Only 45) Positions! https://t.co/eMipZ5iFms $AAPL #APPLE $ABBV $ACN $ADP $AMGN $AMZN $AVA $BATop 25 drugs in 2015 1. $ABBV 2. $GILD 3. $AMGN https://t.co/DnV9uuW55rSeekingAlpha: Dividend Growth Portfolios MUST Have 45 (And Only 45) Positions! https://t.co/GwDenhvZAN $AAPL #APPLE $ABBV $ACN $ADP $AMGN ‚Ä¶Dividend Growth Portfolios MUST Have 45 (And Only 45) Positions! https://t.co/hBpq2I2JIL $AAPL #APPLE $ABBV $ACN $ADP $AMGN $AMZN $AVA $BADividend Growth Portfolios MUST Have 45 (And Only 45) Positions! https://t.co/uuIQE58GxD $AAPL #APPLE $ABBV $ACN $ADP $AMGN $AMZN $AVA $BADividend Growth Portfolios MUST Have 45 (And Only 45) Positions! https://t.co/4NqeV7HSO2 $AAPL #APPLE $ABBV $ACN $ADP $AMGN $AMZN $AVA $BAHad not seen this Nav 1,7 video yet. 

The Passionate Pursuit of Nav 1.7 https://t.co/gl73KmcOZP via @YouTube $AMGN $VRTX $PFE $XENE $NKTR$AAPL $AMAT $AMGN $AMTD $AMZN $ATVI Trade long or long+short positions from the #NASDAQ, up to 1500% since 2010. https://t.co/ldcTl0pR3aValue investors should check out Amgen $AMGN for its low price to book (3.9x) ratio https://t.co/3b77SYi0yx https://t.co/41uQX7VsnzHas A Biotech Recovery Started Yet? $ALXN $AMGN $BIIB  https://t.co/SwkAGegdzO via @benzinga$AMGN high open interest range is 150.00 to 160.00 for option expiration 05/20/2016.  https://t.co/7PJX1ctrjX https://t.co/uCURhPFkG6RT @TalkMarkets: ?2 Undervalued Stocks with Safe and Growing #Dividends $MRK $PFE Also $AGN $ANAC $MDVN $AMGN $GILD $ABBV https://t.co/3efj‚Ä¶?2 Undervalued Stocks with Safe and Growing #Dividends $MRK $PFE Also $AGN $ANAC $MDVN $AMGN $GILD $ABBV https://t.co/3efjKHeDGQAmgen, Inc. $AMGN Sees Large Decrease in Short Interest https://t.co/vIUi4yt9BiAmgen, Inc. $AMGN Sees Large Decrease in Short Interest https://t.co/xaCUCBJWDsRT @csresearch: Estimated impact of US drug price rises on 2015 net income: $ABBV, $AMGN, $LLY, $SHPG have benefited the most https://t.co/‚Ä¶AMGN Bid
See Here ---&gt; https://t.co/B2ifZ5icVI

$AMGN $HHS $E #nasdaq$AMGN:US Amgen, Inc. (AMGN) Stake Cut by CCM Investment Advisers LLC #AMGEN INC  https://t.co/kK70U2JlcE #NASDAQ$AMGN:US Amgen, Inc. (AMGN) Stake Cut by CCM Investment Advisers LLC #AMGEN INC  https://t.co/NTGigm8ArZ #SP500Has A Biotech Recovery Started Yet? $ALXN $AMGN $BIIB https://t.co/Ypogpo0OHS via @benzingaRT @MarketsRecap: ?2 Undervalued Stocks with Safe and Growing #Dividends $MRK $PFE Also $AGN $ANAC $MDVN $AMGN $GILD $ABBV https://t.co/moZ‚Ä¶#Amgen's Breakaway from Cancer√Ç Public Service Announcement Delivers Message That Education... Read more: https://t.co/8o2byLl6NP $AMGN#Amgen's Breakaway from Cancer¬Æ Public Service Announcement Delivers Message That Education... Read more: https://t.co/794VHjq8eC $AMGN?2 Undervalued Stocks with Safe and Growing #Dividends $MRK $PFE Also $AGN $ANAC $MDVN $AMGN $GILD $ABBV https://t.co/moZw8CefgxRT @kapunikun: $AMGN Amgen Kurtosis : -1.4 Skew : -0.31 Correlation Histogram #bigdata https://t.co/batufAV8Qx$AMGN Amgen Kurtosis : -1.4 Skew : -0.31 Correlation Histogram #bigdata https://t.co/batufAV8QxCapital Advisors Inc. OK Has $11,029,000 Position in Amgen, Inc. $AMGN https://t.co/HG0GEQsNmpVMI % Change
See Here ---&gt; https://t.co/g3z8rgiZbO

$VMI $CEQP $AMGN #investingAltfest L J &amp; Co. Inc. Lowers Stake in Amgen, Inc. $AMGN https://t.co/6YwBq4tqKoAltfest L J &amp; Co. Inc. Lowers Stake in Amgen, Inc. $AMGN https://t.co/KfDHOGT6u1$AMGN - Capital Advisors Inc. OK Has $11,029,000 Position in Amgen, Inc. #AMGN https://t.co/ABlPPAQQVy$AMGN - Capital Advisors Inc. OK Has $11,029,000 Position in Amgen, Inc. #AMGN https://t.co/a9H915avBd$AMGN Max Pain is 155.00 for maturity 05/20/2016. Price = 153.27. bullish https://t.co/umec75FmpQ https://t.co/0wNiadgIgZ$AAPL $AMAT $AMGN $AMTD $AMZN $ADI Trade long or long+short positions from the #NASDAQ, up to 1500% since 2010. https://t.co/ldcTl0HsrK",2016-05-18,AMGN,0
31,"WESPAC Advisors SoCal LLC Invests $4,593,000 in Amgen, Inc. $AMGN https://t.co/rsiKl3NXOS$AMGN Max Pain is 155.00 for maturity 05/20/2016. Price = 150.83. bullish https://t.co/umec75FmpQ https://t.co/Sc2IuhrNQ9#Technical scans $CMI $DRIP $CERN $ADBE $ATVI $AMGN $VRX $UWTI $NFLX https://t.co/3mOWS1Cjfx #patterns #doji #oversold #breakouts #trading$AMGN: Amgen to present new data from its oncology portfolio at the 21st Congress of the European Hematology... https://t.co/pjesabwZWYBelow Ichimoku https://t.co/0MIpNlnuoK $MAR $EDC $NWSA $AMGN $AZN $NQ $SID $HOG $DISH $AEE $BWA $RLJ $DHT $SNY $FMCC $STOR $FNSR$AMGN Amgen Announces Voting Results of Annual Meeting of Stockholders
From our Stock News Alerts App$AAPL was top sale among 50 largest hedge funds in Q1.  https://t.co/CxQWyvQTzd  $BRCM $AAP $PXD $MCD $AMGN $QCOM $ADBEThese $ITUS Profits Are much Bigger Than $AMGNRT @AndyBiotech: #ASCO16 $AMGN T-Vec + $MRK Keytruda combo in #Melanoma

14% CR, 48% confirmed ORR
https://t.co/eJPkfQq8U1$AMGN Amgen Highlights Data To Be Presented At 21st Congress Of The European Hematology Association
From our Stock News Alerts App#Amgen Researchers Find Gene Linked to Lower Risk of Heart Disease. Read more: https://t.co/uHxJYaASDB $AMGNAmgen $AMGN ‚Äì Investment Analysts‚Äô Recent Ratings Changes https://t.co/4INZPQhi7EBest outperformers ranked 70-75 $NTRI $SNI $HNI $AMGN $BKSIPO Merus trading up 5% https://t.co/vMqvbEsvHw $MRUS $AMGN $MGNX $JNJIPO Merus trading up 5% https://t.co/tDMTj56NAK $MRUS $AMGN $MGNX $JNJIPO Merus trading up 5% https://t.co/20bOr2RqEJ $MRUS $AMGN $MGNX $JNJIPO Merus trading up 5% https://t.co/ZBfjhZYEXh $MRUS $AMGN $MGNX $JNJAmgen‚Äôs $AMGN Hold Rating Reiterated at Bank of America https://t.co/AFTifXcRqn$AMGN maturity 05/20/2016 oi CallPutRatio of 0.85 puts 16,111 &amp; calls 19,039 bullish. https://t.co/7PJX1cbQsp https://t.co/UPgqStDICjAmgen‚Äôs $AMGN Buy Rating Reiterated at Morgan Stanley https://t.co/i6jj2fMYVTAmgen Inc Reiterated Rating by Bank of America (Ranked 46th) to Hold $AMGN #AMGN https://t.co/bqjkWqL002AMGN Ask Size
See Here ---&gt; https://t.co/wvGiOK4P6B

$AMGN $CHTR $ACH #shareLooking into $AMGN longer term callsBought $Amgn weekly $150 calls at $.19 small positionAmgen Inc Reiterated Rating by Morgan Stanley (Ranked 34th) to Buy $AMGN #AMGN https://t.co/bqjkWr2ARA$AMGN Amgen Researchers Discover Gene Associated With Lower Ri‚Ä¶ https://t.co/TZyEbU7eGgRT @megtirrell: A heart attack gene? $AMGN identifies gene X - we discuss, coming up on @HalftimeReport$AMGN Bayer to Showcase Latest Oncology Research at ASCO 2016‚Ä¶ https://t.co/T2k9l1gfqy$AMGN Amgen Data To Be Presented At ASCO 2016 Demonstrates Mor‚Ä¶ https://t.co/ANSRaVqV7w$AMGN Landmark deCODE genetics Study Points to a New Mechanism‚Ä¶ https://t.co/qvioljowLyRT @toolbox87: $AMGN in the buy zone, Long $AMZN $TSLA over bought now and in the sell zone, $AAPL  $SPY $FB $WMT $MONRT @toolbox87: $AMGN in the buy zone, Long $AMZN $TSLA over bought now and in the sell zone, $AAPL  $SPY $FB $WMT $MON$AMGN in the buy zone, Long $AMZN $TSLA over bought now and in the sell zone, $AAPL  $SPY $FB $WMT $MONPlatelet BioGenesis Wins #Amgen Golden Ticket For LabCentral. Read more: https://t.co/yGfYQZlHPy $AMGNTUP Ex-Div Date
See Here ---&gt; https://t.co/QLxUizIrEN

$TUP $AMGN $DPZ #tradeideasAMGN - Watch - Potential 10%+ Swing $AMGN https://t.co/2oKks5Ffwr$AMGN https://t.co/EIbtfmKcBgIt looks like $TSLA closed the gap and confirmed it with a  double bottom, Expecting a rise to $ 212.5. $SPY $AAPL $FB $AMZN $AMGN $CMIAMGN Top news - May 19th, 2016 $AMGN https://t.co/T0tRD54V4d$amgn down volume#Amgen Data To Be Presented At ASCO 2016 Demonstrates More Insights Into Treatment Options ... Read more: https://t.co/fO5d75HL42 $AMGNRT @jonnajarian: Meg joins us next! RT @megtirrell
A heart attack gene? $AMGN identifies gene X - we discuss, coming up on @HalftimeReporti can make a case $amgn could be at least a 200 dollar stock based on my computer valuation models....thats over 30 percent upside. giddyupMeg joins us next! RT @megtirrell
A heart attack gene? $AMGN identifies gene X - we discuss, coming up on @HalftimeReportRT @megtirrell: A heart attack gene? $AMGN identifies gene X - we discuss, coming up on @HalftimeReport#InFocus @CNBC #CNBC.. $DLX $RAX return to #growth #value the #TechPlague $AAPL Ex. #Biotech $AMGN #HeartHealth #OnDeck + #FedEffect #Dollarmegtirrell: A heart attack gene? $AMGN identifies gene X - we discuss, coming up on HalftimeReportRT @megtirrell: A heart attack gene? $AMGN identifies gene X - we discuss, coming up on @HalftimeReportRT @megtirrell: A heart attack gene? $AMGN identifies gene X - we discuss, coming up on @HalftimeReportA heart attack gene? $AMGN identifies gene X - we discuss, coming up on @HalftimeReport$XLV  $UNH  $GILD  $AMGN  ETF Outflow Alert #etfs https://t.co/q22lxcbeUo$XLV  $UNH  $GILD  $AMGN  ETF Outflow Alert #etfs: Symbols mentioned in this story:  XLV, UNH, GILD, AMGN
 
 ... https://t.co/yEwjIY5M9P11 shares of $AMGN  acquired at 148.579 USD per share (Cost: 1634.36 USD)$AMGN high open interest range is 150.00 to 160.00 for option expiration 05/20/2016.  https://t.co/7PJX1ctrjX https://t.co/SPADej2MgVInteresting epilogue on $amgn purchase - DeCode Genetics https://t.co/BWAq998gtqTrending #Biotech topics include $AGEN, $AMGN, #Keytruda #stocks #invest See more https://t.co/EpbbdqDEG1RT @csresearch: Estimated impact of US drug price rises on 2015 net income: $ABBV, $AMGN, $LLY, $SHPG have benefited the most https://t.co/‚Ä¶The soon to be trend, lower, is kicking in now. $SPY $TSLA $AMGN $GOOGL $NFLX $FB #stockstotrade #stocks #chartsAmgen hits a 1 month low https://t.co/TVSs33cCO3 $AMGN #Amgen https://t.co/PHiTjRbCIOPharmalot.. Pharmalittle.. Good Morning.. lots of news about #cancer drugs.. https://t.co/qcatcwS2eq #pharma $MRK $PFE $AMGN #oncology#FDANOTICE: $AMGN OPTIMISM indicator (as seen by investors in News &amp; Social Media)  shows high expectations. https://t.co/s36Pudq8l1RT @Briefingcom: $AMGN: Amgen's deCODE genetics announces discovery of a 'rare' variation in the sequence of the human genome https://t.co/‚Ä¶$AMGN Max Pain is 155.00 for maturity 05/20/2016. Price = 150.83. bullish https://t.co/umec75FmpQ https://t.co/d3DsvP758vAmgen‚Äôs $AMGN Hold Rating Reiterated at Robert W. Baird https://t.co/Wzj36MWNvgAmgen‚Äôs $AMGN Hold Rating Reiterated at Robert W. Baird https://t.co/BtfEknHqcIMore on the identification of ASGR1 as a potential cardiovascular drug target by Amgen/DeCode $AMGN https://t.co/h5RjO88tGuAmgen, Inc. $AMGN Given ‚ÄúBuy‚Äù Rating at RBC Capital https://t.co/1lyKG18QvwAmgen, Inc. $AMGN Given ‚ÄúBuy‚Äù Rating at RBC Capital https://t.co/13x9aQZFol#Amgen : Cities on Tour of California route win with global exposure . Read more: https://t.co/8zcwv8kHNz $AMGN#Amgen researchers discover gene variation that lowers heart attack risk. Read more: https://t.co/0bhUuQfjud $AMGNRT @AndyBiotech: #ASCO16 $AMGN T-Vec + $MRK Keytruda combo in #Melanoma

14% CR, 48% confirmed ORR
https://t.co/eJPkfQq8U1https://t.co/G9pMgSr1JY &lt; Review of this fantastic traders teaching service!! Try it for FREE! $LLY $DGX $MRK $NVS $AMGN$AMGN received a new alert. Find out why at https://t.co/nZwqReM0tj #stocks #daytrading #trading #mkt  #NYSE #NASDAQ #markets 762$AMGN - Janney Montgomery Scott LLC Sells 1,554 Shares of Amgen, Inc. #AMGN https://t.co/Ffpgpkfd0W$AMGN - Janney Montgomery Scott LLC Sells 1,554 Shares of Amgen, Inc. #AMGN https://t.co/LtbHrcFF42RT @csresearch: Estimated impact of US drug price rises on 2015 net income: $ABBV, $AMGN, $LLY, $SHPG have benefited the most https://t.co/‚Ä¶Janney Montgomery Scott LLC Sells 1,554 Shares of Amgen, Inc. $AMGN https://t.co/M8rQKnmunuRT @rtclark: Dr Burry likes $AMGN https://t.co/trx8JLH1hf A former 100 bagger cc:@chriswmayerRT @Briefingcom: $AMGN: Amgen's deCODE genetics announces discovery of a 'rare' variation in the sequence of the human genome https://t.co/‚Ä¶$AMGN: Amgen's deCODE genetics announces discovery of a 'rare' variation in the sequence of the human genome https://t.co/9qmKM07Aod$AMGN https://t.co/RVPJuVhBkcRT @csresearch: Estimated impact of US drug price rises on 2015 net income: $ABBV, $AMGN, $LLY, $SHPG have benefited the most https://t.co/‚Ä¶Kentucky Retirement Systems Insurance Trust Fund Takes Position in Amgen, Inc. $AMGN https://t.co/xbWR5pyNJf#Amgen : Tour riders power through La Ca√Ø¬ø¬Ωada . Read more: https://t.co/dWRzIe2LtV $AMGN$AAPL $AMAT $AMGN $AMTD $AMZN $ATVI Trade long or long+short positions from the #NASDAQ, up to 1500% since 2010. https://t.co/ldcTl0HsrKAMGN Tick
See Here ---&gt; https://t.co/LO6sE0Xp9K

$AMGN $PPS $T #stock$AMGN sum put oi=16,418 sum call oi=18,536 CallPutRatio=0.89 expiration 05/20/2016 bullish. https://t.co/7PJX1ctrjX https://t.co/ovXXcDBLAYMeyer Handelman Co. Cuts Position in Amgen, Inc. $AMGN https://t.co/hugIh5APjtThese $ITUS Profits Are much Bigger Than $AMGN https://t.co/0OjDeX5BYE#Amgen Researchers Discover Cholesterol Gene 
. Read more: https://t.co/ASi8NSZVjO $AMGNHigh Pole https://t.co/kJ2Aew2891 $AAC $ABUS $ADP $AJRD $ALIM $ALOG $AMCX $AMGN $APOG $ARLP $ARWR $ASHS $ATNM $AVG $BBH $BBL $BETR",2016-05-19,AMGN,1
32,"New England Research &amp; Management Inc. Has $1,442,000 Stake in Amgen, Inc. $AMGN https://t.co/yfkLjrrs5fNew England Research &amp; Management Inc. Has $1,442,000 Stake in Amgen, Inc. $AMGN https://t.co/XW9jlPDlZ3Rathbone Brothers plc Has $20,491,000 Position in Amgen, Inc. $AMGN https://t.co/rfnqzzL0lI$AMGN OI for maturity 05/27/2016. 146.00 Highest put. 150.00 Highest call. bearish https://t.co/15UQueYoRh https://t.co/75KNCSW88n#Amgen : Senior Leaders Advance Discussion on Cancer at 2016 World Medical Innovation Forum . Read more: https://t.co/3IoHHWquRN $AMGNRT @FierceBiotech: Amgen, deCode data dive links gene to lower risk of heart attack: https://t.co/5vQHiBhcHD $AMGNBest outperformers ranked 90-95 $LYB $HKHHY $BK $AMGN $VSIRT @pharmalot: Sanofi shifts top management &amp; top #diabetes exec will leave.. a 'purge' of the old guard.. https://t.co/Vg9zxq92US #pharma‚Ä¶RT @pharmalot: Sanofi shifts top management &amp; top #diabetes exec will leave.. a 'purge' of the old guard.. https://t.co/Vg9zxq92US #pharma‚Ä¶RT @pharmalot: Sanofi shifts top management &amp; top #diabetes exec will leave.. a 'purge' of the old guard.. https://t.co/Vg9zxq92US #pharma‚Ä¶RT @pharmalot: Sanofi shifts top management &amp; top #diabetes exec will leave.. a 'purge' of the old guard.. https://t.co/Vg9zxq92US #pharma‚Ä¶Sanofi shifts top management &amp; top #diabetes exec will leave.. a 'purge' of the old guard.. https://t.co/Vg9zxq92US #pharma $SNY $REGN $AMGNRT SeekingAlpha: Sanofi: High Quality Product Portfolio But Risks Remain https://t.co/kB5qmDoKnz $AMGN $REGN $MDVN $SNYSeekingAlpha: Sanofi: High Quality Product Portfolio But Risks Remain https://t.co/G2cqmaNjGP $AMGN $REGN $MDVN $SNYSanofi: High Quality Product Portfolio But Risks Remain https://t.co/c65yBAbm4C $AMGN $REGN $MDVN $SNY$AMGN Max Pain = 150.00. Maturity = 05/27/2016. Previous close = 150.18. bearish https://t.co/xnVg6eC3qO https://t.co/hHZsyoEaXpAMGN Last Price
See Here ---&gt; https://t.co/fG2INJW5I7

$AMGN $OHI $SNC #financeab=cd $AMGN https://t.co/cPmlXZuUKURT @FierceBiotech: Amgen, deCode data dive links gene to lower risk of heart attack: https://t.co/5vQHiBhcHD $AMGN$AMGN in the buy zone and  looking very good. $TSLA not holding the support here. $AAPL  long. $SPY  $FB$AMGN https://t.co/RcYS4rHSZt$AMGN The company has beaten quarterly profit expectations for nine straight quarters now... https://t.co/N6R4Dgj0HH https://t.co/gqOrErFiDNRT @csresearch: Estimated impact of US drug price rises on 2015 net income: $ABBV, $AMGN, $LLY, $SHPG have benefited the most https://t.co/‚Ä¶$CYTK 
Additional Results From COSMIC-HF at Heart Failure 2016 Congress

Decision from $AMGN to move to Ph3 imminent https://t.co/5wZKXJf9Io$CYTK Fady Malik, MD, Exec VP, R&amp;D

""We are preparing for a potential Phase 3 program in collaboration with $AMGN"" https://t.co/llbCaEvHDuAmgen calls on TV actor 'McDreamy' to lead latest Breakaway from Cancer campaign  https://t.co/25Cfuyqtz5 $AMGN #pharma #marketing$AMGN sum put oi=1,980 sum call oi=2,443 CallPutRatio=0.81 expiration 05/27/2016 bullish. https://t.co/15UQueGNZJ https://t.co/jZudgjx0CaGS prefer exposure to stocks where see upside to estimates and/or pipeline optionality ‚Äì $AGN $AMGN $ABBV $BMY and $REGNGoing ""Old School"" In This Week's Game Plan - Bret Jensen | Seeking Alpha https://t.co/N6R4Dgj0HH via @salphatrending $AMGN $F $GM $XHRRT @jonathanrockoff: Most cash-rich drug cos, per Moody's: $PFE ($39bn), $JNJ (38), $AMGN (31), $MRK (27), $GILD (26), $BMY (9), $ABBV (9),‚Ä¶RT @FierceBiotech: Amgen, deCode data dive links gene to lower risk of heart attack: https://t.co/5vQHiBhcHD $AMGNAmgen, deCode data dive links gene to lower risk of heart attack: https://t.co/4MoKh0XhQv $AMGN story from FierceBiotech #biotech #pharma$AAPL $AMAT $AMGN $AMTD $AMZN $ADI Trade long or long+short positions from the #NASDAQ, up to 1500% since 2010. https://t.co/ldcTl0HsrKAmgen, deCode data dive links gene to lower risk of heart attack: https://t.co/5vQHiBhcHD $AMGN$AMGN has just reached a new high at $149.8.  Found with MOMO Stock Breakout App @ https://t.co/1WLje7D8rC$AMGN OI for maturity 05/27/2016. 146.00 Highest put. 150.00 Highest call. bearish https://t.co/15UQueYoRh https://t.co/fQH6lbdi8nAmgen, Inc. $AMGN Earns Buy Rating from RBC Capital https://t.co/SHM4dbSnEjAmgen, Inc. $AMGN Earns Buy Rating from RBC Capital https://t.co/2RSVdykHQ9Amgen, Inc. $AMGN Stock Rating Reaffirmed by Bank of America https://t.co/H4ayrAMynKMorgan Stanley Reiterates Buy Rating for Amgen, Inc. $AMGN https://t.co/3bpjhN67BeMorgan Stanley Reiterates Buy Rating for Amgen, Inc. $AMGN https://t.co/ODHpYRLNelRT @jonathanrockoff: Most cash-rich drug cos, per Moody's: $PFE ($39bn), $JNJ (38), $AMGN (31), $MRK (27), $GILD (26), $BMY (9), $ABBV (9),‚Ä¶$AMGN if volume improves we are headed higher https://t.co/lDxKkAK6ccRT @jonathanrockoff: Most cash-rich drug cos, per Moody's: $PFE ($39bn), $JNJ (38), $AMGN (31), $MRK (27), $GILD (26), $BMY (9), $ABBV (9),‚Ä¶RT @jonathanrockoff: Most cash-rich drug cos, per Moody's: $PFE ($39bn), $JNJ (38), $AMGN (31), $MRK (27), $GILD (26), $BMY (9), $ABBV (9),‚Ä¶$PFE $JNJ $AMGN are the 3 pharma in Top 10

US companies‚Äô cash pile hits $1.7tn - https://t.co/gmGE4bBdJq https://t.co/5JAwbDtWD6 via @FTLike low Price to Book stocks? Check $AMGN with a PB of 3.9x https://t.co/3b77SYi0yx https://t.co/HYN36crxpY$AAPL $AMAT $AMGN $AMTD $AMZN $ATVI Trade long or long+short positions from the #NASDAQ, up to 1500% since 2010. https://t.co/ldcTl0HsrKThese $ITUS Profits Are much Bigger Than $AMGN$AMGN Max Pain is 150.00 for maturity 05/27/2016. Price = 150.18. bearish https://t.co/xnVg6eC3qO https://t.co/vJBOd6m9of",2016-05-23,AMGN,1
33,"$AMGN Max Pain is 150.00 for maturity 05/27/2016. Price = 149.30. bullish https://t.co/xnVg6eC3qO https://t.co/wusWKD9UdOS&amp;P100 #Stocks Performance $GILD $MSFT $MON $BIIB $V $INTC $CELG $QCOM $ACN $ABBV $TXN $AMGN $MDLZ $GOOGL  more@ https://t.co/cKkr8cKsjuEqis Capital Management Inc. Sells 1,048 Shares of Amgen, Inc. $AMGN https://t.co/DPRqjjTX6uMarshwinds Advisory Co. Lowers Position in Amgen, Inc. $AMGN https://t.co/zBUqhncSJ1Marshwinds Advisory Co. Lowers Position in Amgen, Inc. $AMGN https://t.co/8DsNc1agIZFragasso Group Inc. Sells 5 Shares of Amgen, Inc. $AMGN https://t.co/ewU2KZAmh4RT @ChinaInvest: RT SeekingAlpha: Western Digital: NASDAQ Top Dog Fetches Broker Love In May https://t.co/Jzsrr7a8Ru $AAPL #APPLE $AMGN $AV‚Ä¶AMGN Summary
See Here ---&gt; https://t.co/B3vnBMocJw

$AMGN $SLV $TRIL #investingRT SeekingAlpha: Western Digital: NASDAQ Top Dog Fetches Broker Love In May https://t.co/Jzsrr7a8Ru $AAPL #APPLE $AMGN $AVGO $CSCO $CSX $G‚Ä¶Best outperformers ranked 90-95 $PATK $LYB $HKHHY $BK $AMGNSeekingAlpha: Western Digital: NASDAQ Top Dog Fetches Broker Love In May https://t.co/jQGuKb1jNR $AAPL #APPLE $AMGN $AVGO $CSCO $CSX $GILD‚Ä¶Western Digital: NASDAQ Top Dog Fetches Broker Love In May https://t.co/JAvesTwt31 $AAPL #APPLE $AMGN $AVGO $CSCO $CSX $GILD $INTC $KHCWestern Digital: NASDAQ Top Dog Fetches Broker Love In May https://t.co/4g6B4snWoc $AAPL #APPLE $AMGN $AVGO $CSCO $CSX $GILD $INTC $KHCWestern Digital: NASDAQ Top Dog Fetches Broker Love In May https://t.co/PY7NmmW1IR $AAPL #APPLE $AMGN $AVGO $CSCO $CSX $GILD $INTC $KHCRT @theflynews: BREAKING: Gilead Sciences appoints Kevin Young as COO: https://t.co/2Nt91My2fw $GILD $AMGN https://t.co/VG3lUJJGHNRT @theflynews: BREAKING: Gilead Sciences appoints Kevin Young as COO: https://t.co/2Nt91My2fw $GILD $AMGN https://t.co/VG3lUJJGHNRT @theflynews: BREAKING: Gilead Sciences appoints Kevin Young as COO: https://t.co/2Nt91My2fw $GILD $AMGN https://t.co/VG3lUJJGHNRT @theflynews: BREAKING: Gilead Sciences appoints Kevin Young as COO: https://t.co/2Nt91My2fw $GILD $AMGN https://t.co/VG3lUJJGHNRT @theflynews: BREAKING: Gilead Sciences appoints Kevin Young as COO: https://t.co/2Nt91My2fw $GILD $AMGN https://t.co/VG3lUJJGHNBREAKING: Gilead Sciences appoints Kevin Young as COO: https://t.co/2Nt91My2fw $GILD $AMGN https://t.co/VG3lUJJGHNS&amp;P100 #Stocks Performance $MSFT $GILD $INTC $CELG $MS $V $ABBV $BIIB $AMGN $AXP $CSCO $ORCL $MDLZ $QCOM  more@ https://t.co/cKkr8csQUU$AMGN maturity 05/27/2016 oi CallPutRatio of 0.84 puts 2,323 &amp; calls 2,774 bullish. https://t.co/15UQueYoRh https://t.co/6uqurm0A3uTI.A Day High
See Here ---&gt; https://t.co/RyCBpYTwm3

$TI.A $EMKR $AMGN #investingNot Bad! hoy SP500 Rocket +1,43% y mis favoritas $PHM +5,4% $BAC +1,5% $RCL +2% $ETH +4% $DFS +2% $ITX +3% $AMGN +2% y x su puesto,, $V +3%These $ITUS Profits Are much Bigger Than $AMGNAmgen, Inc. $AMGN Given Consensus Recommendation of ‚ÄúBuy‚Äù by Brokerages https://t.co/1wbKVCzQTS3 Safe Dividend Stocks with Pristine Balance Sheets https://t.co/b7HH2TPieb $AAPL $AMGN $GILD $M via @InvestorsAlley% off high
$CLVS 86,7%
$BLUE 78,6%
$HALO 61,6%
$RLYP 57,8%
$JUNO 41,8%
$REGN 34,5%
$ONCE 30,8%
$GILD 30,2%
$BIIB 25,3%
$AMGN 15,9%RT @tgtxdough: IMHO best slide I tweet all weekend Free cash flow for the larger cap biotechs 2014-2020E $AMGN $CELG $GILD  M&amp;A ?? https://‚Ä¶$AMGN Samsung Targets U.S. Drug Market With Remicade Knockoff‚Ä¶ https://t.co/4KA8qMm9YxAMGN Top news - May 24th, 2016 $AMGN https://t.co/1M3VGFAtCwRT @MarginHunt: Is It Time To Sell Gilead Sciences $GILD? @ideagenerator01 https://t.co/jWa0iC1eVF $AAPL $ABBV $AMGN $BIIB #stocks https://‚Ä¶$AMGN high open interest range is 146.00 to 150.00 for option expiration 05/27/2016.  https://t.co/15UQueYoRh https://t.co/IppuLMg2TvI'm sure many more today... $IBB $GILD $AMGN $BIIB $REGN $CELGPBFX Shares
See Here ---&gt; https://t.co/xiFYsKdFMh

$PBFX $AMGN $FRO #pennystocksRT @FiercePharma: Amgen calls on TV actor 'McDreamy' to lead latest Breakaway from Cancer campaign  https://t.co/25Cfuyqtz5 $AMGN #pharma #‚Ä¶$TWTR is in the buy zone, Double bottom confirmation and capitulation all there. IMO.  $SPY $GOOG $AMGN $LNKD $FB $NFLX $TSLA$AMGN Max Pain is 150.00 for maturity 05/27/2016. Price = 149.30. bullish https://t.co/xnVg6eC3qO https://t.co/mXRcg2VUe8@maralgr @exMBB  stupid theory. It's $MRK $SNY maybe even $AMGN
Azn won't spend 6 bil$ on a new market$AMGN chart https://t.co/AlXbML4D8q via https://t.co/FAyKB6du8KPopular: $UWTI, $DWTI, $JASO, $YHOO, $ZIOP, $COST, $DECK, $HPE, $NVAX, $ASHR, $CELG, $ASPS, $PANW, $CORR, $AMGN, $WDC, $EXPRHere is What Hedgefund Managers Buy And Sell Now - https://t.co/sZh7BuBhhb - $EMC $FB $AAPL $QCOM $AMGN $SNDK $GOOG  $JNJ $MCD $LLYDividend Growth Portfolios MUST Have 45 (And Only 45) Positions! https://t.co/9cKIwSJVf0 $AAPL $ABBV $ACN $ADP $AMGN $AMZN $AVA $BA $BBLFollow #Nasdaq 100 traders &amp; track their tweets under one watchlist $AMGN $QCOM https://t.co/W1OB9ZtUgi https://t.co/aFYDQjEqTBAmgen, Inc. $AMGN Earns ‚ÄúHold‚Äù Rating from Bank of America https://t.co/mUOhshZ4wUAmgen, Inc. $AMGN Earns ‚ÄúHold‚Äù Rating from Bank of America https://t.co/w2P9PU7gdWAmgen‚Äôs $AMGN Buy Rating Reiterated at Morgan Stanley https://t.co/71vWb50pCkperformance update. @zzlangerhans #zzporte $ABBV $ALXN $AMGN $BIIB $BMY $CELG $FPRX $GILD $IBB $INO $REGN $VRX $XBI https://t.co/mKJWA9ohcTValue investors should check out Amgen $AMGN for its low price to book (3.9x) ratio https://t.co/3b77SYi0yx https://t.co/wzQDHxmGBlRT @StockWebTrading: $AAPL $AMAT $AMGN $AMTD $AMZN $ATVI Trade long or long+short positions from the #NASDAQ, up to 1500% since 2010. https‚Ä¶$AAPL $AMAT $AMGN $AMTD $AMZN $ATVI Trade long or long+short positions from the #NASDAQ, up to 1500% since 2010. https://t.co/ldcTl0HsrK$AMGN maturity 05/27/2016 oi CallPutRatio of 0.81 puts 1,980 &amp; calls 2,443 bullish. https://t.co/15UQueYoRh https://t.co/Z2w6q62Mg2Is It Time To Sell Gilead Sciences $GILD? @ideagenerator01 https://t.co/jWa0iC1eVF $AAPL $ABBV $AMGN $BIIB #stocks https://t.co/Nq26RlR5aFRT @Robertlesnicki: Next: $AMGN Year and a half long consolidation. Use #MNM to request the next chart! https://t.co/Zqmm1SFN0iNext: $AMGN Year and a half long consolidation. Use #MNM to request the next chart! https://t.co/Zqmm1SFN0iHigh Pole https://t.co/DCPgcE3Ne7 $AAC $AAWW $ABUS $ADMA $AJRD $ALIM $AMGN $AMSC $APA $ARWR $ASHS $ATNM $ATR $BBH $BHP $BLK $CCS",2016-05-24,AMGN,1
34,"Amgen, Inc. $AMGN Stake Boosted by DnB Asset Management AS https://t.co/PSS5PF93wO$AMGN - Contravisory Investment Management Inc. Decreases Position in Amgen, Inc. #AMGN https://t.co/RwqARMDi10$AMGN - Contravisory Investment Management Inc. Decreases Position in Amgen, Inc. #AMGN https://t.co/M7DAq6W4UALJ TRUST Co LLC Has $12,692,000 Stake in Amgen, Inc. $AMGN https://t.co/cHftLQQ5nLContravisory Investment Management Inc. Decreases Position in Amgen, Inc. $AMGN https://t.co/s0N116ruX3RT @jq1234t: @adamfeuerstein @DewDiligence Don't see bid from big biotech except $AMGN in this case.LJ TRUST Co LLC Has $12,692,000 Stake in Amgen, Inc. $AMGN https://t.co/ysr4jggHG7$AMGN Amgen Announces Early Tender Results Of Senior Notes Exchange Offers
From our Stock News Alerts AppNasdaq100 #Stocks Trend $WDC $BIIB $DISH $INCY $ALXN $AMGN $AAPL $LRCX $VIAB $CSCO $AVGO $CELG $VOD $VRTX $NTAP @ https://t.co/YdSIjFJqHfNasdaq100 #Stocks Performance $WDC $BBBY $STX $BIIB $PCAR $ORLY $ULTA $NFLX $DISH $INCY $ALXN $AMGN $DISCA  more@ https://t.co/YdSIjFJqHfS&amp;P100 #Stocks Trend $SLB $WFC $BIIB $C $GS $COF $MON $GM $AMGN $AAPL $MRK $BAC $CSCO $USB $JPM $CELG $MS $BK  @ https://t.co/cKkr8cKsjuS&amp;P100 #Stocks Performance $COP $SLB $KMI $WFC $HAL $BIIB $C $GS $COF $IBM $MON $CAT $UNP $GM $AMGN $ABT  more@ https://t.co/cKkr8cKsjuExxonmobil Investment Management Inc. TX Has $27,455,000 Position in Amgen, Inc. $AMGN https://t.co/TIHR1H0jkpOver Ichimoku https://t.co/GqMd1bYmi8 $SLM $AMGN $LRCX $ON $PM $NUE $CMI $FLR $CNC $OII $TBT $KBR $NVO $DNOW $MRC $TIME $UMPQ$AMGN: Amgen prices private offering to exchange certain specified series of its outstanding senior notes for new... https://t.co/ej0hnVfXsLBest outperformers ranked 90-95 $BK $AMGN $DORM $SNI $VSIRT SeekingAlpha: Q1 Picks From Michael Burry - The Man Who Predicted The Mortgage Crisis https://t.co/BjKbFm48L3 $THRM $AMGNSeekingAlpha: Q1 Picks From Michael Burry - The Man Who Predicted The Mortgage Crisis https://t.co/A4Ez23NUMQ $THRM $AMGN@adamfeuerstein @DewDiligence Don't see bid from big biotech except $AMGN in this case.$AMGN OI for maturity 05/27/2016. 146.00 Highest put. 155.00 Highest call.  https://t.co/15UQueYoRh https://t.co/1DrX810MKZQ1 Picks From Michael Burry - The Man Who Predicted The Mortgage Crisis https://t.co/YNR6Eqd9uf $THRM $AMGN$AMGN Kewalramani #SpiderMan fan: With great power comes great responsibility, w/ great innovation comes responsibility take next step
$SNYAmgen  $AMGN  Shares Cross Above 200 DMA $BBH #dividends https://t.co/SDjhX2o9BxRT @theflynews: On The Fly: Top stock stories for Wednesday $CSC $HPE $BABA $SNY $MDVN $GILD $CELG $PFE $AZN $NVS $AMGN $DY $... https://t.‚Ä¶RT @theflynews: On The Fly: Top stock stories for Wednesday $CSC $HPE $BABA $SNY $MDVN $GILD $CELG $PFE $AZN $NVS $AMGN $DY $... https://t.‚Ä¶RT @theflynews: On The Fly: Top stock stories for Wednesday $CSC $HPE $BABA $SNY $MDVN $GILD $CELG $PFE $AZN $NVS $AMGN $DY $... https://t.‚Ä¶On The Fly: Top stock stories for Wednesday $CSC $HPE $BABA $SNY $MDVN $GILD $CELG $PFE $AZN $NVS $AMGN $DY $... https://t.co/wRJ4jcgHCN@adamfeuerstein Or $AMGN- $IMNX.$AMGN Amgen Announces Pricing Terms Of Senior Notes Exchange Offers
From our Stock News Alerts AppAlgo trading CLOSING signals: May/25
 $EXEL(-10.7 %) $COG(2.2 %) $ALB(15.9 %) $AMGN(-4.2 %) $AMT(0.9 %) $AMH(5.0 %) $T(0.7 %) $ADM(-10.7 %)Biotech Forum Daily Digest: The Biotech Rally Continues, Relypsa Gets Some Traction, Exelix... https://t.co/Hcpz1irmxD $ABBV $AGN $AMGNNasdaq100 #Stocks Trend $WDC $DISH $MU $WFM $BIIB $VOD $CSCO $INCY $AAPL $AMGN $AVGO $CA $VIAB $NTAP $LRCX  @ https://t.co/YdSIjFJqHfS&amp;P100 #Stocks Trend $WFC $SLB $COF $GS $MON $C $GM $USB $BAC $BIIB $JPM $CSCO $MRK $AAPL $AMGN $BK $MS $INTC  @ https://t.co/cKkr8cKsjuselling everything but $TWTR. $SPY $AAPL  $TSLA $BABA, $FB $AMGN $GOOGL $NFLX $USO $BACRT @princetongb: @bradloncar believe $MDVN bidding war  soon to help bios. Xtandi cash flow sorely needed by $SNY + $AMGN and $PFE for fina‚Ä¶$AMGN Max Pain is 150.00 for maturity 05/27/2016. Price = 152.72. bearish https://t.co/xnVg6eC3qO https://t.co/g8Cw21yPN1SAlphaTrending: Gain 50% From This Bidding War, Part II https://t.co/cmkmKW4Xmr $ACAS $AET $AMGN $ANTM $ARCC $ATCEY $AXLL $AZN $BABA $BAYR‚Ä¶AMGN Top news - May 25th, 2016 $AMGN https://t.co/WkK3SziKvrRT @IBD_Areeves: Seems like pharma's new bumper sticker is ""Honk if you want to buy Medivation"": https://t.co/LARnmwQk1h $SNY $MDVN $CELG $‚Ä¶Gain 50% From This Bidding War, Part II https://t.co/kmm7TLIyS5 $ACAS $AET $AMGN $ANTM $ARCC $ATCEY $AXLL $AZN $BABA $BAYRY $BUD $CBNKSeekingAlpha: Gain 50% From This Bidding War, Part II https://t.co/j6m3H2eZij $ACAS $AET $AMGN $ANTM $ARCC $ATCEY $AXLL $AZN $BABA $BAYRY ‚Ä¶RT @ldbvua: @Adaptimmune Therapeutics $ADAP

$MDT $BSX $TMO $EW $DXCM $IDXX $NVTA $AMGN $SNY $LLY $BAYRY $GILD $BIIB $CELG $REGN https://t.‚Ä¶@Adaptimmune Therapeutics $ADAP

$MDT $BSX $TMO $EW $DXCM $IDXX $NVTA $AMGN $SNY $LLY $BAYRY $GILD $BIIB $CELG $REGN https://t.co/5l3FSjGjknRT SeekingAlpha: Gain 50% From This Bidding War, Part II https://t.co/aRYfyRjMUm $ACAS $AET $AMGN $ANTM $ARCC $ATCEY $AXLL $AZN $BABA $BAY‚Ä¶Gain 50% From This Bidding War, Part II https://t.co/88r2bBC9f3 $ACAS $AET $AMGN $ANTM $ARCC $ATCEY $AXLL $AZN $BABA $BAYRY $BUD $CBNKGain 50% From This Bidding War, Part II https://t.co/iTVBPHCx9Y $ACAS $AET $AMGN $ANTM $ARCC $ATCEY $AXLL $AZN $BABA $BAYRY $BUD $CBNK$AMGN&amp; $MRK w/Blincyto/PD-1&amp; $KITE&amp;Roche w/KTE-C19/PD-1;Interesting $JNJ chose $MGNX MGD011/Ibr.combo instead of Tcell Redir./Chkpnt as wellRT @theflynews: On The Fly: Top stock stories at midday $BABA $HPE $CSC $MDVN $SNY $CELG $GILD $PFE $AZN $NVS $AMGN $SRPT $DY... https://t.‚Ä¶On The Fly: Top stock stories at midday $BABA $HPE $CSC $MDVN $SNY $CELG $GILD $PFE $AZN $NVS $AMGN $SRPT $DY... https://t.co/afVrd5VSYoSeems like pharma's new bumper sticker is ""Honk if you want to buy Medivation"": https://t.co/LARnmwQk1h $SNY $MDVN $CELG $GILD $PFE $AMGNNasdaq100 #Stocks Trend $WDC $WFM $NTAP $BIIB $LRCX $CSCO $AMGN $CELG $VOD $ESRX $INTC $MU $AAPL $BMRN $BIDU  @ https://t.co/YdSIjG11yNS&amp;P100 #Stocks Trend $WFC $GS $MON $C $COF $MS $GM $SLB $JPM $BAC $BIIB $USB $BK $CSCO $AMGN $MRK $MET $CELG  @ https://t.co/cKkr8cKsjuSanofi seeks to replace Medivation board amid reports of competing offers $SNY $MDVN $CELG $GILD $PFE $AMGN $... https://t.co/8Uc8Moqm6HThese $ITUS Profits Are much Bigger Than $AMGNFollow #Nasdaq 100 traders &amp; track their tweets under one watchlist $AMGN $QCOM https://t.co/W1OB9ZtUgi https://t.co/eqxSOaYYB0$AMGN beautiful run here 15 minsStocks With The Most Cash On Hands - https://t.co/p62NkTgOd7 - $AAPL $QCOM $V $INTC $KO $MDT $ORCL $MSFT $MRK $CSCO $AMGN $EMC $F $FB $GILDI am short $TSLA, it is having problems catching up to $SPY. Long $AMGN $TWTR. watching $VXX $AAPL $BABART @biotech_forum: Biotech Forum Daily Digest: The Biotech Rally Continues, Relypsa Gets Some Traction, Exelix... https://t.co/89ckjpPout $‚Ä¶$AMGN maturity 05/27/2016 oi CallPutRatio of 0.72 puts 2,331 &amp; calls 3,258 bullish. https://t.co/15UQueYoRh https://t.co/wOGf39rvIGBiotech Forum Daily Digest: The Biotech Rally Continues, Relypsa Gets Some Traction, Exelix... https://t.co/89ckjpPout $ABBV $AGN $AMGNRT @actaestfabulaXX: Celgene mulling bid for Medivation $CELG $MDVN $SNY $PFE $AZN $AMGN https://t.co/OZsrGB9ebJCelgene mulling bid for Medivation $CELG $MDVN $SNY $PFE $AZN $AMGN https://t.co/OZsrGB9ebJBiotech Forum Daily Digest: The Biotech Rally Continues, Relypsa Gets Some Traction, Exelix... https://t.co/iMiDAqqFeh $ABBV $AGN $AMGNBiotech Forum Daily Digest: The Biotech Rally Continues, Relypsa Gets Some Traction, Exelix... https://t.co/0uJL5SVPAZ $ABBV $AGN $AMGNBiotech Forum Daily Digest: The Biotech Rally Continues, Relypsa Gets Some Traction, Exelix... https://t.co/hZm1napCiW $ABBV $AGN $AMGN$AAPL $AMAT $AMGN $AMTD $AMZN $ADI Trade long or long+short positions from the #NASDAQ, up to 1500% since 2010. https://t.co/ldcTl0HsrKInvestors Sell Shares of Amgen, Inc. $AMGN on Strength $AMGN https://t.co/PutgxF7jFxInvestors Sell Shares of Amgen, Inc. $AMGN on Strength $AMGN https://t.co/Otswwb3ssZBeen waiting for this Wednesday (all reports for last two weeks have led to today), to start seeing some action by $AMGN or $PFE on $MDVN@bradloncar believe $MDVN bidding war  soon to help bios. Xtandi cash flow sorely needed by $SNY + $AMGN and $PFE for financial engineering.RT @MarketsRecap: 3 Safe Dividend Stocks With Pristine Balance Sheets $AAPL $AMGN $GILD Also $GPS $JWN $M $TGT $AMZN https://t.co/NcW1nE1jL5RT @MarketsRecap: 3 Safe Dividend Stocks With Pristine Balance Sheets $AAPL $AMGN $GILD Also $GPS $JWN $M $TGT $AMZN https://t.co/NcW1nE1jL5@tgtxdough $REGN and $AMGN which are most exposed would see the most potential upside if the delay is confirmed.3 Safe Dividend Stocks With Pristine Balance Sheets $AAPL $AMGN $GILD Also $GPS $JWN $M $TGT $AMZN https://t.co/NcW1nE1jL5Morgan Stanley Reaffirms Buy Rating for Amgen, Inc. $AMGN https://t.co/lhDOGa5f8pMorgan Stanley Reaffirms Buy Rating for Amgen, Inc. $AMGN https://t.co/6MBxwILAscRT @FierceBiotech: Amgen, deCode data dive links gene to lower risk of heart attack: https://t.co/5vQHiBhcHD $AMGN@dogonenuts  im not talking old school onco. New school R$D with super high margins like $AMGN Blycinto@dogonenuts Is it? U mean like $AMGN's Blycinto?3 Safe Dividend Stocks With Pristine Balance Sheets $AAPL $AMGN $GILD Also $GPS $JWN $M $TGT $AMZN https://t.co/i8yHDBF9Vt$AMGN high open interest range is 146.00 to 150.00 for option expiration 05/27/2016.  https://t.co/15UQueGNZJ https://t.co/cbf5t6xYdl$AAPL $AMAT $AMGN $AMTD $AMZN $ATVI Trade long or long+short positions from the #NASDAQ, up to 1500% since 2010. https://t.co/ldcTl0HsrKMy money is on either $AMGN or $PFE, not $SFY https://t.co/Zrpm37S3tAHigh Pole https://t.co/tDLK7CG7yu $AAWW $ABUS $ADMA $ADSK $AJRD $ALIM $AMGN $AMSC $ARWR $ASHS $ATR $AVB $BEAV $BRFS $CAB $CBT $CCS",2016-05-25,AMGN,0
35,"Filled Bearish https://t.co/i14MC8ChDr $ACTA $AJX $ALDX $AMGN $AOSL $ASFI $AZN $BBH $BPY $BSQR $BSTC $BZQ $CAJ $CGIX $COYN $CUTR $DCM$AMGN Max Pain is 150.00 for maturity 05/27/2016. Price = 155.57. bearish https://t.co/xnVg6eC3qO https://t.co/BozWpeUWD2Newman Dignan &amp; Sheerar Inc. Purchases 156 Shares of Amgen, Inc. $AMGN https://t.co/Vd2DvE4GOeDaiwa SB Investments Ltd. Has $1,567,000 Position in Amgen, Inc. $AMGN https://t.co/FJYb1f8tiqThese $ITUS Profits Are much Bigger Than $AMGN$AMGN Current Report Filing (8-k)‚Ä¶ https://t.co/Uvv5rJwFig$AMGN Amgen Announces Early Tender Results Of Senior Notes Exc‚Ä¶ https://t.co/ttrsbJx3gGThese $ITUS Profits Are much Bigger Than $AMGNKyprolis Demonstrates Economic Value In Relapsed Or Refractory Multiple Myeloma Manuscript $AMGN https://t.co/yAZX7ORnyY via @YahooFinance$AMGN Kyprolis¬Æ (Carfilzomib) Demonstrates Economic Value In Relapsed Or Refractory Multiple Myeloma Manuscri
From our Stock News Alerts App$AMGN sum put oi=2,632 sum call oi=3,278 CallPutRatio=0.80 expiration 05/27/2016 bullish. https://t.co/15UQueYoRh https://t.co/HAt7op9GzqRT @FredrikRydlun: NASDAQ Dogs refine treasures of technology. Do brokers get it? https://t.co/59oxKunoIP $AAPL $AMGN $AVGO $CSCO $CSX $GIL‚Ä¶NASDAQ Dogs refine treasures of technology. Do brokers get it? https://t.co/59oxKunoIP $AAPL $AMGN $AVGO $CSCO $CSX $GILD $INTC $KHC $MSFTAMGN Top news - May 26th, 2016 $AMGN https://t.co/7esKBf98Me$IONS, formerly ISIS, got beheaded today. Down 40%, it shows dangers of ""investing"" in #SpecBios. Stick w big guns $CELG $GILD $BIIB $AMGNStockSpotify: M&amp;A Chatter $CELG $GILD $MDVN $SNY $AMGN $MON $BAYRY $NYRT $AAPL $AXLL https://t.co/YWU07klZDj https://t.co/DYmW4ztQD4Apple's Next Moves? Hints From M&amp;A Talks https://t.co/i5UM6ZnF8d $ACAS $AMGN $AMZN $ANAC $ARCC $BAM $BIN $BRCD $BUD $CI $COHR $CSC $DEPONasdaq100 #Stocks Trend $DLTR $NFLX $INTU $MU $WFM $CELG $BIIB $VOD $CA $MNST $INTC $AMGN $DISH $TXN $LRCX  @ https://t.co/YdSIjFJqHfS&amp;P100 #Stocks Trend $CELG $BIIB $WMT $INTC $SLB $AMGN $ABT $TXN $WFC $MRK $CSCO $AAPL $JPM $USB $GS $DD $COF  @ https://t.co/cKkr8cKsjuApple's Next Moves? Hints From M&amp;A Talks https://t.co/PhLliD6QMn $ACAS $AMGN $AMZN $ANAC $ARCC $BAM $BIN $BRCD $BUD $CI $COHR $CSC $DEPOApple's Next Moves? Hints From M&amp;A Talks https://t.co/CoOASdB3uD $ACAS $AMGN $AMZN $ANAC $ARCC $BAM $BIN $BRCD $BUD $CI $COHR $CSC $DEPOApple's Next Moves? Hints From M&amp;A Talks https://t.co/igFHycbgAL $ACAS $AMGN $AMZN $ANAC $ARCC $BAM $BIN $BRCD $BUD $CI $COHR $CSC $DEPOApple's Next Moves? Hints From M&amp;A Talks https://t.co/0QFqxVQdHH $ACAS $AMGN $AMZN $ANAC $ARCC $BAM $BIN $BRCD $BUD $CI $COHR $CSC $DEPO$AMGN OI for maturity 05/27/2016. 152.50 Highest put. 155.00 Highest call. bearish https://t.co/15UQueYoRh https://t.co/sgtRJeySK9$AMGN Form 8-K https://t.co/CULWJ5Wjuu #biotechstocks #biotech #stocksIs It Time To Worry About Debt Levels Again? - Bret Jensen | Seeking Alpha https://t.co/H88G9KA8E7 via @salphatrending $AAPL $AMGN $GILDRBC‚Äôs Michael Yee and team writes that $MDVN purchase ‚Äúmay not be the best value creation‚Äù for $AMGN $GILD &amp; $CELG https://t.co/0TJGJU6nRx@arenella1 the latest rumor as of this am: $CELG may enter the arena to join the fight for $MDVN along with 3 others, including $AMGN $SNYAMGN Quotes
See Here ---&gt; https://t.co/eVCGHYr83H

$AMGN $GLDD $CALA #stocks$AAPL $AMGN $GILD Is It Time To Worry About Debt Levels Again? https://t.co/BRT4iGa1ds https://t.co/210q5HWxqHXLV Has Rebounded And Is Ready To Break Out https://t.co/eITCQvyECs $AMGN $GILD $JNJ $PFE $XLVXLV Has Rebounded And Is Ready To Break Out https://t.co/hXKfK71UXR $AMGN $GILD $JNJ $PFE $XLVXLV Has Rebounded And Is Ready To Break Out https://t.co/3nrO6lVkdw $AMGN $GILD $JNJ $PFE $XLVThese $ITUS Profits Are much Bigger Than $AMGNRT @marketexclusive: Sanofi SA (NYSE:SNY) Wants New Board Of Directors For Medivation Inc (NASDAQ:MDVN) https://t.co/FfDjdnMLdY $SNY $MDVN‚Ä¶RT @marketexclusive: Sanofi SA (NYSE:SNY) Wants New Board Of Directors For Medivation Inc (NASDAQ:MDVN) https://t.co/FfDjdnMLdY $SNY $MDVN‚Ä¶RT @marketexclusive: Sanofi SA (NYSE:SNY) Wants New Board Of Directors For Medivation Inc (NASDAQ:MDVN) https://t.co/FfDjdnMLdY $SNY $MDVN‚Ä¶RT @marketexclusive: Sanofi SA (NYSE:SNY) Wants New Board Of Directors For Medivation Inc (NASDAQ:MDVN) https://t.co/FfDjdnMLdY $SNY $MDVN‚Ä¶RT @marketexclusive: Sanofi SA (NYSE:SNY) Wants New Board Of Directors For Medivation Inc (NASDAQ:MDVN) https://t.co/FfDjdnMLdY $SNY $MDVN‚Ä¶RT @marketexclusive: Sanofi SA (NYSE:SNY) Wants New Board Of Directors For Medivation Inc (NASDAQ:MDVN) https://t.co/FfDjdnMLdY $SNY $MDVN‚Ä¶RT @marketexclusive: Sanofi SA (NYSE:SNY) Wants New Board Of Directors For Medivation Inc (NASDAQ:MDVN) https://t.co/FfDjdnMLdY $SNY $MDVN‚Ä¶RT @marketexclusive: Sanofi SA (NYSE:SNY) Wants New Board Of Directors For Medivation Inc (NASDAQ:MDVN) https://t.co/FfDjdnMLdY $SNY $MDVN‚Ä¶Thoughts on $AMGN https://t.co/7jwccsAWJk$AAPL $AMAT $AMGN $AMTD $AMZN $ATVI Trade long or long+short positions from the #NASDAQ, up to 1500% since 2010. https://t.co/ldcTl0HsrKSanofi SA (NYSE:SNY) Wants New Board Of Directors For Medivation Inc (NASDAQ:MDVN) https://t.co/FfDjdnMLdY $SNY $MDVN $AMGN $PFE $GILD $NVS$INCY triggered 5/11; $BMRN 5/17; $JAZZ 5/18; $SHPG 5/19; $REGN 5/23; $AMGN would trigger potential breakout at 155.84#FusionIQ NEW Negative Timing Signal on $AMGN Today https://t.co/9ImlXz4YNa Please Retweet #SignalsA few stocks with bullish engulfing from yesterday to watch: $amgn $bbby $cemp $sgen $sxl $wdayThese $ITUS Profits Are much Bigger Than $AMGNThese $ITUS Profits Are much Bigger Than $AMGN$MDVN: Three Biotech Giants Enter. Which One Leaves? - Report Suggests $GILD has joined $AMGN $SNY $CELG  #Barron's https://t.co/snCUn6NkOB$AMGN Max Pain is 150.00 for maturity 05/27/2016. Price = 155.57. bearish https://t.co/xnVg6eC3qO https://t.co/q53dFvSSgr$AMGN:

New SEC Filing for AMGN: Form 8-K (No. 0001193125-16-602716):

https://t.co/hu0DKZV2Dg https://t.co/lpYlcDsbTE$AMGN Amgen Announces Pricing Terms Of Senior Notes Exchange O‚Ä¶ https://t.co/v5p0213a6R$AMGN ALERT: New Amgen SEC Filing
From our Stock News Alerts AppOne Amgen Center Drive  https://t.co/ORQEXEh0tj $AMGNThese $ITUS Profits Are much Bigger Than $AMGNThese $ITUS Profits Are much Bigger Than $AMGNThese $ITUS Profits Are much Bigger Than $AMGNThese $ITUS Profits Are much Bigger Than $AMGN$SPY $DIA $IWM $QQQ $IBB $XBI. $MDVN MUST not be sold to $SNY... Sell it to $PFE / $AMGN.$SPY $DIA $IWM $QQQ $IBB $XBI. $MDVN MUST not be sold to $SNY... Sell it to $PFE / $AMGN.RT @theflynews: On The Fly: Top stock stories for Wednesday $CSC $HPE $BABA $SNY $MDVN $GILD $CELG $PFE $AZN $NVS $AMGN $DY $... https://t.‚Ä¶Amgen, Inc. $AMGN Shares Gap Up to $152.72 https://t.co/w9eSUDwsjrRT @theflynews: On The Fly: Top stock stories for Wednesday $CSC $HPE $BABA $SNY $MDVN $GILD $CELG $PFE $AZN $NVS $AMGN $DY $... https://t.‚Ä¶https://t.co/G9pMgSr1JY &lt; Review of this fantastic traders teaching service!! Try it for FREE! $LLY $DGX $MRK $NVS $AMGN$AMGN sum put oi=2,331 sum call oi=3,258 CallPutRatio=0.72 expiration 05/27/2016 bullish. https://t.co/15UQueYoRh https://t.co/xHPhQGuHlAFLWS E.P.S.
See Here ---&gt; https://t.co/wldRTpaLy0

$FLWS $AMGN $TSRA #nasdaq",2016-05-26,AMGN,1
36,"AHL Stock Message Board
See Here ---&gt; https://t.co/wpYnVMu3DF

$AHL $AMGN $DE #investRT @StockTwits: So cool. A visual with the stocks with the most phase 2 trials. $CELG, $MRK, $AMGN, $BIIB https://t.co/rfTQQH9CZ4$AMGN Max Pain = 155.00. Maturity = 06/03/2016. Previous close = 156.74. bearish https://t.co/eW9tG6xrrp https://t.co/O6w4jPQHeTRT @slammingpicks: StockTwits: So cool. A visual with the stocks with the most phase 2 trials. $CELG, $MRK, $AMGN, $BIIB https://t.co/8J9E3‚Ä¶StockTwits: So cool. A visual with the stocks with the most phase 2 trials. $CELG, $MRK, $AMGN, $BIIB https://t.co/h0blBCp2RZStockTwits: So cool. A visual with the stocks with the most phase 2 trials. $CELG, $MRK, $AMGN, $BIIB https://t.co/8J9E3L42cVRT @StockTwits: So cool. A visual with the stocks with the most phase 2 trials. $CELG, $MRK, $AMGN, $BIIB https://t.co/rfTQQH9CZ4RT @StockTwits: So cool. A visual with the stocks with the most phase 2 trials. $CELG, $MRK, $AMGN, $BIIB https://t.co/rfTQQH9CZ4RT @Top5Traders: StockTwits: So cool. A visual with the stocks with the most phase 2 trials. $CELG, $MRK, $AMGN, $BIIB https://t.co/VmuYQHM‚Ä¶NR7 Stocks https://t.co/EfZDloQzb2 $CPXX $PANW $ULTA $TDW $NSAM $WIN $ATVI $PSTG $WY $FLEX $BTG $TWX $HOV $AMGN $COG $HBI $TNKStockTwits: So cool. A visual with the stocks with the most phase 2 trials. $CELG, $MRK, $AMGN, $BIIB https://t.co/VmuYQHMIHUSo cool. A visual with the stocks with the most phase 2 trials. $CELG, $MRK, $AMGN, $BIIB https://t.co/rfTQQH9CZ4RT @OphirGottlieb: (1/3) 

Tweet Storm

1. Phase III Trials: $GILD $PFE $CELG $LLY $AMGN $MRK

--&gt; https://t.co/MrZeDP0miW https://t.co/H6e‚Ä¶Nasdaq100 #Stocks Trend $WDC $MU $VRTX $BIIB $NXPI $DISH $DLTR $SIRI $CA $AMGN $MXIM $AKAM $CMCSA $BMRN $TRIP  @ https://t.co/YdSIjFJqHfS&amp;P100 #Stocks Trend $BIIB $ABT $AMGN $CMCSA $IBM $PFE $AMZN $ABBV $WFC $USB $MDLZ $MSFT $BMY $TWX $GOOGL $UPS @ https://t.co/cKkr8cKsjuS&amp;P100 #Stocks Performance $MON $BIIB $AMZN $UNP $GILD $MSFT $KMI $ABT $AMGN $CAT $CMCSA $IBM $SO $VZ $BMY more@ https://t.co/cKkr8cKsjuThese $ITUS Profits Are much Bigger Than $AMGN(2/3) 

Tweet Storm

2. Phase II Trials:$PFE $CELG $MRK $AMGN $BIIB

--&gt; https://t.co/MrZeDP0miW https://t.co/PQiBHM7kuI(1/3) 

Tweet Storm

1. Phase III Trials: $GILD $PFE $CELG $LLY $AMGN $MRK

--&gt; https://t.co/MrZeDP0miW https://t.co/H6exjPP3qF$AMGN:US Vetr Inc. Lowers Amgen, Inc. (AMGN) to Buy #AMGEN INC  https://t.co/pid2x3bSZi #NASDAQ$AMGN:US Vetr Inc. Lowers Amgen, Inc. (AMGN) to Buy #AMGEN INC  https://t.co/Hq6YpwY9dr #SP500$AMGN Long setup for 6/17 Expiration. https://t.co/ih6rYFMUWN$AMGN ALERT: New Amgen SEC Filing
From our Stock News Alerts App$XBI $AMGN $GILD $CPXX $JAZZ $IBB Biotech Sector breaks huge downtrend today! https://t.co/pgRbb4WmOr$CELG bad behavior intc.... right into $AMGNNasdaq100 #Stocks Trend $VRTX $BIIB $MU $DLTR $DISH $AMGN $EBAY $CELG $FISV $ULTA $VIAB $WDC $AMZN $NXPI $REGN  @ https://t.co/YdSIjFJqHfS&amp;P100 #Stocks Trend $BIIB $ABT $AMGN $CELG $AMZN $ABBV $MDLZ $TWX $GOOGL $MON $CMCSA $USB $WFC $GS $FDX $BMY  @ https://t.co/cKkr8cKsjuS&amp;P100 #Stocks Performance $MON $BIIB $AMZN $UNP $GILD $KMI $ABT $VZ $AMGN $FDX $TWX $ABBV $CMCSA $NEE  more@ https://t.co/cKkr8cKsju$AMGN leading bios here$AMGN sum put oi=1,827 sum call oi=1,805 CallPutRatio=1.01 expiration 06/03/2016 bearish. https://t.co/X2hv8EN51m https://t.co/9ea23VaTIQAmgen, Inc. $AMGN Shares Bought by Campbell Newman Asset Management Inc. https://t.co/Y2BSxUmFUVAmgen, Inc. $AMGN Stake Held by TNB Financial https://t.co/FGv5Tga09XRT @BioWorld: $AMGN myeloma drug Kyprolis to benefit from surprise EMA rebuff of Takeda‚Äôs Ninlaro$AMGN myeloma drug Kyprolis to benefit from surprise EMA rebuff of Takeda‚Äôs NinlaroAMGN Top news - May 31st, 2016 $AMGN https://t.co/bipevZKgQV$AMGN OI for maturity 06/03/2016. 155.00 Highest put. 155.00 Highest call. bearish https://t.co/X2hv8EN51m https://t.co/RjZrcMUbGJNasdaq100 #Stocks Trend $VRTX $MU $BIIB $DLTR $BMRN $CERN $DISH $ALXN $AKAM $EBAY $AMGN $CELG $VIAB $FISV $ULTA @ https://t.co/YdSIjFJqHfS&amp;P100 #Stocks Trend $BIIB $AMGN $CELG $ABT $WFC $PFE $AIG $COF $MDLZ $KMI $AMZN $ABBV $AXP $IBM $TXN $HAL $GS @ https://t.co/cKkr8cKsjuS&amp;P100 #Stocks Performance $BIIB $KMI $AMZN $MON $UNP $GILD $CAT $AGN $GS $VZ $FDX $MS $AMGN $ABBV $CELG  more@ https://t.co/cKkr8cKsjuApple's Next Moves? Hints From M&amp;A Talks https://t.co/Ov310RREAc $ACAS $AMGN $AMZN $ANAC $ARCC $BAM $BIN $BRCD $BUD $CI $COHR $CSC $DEPO$VXX is rising quietly, so  is $TWTR, $AMGN. $TSLA sucks to trade, $BABA trying to hold, $AAPL's done. $SPYVetr users have downgraded Amgen Inc. to a BUY Rating (4 stars), giving $AMGN a target price of $175.53 https://t.co/sgyPwK93LkWhat does $SFY not understand about their price being too low for $MDVN?  Now $CELG $GILD and $AMGN may bid  https://t.co/JsOJwsWdMr $MnA#Amgen receives positive CHMP opinion to extend indication of Kyprolis to treat relapsed mu... Read more: https://t.co/TglUBoJXzz $AMGN$AMGN:US Vetr Inc. Lowers Amgen, Inc. (AMGN) to Buy #AMGEN INC  https://t.co/aLUuoP0YhJ #NASDAQ$AMGN explosive@SPEQL8R I shorted it at $123 resistance and covered $117...also bought $AMGN at 150...waiting for $160 R or see where it fails!XBI Tops the Biotechnology ETFs in the Last Week of May $AMGN $GILD $IBB $JNJ https://t.co/IQKXCetaxhWeekly S&amp;P100 #Stocks Trend $BIIB $CELG $INTC $ABT $AMGN $WFC $TXN $COF $IBM $MDLZ $BLK $USB $GM $PFE $MRK  @ https://t.co/cKkr8csQUUWeekly S&amp;P100 #Stocks Performance $MON $BIIB $AAPL $ABBV $CELG $INTC $ABT $COST $AMGN $WFC $TXN $COF $HAL  more@ https://t.co/cKkr8csQUU$AAPL $AMAT $AMGN $AMTD $AMZN $ADI Trade long or long+short positions from the #NASDAQ, up to 1500% since 2010. https://t.co/ldcTl0pR3a$AMGN Max Pain = 155.00. Maturity = 06/03/2016. Previous close = 156.74. bearish https://t.co/eW9tG6xrrp https://t.co/5xPMuwqbEm$AMGN in ABC Bullish Pattern, Targets https://t.co/YNsN9nlIK1Benzinga: Barron's Picks And Pans: REITs, Brown-Forman, ConAgra Foods And More $AMGN $AVB $CAG $PSA $TSLA https://t.co/3EwzACwJsVBenzinga: Barron's Picks And Pans: REITs, Brown-Forman, ConAgra Foods And More $AMGN $AVB $CAG $PSA $TSLA https://t.co/8UKcRA7RVjBarron's Picks And Pans: REITs, Brown-Forman, ConAgra Foods And More $AMGN $AVB $CAG $PSA $TSLA https://t.co/MdPSsmRH4GAmgen $AMGN ‚Äì Investment Analysts‚Äô Recent Ratings Updates https://t.co/VErxA4R6RuInteresting find: When $RLYP was spun from $AMGN they were  given two additional assets ILY102 and 103. The former is a NA+ binder for CHFAmgen $AMGN ‚Äì Investment Analysts‚Äô Recent Ratings Updates https://t.co/1FeDBIj26EBiotech Trade Alerts Archive -2016-05-27- $PTLA, $ABBV, $MRK, $GILD, $AMGN, $RHHBY, $CANF, $SHPG,¬†$ALDX https://t.co/kLnWoLw3PHRT @theflynews: On The Fly: Top five weekend stock stories $VIA $VIAB $CBS $BAYRY $MON $ABBV $BIIB $ICPT $SU $VZ $CAG $AMGN $... https://t.‚Ä¶@turdcapital Actually, $RLYP amended its license w/ $AMGN and owes NO royalty on Veltassa. https://t.co/2LWmjcMkIu https://t.co/YUZJrdrxOc@exMBB https://t.co/pdC8R7EZ4H The tech was pulled from $AMGN's Ilypsa which spun off $RLYP@exMBB $RLYP was spun from $AMGN when they did so the poly-binding was also in-liscenced for the dev of veltassa. Ill go find it.Amgen, Inc. $AMGN Lowered to Buy at Vetr Inc. https://t.co/FxsFOVOB2BAmgen, Inc. $AMGN Lowered to Buy at Vetr Inc. https://t.co/z6yRwWELhK$AMGN:US Vetr Inc. Lowers Amgen, Inc. (AMGN) to Buy #AMGEN INC  https://t.co/JeB9dsgGKB #NASDAQThese $ITUS Profits Are much Bigger Than $AMGN$AMGN received a new alert. Find out why at https://t.co/nZwqReM0tj #stocks #daytrading #trading #mkt  #NYSE #NASDAQ #markets 192Equities Research Analysts‚Äô Downgrades for May, 30th $AMGN, AR, BIDU, CHK, ELY, GOOG, HEES, HZNP, IDN, IDTI https://t.co/gnpUcYkSvHAmgen downgraded by Vetr Inc. to buy. $175.53 PT. https://t.co/vu2CRkMsAU $AMGN #AMGN$AMGN,AR,BIDU,CHK,ELY,GOOG,HEES,HZNP,IDN,IDTI - Equities Research Analysts' Downgrades for May, 30th #AMGN, AR‚Ä¶ https://t.co/7U8tOj0o9CAmgen downgraded by Vetr Inc. to buy. $175.53 PT. https://t.co/46PASv4BDo $AMGN #AMGNRT @theflynews: On The Fly: Top five weekend stock stories $VIA $VIAB $CBS $BAYRY $MON $ABBV $BIIB $ICPT $SU $VZ $CAG $AMGN $... https://t.‚Ä¶RT @theflynews: On The Fly: Top five weekend stock stories $VIA $VIAB $CBS $BAYRY $MON $ABBV $BIIB $ICPT $SU $VZ $CAG $AMGN $... https://t.‚Ä¶RT @theflynews: On The Fly: Top five weekend stock stories $VIA $VIAB $CBS $BAYRY $MON $ABBV $BIIB $ICPT $SU $VZ $CAG $AMGN $... https://t.‚Ä¶RT @theflynews: On The Fly: Top five weekend stock stories $VIA $VIAB $CBS $BAYRY $MON $ABBV $BIIB $ICPT $SU $VZ $CAG $AMGN $... https://t.‚Ä¶On The Fly: Top five weekend stock stories $VIA $VIAB $CBS $BAYRY $MON $ABBV $BIIB $ICPT $SU $VZ $CAG $AMGN $... https://t.co/XIAfss57m5$AMGN maturity 06/03/2016 oi CallPutRatio of 0.96 puts 1,196 &amp; calls 1,246 bullish. https://t.co/X2hv8EN51m https://t.co/rCVTNJtrir$AAPL $AMAT $AMGN $AMTD $AMZN $ATVI Trade long or long+short positions from the #NASDAQ, up to 1500% since 2010. https://t.co/ldcTl0HsrK",2016-05-31,AMGN,1
37,"S&amp;P100 #Stocks Trend $C $MDLZ $CMCSA $RTN $TWX $PFE $BIIB $USB $AMGN $BMY $MON $JPM $UNH $WFC $MET $AXP $ABBV  @ https://t.co/cKkr8csQUURT @bret_jensen: $RLYP $SNY $MRK $AMGN The only questions are who buys Relypsa, at what price and when.  Place your bets now https://t.co/e‚Ä¶$RLYP $SNY $MRK $AMGN The only questions are who buys Relypsa, at what price and when.  Place your bets now https://t.co/eWTRc3VLyQWhere The Big Short Is Finding Value https://t.co/ehE9CClFys $AAPL $HCA $FSLR $AMGN$AMGN high open interest range is 155.00 to 155.00 for option expiration 06/03/2016. bearish https://t.co/X2hv8EN51m https://t.co/E0UpPHy9aLS&amp;P100 #Stocks Trend $CMCSA $PFE $RTN $TWX $C $BIIB $USB $AMGN $MDLZ $BMY $AMZN $MON $JPM $BAC $MET $AXP $ABBV @ https://t.co/cKkr8cKsjuCue Financial Group Inc. Has $1,038,000 Stake in Amgen, Inc. $AMGN https://t.co/7Pb8qRPL5z$AMGN got 8% royalty to palbo through $ONXX acq.  BofE math =~2B-3B NPV. Nexavar + Stivarga still &gt; $1B sales... https://t.co/bKRzLas7wHCue Financial Group Inc. Has $1,038,000 Stake in Amgen, Inc. $AMGN https://t.co/ALSZoDcfydJacobs &amp; Co. CA Raises Position in Amgen, Inc. $AMGN https://t.co/uOoLJPA1Z1Amgen, Inc. $AMGN Shares Sold by Blue Fin Capital Inc. https://t.co/EUlHzsCZ2PAmgen, Inc. $AMGN Stake Raised by Mission Wealth Management LLC https://t.co/OzTXD3EvJAMittelfristiges Signal! $AMGN: Eine Doppeltief wurde bei 158.250 USD nach oben durchbrochen:  https://t.co/BkPADp9HWw$AMGN ripping higherAmgen‚Äôs Autumn Gems $AMGN https://t.co/ZO8quvPoeH$AMGN Max Pain = 155.00. Maturity = 06/03/2016. Previous close = 157.95. bearish https://t.co/eW9tG6xrrp https://t.co/7XOp0f0vW9AMGN Top news - Jun 1st, 2016 $AMGN https://t.co/oP9yf6gJB0S&amp;P100 #Stocks Trend $PFE $MDLZ $AMZN $CMCSA $BIIB $AMGN $BMY $MON $ABBV $TWX $MO $EMC $CSCO $NEE $TXN $CELG  @ https://t.co/cKkr8cKsjuWhy am i still looking at $AMGN when i got out earlier... obession gone awry$amgn is starting to cookApple's Next Moves? Hints From M&amp;A Talks https://t.co/Ov310RREAc $ACAS $AMGN $AMZN $ANAC $ARCC $BAM $BRCD $BUD $CI $COHR $CSC $DEPO $DFWant the latest analyst ratings on $VTL $CIO $AMGN $CNI $ISRG? Get Them Delivered to Your Inbox https://t.co/nSJuDsYidjThese $ITUS Profits Are much Bigger Than $AMGN$AMGN:US Amgen, Inc. (AMGN) Shares Gap Up to $156.74 #AMGEN INC  https://t.co/6wZMF1PvgZ #SP500Watching $aet, $amgn, $unh, adbe etc$AMGN sum put oi=1,983 sum call oi=1,898 CallPutRatio=1.04 expiration 06/03/2016 bearish. https://t.co/X2hv8EN51m https://t.co/DsfiCFPWf9$AMGN setting up a long over $158 (not yet, it's reached a short-term saturation point). https://t.co/YhF59JW6W6These $ITUS Profits Are much Bigger Than $AMGNRT @OphirGottlieb: (2/3) 

Tweet Storm

2. Phase II Trials:$PFE $CELG $MRK $AMGN $BIIB

--&gt; https://t.co/MrZeDP0miW https://t.co/PQiBHM7kuIRT @OphirGottlieb: (1/3) 

Tweet Storm

1. Phase III Trials: $GILD $PFE $CELG $LLY $AMGN $MRK

--&gt; https://t.co/MrZeDP0miW https://t.co/H6e‚Ä¶Weekly Nasdaq100 #Stocks Trend $DLTR $ULTA $MU $WDC $VIAB $DISH $BIIB $VRTX $AKAM $AMGN $ALXN $NXPI $CA $TRIP  @ https://t.co/YdSIjFJqHfWeekly S&amp;P100 #Stocks Trend $BIIB $ABT $IBM $AMGN $PFE $CMCSA $ABBV $AMZN $WFC $USB $MDLZ $TWX $MSFT $GOOGL  @ https://t.co/cKkr8cKsjuWeekly S&amp;P100 #Stocks Performance $BIIB $KMI $COST $ABT $ABBV $IBM $UNP $TWX $AMGN $WFC $AGN $MON $MSFT  more@ https://t.co/cKkr8cKsjuUnicorn Bay rating for $AMGN is 3.71 out of 5. https://t.co/KGl3e9aGjoDo you know that #WallStreet price for $AMGN is $182.35 https://t.co/jyn12g7slaWe calculated 63-day Expected Return of $AMGN for you: 6.93% https://t.co/sG9C8sduf7$AMGN best value in biotech with earnings and rev growth.Vetr Inc. Downgrades Amgen, Inc. $AMGN to Buy https://t.co/W7vljPHjhVVetr Inc. Downgrades Amgen, Inc. $AMGN to Buy https://t.co/JQ16JTcgMQHMTV Last Trade
See Here ---&gt; https://t.co/YQ7y3fnwjO

$HMTV $AMGN $VOYA #nasdaq$AMGN:US Amgen, Inc. (AMGN) Shares Gap Up to $156.74 #AMGEN INC  https://t.co/as2iZjA15M #SP500AMGN Bid
See Here ---&gt; https://t.co/IsweRFEXMF

$AMGN $DEG $SREV #invest$AMGN OI for maturity 06/03/2016. 155.00 Highest put. 155.00 Highest call. bearish https://t.co/X2hv8EN51m https://t.co/gPGrJVYfXcAmgen, Inc. $AMGN Shares Gap Up to $156.74 https://t.co/VmJiHmdDcT$AAPL $AMAT $AMGN $AMTD $AMZN $ATVI Trade long or long+short positions from the #NASDAQ, up to 1500% since 2010. https://t.co/ldcTl0HsrKThese $ITUS Profits Are much Bigger Than $AMGNVideo: A Gene That Could Prevent a Heart Attack 
https://t.co/tdWKveeSSt
$AMGN $XLV $IBB #CNBC #stocks #finance https://t.co/ePe3xgKeJYRT @StockTwits: So cool. A visual with the stocks with the most phase 2 trials. $CELG, $MRK, $AMGN, $BIIB https://t.co/rfTQQH9CZ4",2016-06-01,AMGN,1
38,"RT @hedgefundclone: $XBI $BIIB $AMGN $IBB Biotech Stocks officially breaking out today, $XBI should fill back gap at $70! https://t.co/DMn7‚Ä¶Over Bollinger https://t.co/wogC3IfJoy $XIV $FXI $EBIO $XBI $TEVA $SVXY $LABU $FIT $SDLP $UNH $EPI $IPG $HOLX $WYNN $GRUB $AMGN $JNPRNasdaq100 #Stocks Trend $DISH $BMRN $INCY $ALXN $TRIP $CELG $VRTX $TMUS $AMZN $AMGN $VIAB $WFM $CA $PAYX $CTXS  @ https://t.co/YdSIjFJqHfS&amp;P100 #Stocks Trend $ABBV $MDT $CELG $AMZN $AMGN $UNH $RTN $BIIB $AXP $TWX $C $CMCSA $DD $V $MDLZ $BMY $JNJ  @ https://t.co/cKkr8cKsjuS&amp;P100 #Stocks Performance $ABBV $MDT $DD $CELG $AGN $CAT $BMY $JNJ $DOW $AMZN $AMGN $UNH $PCLN $BIIB $V  more@ https://t.co/cKkr8cKsju$AMGN OI for maturity 06/03/2016. 155.00 Highest put. 155.00 Highest call. bearish https://t.co/X2hv8EN51m https://t.co/4w0qkkPy00Interview with Connor Bruggeman SchoolTrader Extraordinaire!: https://t.co/DgrNThhkJM $NFLX $HIMX $INO $AMGN $GOOGLRT @hedgefundclone: $XBI $BIIB $AMGN $IBB Biotech Stocks officially breaking out today, $XBI should fill back gap at $70! https://t.co/DMn7‚Ä¶RT @BioWorld: $AMGN myeloma drug Kyprolis to benefit from surprise EMA rebuff of Takeda‚Äôs NinlaroRT @hedgefundclone: $XBI $BIIB $AMGN $IBB Biotech Stocks officially breaking out today, $XBI should fill back gap at $70! https://t.co/DMn7‚Ä¶Nasdaq100 #Stocks Trend $BMRN $DISH $ALXN $CELG $TRIP $VRTX $WFM $AMGN $ESRX $CTXS $FISV $MNST $ULTA $INCY  @ https://t.co/YdSIjFJqHfS&amp;P100 #Stocks Trend $MDT $ABBV $CELG $UNH $AMGN $RTN $BIIB $AXP $TWX $CMCSA $PFE $V $MDLZ $JNJ $BMY $AMZN  @ https://t.co/cKkr8cKsjuS&amp;P100 #Stocks Performance $MDT $ABBV $DD $CELG $JNJ $CAT $AGN $BMY $DOW $UNH $AMGN $BIIB $AMZN $MRK $RTN  more@ https://t.co/cKkr8cKsju$AMGN Max Pain = 155.00. Maturity = 06/03/2016. Previous close = 158.05. bearish https://t.co/eW9tG6xrrp https://t.co/c6asT9dLMNAmgen, Inc. $AMGN is CrestPoint Capital Management LLC‚Äôs 9th Largest Position https://t.co/AKDArNQeFLAmgen, Inc. $AMGN is CrestPoint Capital Management LLC‚Äôs 9th Largest Position https://t.co/ZW8QGIkm8S$IWM still outperforming $SPY, expect this to continue. $AMGN, $IBM keep climbing.Do you know that #WallStreet price for $AMGN is $182.35 https://t.co/jyn12gp3cICoastline Trust Co Boosts Stake in Amgen, Inc. $AMGN https://t.co/RJ7iJb07IRAmgen, Inc. $AMGN Shares Bought by M. Kraus &amp; Co https://t.co/GIzbE4HiIpRT @hedgefundclone: $XBI $BIIB $AMGN $IBB Biotech Stocks officially breaking out today, $XBI should fill back gap at $70! https://t.co/DMn7‚Ä¶$XBI $BIIB $AMGN $IBB Biotech Stocks officially breaking out today, $XBI should fill back gap at $70! https://t.co/DMn7Hk5qcpPopular: $RLYP, $JCP, $MDT, $CST, $DATA, $SVXY, $PBF, $ACN, $CARA, $TNA, $OLED, $AMGNWondering about risks of $AMGN? The 63-day volatility is 10.32% https://t.co/08XQBOGBC6$QQQ Top 20 Holdings: Tech lags $AAPL $MSFT $GOOG but $AMZN Bios pop $CELG $AMGN $BIIB $WBA Bull Fight! $NDX $COMPQ https://t.co/GqRiiVE39Rperformance update. @zzlangerhans #zzporte $ABBV $ALXN $AMGN $BIIB $CELG $FPRX $GILD $IBB $INO $MDVN $REGN $VRX $XBI https://t.co/wnL9Sfqd3pThese $ITUS Profits Are much Bigger Than $AMGNAMGN Top news - Jun 2nd, 2016 $AMGN https://t.co/pby2OTMlYE$ADAP @Adaptimmune Therapeutics

$MDT $BSX $TMO $EW $DXCM $IDXX $NVTA $AMGN $SNY $LLY $BAYRY $GILD $BIIB $CELG $REGN https://t.co/J753ayJve8$AMGN maturity 06/03/2016 oi CallPutRatio of 1.02 puts 2,017 &amp; calls 1,984 bearish. https://t.co/X2hv8EN51m https://t.co/i7DV6vBlEOAmgen, Inc. $AMGN Shares Gap Up to $156.74 https://t.co/xSxyejk5oKAmgen, Inc. $AMGN Shares Gap Up to $156.74 https://t.co/ddT96RLohQS&amp;P500 #Stocks Trend $AET $ABBV $WYNN $CNC $ALXN $MNK $WAT $ESRX $AMGN $RTN $MNST $HOLX $WFM $WDC $MCK $UNH  @ https://t.co/RPeaHBHYi0Nasdaq100 #Stocks Trend $BMRN $DISH $ALXN $ESRX $AMGN $MNST $WFM $ULTA $WDC $VRTX $BIIB $DLTR $FISV $LRCX $REGN @ https://t.co/YdSIjFJqHfS&amp;P100 #Stocks Trend $ABBV $AMGN $RTN $UNH $BIIB $TWX $CMCSA $MDLZ $BMY $MON $CELG $MRK $V $FOXA $CSCO $AXP  @ https://t.co/cKkr8cKsjuS&amp;P100 #Stocks Performance $ABBV $MDT $F $CELG $UNH $JNJ $AGN $BMY $DD $LLY $CAT $BIIB $AMGN $MRK $RTN  more@ https://t.co/cKkr8cKsju$Mdvn gonna happen. Gut says Monday for 70-75 from $pfe or $amgnThis is a rarity these days on #WallStreet my #401K $AMGN $BABA $BLUE $CELG $FB $JUNO $KITE $VRX all green today!!! https://t.co/NaxMuKDS9GApple's Next Moves? Hints From M&amp;A Talks https://t.co/Ov310RREAc $ACAS $AMGN $AMZN $ANAC $ARCC $BAM $BRCD $BUD $CI $COHR $CSC $DEPO $DFAmgen hits a 1 month high https://t.co/TVSs33cCO3 $AMGN #Amgen https://t.co/qLpfGADB3e$AAPL $AMAT $AMGN $AMTD $AMZN $ADI Trade long or long+short positions from the #NASDAQ, up to 1500% since 2010. https://t.co/ldcTl0HsrKUS companies are hoarding cash $AAPL $MSFT $GOOG $CSCO $ORCL $PFE $JNJ $INTC $AMGN $QCOM 
https://t.co/P1Ay9qkcFc https://t.co/XauvmANTQT$AMGN high open interest range is 155.00 to 155.00 for option expiration 06/03/2016. bearish https://t.co/X2hv8EN51m https://t.co/2U9vpWAkYsThe Medicines Company hits enrollment target in mid-stage study of RNAi therapeutic for t... https://t.co/d3mmxtHzOD $MDCO $ALNY $AMGN $REGNRT @StockTwits: So cool. A visual with the stocks with the most phase 2 trials. $CELG, $MRK, $AMGN, $BIIB https://t.co/rfTQQH9CZ4RT @MarketCurrents: The Medicines Company hits enrollment target in mid-stage study of RNAi therap... https://t.co/KiBeshijNU #premarket $M‚Ä¶The Medicines Company hits enrollment target in mid-stage study of RNAi therap... https://t.co/DUOX2std4Y #premarket $MDCO $ALNY $AMGN $REGNThe Medicines Company hits enrollment target in mid-stage study of RNAi therap... https://t.co/icoPFVy9bR #premarket $MDCO $ALNY $AMGN $REGNThe Medicines Company hits enrollment target in mid-stage study of RNAi therap... https://t.co/KiBeshijNU #premarket $MDCO $ALNY $AMGN $REGNWeekly S&amp;P100 #Stocks Trend $CMCSA $MDLZ $C $TWX $BIIB $PFE $RTN $AMGN $USB $BMY $MON $ABBV $WFC $AXP $UNH  @ https://t.co/cKkr8cKsjuWeekly S&amp;P100 #Stocks Performance $AGN $COST $TWX $DUK $ABBV $BIIB $ABT $SO $CMCSA $BMY $AMGN $AMZN $EXC  more@ https://t.co/cKkr8cKsjuAmgen, Inc. $AMGN Cut to Buy at Vetr Inc. https://t.co/vrfhpkbRgnAmgen, Inc. $AMGN Cut to Buy at Vetr Inc. https://t.co/DuMei9RquFRT @AndyBiotech: Biotech and Pharma companies with most Medicare Part B exposure (via GS)

$REGN $AMGN $SGEN $BXLT $BIIB https://t.co/68nii‚Ä¶These $ITUS Profits Are much Bigger Than $AMGN$AMGN Max Pain = 155.00. Maturity = 06/03/2016. Previous close = 157.95. bearish https://t.co/eW9tG6xrrp https://t.co/LK0R2nQNAxThese $ITUS Profits Are much Bigger Than $AMGNhttps://t.co/G9pMgSr1JY &lt; Review of this fantastic traders teaching service!! Try it for FREE! $LLY $DGX $MRK $NVS $AMGNRT @StockWebTrading: $AAPL $AMAT $AMGN $AMTD $AMZN $ATVI Trade long or long+short positions from the #NASDAQ, up to 1500% since 2010. https‚Ä¶$AAPL $AMAT $AMGN $AMTD $AMZN $ATVI Trade long or long+short positions from the #NASDAQ, up to 1500% since 2010. https://t.co/ldcTl0HsrKBMO Ex-Div Date
See Here ---&gt; https://t.co/CWuzl9Bntx

$BMO $PBR $AMGN #finance$AMGN Assuming no weekly growth for remainder of quarter implies 2Q16 estimates of $26mn/$23mn for Repatha/Praluent PER IMS$AMGN maturity 06/03/2016 oi CallPutRatio of 1.04 puts 1,983 &amp; calls 1,898 bearish. https://t.co/X2hv8EN51m https://t.co/oDI69ojsjr",2016-06-02,AMGN,0
39,"Over PC https://t.co/nnhjRXp0hh $DIA $AET $CETX $IWD $SSO $CBG $AMGN $QRVO $UPRO $EXPD $JNS $EWQ $LSCC $CMI $CNC $LRGF $WDR$AMGN high open interest range is 155.00 to 162.50 for option expiration 06/10/2016.  https://t.co/jCaTN0IBi4 https://t.co/60YJt885Z3$AMGN: Amgen announces data from a secondary analysis of the pivotal Phase 3 Aspire trial was presented at ASCO https://t.co/klxkwlgftFVAL E.P.S.
See Here ---&gt; https://t.co/RAt7QRVr4h

$VAL $AMGN $AIR #stockAAN panel on #Enbrel: ""insufficient evidence"" to determine if safe or effective for poststroke disability"" https://t.co/WKoPwq1B1e $AMGN$BDSI finally gapping up today, serious upside ( 52-week high -$9.91)  $AGN still heavily undervalued. Like $GILD $AMGN $VRX $FPRXRT @HumbleBioTrader: $AMGN Announces Kyprolis Phase 3 Data in Relapsing Multiple Myeloma; Improved PFS, ORR Noted https://t.co/evrzpmnMqG v‚Ä¶$AMGN..New Ph 3 Second Analysis Shows PFS benefit in Early Relapse MM Pts Treated W/Kyprolis¬Æ -Based Regimen https://t.co/3NpmOXmQMN$AMGN New Phase 3 Secondary Analysis Shows Progression-Free Survival Benefit In Early Relapsing Multiple Myel
From our Stock News Alerts App$AMGN Announces Kyprolis Phase 3 Data in Relapsing Multiple Myeloma; Improved PFS, ORR Noted https://t.co/evrzpmnMqG via @Street_Insidertook profits on $AMGNRT @embryonicstem: #Biotech stocks making big gains today $KITE $AMRS $BLUE  $USMJ $JUNO $AMGN | $IBB $SPY $DIA $IWM $SPX $RUTAs If The Bringer of Kyprolis to $AMGN expands her pipeline w/o the knowledge that pegpH20 works https://t.co/Pd4NLdMjFu $HALOAmgen, Inc. $AMGN Position Held by Howard Capital Management https://t.co/rdHhd0eoVwKelman Lazarov Inc. Invests $252,000 in Amgen, Inc. $AMGN https://t.co/ekaK5RaqS8Amgen, Inc. $AMGN Position Held by Howard Capital Management https://t.co/Fxne8aGtt8Kelman Lazarov Inc. Invests $252,000 in Amgen, Inc. $AMGN https://t.co/agR4QxHicfHandelsinvest Investeringsforvaltning Maintains Stake in Amgen, Inc. $AMGN https://t.co/oo8NviX8U1Amgen, Inc. $AMGN Position Raised by FirstMerit Bank N A Trustee https://t.co/RKGyEWMDDPWendell David Associates Inc. Maintains Position in Amgen, Inc. $AMGN https://t.co/KYUOISJt0ART @Maximum_Pain_cm: $AMGN Max Pain = 155.00. Maturity = 06/10/2016. Previous close = 159.19. bearish https://t.co/ixmbjKaC0H https://t.co/‚Ä¶SAlphaTrending: This Bull's Getting Old, So Where Is The Value? - Part 3 https://t.co/ptjRttICtV $AAPL #APPLE $ABBV $ABC $AMGN $AMP $BA $B‚Ä¶$AMGN Max Pain = 155.00. Maturity = 06/10/2016. Previous close = 159.19. bearish https://t.co/ixmbjKaC0H https://t.co/sMIK2JAzAbSAlphaTrending: This Bull's Getting Old, So Where Is The Value? - Part 3 https://t.co/ptd0OGP9Q2 $AAPL #APPLE $ABBV $ABC $AMGN $AMP $BA $B‚Ä¶This Bull's Getting Old, So Where Is The Value? - Part 3 https://t.co/3Q5lIJ3pfm $AAPL #APPLE $ABBV $ABC $AMGN $AMP $BA $BMO $BNS $BRK.BAMGN Last Trade
See Here ---&gt; https://t.co/JDpqgyUihY

$AMGN $TBRA $HSBC #shareAMGN Top news - Jun 6th, 2016 $AMGN https://t.co/J0RJXPFDdXA trifecta of top healthcare value stocks for dividend investors, from Mike Nadel on Seeking Alpha: https://t.co/IvGiCcQ2X7 $OHI $AMGN $MCKThis Bull's Getting Old, So Where Is The Value? - Part 3 https://t.co/ADfEe1fJJe $AAPL #APPLE $ABBV $ABC $AMGN $AMP $BA $BMO $BNS $BRK.BThis Bull's Getting Old, So Where Is The Value? - Part 3 https://t.co/NhJDDVMs0D $AAPL #APPLE $ABBV $ABC $AMGN $AMP $BA $BMO $BNS $BRK.BThis Bull's Getting Old, So Where Is The Value? - Part 3 https://t.co/8FM9o5gvDD $AAPL #APPLE $ABBV $ABC $AMGN $AMP $BA $BMO $BNS $BRK.B#Biotech stocks making big gains today $KITE $AMRS $BLUE  $USMJ $JUNO $AMGN | $IBB $SPY $DIA $IWM $SPX $RUT#Biotech stocks making big gains today $KITE $AMRS $BLUE $JUNO $AMGN | $IBB $SPY $DIA $IWM $SPX $RUTNasdaq100 #Stocks Trend $LBTYA $MNST $DISH $TMUS $MDLZ $AVGO $CELG $HSIC $PCLN $PAYX $CA $CSX $WFM $AMGN $ULTA  @ https://t.co/YdSIjFJqHfS&amp;P100 #Stocks Trend $UNH $MDT $RTN $MDLZ $ABBV $HAL $V $CELG $MO $DOW $DD $PG $BMY $PCLN $JNJ $NEE $UNP $AMGN @ https://t.co/cKkr8cKsjuWe calculated 21-day Expected Return of $AMGN for you: 3.56% https://t.co/sG9C8sv56FThese $ITUS Profits Are much Bigger Than $AMGN$AMGN sum put oi=2,055 sum call oi=2,079 CallPutRatio=0.99 expiration 06/10/2016 bullish. https://t.co/jCaTN0IBi4 https://t.co/NeflV29vVZRT @WrigleyTom: Some nHod

$IBB $BIB $XBI $GILD $AMGN
$PBYI $MYL $ICPT $ACAD $ALNY
$KITE $JUNO $BLUE $NVCR $VBLT
$RDUS $CELG $VRTX $CYCC $C‚Ä¶RT @WrigleyTom: Some nHod

$IBB $BIB $XBI $GILD $AMGN
$PBYI $MYL $ICPT $ACAD $ALNY
$KITE $JUNO $BLUE $NVCR $VBLT
$RDUS $CELG $VRTX $CYCC $C‚Ä¶RT @WrigleyTom: Some nHod

$IBB $BIB $XBI $GILD $AMGN
$PBYI $MYL $ICPT $ACAD $ALNY
$KITE $JUNO $BLUE $NVCR $VBLT
$RDUS $CELG $VRTX $CYCC $C‚Ä¶Some nHod

$IBB $BIB $XBI $GILD $AMGN
$PBYI $MYL $ICPT $ACAD $ALNY
$KITE $JUNO $BLUE $NVCR $VBLT
$RDUS $CELG $VRTX $CYCC $CLVSAmgen researchers discover gene associated with lower risk of heart disease https://t.co/dclYDst5HW via @WSJ $AMGNApple's Next Moves? Hints From M&amp;A Talks https://t.co/Ov310RREAc $ACAS $AMGN $AMZN $ANAC $ARCC $BAM $BRCD $BUD $CI $COHR $CSC $DEPO $DFBiotechs: Ready To Move Higher, Much Higher https://t.co/3zHCt3NpPE
$sny $depo $cpxx $biib $amgn $grfs $irwd $alny $nktr $espr $labu $ubioAmgen hits a 1 month high https://t.co/TVSs33cCO3 $AMGN #Amgen https://t.co/UGv6SV9o5QBiotech: What‚Äôs the Trade? https://t.co/RMc6ng0q9m $GILD $CELG $BIIB $AMGNRT @biosimilarz: $MYL's/Biocon's trastuzumab p3 data has made significant headlines, but $AMGN's bevacizumab p3 data hasn't; I wonder why t‚Ä¶CLB Ideas
See Here ---&gt; https://t.co/XJcFVCZXIF

$CLB $AMGN $STML #investing$AAPL $AMAT $AMGN $AMTD $AMZN $ATVI Trade long or long+short positions from the #NASDAQ, up to 1500% since 2010. https://t.co/ldcTl0HsrKAMGEN has been rising in this channel from $130. I expect it ends near $172 &amp; then reverses below $130. $AMGN $IBB https://t.co/Ee2qB6ocJ4Biotechnology: Ready To Move Higher - Much Higher https://t.co/qx0VP9tXFz $ABBV $ACAD $AGN $ALNY $ALPMY $AMGN $ANAC $BIB $BIIB $CELG $CPXX$AMGN high open interest range is 155.00 to 162.50 for option expiration 06/10/2016.  https://t.co/jCaTN0IBi4 https://t.co/0RHJwm0JsGRT @CashRocket: TOP UPCOMING EVENTS IN 2016: $BIIB $VRTX $ESPR $MDCO $SCYX $PRTA $AMGN $CELG $KITE $INFI $GILD $ACOR $PTI $FGEN https://t.c‚Ä¶RT @ezzmoney2day: ERY Direxion Daily Energy Bear 3x Shares Bid Size
https://t.co/mWoSZ3O2NS

$ERY $AMGN $HPE $CVX  #nasdaq #stockmarketRT @lancejepsen: Amgen Inc Kyprolis (Carfilzomib) Gets FDA Approval $AMGN https://t.co/hUs8hBeym9 https://t.co/9QY6CePwG8RT @biosimilarz: $MYL's/Biocon's trastuzumab p3 data has made significant headlines, but $AMGN's bevacizumab p3 data hasn't; I wonder why t‚Ä¶$MYL's/Biocon's trastuzumab p3 data has made significant headlines, but $AMGN's bevacizumab p3 data hasn't; I wonder why that is...?SCTY SolarCity Corp. 52Wk High
https://t.co/msJMdEy1mj

$SCTY $MNST $FFR $AMGN  #stockmarket #pennystocksERY Direxion Daily Energy Bear 3x Shares Bid Size
https://t.co/mWoSZ3O2NS

$ERY $AMGN $HPE $CVX  #nasdaq #stockmarketAMGN Amgen, Inc. Change
https://t.co/kWZE2EOlCT

$AMGN $FNMA $COD.L $CHK  #investing #stockmarketALB Albemarle Corp. Stock Forum
https://t.co/fg08Idmslr

$ALB $EGO $AMGN $IBB  #pennystocks #stocksRT @AndysCycles: $IBB biotech index components. $ENDP $VRTX $MYL $BIIB $ALXN $AMGN $ILMN $REGN $CELG $BMRN $INCY $JAZZ $GILD $MDVN https://‚Ä¶$AMGN #Options volume chart in animation. More with #OptionsPro FREE app at https://t.co/K8PrRVM20E https://t.co/5QFNLbSvLy$IBB biotech index components. $ENDP $VRTX $MYL $BIIB $ALXN $AMGN $ILMN $REGN $CELG $BMRN $INCY $JAZZ $GILD $MDVN https://t.co/EdsQv7PvjxWondering about #sentiment indicator for $AMGN? The Short Ratio is 2.69% https://t.co/HcLgB2rjNXGet to know the main five #Biotech stocks in the US $GILD $AMGN $CELG $BIIB $REGN https://t.co/2ufHFlwWMh https://t.co/BTfEluIMZXRT @Maximum_Pain_cm: $AMGN Max Pain = 155.00. Maturity = 06/10/2016. Previous close = 159.19. bearish https://t.co/ixmbjKaC0H https://t.co/‚Ä¶RT @Maximum_Pain_cm: $AMGN Max Pain = 155.00. Maturity = 06/10/2016. Previous close = 159.19. bearish https://t.co/ixmbjKaC0H https://t.co/‚Ä¶$AMGN Max Pain = 155.00. Maturity = 06/10/2016. Previous close = 159.19. bearish https://t.co/ixmbjKaC0H https://t.co/iWRfAId1Sd$AMGN Max Pain = 155.00. Maturity = 06/10/2016. Previous close = 159.19. bearish https://t.co/ixmbjKaC0H https://t.co/iiF5uB1pwNThese $ITUS Profits Are much Bigger Than $AMGN@BioAcumen yes, I think if no counter bid from $AMGN $CELG $GILD etc then $SNY offer is actually good.$18B for 100% $MDVN is nothing cheap.",2016-06-06,AMGN,0
40,"$AMGN Max Pain is 155.00 for maturity 06/10/2016. Price = 160.19. bearish https://t.co/ixmbjKaC0H https://t.co/y36vRmTCwpStochastic Sell https://t.co/UKlxOgWcW9 $CELG $FLEX $CBG $CSX $UNP $USMV $TEVA $VIAB $AET $GERN $TWTR $EIX $MDLZ $SPY $AMGN $ZNGA $ZTS#Amgen : New National Survey Sheds Light on How to Better Engage Students in Science Educat... Read more: https://t.co/DDAr3uqcic $AMGN$AMGN:US Narwhal Capital Management Raises Stake in Amgen, Inc. (AMGN) #AMGEN INC  https://t.co/XwafxUzMyK #SP500RT @ScripMandy: Joshua Ofman, $AMGN SVP of global value, access &amp; policy: All parties need to work together with patients at the center. #B‚Ä¶RT @ScripMandy: $AMGN Ofman: patient pays co-pay based on list price: PBM keeps rebate. #BIO2016SLV VanEck Vectors Semiconductor ETF Ask
https://t.co/22AWUfXDJz

$SLV $TNA $AMGN $SN  #share #investingRT @ScripMandy: $AMGN Ofman: patient pays co-pay based on list price: PBM keeps rebate. #BIO2016$AMGN Ofman: patient pays co-pay based on list price: PBM keeps rebate. #BIO2016RT @ScripMandy: Joshua Ofman, $AMGN SVP of global value, access &amp; policy: All parties need to work together with patients at the center. #B‚Ä¶$AMGN Ofman: Problem w/PCSK9 inhibitor negotiations is deals include rebates, which patients don't benefit from. #BIO2016FXI VanEck Vectors Gold Miners ETF Volume
https://t.co/dgu01QQklM

$FXI $V $UGAZ $AMGN  #share #investRT @MarginHunt: Great News For Gilead $GILD https://t.co/j8i4gOvTZ8 #trading at very low #valuation $ABBV $AMGN $BIIB $CELG #stocks https:/‚Ä¶Great News For Gilead $GILD https://t.co/j8i4gOvTZ8 #trading at very low #valuation $ABBV $AMGN $BIIB $CELG #stocks https://t.co/jq3mBvdZ7U$AMGN Ofman: Patients still not getting access, because of extensive cost containment.$AMGN Ofman: right now a lot of negotiations with a lot of payers, but not benefiting patients.$AMGN Ofman: too often patients paying too much out of pocket. #BIO2016RT @ScripMandy: Joshua Ofman, $AMGN SVP of global value, access &amp; policy: All parties need to work together with patients at the center. #B‚Ä¶Joshua Ofman, $AMGN SVP of global value, access &amp; policy: All parties need to work together with patients at the center. #BIO2016$AMGN knew to stay away from this today! -0.80% .For #great #trades,get the #free #android #app: https://t.co/mDjS7SZlMl$AMGN maturity 06/10/2016 oi CallPutRatio of 0.98 puts=2,228 calls=2,263 bullish. https://t.co/jCaTN0IBi4 https://t.co/q0eqigtBqyAMGN Amgen, Inc. Stock Message Board
https://t.co/eRQzis5vAO

$AMGN $DUST $BTE.TO $ED  #tradeideas #stocksRT @AndysCycles: $IBB #Biotech top components sorted by 1month chg. $MDVN $INCY $VRTX $ILMN $BMRN $REGN $BIIB $CELG $AMGN $MYL $GILD https:‚Ä¶Profit Investment Management LLC Has $449,000 Position in Amgen, Inc. $AMGN https://t.co/F2Dicmp56DRegent Investment Management LLC Maintains Position in Amgen, Inc. $AMGN https://t.co/ohtEin7wN2RT @biosimilarz: $MYL's/Biocon's trastuzumab p3 data has made significant headlines, but $AMGN's bevacizumab p3 data hasn't; I wonder why t‚Ä¶Mittelfristiges Signal! $AMGN: Ein Trendkanal wurde bei 159.115 USD nach unten durchbrochen:  https://t.co/cdpSr4qB5o$TSLA extremely overbought and overpriced. Sell this beast to $80. $SPY $TWTR $HMNY $FB $AMGN $GILD $USOAMGN Top news - Jun 7th, 2016 $AMGN https://t.co/TlSurc78pCRT @biosimilarz: $MYL's/Biocon's trastuzumab p3 data has made significant headlines, but $AMGN's bevacizumab p3 data hasn't; I wonder why t‚Ä¶RT @biosimilarz: $MYL's/Biocon's trastuzumab p3 data has made significant headlines, but $AMGN's bevacizumab p3 data hasn't; I wonder why t‚Ä¶Enjoyed discussing pricing with Steven Pearson (ICER); $MRK; $LLY and $AMGN -- much more to come.Valuation Dashboard: Healthcare https://t.co/m5E8DEMPKL $ABBV $ABC $AKRX $AMGN $BIIB $BSX $CRL $GILD $IBB $MCK $PFE $SPY $STJ $UTHR $VARValuation Dashboard: Healthcare https://t.co/czT3eBBzpc $ABBV $ABC $AKRX $AMGN $BIIB $BSX $CRL $GILD $IBB $MCK $PFE $SPY $STJ $UTHR $VARValuation Dashboard: Healthcare https://t.co/BGgvWzNlLt $ABBV $ABC $AKRX $AMGN $BIIB $BSX $CRL $GILD $IBB $MCK $PFE $SPY $STJ $UTHR $VARLooking at the PDUFA FDA calendar for the rest of 16' $AMGN is the clear winner with 6 drugs up for review.$AMGN high open interest range is 155.00 to 162.50 for option expiration 06/10/2016.  https://t.co/jCaTN0IBi4 https://t.co/EYgWpAtczGRT @BPGAG: $GILD shook some quick pounces on $87.50 area this morning with quick move to test $86. $89+ ? #biotech #stocks #trading $IBB $C‚Ä¶$GILD shook some quick pounces on $87.50 area this morning with quick move to test $86. $89+ ? #biotech #stocks #trading $IBB $CELG $AMGNASCO2016: #Amgen Release: New Phase 3 Secondary Analysis Shows Progression-Free Survival Be... Read more: https://t.co/YRlbRxpIqk $AMGNHas A Biotech Recovery Started Yet? $GILD BIIB $VRX $AMGN 
https://t.co/TzVGl2earIApple's Next Moves? Hints From M&amp;A Talks https://t.co/Ov310RREAc $ACAS $AMGN $AMZN $ANAC $ARCC $BAM $BRCD $BUD $CI $COHR $CSC $DEPO $DF$AMGN New National Survey Sheds Light On How To Better Engage Students In Science Education
From our Stock News Alerts AppThis Bull's Getting Old, So Where Is The Value? - Part 3 https://t.co/5ebEyJVCJM $AAPL $ABBV $ABC $AMGN $AMP $BA $BMO $BNS $BRK.B $CAH $CMRT @WrigleyTom: Today

$GM Annual Mtg
$RL Investor Day

Jefferies Healthcare Conf
$KITE $ALDR $LBIO etc

Goldman Healthcare Conf
$AMGN $VRT‚Ä¶RT @Maximum_Pain_cm: $AMGN Max Pain = 155.00. Maturity = 06/10/2016. Previous close = 160.19. bearish https://t.co/ixmbjKaC0H https://t.co/‚Ä¶$AMGN Max Pain = 155.00. Maturity = 06/10/2016. Previous close = 160.19. bearish https://t.co/ixmbjKaC0H https://t.co/SlyOGp30vXRT @WrigleyTom: Today

$GM Annual Mtg
$RL Investor Day

Jefferies Healthcare Conf
$KITE $ALDR $LBIO etc

Goldman Healthcare Conf
$AMGN $VRT‚Ä¶Today

$GM Annual Mtg
$RL Investor Day

Jefferies Healthcare Conf
$KITE $ALDR $LBIO etc

Goldman Healthcare Conf
$AMGN $VRTX $MYL $RDUS etc@redacre Sort of yes and no. The top five securities are given an 8% weight every time it rebalances. $BIIB $REGN $AMGN $GILD, and $CELG.AMGN Financials
See Here ---&gt; https://t.co/0FfevpVqlk

$AMGN $REXX $BPOP #invest#Amgen Announces Launch Of KYPROLIS (carfilzomib) CENTRAL, An Online News Resource Demonstr... Read more: https://t.co/GJiMvaHmc3 $AMGNRT @DividendSheet: Here Is Jason Fiber's Stock Portfolio - https://t.co/H1XSWXZMMJ - $CL $CSCO $CVS $GE $GD $FLO $EMR $AAPL $AMGN $DE $MI $‚Ä¶RT @DividendSheet: Here Is Jason Fiber's Stock Portfolio - https://t.co/H1XSWXZMMJ - $CL $CSCO $CVS $GE $GD $FLO $EMR $AAPL $AMGN $DE $MI $‚Ä¶These $ITUS Profits Are much Bigger Than $AMGNThese $ITUS Profits Are much Bigger Than $AMGNHere Is Jason Fiber's Stock Portfolio - https://t.co/H1XSWXZMMJ - $CL $CSCO $CVS $GE $GD $FLO $EMR $AAPL $AMGN $DE $MI $MD $MDT $MO $O $JNJBtw, Estimated #Earnings Per Share for $AMGN is $2.77 it's 1.73% of the current price https://t.co/IfKOfHY5SqThese $ITUS Profits Are much Bigger Than $AMGNStocks Im long &amp; calculated upside:
$AMGN: +29%
$AXP: +24%
$F: +32%
$GOOG: +28%
$HCA: +39%
$JNJ: +22%
$SEDG: +38%
$VRX: +57%
$TGT: +31%
FCF!RT @Maximum_Pain_cm: $AMGN sum put oi=2,055 sum call oi=2,079 CallPutRatio=0.99 expiration 06/10/2016 bullish. https://t.co/jCaTN0IBi4 http‚Ä¶$AMGN sum put oi=2,055 sum call oi=2,079 CallPutRatio=0.99 expiration 06/10/2016 bullish. https://t.co/jCaTN0IBi4 https://t.co/nrIeKouSAIThis Bull's Getting Old, So Where Is The Value? - Part 3 https://t.co/OUfvSQbA9e $AAPL $ABBV $ABC $AMGN $AMP $BA $BMO $BNS $BRK.B $CAH $CM",2016-06-07,AMGN,0
41,"$AMGN sum put oi=2,313 sum call oi=2,187 CallPutRatio=1.06 expiration 06/10/2016 bearish. https://t.co/jCaTN0IBi4 https://t.co/ECMbEVxEwvRT @Biotech_5: AH #Biotech Movers
$BCRX+3.09% 6K shares traded
$SPPI+1.95% 66K 
$AMGN+1.82% 36K
$SHPG+1.49% 21K
$PDLI-1.74% 31K
$INSM-18.40‚Ä¶$AMGN Goldman Sachs 37th Annual Global Healthcare Conference Audio is now available #earnings https://t.co/ydpmEkAT5hGood news, migraine sufferers! Amgen just posted positive data for its drug - $AMGN https://t.co/8TBCFu1LYiAH #Biotech Movers
$BCRX+3.09% 6K shares traded
$SPPI+1.95% 66K 
$AMGN+1.82% 36K
$SHPG+1.49% 21K
$PDLI-1.74% 31K
$INSM-18.40% 15K$AMGN: Amgen and Novartis (NVS) announce positive top-line results from the global Phase 2 study evaluating the... https://t.co/mCYOYLvVFw$AMGN https://t.co/Ki93y8iUBNRT @AJRotunno1984: https://t.co/ejxWGhC1q7 $AMGNRT @megtirrell: $AMGN says AMG 334 met primary goal in change in monthly migraine days in ph2 study; reduced by 6.6 days vs 4.2 for placebo‚Ä¶Good news, migraine sufferers! #Amgen just posted positive data for its drug. Read more: https://t.co/OBy4mgBq13 $AMGNBRIEF-#Amgen says migraine prevention drug meets main goal of a mid-stage study. Read more: https://t.co/3KyjqDZafD $AMGN$amgn ph 2 chronic migraine trial (AMG 334) hit primary endpoint. Both dose levels had the exact same reduction of 6.6 migraine days.Amgen's AMG 334 successful in mid-stage migraine study $AMGN https://t.co/unvte2erYtAmgen's AMG 334 successful in mid-stage migraine study https://t.co/D6S0IUD68J $AMGNAmgen's AMG 334 successful in mid-stage migraine study https://t.co/K2AJE8dRgW $AMGNAmgen's AMG 334 successful in mid-stage migraine study https://t.co/eHEEF6uzr8 $AMGN$AMGN Erenumab (AMG 334) Sig Reduces Pts' Monthly Migraine Days In Ph2 Study For Prevention Of Chronic Migraine https://t.co/Z0PAs1sjk3RT @megtirrell: $AMGN says AMG 334 met primary goal in change in monthly migraine days in ph2 study; reduced by 6.6 days vs 4.2 for placebo‚Ä¶$AMGN Announces AMG 334 Significantly Reduces Patients' Monthly Migraine Days In Phase 2 Study  https://t.co/ioM1GAXUTURT @megtirrell: $AMGN says AMG 334 met primary goal in change in monthly migraine days in ph2 study; reduced by 6.6 days vs 4.2 for placebo‚Ä¶RT @megtirrell: $AMGN says AMG 334 met primary goal in change in monthly migraine days in ph2 study; reduced by 6.6 days vs 4.2 for placebo‚Ä¶https://t.co/ejxWGhC1q7 $AMGNRT @megtirrell: $AMGN says AMG 334 met primary goal in change in monthly migraine days in ph2 study; reduced by 6.6 days vs 4.2 for placebo‚Ä¶$AMGN Amgen Announces Erenumab (AMG 334) Significantly Reduces Patients' Monthly Migraine Days In Phase 2 Stu
From our Stock News Alerts AppRT @megtirrell: $AMGN says AMG 334 met primary goal in change in monthly migraine days in ph2 study; reduced by 6.6 days vs 4.2 for placebo‚Ä¶megtirrell: $AMGN says AMG 334 met primary goal in change in monthly migraine days in ph2 study; reduced by 6.6 days vs 4.2 for placebo $AL‚Ä¶$AMGN says AMG 334 met primary goal in change in monthly migraine days in ph2 study; reduced by 6.6 days vs 4.2 for placebo $ALDR $LLY $TEVART @AndyBiotech: $AMGN #PCSK9 Repatha CVOT top-line data pushed back to 1Q17 and full data expected at #ACC17.

$REGN $SNY $PFE CC @cardiob‚Ä¶$AMGN OI for maturity 06/10/2016. 155.00 Highest put. 162.50 Highest call.  https://t.co/jCaTN0IBi4 https://t.co/Me0irhn2T4MM Excerpt re Phase III POLLUX (Dara+Rd) from Barclays EHA2016 Preview $CELG $JNJ $AMGN https://t.co/yVKC1MiSYuAmgen puts Kyprolis patient stories at the heart of new awareness push https://t.co/GV7Kd8BEN1 $AMGN #pharma #marketing by @CarlyHFierceAmgen puts Kyprolis patient stories at the heart of new awareness push: https://t.co/8zLYCerzYb $AMGN #pharma #marketingAmgen, Inc. $AMGN is Rosenbaum Jay D.‚Äôs 3rd Largest Position https://t.co/DPjZpoj97oAmgen, Inc. $AMGN is Rosenbaum Jay D.‚Äôs 3rd Largest Position https://t.co/8XiL01V0utCarroll Financial Associates Inc. Reduces Stake in Amgen, Inc. $AMGN https://t.co/858QYajjtVCarroll Financial Associates Inc. Reduces Stake in Amgen, Inc. $AMGN https://t.co/TgXaAoBiYyAmgen, Inc. $AMGN Shares Sold by Tompkins Financial Corp https://t.co/ownOp3OJM8RT @StockTradePicks: $FOSL downgraded to strong sell by S&amp;P on increased liquidity fears https://t.co/t7YH8uX7b1 &amp; https://t.co/8Odm51VEt2‚Ä¶RT @AndyBiotech: $AMGN #PCSK9 Repatha CVOT top-line data pushed back to 1Q17 and full data expected at #ACC17.

$REGN $SNY $PFE CC @cardiob‚Ä¶AbbVie is falling on a downgrade, while Novartis touts Cosentyx over Humira: https://t.co/G5QLI9V47P $ABBV $NVS $LLY $AMGN $PFE $CHRSStock Analysts‚Äô Updated EPS Estimates for June, 8th $AMGN, BIIB, COT, DDD, DOV, FFIV, LC, NTDOY, QSII, RL https://t.co/wlvVSwNxUuRT @MarginHunt: Great News For Gilead $GILD https://t.co/j8i4gOvTZ8 #trading at very low #valuation $ABBV $AMGN $BIIB $CELG #stocks https:/‚Ä¶AMGN Top news - Jun 8th, 2016 $AMGN https://t.co/SW73B0qThk$AMGN Amgen Inc at Goldman Sachs Global Healthcare Conference Transcript is now available #earnings https://t.co/YbmDSP2tsvRT @Maximum_Pain_cm: $AMGN Max Pain is 157.50 for maturity 06/10/2016. Price = 158.89. bearish https://t.co/ixmbjKaC0H https://t.co/GnICGaQ‚Ä¶SAlphaTrending: 2 New Bidding Wars https://t.co/YE7hq5dx8A $AMGN $AZN $BRK.A $BRK.B $BUD $BX $CLNY $ELRC $GAS $GCI $GIS $GXP $KO $LC $LDRH‚Ä¶2 New Bidding Wars https://t.co/zneT4O3Zup $AMGN $AZN $BRK.A $BRK.B $BUD $BX $CLNY $ELRC $GAS $GCI $GIS $GXP $KO $LC $LDRH $MDVN $MEG$AMGN Max Pain is 157.50 for maturity 06/10/2016. Price = 158.89. bearish https://t.co/ixmbjKaC0H https://t.co/GnICGaQwXOSAlphaTrending: 2 New Bidding Wars https://t.co/b1bPisCXjm $AMGN $AZN $BRK.A $BRK.B $BUD $BX $CLNY $ELRC $GAS $GCI $GIS $GXP $KO $LC $LDRH‚Ä¶2 New Bidding Wars https://t.co/MAarHCFTyz $AMGN $AZN $BRK.A $BRK.B $BUD $BX $CLNY $ELRC $GAS $GCI $GIS $GXP $KO $LC $LDRH $MDVN $MEG2 New Bidding Wars https://t.co/GTBEiRGcgJ $AMGN $AZN $BRK.A $BRK.B $BUD $BX $CLNY $ELRC $GAS $GCI $GIS $GXP $KO $LC $LDRH $MDVN $MEG2 New Bidding Wars https://t.co/qXZLlLjskR $AMGN $AZN $BRK.A $BRK.B $BUD $BX $CLNY $ELRC $GAS $GCI $GIS $GXP $KO $LC $LDRH $MDVN $MEGVetr users have downgraded Amgen Inc. to a HOLD Rating (3 stars), giving $AMGN a target price of $159.50 https://t.co/sgyPwK93LkAmgen‚Äôs $AMGN ‚ÄúHold‚Äù Rating Reiterated at Bank of America https://t.co/erbbJSMz8cBiotech Stocks: Much Ado About Nothing at ASCO? $CELG $GILD $REGN $AMGN https://t.co/ujBtmgfS5qAmgen Inc Reiterated Rating by Bank of America (Ranked 45th) to Hold with 182 PT $AMGN #AMGN https://t.co/bqjkWr2ARAAmgen's hold rating reiterated at Bank of America. $182.00 PT. https://t.co/8OmjQGuMc9 $AMGN #AMGNRT @AndyBiotech: $AMGN #PCSK9 Repatha CVOT top-line data pushed back to 1Q17 and full data expected at #ACC17.

$REGN $SNY $PFE CC @cardiob‚Ä¶Amgen Inc. Receives a Hold from Merrill Lynch $AMGN https://t.co/AEzehOj0QdCatabasis' lipid drug flunks mid-stage study in patients with high cholesterol $CATB  
$AMGN $REGN $MRK $ESPR  https://t.co/15AeXZOUTDBAML $AMGN Repatha CVOT data delayed to 1H17; expects results from imaging study in 2H16 $SNY $REGN $MRK $ESPRJune 8 Biotech Update $AMGN $MDCO $REGN $SRPT https://t.co/627LqSuXG7$AMGN likely to report data from its PCSK9 cardiovascular outcomes trial FOURIER in the 2H16 #cholesterol $SNY $REGN #praluent #repatha@AndyBiotech BAML $AMGN  event rates in many recent CV studies have been lower previous estimates possibly due to improving standard-of-careRT @AndyBiotech: $AMGN Repatha CVOT has now accrued ~85% of requisite events and will continue to accrue remaining events over the summer.‚Ä¶RT @AndyBiotech: $AMGN #PCSK9 Repatha CVOT top-line data pushed back to 1Q17 and full data expected at #ACC17.

$REGN $SNY $PFE CC @cardiob‚Ä¶Apple's Next Moves? Hints From M&amp;A Talks https://t.co/Ov310RREAc $ACAS $AMGN $AMZN $ANAC $ARCC $BAM $BRCD $BUD $CI $COHR $CSC $DEPO $DFValuation Dashboard: Healthcare https://t.co/13UYs6F7cI $ABBV $ABC $AKRX $AMGN $BIIB $BSX $CRL $GILD $IBB $MCK $PFE $SPY $STJ $UTHR $VARRT @AndyBiotech: $AMGN #PCSK9 Repatha CVOT top-line data pushed back to 1Q17 and full data expected at #ACC17.

$REGN $SNY $PFE CC @cardiob‚Ä¶RT @Maximum_Pain_cm: $AMGN maturity 06/10/2016 oi CallPutRatio of 1.06 puts=2,313 calls=2,187 bearish. https://t.co/jCaTN0IBi4 https://t.co‚Ä¶$AMGN maturity 06/10/2016 oi CallPutRatio of 1.06 puts=2,313 calls=2,187 bearish. https://t.co/jCaTN0IBi4 https://t.co/Nv8cZD0RhORT @AndyBiotech: $AMGN Repatha CVOT has now accrued ~85% of requisite events and will continue to accrue remaining events over the summer.‚Ä¶RT @AndyBiotech: $AMGN #PCSK9 Repatha CVOT top-line data pushed back to 1Q17 and full data expected at #ACC17.

$REGN $SNY $PFE CC @cardiob‚Ä¶Get your say in on $AMGN at SpeculatingStocks, the discovery engine. https://t.co/AK5gZu4uvJ #stocksRT @AndyBiotech: $AMGN Repatha CVOT has now accrued ~85% of requisite events and will continue to accrue remaining events over the summer.‚Ä¶RT @AndyBiotech: $AMGN Repatha CVOT has now accrued ~85% of requisite events and will continue to accrue remaining events over the summer.‚Ä¶RT @AndyBiotech: $AMGN #PCSK9 Repatha CVOT top-line data pushed back to 1Q17 and full data expected at #ACC17.

$REGN $SNY $PFE CC @cardiob‚Ä¶$AMGN Repatha CVOT has now accrued ~85% of requisite events and will continue to accrue remaining events over the summer.
$REGN $SNY $PFEQuick summary for #ASCO16 heavyweights $AMGN $CELG $GILD $REGN

Biotech Stocks: Much Ado About Nothing at ASCO? https://t.co/QoBhNa3tB1RT @AndyBiotech: $AMGN #PCSK9 Repatha CVOT top-line data pushed back to 1Q17 and full data expected at #ACC17.

$REGN $SNY $PFE CC @cardiob‚Ä¶RT @AndyBiotech: $AMGN #PCSK9 Repatha CVOT top-line data pushed back to 1Q17 and full data expected at #ACC17.

$REGN $SNY $PFE CC @cardiob‚Ä¶RT @AndyBiotech: $AMGN #PCSK9 Repatha CVOT top-line data pushed back to 1Q17 and full data expected at #ACC17.

$REGN $SNY $PFE CC @cardiob‚Ä¶$JNJ Johnson &amp; Johnson: Peer Performance In The #Pharmaceuticals Segment  https://t.co/HBnvHl45bD   $JNJ, $AMGN, $BMY, $MRK, $PFEAmgen, Inc. $AMGN Lowered to Hold at Vetr Inc. https://t.co/gGasv7ACnZRT @AndyBiotech: $AMGN #PCSK9 Repatha CVOT top-line data pushed back to 1Q17 and full data expected at #ACC17.

$REGN $SNY $PFE CC @cardiob‚Ä¶These $ITUS Profits Are much Bigger Than $AMGNhttps://t.co/G9pMgSID8y &lt; Review of this fantastic traders teaching service!! Try it for FREE! $LLY $DGX $MRK $NVS $AMGN$AMGN:US Amgen, Inc. (AMGN) Downgraded by Vetr Inc. #AMGEN INC  https://t.co/5gyvkT4JyN #SP500RT @AndyBiotech: $AMGN #PCSK9 Repatha CVOT top-line data pushed back to 1Q17 and full data expected at #ACC17.

$REGN $SNY $PFE CC @cardiob‚Ä¶Amgen, Inc. $AMGN Downgraded by Vetr Inc. https://t.co/kSADHQbY0SAmgen, Inc. $AMGN Downgraded by Vetr Inc. https://t.co/FeRuvIPWdVAmgen downgraded by Vetr Inc. to hold. $159.50 PT. https://t.co/OFk7geURuP $AMGN #AMGNRT @AndyBiotech: $AMGN #PCSK9 Repatha CVOT top-line data pushed back to 1Q17 and full data expected at #ACC17.

$REGN $SNY $PFE CC @cardiob‚Ä¶$AMGN high open interest range is 155.00 to 162.50 for option expiration 06/10/2016.  https://t.co/jCaTN0IBi4 https://t.co/8r9J65V5d3RT @seeitmarket: 5 Large Cap Biotech Stocks With Long-Term Upside (from Apr. 5) - https://t.co/T46RnBtL3B  by @OphirGottlieb  $CELG $GILD $‚Ä¶RT @AndyBiotech: $AMGN #PCSK9 Repatha CVOT top-line data pushed back to 1Q17 and full data expected at #ACC17.

$REGN $SNY $PFE CC @cardiob‚Ä¶RT @seeitmarket: 5 Large Cap Biotech Stocks With Long-Term Upside (from Apr. 5) - https://t.co/T46RnBtL3B  by @OphirGottlieb  $CELG $GILD $‚Ä¶RT @AndyBiotech: $AMGN #PCSK9 Repatha CVOT top-line data pushed back to 1Q17 and full data expected at #ACC17.

$REGN $SNY $PFE CC @cardiob‚Ä¶RT @seeitmarket: 5 Large Cap Biotech Stocks With Long-Term Upside (from Apr. 5) - https://t.co/T46RnBtL3B  by @OphirGottlieb  $CELG $GILD $‚Ä¶seeitmarket: 5 Large Cap Biotech Stocks With Long-Term Upside (from Apr. 5) - https://t.co/WpFdFTLfP3  by OphirGottlieb  $CELG $GILD $AMGN‚Ä¶RT @seeitmarket: 5 Large Cap Biotech Stocks With Long-Term Upside (from Apr. 5) - https://t.co/T46RnBtL3B  by @OphirGottlieb  $CELG $GILD $‚Ä¶RT @seeitmarket: 5 Large Cap Biotech Stocks With Long-Term Upside (from Apr. 5) - https://t.co/T46RnBtL3B  by @OphirGottlieb  $CELG $GILD $‚Ä¶RT @seeitmarket: 5 Large Cap Biotech Stocks With Long-Term Upside (from Apr. 5) - https://t.co/T46RnBtL3B  by @OphirGottlieb  $CELG $GILD $‚Ä¶RT @seeitmarket: 5 Large Cap Biotech Stocks With Long-Term Upside (from Apr. 5) - https://t.co/T46RnBtL3B  by @OphirGottlieb  $CELG $GILD $‚Ä¶5 Large Cap Biotech Stocks With Long-Term Upside (from Apr. 5) - https://t.co/T46RnBtL3B  by @OphirGottlieb  $CELG $GILD $AMGN $BIIB $REGNRT @AndyBiotech: $AMGN #PCSK9 Repatha CVOT top-line data pushed back to 1Q17 and full data expected at #ACC17.

$REGN $SNY $PFE CC @cardiob‚Ä¶RT @AndyBiotech: $AMGN #PCSK9 Repatha CVOT top-line data pushed back to 1Q17 and full data expected at #ACC17.

$REGN $SNY $PFE CC @cardiob‚Ä¶RT @CatalanGrand: I am bearish on $AMGN with a target price of $150.95 in 6 mos. on Vetr! https://t.co/KIJgyThZCQI am bearish on $AMGN with a target price of $150.95 in 6 mos. on Vetr! https://t.co/KIJgyThZCQRT @AndyBiotech: $AMGN #PCSK9 Repatha CVOT top-line data pushed back to 1Q17 and full data expected at #ACC17.

$REGN $SNY $PFE CC @cardiob‚Ä¶RT @AndyBiotech: $AMGN #PCSK9 Repatha CVOT top-line data pushed back to 1Q17 and full data expected at #ACC17.

$REGN $SNY $PFE CC @cardiob‚Ä¶RT @AndyBiotech: $AMGN #PCSK9 Repatha CVOT top-line data pushed back to 1Q17 and full data expected at #ACC17.

$REGN $SNY $PFE CC @cardiob‚Ä¶$AMGN #PCSK9 Repatha CVOT top-line data pushed back to 1Q17 and full data expected at #ACC17.

$REGN $SNY $PFE CC @cardiobriefRT @SA_Portfolio: Valuation Dashboard: Healthcare https://t.co/czT3eBBzpc $ABBV $ABC $AKRX $AMGN $BIIB $BSX $CRL $GILD $IBB $MCK $PFE $SPY‚Ä¶",2016-06-08,AMGN,0
42,"RT @BentheFidler: In Race to Relief, Amgen Touts New But Incomplete Migraine Data https://t.co/EV8VQrFGBb by @alexlash $AMGN $LLY $TEVA $AL‚Ä¶RT @BentheFidler: In Race to Relief, Amgen Touts New But Incomplete Migraine Data https://t.co/EV8VQrFGBb by @alexlash $AMGN $LLY $TEVA $AL‚Ä¶Explore #fundamental numbers and pros and cons for $AMGN https://t.co/olJdqsNFGs1234 Bullish https://t.co/HSGR70tR0n $AMGN $NTES $CMA $LGF $PGX $STI $ARRY $CELG $XLF $RLYP $EXC $MCK $GLW $FHN $CSCO $IBB $CLDXGSM EOD Data
See Here ---&gt; https://t.co/EU7TVtJeb7

$GSM $AMGN $PCCC #tradeideasARGS Short Sales
See Here ---&gt; https://t.co/oznk7Sw02v

$ARGS $BKFS $AMGN #share$AMGN high open interest range is 155.00 to 160.00 for option expiration 06/10/2016.  https://t.co/jCaTN0IBi4 https://t.co/fNxuI39CAA#Amgen Shows Off Mid-Stage Migraine Data, Needs to Compete With Eli Lilly, Teva and Alder B... Read more: https://t.co/A78d3XHA6B $AMGN#Amgen Shows Off Mid-Stage Migraine Data  . Read more: https://t.co/8aHLShzh0E $AMGN$AMGN $1 dividend payable to owners of record today!Popular: $HRB, $MFRM, $ONVO, $FCX, $XLU, $HIIQ, $XBI, $RAD, $AMGN, $TIME, $NBR, $NI, $F, $WIX, $DW, $RWT, $W, $BV$AMGN P&amp;FDaily -  https://t.co/C31CgFBjkI] P&amp;F Wkly - https://t.co/olfXXdb8Uo] Very defined POC, bb pinchIn Race to Relief, #Amgen Touts New But Incomplete Migraine Data. Read more: https://t.co/2aE4R9eBJM $AMGNStory of the highest paid research scientist in drug industry. https://t.co/2B5SdXxCVs $REGN $IBB $AMGN $PG $CELG $GILD$AMGN ALERT: New Amgen SEC Filing
From our Stock News Alerts App$AMGN:

New Insider Filing on AMGN and Director:

https://t.co/1z1zQRPcmm https://t.co/816eCyjoszAmgen Inc. director just disposed of 3,167 shares  https://t.co/QPb8fayaUg $AMGN$AMGN is one of the few stocks with low valuation ratios and higher growth ratesRT @megtirrell: $AMGN says AMG 334 met primary goal in change in monthly migraine days in ph2 study; reduced by 6.6 days vs 4.2 for placebo‚Ä¶Amgen, Inc. $AMGN Earns Market Perform Rating from Leerink Swann https://t.co/0Ypxwflqp4Amgen, Inc. $AMGN Earns Market Perform Rating from Leerink Swann https://t.co/s9SaN2LLzBBT Current Price
See Here ---&gt; https://t.co/XMZuNCIaXF

$BT $AMGN $FTR #stocksAmgen Inc Reiterated Rating by Leerink Swann (Ranked 70th) to Market Perform $AMGN #AMGN https://t.co/bqjkWr2ARAAmgen's market perform rating reiterated at Leerink Swann. https://t.co/0iAvVYDyGf $AMGN #AMGNAmgen, Inc. $AMGN Given Outperform Rating at BMO Capital Markets https://t.co/uH5HIbEsxlAmgen Inc Reiterated Rating by BMO Capital Markets (Ranked 12th) to Outperform with 186 PT $AMGN #AMGN https://t.co/bqjkWr2ARA$AMGN - Amgen, Inc. #AMGN Given Outperform Rating at BMO Capital Markets https://t.co/XBiXQz4cBxRT @CarlyHFierce: Amgen puts Kyprolis patient stories at the heart of new awareness push: https://t.co/8zLYCerzYb $AMGN #pharma #marketingAmgen's outperform rating reiterated at BMO Capital Markets. $186.00 PT. https://t.co/9bQLg1hYOM $AMGN #AMGNAmgen, Inc. $AMGN Shares Bought by Windward Capital Management Co. CA https://t.co/CEPxZtsF5CRaymond James Trust N.A. Has $4,296,000 Position in Amgen, Inc. $AMGN https://t.co/udf8j3UeqNAmgen, Inc. $AMGN Shares Bought by UMB Bank N A MO https://t.co/4f8jm1AtM8Amgen, Inc. $AMGN Shares Bought by UMB Bank N A MO https://t.co/AXcBWa2eSSAmgen, Inc. $AMGN Position Decreased by OLD National Bancorp IN https://t.co/VPHk8OnehfAmgen, Inc. $AMGN Position Decreased by OLD National Bancorp IN https://t.co/j1xwc49ltJ$AMGN Max Pain is 157.50 for maturity 06/10/2016. Price = 158.00. bearish https://t.co/ixmbjKaC0H https://t.co/Fy946KyWvDThese $ITUS Profits Are much Bigger Than $AMGNAMGN Top news - Jun 9th, 2016 $AMGN https://t.co/3qq5BTxRgXNot sure what to do with $AMGN? Explore our #fundamental pros and cons.  https://t.co/ZW5e637quVRT @cfromhertz: Biotech $IBB $XBI very weak after we saw a HUGE put buyer:
&gt; 8,719 IBB Sep 250p @ $6.20   OPENING /   $5.4mm trade
$CELG $A‚Ä¶5-star analyst Ian Somaiya from BMO Capital reiterated a BUY on $AMGN. Ian has a 61% success rate https://t.co/WExqQHeDj7 #NASDAQ #stocksBiotech $IBB $XBI very weak after we saw a HUGE put buyer:
&gt; 8,719 IBB Sep 250p @ $6.20   OPENING /   $5.4mm trade
$CELG $AMGN $BIIB $GILDBiotech stocks breaking low  $IBB $GILD $IBB $XBI $LABU $AMGN bearish options flowLeerink Affirms Amgen $AMGN at 'Market Perform'; CGRP Further Validated as Migraine Prevention ... https://t.co/1yWrMaUhyp$AMGN maturity 06/10/2016 oi CallPutRatio of 0.88 puts=2,379 calls=2,718 bullish. https://t.co/jCaTN0IBi4 https://t.co/1Avey2hrZWRT @fwpharma: Amgen's experimental drug erenumab significantly cuts #migraine days in mid-stage study https://t.co/5BctiUrPCD $AMGNAmgen's experimental drug erenumab significantly cuts #migraine days in mid-stage study https://t.co/5BctiUrPCD $AMGNThese $ITUS Profits Are much Bigger Than $AMGNSFTW Investor long-term stock recommendation: $AMGN Amgen Inc. (SS: 77) https://t.co/ajLDr7suct9-junio -2016 ‚Äì Ideas del Pre-Market para observar: $AMGN, $OREX, $IMNP, https://t.co/zwZT1ieI8L #biotech #biotechnologyRT @ScripDonnaDC: #FDA July 13  Arthritis Advisory Committee $NVS Sandoz #biosimilar to $AMGN #Enbrel 
https://t.co/t3neXBDqMR 
#pharma #bi‚Ä¶RT @zbiotech: key to $VRX brodalumab panel...not the efficacy...the suicid(es)al thoughts, big reason $AMGN and $AZN bailed on itRT @PinkSheetSutter: @US_FDA #biosimilar adcomm #3: $NVS Sandoz version of $AMGN's Enbrel gets panel vetting 7/13 https://t.co/P7eK3rtNOWRT @zbiotech: key to $VRX brodalumab panel...not the efficacy...the suicid(es)al thoughts, big reason $AMGN and $AZN bailed on itRT @ScripDonnaDC: #FDA July 13  Arthritis Advisory Committee $NVS Sandoz #biosimilar to $AMGN #Enbrel 
https://t.co/t3neXBDqMR 
#pharma #bi‚Ä¶key to $VRX brodalumab panel...not the efficacy...the suicid(es)al thoughts, big reason $AMGN and $AZN bailed on itThese $ITUS Profits Are much Bigger Than $AMGN@AndyBiotech how could any of us forget why this program was abandoned by $AMGN? https://t.co/8xz96NlBv4RT @ScripDonnaDC: #FDA July 13  Arthritis Advisory Committee $NVS Sandoz #biosimilar to $AMGN #Enbrel 
https://t.co/t3neXBDqMR 
#pharma #bi‚Ä¶@US_FDA #biosimilar adcomm #3: $NVS Sandoz version of $AMGN's Enbrel gets panel vetting 7/13 https://t.co/P7eK3rtNOW$AMGN Mid-stage study for erenumab meets primary¬†endpoint https://t.co/LlT25FXFIORT @ScripDonnaDC: #FDA July 13  Arthritis Advisory Committee $NVS Sandoz #biosimilar to $AMGN #Enbrel 
https://t.co/t3neXBDqMR 
#pharma #bi‚Ä¶#FDA July 13  Arthritis Advisory Committee $NVS Sandoz #biosimilar to $AMGN #Enbrel 
https://t.co/t3neXBDqMR 
#pharma #biotech #biosimilars@PDRennert  Thanks, Paul. $AMGN's CVOT now pushed to 2017 I understand, not sure about $LLY's alz dataDMRC Ex-Div Date
See Here ---&gt; https://t.co/M2gCDNneTd

$DMRC $UHS $AMGN #stockmarketPremarket Biotech Digest: $AMGN Attractive, $SRPT Public Offering, $IMNP¬†Soars https://t.co/rpYpLBt6QgApple's Next Moves? Hints From M&amp;A Talks https://t.co/Ov310RREAc $ACAS $AMGN $AMZN $ANAC $ARCC $BAM $BRCD $BUD $CI $COHR $CSC $DEPO $DF#Amgen Announces Erenumab (AMG 334) Significantly Reduces Patients' Monthly Migraine Days I... Read more: https://t.co/HsqJGxsMrA $AMGN#Amgen Novartis International AG: Novartis announces AMG 334 significantly reduces patients... Read more: https://t.co/bnBMrsXDek $AMGN#Amgen : Announces Erenumab (AMG 334) Significantly Reduces Patients' Monthly Migraine Days... Read more: https://t.co/dxvcMyOY9S $AMGN#Amgen's phase 2 study of erenumab in chronic migraine meets primary endpoint. Read more: https://t.co/EwTOm6jLxn $AMGN#Amgens phase 2 study of erenumab in chronic migraine meets primary endpoint. Read more: https://t.co/VTFzZTXCm7 $AMGNSeeing lots of golfers in drug ads (Mickelson $AMGN Enbrel; Palmer $JNJ Xarelto) . Now Jim Furyk for $PFE 
https://t.co/0p4nFmaZV4 
#pharma@CNS_Investing $TEVA, $AMGN, $LLY and $ALDR are looking the best dosage/tolerability. IMO $TEVA is in pole position now.#Amgen Says Migraine Prevention Drug Meets Main Goal of Study. Read more: https://t.co/RshLRKrWtU $AMGN#Amgen Novartis migraine drug meets primary endpoint in Phase II study. Read more: https://t.co/tfJqVSj4DS $AMGN$AMGN OI for maturity 06/10/2016. 155.00 Highest put. 160.00 Highest call.  https://t.co/jCaTN0IBi4 https://t.co/ShjeiaFPRORT @tgtxdough: IMHO best slide I tweet all weekend Free cash flow for the larger cap biotechs 2014-2020E $AMGN $CELG $GILD  M&amp;A ?? https://‚Ä¶In Race to Relief, Amgen Touts New But Incomplete Migraine Data https://t.co/EV8VQrFGBb by @alexlash $AMGN $LLY $TEVA $ALDRRT @Datamonitor_IG: $NVS and $AMGN announce #AMG334 (erenumab) significantly
reduces patients' monthly migraine days in Phase II chronic mi‚Ä¶RT @Biotech_5: AH #Biotech Movers
$BCRX+3.09% 6K shares traded
$SPPI+1.95% 66K 
$AMGN+1.82% 36K
$SHPG+1.49% 21K
$PDLI-1.74% 31K
$INSM-18.40‚Ä¶Amgen‚Äôs $AMGN Hold Rating Reaffirmed at Bank of America https://t.co/SAqAnUi7raVetr Inc. Downgrades Amgen, Inc. $AMGN to Hold https://t.co/LR8IhJqZNdAmgen‚Äôs $AMGN Hold Rating Reaffirmed at Bank of America https://t.co/v9Ir9KWBIART @tgtxdough: CS $AMGN Thoughts on AMG-334 Chronic Migraine
Phase 2 Data     $ALDR this weekend? https://t.co/suGzl1MtBSAmgen‚Äôs $AMGN Hold Rating Reaffirmed at Bank of America https://t.co/l4OTBC9ITgVetr Inc. Downgrades Amgen, Inc. $AMGN to Hold https://t.co/5te4QRUVmhVetr Inc. Downgrades Amgen, Inc. $AMGN to Hold https://t.co/0vSKEV35np#Amgen posts good data for migraine drug. Read more: https://t.co/ylSsMhvpA1 $AMGNRT @Datamonitor_IG: $NVS and $AMGN announce #AMG334 (erenumab) significantly
reduces patients' monthly migraine days in Phase II chronic mi‚Ä¶@tgtxdough $AMGN lots of CASH to make a deal https://t.co/kdtutiD675CS $AMGN Thoughts on AMG-334 Chronic Migraine
Phase 2 Data     $ALDR this weekend? https://t.co/suGzl1MtBS$AMGN #Amgen 's AMG 334 successful in mid-stage #migraine study https://t.co/ULTcCM6g4zThese #Migraine studies might be susceptible to high 'placebo' response, from Ph2 to Ph3 $AMGN $ALDR $Teva etcTTNP 52Wk Low
See Here ---&gt; https://t.co/fapmWm0X80

$TTNP $AMGN $INCC #tradeideasThese $ITUS Profits Are much Bigger Than $AMGNRT @bigbluecup721: IEF iShares 7-10 Year Treasury Bond ETF Dividend
https://t.co/F8YXi1Oxmh

$IEF $ATW $GDXJ $AMGN  #pennystocks #investIEF iShares 7-10 Year Treasury Bond ETF Dividend
https://t.co/F8YXi1Oxmh

$IEF $ATW $GDXJ $AMGN  #pennystocks #invest$NVS and $AMGN announce #AMG334 (erenumab) significantly
reduces patients' monthly migraine days in Phase II chronic migraine studyAMGN Amgen, Inc. Exchange
https://t.co/fHj3NxAj4G

$AMGN $SILJ $VLO $DB  #finance #stocksJDST Direxion Daily Junior Gold Miners Index Bear 3x Shares Bid Size
https://t.co/7oEGgyeXvU

$JDST $AMZN $DIS $AMGN  #investing #shareGILD Gilead Sciences, Inc. Prev Close
https://t.co/lCBpQlKeyE

$GILD $SLW.TO $TAP $AMGN  #stockmarket #financeRT @CashRocket: TOP UPCOMING EVENTS IN 2016: $BIIB $VRTX $ESPR $MDCO $SCYX $PRTA $AMGN $CELG $KITE $INFI $GILD $ACOR $PTI $FGEN https://t.c‚Ä¶AMGN Amgen, Inc. E.P.S.
https://t.co/cUpbEW7WT4

$AMGN $SU $TSLA $XBI  #finance #stockmarketAMCX AMC Networks Inc. Yield
https://t.co/VOkiazF25x

$AMCX $HYG $AMGN $GNCA  #tradeideas #financeAMBA Ambarella, Inc. Stock Forum
https://t.co/bX14Zq7lEe

$AMBA $AMGN $ONVO $DBC  #stock #nasdaqRT @CarolineYLChen: $amgn ph 2 chronic migraine trial (AMG 334) hit primary endpoint. Both dose levels had the exact same reduction of 6.6‚Ä¶YRI.TO Yamana Gold Inc. Market Cap
https://t.co/iq2K8HszKj

$YRI.TO $AMGN $NUE $AXP  #stock #investingInterview with Connor Bruggeman SchoolTrader Extraordinaire!: https://t.co/DgrNThyW8m $NFLX $HIMX $INO $AMGN $GOOGLFITX Ask Size
See Here ---&gt; https://t.co/Rtj0vyRJwC

$FITX $AMGN $CRT #stocksRT @AndyBiotech: $AMGN Repatha CVOT has now accrued ~85% of requisite events and will continue to accrue remaining events over the summer.‚Ä¶BIIB Biogen Inc. Shares
https://t.co/D4s3BlXmAi

$BIIB $MRK $HGU.TO $AMGN  #invest #shareAMGN Amgen, Inc. Quotes
https://t.co/fV6ZPLuALD

$AMGN $XLE $IWM $DNN  #tradeideas #stockmarket$AMGN Max Pain = 157.50. Maturity = 06/10/2016. Previous close = 158.89. bearish https://t.co/ixmbjKaC0H https://t.co/6aIcRz1ynhRT @megtirrell: $AMGN says AMG 334 met primary goal in change in monthly migraine days in ph2 study; reduced by 6.6 days vs 4.2 for placebo‚Ä¶RT @_North_Carolina: Good news, migraine sufferers! Amgen just posted positive data for its drug - $AMGN https://t.co/8TBCFu1LYi",2016-06-09,AMGN,0
43,"$AMGN:US St. Johns Investment Management Company LLC Buys 10 Shares of Amgen, Inc. (AMGN) #AMGEN INC  https://t.co/jkWXZb6a1m #NASDAQ#Amgen Release: New Analyses From Pivotal Phase 3 Studies Show Kyprolis (Carfilzomib) Allow... Read more: https://t.co/5kuEcTMUN5 $AMGN$AMGN:US St. Johns Investment Management Company LLC Buys 10 Shares of Amgen, Inc. (AMGN) #AMGEN INC  https://t.co/NZ9NPg6uqi #SP500$AMGN: Amgen announces scheduling of FDA AdCom for its biosimilar candidate to Humira https://t.co/BKrofvX0fm$AMGN Max Pain = 155.00. Maturity = 06/17/2016. Previous close = 154.78. bullish https://t.co/VWhprrsDL8 https://t.co/iBqfAi0xYHhttps://t.co/G9pMgSr1JY &lt; Review of this fantastic traders teaching service!! Try it for FREE! $LLY $DGX $MRK $NVS $AMGN$AMGN $ABBV:

Ad Comm will review Amgen‚Äôs BLA for Humira biosimilar ABP 501 ‚Ä¶:

https://t.co/Xcl58yPFAAAd Comm will review Amgen's BLA for Humira biosimilar ABP 501; PDUFA date September 25 $AMGN $ABBV $NVS https://t.co/7QU8owl8o5Ad Comm will review Amgen's BLA for Humira biosimilar ABP 501; PDUFA date September 25 https://t.co/V3f1FFi94C $AMGN $ABBV $NVSAd Comm will review Amgen's BLA for Humira biosimilar ABP 501; PDUFA date September 25 https://t.co/WOkj5uibFV $AMGN $ABBV $NVSAd Comm will review Amgen's BLA for Humira biosimilar ABP 501; PDUFA date September 25 https://t.co/UoWEcJi7d0 $AMGN $ABBV $NVS$AMGN Amgen Announces FDA Advisory Committee Meeting To Review ABP 501, A Biosimilar Candidate To Adalimumab
From our Stock News Alerts App$AMGN:

Amgen (AMGN) Announces FDA Advisory Committee Meeting for ‚Ä¶:

https://t.co/Iy71r7zSRjNew Century Investment Management Inc. Boosts Stake in Amgen, Inc. $AMGN https://t.co/K4RlXjPtPp#Amgen : presents new data for Kyprolis in multiple myeloma at EHA. Read more: https://t.co/Si9J8N6GDP $AMGNTexas Permanent School Fund Sells 7,483 Shares of Amgen, Inc. $AMGN https://t.co/MFgUuHD3m4Wade G W &amp; Inc. Acquires 53 Shares of Amgen, Inc. $AMGN https://t.co/lAopu8Nu2FGlenmede Trust Co. NA Acquires 78,547 Shares of Amgen, Inc. $AMGN https://t.co/9grDwJy2K0AMGN Summary
See Here ---&gt; https://t.co/2M8MyRZmvc

$AMGN $TGNA $BAP #stockmarket$AMGN maturity 06/17/2016 oi CallPutRatio of 0.85 puts=8,485 calls=9,946 bullish. https://t.co/uxAK7XtWZz https://t.co/RU1Z93xRaBRT @ByJonGardner: Darzalex -- the Harvoni of 2016: https://t.co/od7XMfbFO3 $JNJ $AMGN $BMY $ABBV $CELGHere is What Might Shelter #Amgen Neurological Share $AMGN ‚ûú https://t.co/5Oix8AR7Zx https://t.co/P6HMsdhgZIAMGN Top news - Jun 13th, 2016 $AMGN https://t.co/AWuqhblJAd$AMGN $MRK:

Tricking the Common Cold Into Destroying Cancer:

https://t.co/uzoQmPnetPLast Week Was a Mixed Bag for the Biotech Sector $AMGN $BIIB $GILD $IBB https://t.co/wrXxghxk9iRT @CashRocket: TOP UPCOMING EVENTS IN 2016: $BIIB $VRTX $ESPR $MDCO $SCYX $PRTA $AMGN $CELG $KITE $INFI $GILD $ACOR $PTI $FGEN https://t.c‚Ä¶Why Amgen is a Strong Buy Right Now $AMGN ‚ûú https://t.co/m2wmKRqWQP https://t.co/olma7uXzFVRT @ByJonGardner: Darzalex -- the Harvoni of 2016: https://t.co/od7XMfbFO3 $JNJ $AMGN $BMY $ABBV $CELGAnalyst Actions and Breaking News $AAPL $AMGN $CTL $HIG $ICFI $KGC $MDVN $MNK #stocks https://t.co/j0MUiBrQrf https://t.co/bcUqLYsS3WRT @ByJonGardner: Darzalex -- the Harvoni of 2016: https://t.co/od7XMfbFO3 $JNJ $AMGN $BMY $ABBV $CELGRT @PinkSheetSutter: @US_FDA #biosimilar AdComm doubleheader! $AMGN's version of $ABBV's Humira 7/12, followed by 7/13 review of $NVS Sando‚Ä¶RT @WrigleyTom: Biotech Healthcare nLod
Losing early RS
some ugly candles
$IBB $JUNO $NVCR $SGEN
$HZNP $AMGN $RDUS $PRTA
$FPRX $NBIX $ACAD‚Ä¶$AMGN:

Why Amgen, Inc. (AMGN) is a Strong Buy Right Now:

https://t.co/cJV9EhHuJKRT @ByJonGardner: Darzalex -- the Harvoni of 2016: https://t.co/od7XMfbFO3 $JNJ $AMGN $BMY $ABBV $CELGRT @ByJonGardner: Darzalex -- the Harvoni of 2016: https://t.co/od7XMfbFO3 $JNJ $AMGN $BMY $ABBV $CELGRT @pelias01: 5 Attractive Biotechnology Stocks For Healthy, Long-Term Returns https://t.co/E96WmEyXwC $ABBV $AMGN $BIIB $CELG $JAZZ5 Attractive Biotechnology Stocks For Healthy, Long-Term Returns https://t.co/E96WmEyXwC $ABBV $AMGN $BIIB $CELG $JAZZRT @ByJonGardner: Darzalex -- the Harvoni of 2016: https://t.co/od7XMfbFO3 $JNJ $AMGN $BMY $ABBV $CELGDarzalex -- the Harvoni of 2016: https://t.co/od7XMfbFO3 $JNJ $AMGN $BMY $ABBV $CELGRT @fsgijh: Could @Amgen's results cement its position in acute #leukemia? https://t.co/cwF4YQ4GjZ $AMGNRT @WrigleyTom: Biotech Healthcare nLod
Losing early RS
some ugly candles
$IBB $JUNO $NVCR $SGEN
$HZNP $AMGN $RDUS $PRTA
$FPRX $NBIX $ACAD‚Ä¶RT @WrigleyTom: Biotech Healthcare nLod
Losing early RS
some ugly candles
$IBB $JUNO $NVCR $SGEN
$HZNP $AMGN $RDUS $PRTA
$FPRX $NBIX $ACAD‚Ä¶Could @Amgen's results cement its position in acute #leukemia? https://t.co/cwF4YQ4GjZ $AMGNLarge Cap Growth Stocks ‚Äì a study by Ruben Satink ‚Äì $AMGN $GILD $MYL¬†$TEVA https://t.co/U0VKUdbZQ8 https://t.co/944QWUEEwwRT @WrigleyTom: Biotech Healthcare nLod
Losing early RS
some ugly candles
$IBB $JUNO $NVCR $SGEN
$HZNP $AMGN $RDUS $PRTA
$FPRX $NBIX $ACAD‚Ä¶RT @WrigleyTom: Biotech Healthcare nLod
Losing early RS
some ugly candles
$IBB $JUNO $NVCR $SGEN
$HZNP $AMGN $RDUS $PRTA
$FPRX $NBIX $ACAD‚Ä¶RT @WrigleyTom: Biotech Healthcare nLod
Losing early RS
some ugly candles
$IBB $JUNO $NVCR $SGEN
$HZNP $AMGN $RDUS $PRTA
$FPRX $NBIX $ACAD‚Ä¶Biotech Healthcare nLod
Losing early RS
some ugly candles
$IBB $JUNO $NVCR $SGEN
$HZNP $AMGN $RDUS $PRTA
$FPRX $NBIX $ACAD $GILD $SRPT$AMGN high open interest range is 150.00 to 155.00 for option expiration 06/17/2016.  https://t.co/uxAK7XtWZz https://t.co/Qy9a6UyPTkRT @ScripDonnaDC: #FDA July 12 Arthritis Advisory Committee meeting for $AMGN's #biosimilar of $ABBV Humira 
https://t.co/PaR6AWwsUX
#biosi‚Ä¶Amgen, Inc. $AMGN Earns ‚ÄúHold‚Äù Rating from Bank of America https://t.co/ToAfm7ovIGAmgen, Inc. $AMGN Earns ‚ÄúHold‚Äù Rating from Bank of America https://t.co/OYBK76mImdAmgen, Inc. $AMGN Earns ‚ÄúHold‚Äù Rating from Bank of America https://t.co/e1NfPdWo3eRT @PinkSheetSutter: @US_FDA #biosimilar AdComm doubleheader! $AMGN's version of $ABBV's Humira 7/12, followed by 7/13 review of $NVS Sando‚Ä¶$AMGN $1 dividend payable to owners of record today!To Win The Investing Gambling Game Know The Cards And Terms Needed To Play https://t.co/jwvkjeijdL $AMGN $CLDT $CSCO $HOG $KO $NKE $SBUXTo Win The Investing Gambling Game Know The Cards And Terms Needed To Play https://t.co/k4cxYxb6iY $AMGN $CLDT $CSCO $HOG $KO $NKE $SBUXRT @ScripDonnaDC: #FDA July 12 Arthritis Advisory Committee meeting for $AMGN's #biosimilar of $ABBV Humira 
https://t.co/PaR6AWwsUX
#biosi‚Ä¶RT @PinkSheetSutter: @US_FDA #biosimilar AdComm doubleheader! $AMGN's version of $ABBV's Humira 7/12, followed by 7/13 review of $NVS Sando‚Ä¶#FDA July 12 Arthritis Advisory Committee meeting for $AMGN's #biosimilar of $ABBV Humira 
https://t.co/PaR6AWwsUX
#biosimilars #pharmaRT @PinkSheetSutter: @US_FDA #biosimilar AdComm doubleheader! $AMGN's version of $ABBV's Humira 7/12, followed by 7/13 review of $NVS Sando‚Ä¶@US_FDA #biosimilar AdComm doubleheader! $AMGN's version of $ABBV's Humira 7/12, followed by 7/13 review of $NVS Sandoz's #Enbrel copyIAU iShares Gold Trust Bid
https://t.co/DVPOwMybQr

$IAU $AMGN $IAU $TVIX  #invest #stockmarket$AMGN:

Amgen‚Äôs Results Could Cement Its Position In Acute Leukemia:

https://t.co/9T9uhnUMbmAmgen, Inc. $AMGN Stock Rating Reaffirmed by BMO Capital Markets https://t.co/nXa41fcNhnPremarket Biotech Digest: $MDCO Insider Buys, $EGRX Soars, $AMGN Announces Encouraging¬†Data https://t.co/la8T8y9u6DAmgen, Inc. $AMGN Stock Rating Reaffirmed by BMO Capital Markets https://t.co/M7c8JRClKFLeerink Swann Reiterates ‚ÄúMarket Perform‚Äù Rating for Amgen, Inc. $AMGN https://t.co/r7N698BjQNBiotech Trade Alerts Archive -2016-06-10- $OXGN, $CRBP, $JNJ, $GBT, $INCY, $BMY, $XLRN, $AMGN,¬†$MRK https://t.co/AW0yZVpYCLCYNO News
See Here ---&gt; https://t.co/R03CKxt13y

$CYNO $AMGN $TNDM #investAXTI American Xtal Technology Last Trade
https://t.co/zTbpif0GNU

$AXTI $CCXI $AMGN $LUV  #stock #shareAMGN Amgen, Inc. Stock Forum
https://t.co/WDFUACgSMx

$AMGN $CSCO $FUSVX $ELTP  #invest #stockmarketRT @Maximum_Pain_cm: $AMGN Max Pain = 155.00. Maturity = 06/17/2016. Previous close = 154.78. bullish https://t.co/VWhprrsDL8 https://t.co/‚Ä¶$AMGN Max Pain = 155.00. Maturity = 06/17/2016. Previous close = 154.78. bullish https://t.co/VWhprrsDL8 https://t.co/aaeoRW7cMHUUP PowerShares DB US Dollar Index Bullish Fund Market Cap
https://t.co/iP0VyDMEYY

$UUP $ARM.L $CDE $AMGN  #stocks #stockSBB.TO Sabina Silver Corp. Short Sales
https://t.co/hgEk44W037

$SBB.TO $NUGT $AMGN $TLT  #nasdaq #stockmarketCHK Chesapeake Energy Corp. Short Sales
https://t.co/vJa2Hist4I

$CHK $PUM.V $AMGN $SUNW  #stock #tradeideasAMGN Amgen, Inc. Market Cap
https://t.co/rY2RdT92z5

$AMGN $CNXT $LLOY.L $DB  #finance #stockmarket5 attractive #biotech #stocks for healthy Long-Term returns
$CELG
$JAZZ
$AABV
$AMGN
$BIIB
https://t.co/yAwHqp2fPC
#invest #nasdaq #financeAmgen, Inc. $AMGN Downgraded to Hold at Vetr Inc. https://t.co/cbnsHXYd3XAmgen announces exchange offers of Senior Notes $AMGN https://t.co/zxIftKJe1sRT @Maximum_Pain_cm: $AMGN maturity 06/17/2016 oi CallPutRatio of 0.83 puts=8,277 calls=10,000 bullish. https://t.co/uxAK7XtWZz https://t.c‚Ä¶$AMGN maturity 06/17/2016 oi CallPutRatio of 0.83 puts=8,277 calls=10,000 bullish. https://t.co/uxAK7XtWZz https://t.co/PFoC8kFB8qTEP Tallgrass Energy Partners, LP Change
https://t.co/YjUWHrKGji

$TEP $CNP $AMGN $PJC/A.TO  #finance #investRT @Sandro_power: $AMGN is setup for higher prices. My chart plan explains some key points. Confirmation is key https://t.co/8ppBC2oYUE",2016-06-13,AMGN,0
44,"EWY iShares MSCI South Korea Capped ETF Stock Message Board
https://t.co/VxTasGFLEo

$EWY $RSX $SQBG $AMGN  #investing #stockmarketAMGN Amgen, Inc. Tick
https://t.co/Yk6Yujt58h

$AMGN $EWY $XLV $DXD  #stock #investing$AMGN $AMZN $ANTMTop June Dividend Picks https://t.co/xUBVaf47gF ‚Ä¶ $AAPL #APPLE $ABBV $ABT $AFL $AMGN $AMZN $ANTM $BA $BDX $CAH $CRI https://t.co/pJxcmdGUvUSYF Synchrony Financial Change
https://t.co/3hRtJOU7Ht

$SYF $JNK $VTI $AMGN  #invest #tradeideas#Amgen The Motley Fool: Bonds better than stocks?. Read more: https://t.co/v4mE3amh89 $AMGNRT @Amgen: Today our CEO sat down with @CNBC‚Äôs @Megtirrell to discuss biotech innovation https://t.co/63Wl3HbmsC #Amgen $AMGN https://t.co/‚Ä¶$AMGN:US Amgen : FDA Panel To Review ABP 501, Biosimilar Candidate To Adalimumab #AMGEN INC  https://t.co/GDtlwOTQcU #NASDAQRT @Maximum_Pain_cm: $AMGN sum put oi=8,837 sum call oi=9,973 CallPutRatio=0.89 expiration 06/17/2016 bullish. https://t.co/uxAK7XtWZz http‚Ä¶RT @Amgen: Today our CEO sat down with @CNBC‚Äôs @Megtirrell to discuss biotech innovation https://t.co/63Wl3HbmsC #Amgen $AMGN https://t.co/‚Ä¶$AMGN sum put oi=8,837 sum call oi=9,973 CallPutRatio=0.89 expiration 06/17/2016 bullish. https://t.co/uxAK7XtWZz https://t.co/bTDZFXUS22Top June Dividend Picks https://t.co/ZLDlW0dMEt $AAPL #APPLE $ABBV $ABT $AFL $AMGN $AMZN $ANTM $BA $BDX $CAH $CRI $CSCO $DEO $DIS $FB $GDTop June Dividend Picks https://t.co/VQyoqx2H8p $AAPL #APPLE $ABBV $ABT $AFL $AMGN $AMZN $ANTM $BA $BDX $CAH $CRI $CSCO $DEO $DIS $FB $GD$AMGN:US Amgen : FDA Panel To Review ABP 501, Biosimilar Candidate To Adalimumab #AMGEN INC  https://t.co/IcQ3mWjil4 #SP500RT @Amgen: Today our CEO sat down with @CNBC‚Äôs @Megtirrell to discuss biotech innovation https://t.co/63Wl3HbmsC #Amgen $AMGN https://t.co/‚Ä¶Today our CEO sat down with @CNBC‚Äôs @Megtirrell to discuss biotech innovation https://t.co/63Wl3HbmsC #Amgen $AMGN https://t.co/MLgxL1u4KG$AMGN:

New SEC Filing for AMGN: Form 8-K (No. 0001193125-16-621372):

https://t.co/LVvLPsSB8C https://t.co/BtEjrjLvLX$AMGN ALERT: New Amgen SEC Filing
From our Stock News Alerts App#Amgen Announces FDA Advisory Committee Meeting To Review ABP 501, A Biosimilar Candidate T... Read more: https://t.co/MwUofcWyft $AMGNRT @JacobPlieth: Blincyto: the elephant in the room for CD19-directed CAR-T therapy $AMGN https://t.co/xXn4N05kXt #EHA2016 $KITE $NVS $JUNORT @FDAadcomm: Upcoming US #FDA Advisory Committee meetings $LLY $AMGN $ABBV $NVS $VRX #opioid Details at https://t.co/1EukYYc6HG https://t‚Ä¶Sii Investments Inc. WI Sells 289 Shares of Amgen, Inc. $AMGN https://t.co/CulasRbqMv$AMGN high open interest range is 150.00 to 155.00 for option expiration 06/17/2016.  https://t.co/uxAK7XtWZz https://t.co/FwfjIzixgpGranite Investment Partners LLC Holds Position in Amgen, Inc. $AMGN https://t.co/VAQESbe17bRT @FDAadcomm: Upcoming US #FDA Advisory Committee meetings $LLY $AMGN $ABBV $NVS $VRX #opioid Details at https://t.co/1EukYYc6HG https://t‚Ä¶Upcoming US #FDA Advisory Committee meetings $LLY $AMGN $ABBV $NVS $VRX #opioid Details at https://t.co/1EukYYc6HG https://t.co/eUp7xWRdcmFactory Mutual Insurance Co. Decreases Stake in Amgen, Inc. $AMGN https://t.co/Sh3YNrfUslRT @biosimilarz: $AMGN's adalimumab #biosimilar, ABP 501, gets AdCom date; https://t.co/NkVy4RxEIm CC @FDAadcommFactory Mutual Insurance Co. Decreases Stake in Amgen, Inc. $AMGN https://t.co/AmqJkwtpKsAMGN Top news - Jun 14th, 2016 $AMGN https://t.co/iI7SsnW7AR$AMGN is trading well below its historical PE and EV/EBITDA ratios https://t.co/Jc6DlNlJq9 #stocks #investing https://t.co/BAXqJEjEGZ@megtirrell $AMGN has 1541 current nephrology focused employees on Linkedin. Would they be interested in HK co $RLYP?
h/t @exMBBIs Dividend Growth Doomed To Slow? What You Can Do About It $SPY $IBB $AMGN $GILD $CELG $AAPL $CSCO $GOOG $FB $NKE https://t.co/ROB0yBMXyURT @trendcache: Trending #Biotech topics include $AMGN, $SCRC, $MRK #stocks #invest See more https://t.co/EpbbdqDEG1megtirrell: Up next from #PJCHeartland: $AMGN CEO Bob Bradway. What do you want to know?Up next from #PJCHeartland: $AMGN CEO Bob Bradway. What do you want to know?EHA - #CAR-T Has $AMGN #Blincyto Breathing Down Its Neck who has $AFMD #AFM11 crawling up its Neck ;) https://t.co/hgBbxlLBUI $AMGNHey, that's my birthday! $AMGN https://t.co/z3f9VGTuXe$AMGN Max Pain is 155.00 for maturity 06/17/2016. Price = 153.08. bullish https://t.co/VWhprrsDL8 https://t.co/lM7W1aUYH1$AMGN's #biosimilar Humira gets an @US_FDA Advisory committee meeting -- PDUFA date is Sept. 25 https://t.co/CzAuWqJtJ0$AMGN:

Amgen‚Äôs Biosimilar of AbbVie‚Äôs Humira to Face FDA Panel:

https://t.co/6pk7ArMFUpZiarco $pfe $amgn https://t.co/QRrxeqPQNy$AMGN:US Amgen : FDA Panel To Review ABP 501, Biosimilar Candidate To Adalimumab #AMGEN INC  https://t.co/pU8N4fjY7M #NASDAQ#StockNews ‚Äï REPORT: Pfizer-backed biotech Ziarco is exploring a sale: $PFE $AMGN https://t.co/J87TKGDKYY ‚Üí via @AlertTradeREPORT: Pfizer-backed biotech Ziarco is exploring a sale: https://t.co/pz2yAbkPdX $PFE $AMGNRT @megtirrell: We're live @ Piper Jaffray Heartland Summit today! Tune in for interviews with $MDT $AMGN starting on @SquawkStreet https:/‚Ä¶RT @Sandro_power: $AMGN is setup for higher prices. My chart plan explains some key points. Confirmation is key https://t.co/8ppBC2oYUERT @megtirrell: We're live @ Piper Jaffray Heartland Summit today! Tune in for interviews with $MDT $AMGN starting on @SquawkStreet https:/‚Ä¶RT @megtirrell: We're live @ Piper Jaffray Heartland Summit today! Tune in for interviews with $MDT $AMGN starting on @SquawkStreet https:/‚Ä¶RT @megtirrell: We're live @ Piper Jaffray Heartland Summit today! Tune in for interviews with $MDT $AMGN starting on @SquawkStreet https:/‚Ä¶megtirrell: We're live @ Piper Jaffray Heartland Summit today! Tune in for interviews with $MDT $AMGN starting on ‚Ä¶ https://t.co/1zShXBrVmkWe're live @ Piper Jaffray Heartland Summit today! Tune in for interviews with $MDT $AMGN starting on @SquawkStreet https://t.co/GODJsL9EqoRT @PinkSheetSutter: @US_FDA #biosimilar AdComm doubleheader! $AMGN's version of $ABBV's Humira 7/12, followed by 7/13 review of $NVS Sando‚Ä¶EHA - CAR-T Has Blincyto Breathing Down Its Neck https://t.co/Leh1VNtZDv $AMGNEHA - CAR-T Has Blincyto Breathing Down Its Neck https://t.co/PFS896gwJk $AMGNTo Win The Investing Gambling Game Know The Cards And Terms Needed To Play https://t.co/bb4yQdpOo6 $AMGN $CLDT $CSCO $HOG $KO $NKE $SBUXIs Dividend Growth Doomed To Slow? What You Can Do About It https://t.co/b13ETAVXe7 $AAPL $AMGN $ANCTF $ANCUF $BBL $BHP $BIIB $CELG $CSCOFDA advisory committee to review #Amgen's BLA for adalimumab biosimilar. Read more: https://t.co/Ah4f5cHUHW $AMGNFDA to review data on #Amgens Humira biosimilar. Read more: https://t.co/TSjt9m5lvi $AMGNLeerink Swann Reaffirms Market Perform Rating for Amgen, Inc. $AMGN https://t.co/534fjIyoIU#ASCO16 - a Q does #pharma loose $$$ in either case or market? Probably not! #financialtoxicity $BMY  $PFE $AMGN https://t.co/x7Uex0c5McLeerink Swann Reaffirms Market Perform Rating for Amgen, Inc. $AMGN https://t.co/cnTZcX6iEYIs Dividend Growth Doomed To Slow? What You Can Do About It https://t.co/sGpAnhQh0U $AAPL #APPLE $AMGN $ANCTF $ANCUF $BBL $BHP $BIIB $CELGIs Dividend Growth Doomed To Slow? What You Can Do About It https://t.co/fxJATQbQZH $AAPL #APPLE $AMGN $ANCTF $ANCUF $BBL $BHP $BIIB $CELGSandoz #Enbrel Copycat Next #Biosimilar To Get Panel Treatment 
$NVS #GP2015 $AMGN #FDA https://t.co/QrRiVFNiJrRT @Maximum_Pain_cm: $AMGN maturity 06/17/2016 oi CallPutRatio of 0.89 puts=8,837 calls=9,973 bullish. https://t.co/uxAK7XtWZz https://t.co‚Ä¶$AMGN maturity 06/17/2016 oi CallPutRatio of 0.89 puts=8,837 calls=9,973 bullish. https://t.co/uxAK7XtWZz https://t.co/bItNa9XegP$AMGN:US Amgen : FDA Panel To Review ABP 501, Biosimilar Candidate To Adalimumab #AMGEN INC  https://t.co/Y1pYPqFbSZ #SP500$AMGN started a new Phase I trial (NCT02792517) to study the interaction between AMG 334 and oral contraceptive drugs in healthy females.FDA Advisory Committee Meeting To Review ABP 501, A Biosimilar Candidate To Adalimumab $AMGN https://t.co/GN59YUdVZCAmgen‚Äôs $AMGN ‚ÄúOutperform‚Äù Rating Reiterated at BMO Capital Markets https://t.co/5Rsure6YAQAmgen‚Äôs $AMGN ‚ÄúOutperform‚Äù Rating Reiterated at BMO Capital Markets https://t.co/qA1OhCGHL4AbbVie - European Ombudsman Report Moot https://t.co/UnnoHCyLRc $ABBV, $ABT, $AMGN, $BMY, $GILD, $GSK, $JNJ, $LLY, $MRK, $NVS, $PFEEsperion Therapeutics: Why IMPROVE-IT Hasn't Cast A Shadow Over ETC-1002 https://t.co/ky4MVpcfXW $AMGN $MRK $REGN $SNY $ESPR$ABBV $AMGN $BMY:

AbbVie ‚Äì European Ombudsman Report Moot:

https://t.co/VxYF5qJMthAbbVie - European Ombudsman Report Moot https://t.co/AbpTu6Gom2 $ABT $AMGN $BMY $GILD $GSK $JNJ $LLY $MRK $NVS $PFE $ABBVRT @lancejepsen: Analyst Actions and Breaking News $AAPL $AMGN $CTL $HIG $ICFI $KGC $MDVN $MNK #stocks https://t.co/j0MUiBrQrf https://t.co‚Ä¶RT @biosimilarz: $AMGN's adalimumab #biosimilar, ABP 501, gets AdCom date; https://t.co/NkVy4RxEIm CC @FDAadcommEsperion Therapeutics: Overview Of The Risks Posed To ETC-1002's Efficacy https://t.co/LmYOecYXzG $PFE $BMY $MRK $TKPYY $ESPR $AMGN$AMGN's adalimumab #biosimilar, ABP 501, gets AdCom date; https://t.co/NkVy4RxEIm CC @FDAadcommAmgen, Inc. $AMGN Upgraded to Buy by Vetr Inc. https://t.co/6zEVSTrRSg$AMGN:US Amgen : FDA Panel To Review ABP 501, Biosimilar Candidate To Adalimumab #AMGEN INC  https://t.co/c5NR02lQu1 #NASDAQ#Amgen: FDA Panel To Review ABP 501, Biosimilar Candidate To Adalimumab. Read more: https://t.co/AQLQzXb4s7 $AMGNVetr users have upgraded Amgen Inc. to a BUY Rating (3.5 stars), giving $AMGN a target price of $159.50 https://t.co/sgyPwK93LkFDA to discuss #Amgen's Humira biosimilar. Read more: https://t.co/zI82Mbyf0m $AMGNVetr Inc. Upgrades Amgen, Inc. $AMGN to ‚ÄúBuy‚Äù https://t.co/K48usW9pAJVetr Inc. Upgrades Amgen, Inc. $AMGN to ‚ÄúBuy‚Äù https://t.co/Vbxtnnl5KoVetr Inc. Upgrades Amgen, Inc. $AMGN to ‚ÄúBuy‚Äù https://t.co/5CT3be9sfVAmgen upgraded by Vetr Inc. to buy. $159.50 PT. https://t.co/2H2ub2DU7z $AMGN #AMGNRT @Datamonitor_IG: $NVS and $AMGN announce #AMG334 (erenumab) significantly
reduces patients' monthly migraine days in Phase II chronic mi‚Ä¶$AMGN high open interest range is 150.00 to 155.00 for option expiration 06/17/2016.  https://t.co/uxAK7XtWZz https://t.co/tl7dYepGYk$AMGN FDA has set a Biosimilar User Fee Act (BsUFA) target action date of Sept. 25, 2016 for ABP 501.$AMGN announces scheduling of FDA AdCom for its biosimilar candidate to HumiraRT @DailyStockPlays: MACD Bearish https://t.co/WwSUPePCZN $SHW $MHK $MSTR $AMGN $ICPT $IWV $RNR $VGT $VUG $IYW $IWD $CELG $IXJ $IWF $TQQQ $‚Ä¶MACD Bearish https://t.co/WwSUPePCZN $SHW $MHK $MSTR $AMGN $ICPT $IWV $RNR $VGT $VUG $IYW $IWD $CELG $IXJ $IWF $TQQQ $ITOT $VSS#Amgen Announces FDA Advisory Committee Meeting To Review ABP 501, A Biosimilar Candidate T... Read more: https://t.co/MorSIRcv2S $AMGN",2016-06-14,AMGN,0
45,"RT @lancejepsen: Analyst Actions and Breaking News $AAPL $AMGN $CTL $HIG $ICFI $KGC $MDVN $MNK #stocks https://t.co/j0MUiBrQrf https://t.co‚Ä¶@exMBB getting ready to buy $kite? $amgnIWM iShares U.S. Real Estate ETF Last Trade
https://t.co/1m9yf5eJlJ

$IWM $EWS $AMGN $BSPM  #investing #stockmarketIPI Ingersoll-Rand Plc E.P.S.
https://t.co/mi921lMkmW

$IPI $EWS $AMGN $WYNN  #share #shareAmgen‚Äôs $AMGN Market Perform Rating Reiterated at Leerink Swann https://t.co/yAFJbWPgH7GG Gilead Sciences, Inc. Investor Opinions
https://t.co/eW4zCrgVKI

$GG $AMGN $IAE $ACIA  #share #pennystocksRT @ezzmoney2day: CPB Campbell Soup Co. Investor Opinions
https://t.co/e3VVYNUgMO

$CPB $UPRO $AMGN $NKE  #share #stocksCPB Campbell Soup Co. Investor Opinions
https://t.co/e3VVYNUgMO

$CPB $UPRO $AMGN $NKE  #share #stocksCHK Chesapeake Energy Corp. Chart
https://t.co/dQ26mdZjeA

$CHK $AMGN $GRCU $LABD  #stock #shareYesterday $AMGN refinanced $3.8B of debt, pushing out maturity by 10 yrs. And raised add'l $1.1B in new debt. Hmm... https://t.co/TyuT9bAfcR$AMGN:US Vetr Inc. Upgrades Amgen, Inc. (AMGN) to Buy #AMGEN INC  https://t.co/VXgMJy3wzZ #NASDAQFXI Galena Biopharma, Inc. Tick
https://t.co/51MqsPEw1S

$FXI $AMGN $TBT $XIV  #stockmarket #stockmarketVetr users have upgraded Amgen Inc. to a STRONG BUY Rating (4.5 stars), giving $AMGN a target price of $172.76 https://t.co/sgyPwK93LkAMGN American Manganese Inc Bid
https://t.co/mnrUOyHLLN

$AMGN $INFI $AMD $HAL  #stockmarket #stock$ADAP @Adaptimmune Therapeutics

$MDT $BSX $TMO $EW $DXCM $IDXX $NVTA $AMGN $SNY $LLY $BAYRY $GILD $BIIB $CELG $REGN https://t.co/n0u1iP7r2x$AMGN not afraid 2 make ""bigger deals"" while stay disciplined. Last was $1.5B 4 Dezima Ph2b. https://t.co/JxTCJtM1Ha https://t.co/SgnE94TcEQRT @BiotechGems: 3 Safe Dividend Stocks with Pristine Balance Sheets https://t.co/b7HH2TPieb $AAPL $AMGN $GILD $M via @InvestorsAlleyCVX Chevron Corp. Last Trade
https://t.co/AV3j3t0YQV

$CVX $WIN.TO $SN $AMGN  #nasdaq #financeBMY Bristol Myers Squibb Co. Message Board Posts
https://t.co/DaKfvTRXBE

$BMY $GG $VEU $AMGN  #stocks #nasdaq$AMGN:

Amgen CEO: Volatile climate impacts deals ‚Äì CNBC:

https://t.co/oW0uBi6BpeAMGN Amgen, Inc. Message Board Posts
https://t.co/54VFnyM3dz

$AMGN $TREE $SDS $DLPH  #pennystocks #tradeideas| $AMGN | Open : 152.74 High : 153.48 Low : 151.64 Close : 152.99 Volume : 2.1M Change : -0.09 (-0.06%)RT @Maximum_Pain_cm: $AMGN Max Pain is 155.00 for maturity 06/17/2016. Price = 153.08. bullish https://t.co/VWhprrsDL8 https://t.co/nFa2d7Z‚Ä¶$AMGN Max Pain is 155.00 for maturity 06/17/2016. Price = 153.08. bullish https://t.co/VWhprrsDL8 https://t.co/nFa2d7Z1i8DB Deutsche Bank AG Ask
https://t.co/V7y5jeqkBg

$DB $BSPM $AMGN $SUPN  #finance #tradeideasTo Win The Investing Gambling Game Know The Cards And Terms Needed To Play https://t.co/PZwyPchbNg $AMGN $CLDT $CSCO $HOG $KO $NKE $SBUXAMGN Amgen, Inc. Quotes
https://t.co/gjMZEcFnZT

$AMGN $DBC $GILD $XLE  #pennystocks #pennystocks$AMGN - SELL Signal at 152.99 on Jun 14, 16 By https://t.co/6PpjiKmc9G Trading Robot #Stockstowatch #Stockmarket #trading #trade #investingRT @stockfollower4u: GLDD Stock Forum
See Here ---&gt; https://t.co/2CdjpGzEnW

$GLDD $AMGN $ROST #stocksGLDD Stock Forum
See Here ---&gt; https://t.co/2CdjpGzEnW

$GLDD $AMGN $ROST #stocksRT @Amgen: Today our CEO sat down with @CNBC‚Äôs @Megtirrell to discuss biotech innovation https://t.co/63Wl3HbmsC #Amgen $AMGN https://t.co/‚Ä¶Filled Bearish https://t.co/sM5JpCfSHB $AAC $AAV $ABG $ACIW $ADX $ALV $AMGN $AMKR $AMRN $ANTX $AOS $APPY $ARLZ $ASML $ASR $ATHN $AUDCGS Goldman Sachs Group, Inc. Ex-Div Date
https://t.co/Ggx8CV0KFX

$GS $NG $COP $AMGN  #invest #stocks",2016-06-15,AMGN,1
